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Abstract 
Cancer and anxiety/depression commonly occur as co-morbid conditions, leading to 
poorer health and illness outcomes as well as reduced quality of life in those affected. 
However, currently too little is understood about the impact of this combination of illnesses. 
In order to determine how people with cancer and anxiety/depression can be best supported to 
improve health and illness outcomes, as well as to identify what supports and services they 
may need, it is important to understand the psychological processes underlying coping 
behaviours and illness outcomes for people with each illness separately and for those with 
combinations of cancer and anxiety/depression. This thesis therefore aimed to firstly examine 
how the illness representations of people with cancer (Study 1) and of people with depression 
(Study 2) separately influenced coping responses and illness outcomes. Secondly, this thesis 
aimed to examine how having a combination of cancer and anxiety/depression would 
influence illness representations, coping and self-management behaviours, and support needs 
(Study 3), as well as how such support needs might differ across cancer patients with varying 
histories of anxiety/depression (Study 4). 
The leading psychological model of self-regulation in the face of illness is 
Leventhal’s Common Sense Model of health and illness (CSM), which assumes that people 
form and access subjective representations of their illness based on common-sense 
assumptions. These idiosyncratic representations then guide individual coping attempts and 
processes. The CSM’s illness representation dimensions have been found to be reliably 
associated with coping and outcomes for a variety of chronic illnesses. However, although 
several studies have investigated these relationships in people with cancer, no systematic 
review and meta-analysis to summarise these associations had yet been conducted. The same 
lack of a systematic overview of the evidence was also found for anxiety/depression.  
Based on these existing gaps in the literature, two separate systematic reviews and meta-
ix 
analyses were conducted to determine the strength and direction of the relationships between 
illness representations and coping behaviours as well as illness outcomes in people with 
cancer (Study 1) and in people with depression (Study 2). The systematic literature search for 
Study 1 located 54 studies, with 38 providing sufficient data for meta-analysis and 16 
narratively reviewed, while the literature search for Study 2 located 19 studies, with 10 
included in the meta-analysis and nine narratively reviewed. During the systematic review 
process for Study 2 only one study examining illness representations in people with anxiety 
was located, making a review of people with anxiety impossible. Both reviews found 
substantial relationships between illness representations and coping as well as illness 
outcomes, with findings suggesting that for people with cancer and for people with 
depression, higher identity (more symptoms), a more chronic and cyclical timeline, more 
severe consequences, less personal and treatment control, less illness coherence, and stronger 
emotional representations were associated with maladaptive coping strategies and increased 
psychological distress. 
This evidence base served as a starting point for the second set of studies in this 
thesis. As cancer and anxiety/depression commonly co-occur, whether and how the CSMs 
illness representation dimensions were associated with coping and outcomes in people with 
multimorbid cancer and anxiety/depression was explored. As no research had yet investigated 
the multimorbid representations of people with cancer and anxiety/depression specifically, 
Study 3 included 21 semi-structured interviews and used theoretical thematic analysis to 
examine the structure and content of individual’s representations of co-morbid cancer and 
anxiety/depression, as well as how these related to coping and self-management. This study 
found that participants most often perceived their cancer and anxiety/depression as related, 
with these interactions often considered causal (albeit with heterogeneity in which illness 
caused the other). In terms of illness representations, personal control and illness coherence 
x 
emerged as important determinants of illness behaviour, with these representations shown to 
have both positive and negative influences on coping and self-management. These results 
suggested that better understanding of multimorbid representations by health professionals 
have the potential to lead to improved self-management strategies and health care interactions 
for people with cancer and anxiety/depression. As Study 3 began to identify differing support 
needs across people with cancer and anxiety/depression, Study 4 used inductive thematic 
analysis on data obtained from 21 semi-structured interviews to examine how the existing 
needs and supports of this population differed based on experiences of varied histories of 
anxiety/depression (e.g., episodic versus long-term). This study found important differences 
across cancer patients with varying histories of anxiety/depression, with people who had a 
history of long-term anxiety/depression that was not associated with cancer generally coping 
better, experiencing less fear of cancer recurrence, and requiring less support from hospitals 
and support services. These results highlight a need for both researchers and health 
professionals to give more consideration to the origin and history of a cancer patient’s 
anxiety/depression in order to facilitate better coping and improve and increase appropriate 
support provision across cancer diagnosis, treatment, and survivorship. 
Overall, across the research in this thesis, subjective illness representations such as 
personal control, consequences, timeline, and illness coherence, have been found to be 
important predictors of coping behaviours, self-management strategies, and illness outcomes 
in people with cancer, people with depression, and people with co-morbid cancer and 
anxiety/depression, supporting the importance of the CSM as a theoretical basis from which 
to explore such representations. Further, multimorbid representations such as combined or 
competing causal representations, prioritisation of a perceived most challenging illness, 
beliefs about fear of cancer recurrence, and synergies/antagonisms in the management of 
illnesses, were found to be associated with self-management strategies and illness outcomes 
xi 
in people with co-morbid cancer and anxiety/depression, with the support needs of these 
people found to vary based on their history with anxiety/depression.  
The discovery of these multimorbid illness representations suggests that the CSM 
may need to be adapted to be more appropriate for people with multiple illnesses. These 
findings also highlight the need for future research to trial interventions aimed at changing 
incorrect or maladaptive representations for people with cancer, people with depression, and 
people with both cancer and anxiety/depression. At the same time, the findings of this thesis 
highlighted the role of support providers in improving outcomes for people with cancer and 
anxiety/depression, suggesting a need for increased understanding of illness representations 
and illness history by providers, improved communication between patients and health 
professionals, and increased support provision and access to psycho-oncological services for 
patients. 
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Cancer Prevalence and Associated Outcomes  
Worldwide there were approximately 14 million new cancer cases in 2012, with 
almost 32.5 million cancer patients/survivors within the first five years of their diagnosis 
(International Agency for Research on Cancer & World Health Organisation, 2014). In 
Australia, cancer is one of the most commonly experienced diseases, with the risk of 
receiving a cancer diagnosis before the age of 85 years one in two for males and one in three 
for females (Cancer Australia, 2016). With regard to cancer prevalence, in Australia in 2012 
there were 122,093 new cancer cases diagnosed at an age-standardised incidence rate of 485 
cases per 100,000 people (Australian Institute of Health and Welfare [AIHW], 2016), with 
this number expected to grow to an estimated 130,466 people in 2016 (Cancer Australia, 
2016). In terms of mortality, although 44,108 people died from cancer in 2013, the age-
standardised mortality rate for all cancers has fallen by approximately 20% from 1982 to now 
(AIHW, 2014). The reasons for this drop in mortality are mainly attributed to increases in 
early detection rates and improved treatment methods (Alfano & Rowland, 2006; Stewart & 
Wild, 2014). Because of these advances and the associated drop in mortality rates, people 
with cancer are now living longer, with 1.7% of the Australian population, or 370,474 people, 
living with cancer at the end of 2009 (after being diagnosed in the previous five years). 
Furthermore, 67% of people diagnosed with cancer are now surviving for at least five years’ 
post-diagnosis (between 2007-2011; AIHW, 2014), with better psychosocial support needed 
to improve the outcomes for these cancer patients and survivors. 
The improved survival rate for people diagnosed with cancer means that a 
considerable proportion of the Australian population live with the continued effects of cancer. 
These effects include both physical post-treatment side effects and mental health problems 
such as fatigue, poor role and physical functioning, psychological distress, cognitive 
impairment, anxiety, depression, fear of cancer recurrence, and a poorer quality of life 
3 
(Ahles, Root, & Ryan, 2012; Edwards & Clarke, 2004; Harrington, Hanse, Moskowitz, Todd, 
& Feuerstein, 2010; Simard et al., 2013; Singer, Das-Munshi, & Brähler, 2010; Stein, Syrjala, 
& Andrykowski, 2008). Further, these poor mental and physical health outcomes are often 
long-term (Stein et al., 2008). One systematic review for example found that survivors 
experienced poor outcomes for up to ten years post diagnosis (Harrington et al., 2010). To 
both cope with and self-manage these outcomes is an extraordinary challenge for cancer 
patients and survivors. However, the use of particular adaptive coping strategies, such as 
cognitive reappraisal and problem-focused coping, can improve adjustment to cancer 
(O'Brien & Moorey, 2010). Further, productive and proactive self-management strategies can 
be facilitated by appropriate self-management interventions and partnerships between 
patients and health care providers. Such self-management strategies have been found to 
decrease symptom distress and uncertainty, and improve communication and quality of life 
(McCorkle et al., 2011). However, the effectiveness of such interventions could be improved 
by better matching them with people’s needs, their ideas about their illnesses, and their 
subjective understanding of their illnesses, as cancer-related perceptions have been found to 
influence coping responses and illness outcomes (e.g., treatment decision making: Kendel et 
al., 2016). This thesis therefore provides an examination of the dimensions and parameters of 
these subjective ideas, perceptions, understandings, and needs in people with cancer and 
anxiety/depression. 
Co-morbid Cancer and Anxiety/Depression 
Nearly all people with cancer experience some psychological distress after being 
diagnosed and throughout their treatment. However, for many this distress is short-term, 
meaning that when they recover from their cancer they are likely to re-gain psychological 
health and equilibrium, with few significant long-term effects experienced (Stein et al., 
2008). For others, however, the cancer experience can lead to more severe psychological 
4 
impairment, which is evident in the high number of diagnoses of mental illnesses in cancer 
patients. The most prominent of these co-morbid mental illnesses are anxiety and depression. 
However, reported prevalence rates vary due to differing conceptualisations of illness, 
measurement techniques, and populations of interest (Massie, 2004; Pasquini & Biondi, 
2007). An examination of the prevalence rates of depression amongst people with cancer in 
60 studies found prevalence rates ranging up to 52%, stating that the association between 
cancer and high levels of depression is beyond doubt (Massie, Lloyd-Williams, Irving, & 
Miller, 2011). Although rates of anxiety amongst people with cancer also vary, it has been 
suggested that anxiety co-occurs with cancer at an equivalent or greater rate than depression 
(Mystakidou et al., 2005; Roy-Byrne et al., 2008).  
Both anxiety and depression in cancer patients can be specifically associated with the 
cancer itself, or relate to pre-existing anxiety or depression (Fulcher, Kim, Smith, & Sherner, 
2014; Jacobsen, Donovan, Swaine, & Watson, 2006; Mehta & Roth, 2015; Stark & House, 
2000). More specifically, sources of anxiety and depression amongst cancer patients include 
pre-existing diagnoses (mental illness predating a cancer diagnosis) that may be re-activated 
or exacerbated by the cancer experience, acute or chronic reactions to the diagnosis of cancer, 
the disruption of life plans, adverse responses to cancer symptoms or treatment side-effects, 
the effect of treatment on the central nervous system, reduced quality of life, and fears 
associated with cancer progression or recurrence (Jacobsen et al., 2006). Experiences of 
depression and anxiety are not limited to the active treatment stage of the cancer process but 
often persist for months or years post treatment. A key source of this long-term anxiety 
and/or depression is greater stress and burden associated with the cancer experience, coupled 
with a lack of available resources (Stein et al., 2008). 
As cancer is often associated with coping difficulties and poor health outcomes, it can 
be assumed that an additional diagnosis of anxiety and/or depression would only increase 
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such coping difficulties and compound poor outcomes. Research supports this assumption, 
with co-morbid cancer and anxiety/depression found to be associated with poorer social, 
emotional, and role functioning, adherence to treatment, and several domains of quality of 
life (including overall) (L. F. Brown, Kroenke, Theobald, Wu, & Tu, 2010; Mystakidou et al., 
2005; Pasquini & Biondi, 2007). With regard to employment, co-morbid cancer and 
anxiety/depression have been associated with an increase in disability days (days in bed or 
with a >50% reduction in work/usual activities) and with an inability to work (Kroenke et al., 
2010). Perhaps the most concerning findings for this population are however that co-morbid 
depression can predict elevated mortality (Pinquart & Duberstein, 2010; Satin, Linden, & 
Phillips, 2009), increase the risk of suicide (Misono, Weiss, Fann, Redman, & Yueh, 2008; 
Robinson, Renshaw, Okello, Moller, & Davies, 2009; Robson, Scrutton, Wilkinson, & 
MacLeod, 2010), and increase the desire for hastened death by up to four times in terminally 
ill cancer patients (Breitbart, Rosenfeld, Pessin, & et al., 2000). 
In order to increase adaptive coping responses and improve the poor health outcomes 
associated with the co-morbid experience of cancer and anxiety/depression, we need to learn 
more about the factors that are influencing these outcomes, with people’s cognitive 
representations of illness (understanding of their illnesses) one such influencing factor. A 
better understanding of these cognitive representations can provide a greater insight into how 
people think about and experience their illnesses. In addition to this, an examination of how 
these cognitive representations may influence the coping and self-management of, as well as 
the illness outcomes associated with, cancer and anxiety/depression is needed. This new 
knowledge could in turn lead to improvements in current interventions, or the development of 
new effective support measures and future interventions that improve the health and well-
being of people with these illnesses. This appears to be an area in need of innovation, as 
current evidence from systematic and meta-analytic reviews have mixed outcomes and 
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disparate conclusions regarding the effectiveness of interventions for cancer patients with 
psychological distress, anxiety, and depression (Galway et al., 2012; Jacobsen & Jim, 2008; 
Lepore & Coyne, 2006). This thesis will therefore attempt to examine the relationships 
between cognitive representations and illness outcomes in people with cancer and 
anxiety/depression with a view to improving future interventions. 
The Common Sense Model of Health and Illness 
The most widely used model of the psychological processes underlying coping 
behaviours and health outcomes in people with chronic illness is the Common Sense Model 
of Self-Regulation of Health and Illness (CSM; Leventhal, Meyer, & Nerenz, 1980). The 
CSM aims to explain how people understand and respond to a health threat or illness. The 
model conceptualises an individual as an active problem solver who is required to manage 
two phenomena in parallel, their perceptions or representations of a health threat (e.g., 
symptoms, being told that something is wrong by a doctor, or encountering an advertisement 
related to an illness) or illness (what is this health threat or illness, and what can I do about 
it), and their associated emotional responses to that health threat or illness (how do I feel 
about the health threat or illness and how can I feel better about it) (Diefenbach & 
Leventhal, 1996). The model is hierarchically organised, with three main constructs: illness 
representations, coping responses, and appraisal. Illness representations, people’s 
interpretation of or beliefs about a health threat or illness, and emotional responses, are 
formed based on existing schemata including current and past illness experience, information 
from the external social environment, and general knowledge (Leventhal et al., 1980). These 
cognitive representations, as well as their associated emotional responses, work in parallel to 
guide coping responses and self-management strategies, which are later appraised in terms of 
their success or failure in controlling the health threat and its consequences (Hale, Treharne, 
& Kitas, 2007). Outcome appraisals then lead to the refinement of one’s illness 
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representations, as well as the selection of new coping and management strategies 
(Diefenbach & Leventhal, 1996). The CSM includes illness representations, coping 
responses, and appraisal, as part of a multi-directional and self-regulative feedback loop (see 
Figure 1.1), meaning that these processes are subject to change and evolution over time 
(Leventhal, Leventhal, & Contrada, 1998). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. The common sense model of self-regulation of health and illness (Leventhal et 
al., 1980), adapted from Diefenbach and Leventhal (1996). 
 
 
Illness Representations 
The key construct within the CSM are subjective illness representations (sometimes 
referred to as illness perceptions), defined as individual’s lay beliefs about illness. This 
means that rather than being accurate and correct, these representations encompass what 
people understand about the illness and what they believe to be accurate and correct. These 
representations are how people make sense of their illness, and according to the theory, they 
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explain how individuals attempt to cope with their illness (Hale et al., 2007; Leventhal et al., 
1998; Leventhal et al., 1980). The model proposes several distinct illness representation 
dimensions: identity, cause, timeline (acute/chronic), timeline (cyclical), consequences, 
curability/controllability, personal control, treatment control, illness coherence, and 
emotional representations (Diefenbach & Leventhal, 1996; Leventhal et al., 1998; Leventhal 
et al., 1980; Moss-Morris et al., 2002). Identity refers to the label or name of the health threat 
or illness (e.g., cancer) and its symptoms (e.g., weight loss). Cause refers to the perceived 
cause of the health threat or illness (e.g., poor diet). Timeline refers to beliefs about the length 
of illness development, duration, and recovery (e.g., acute or chronic). Consequences (both 
imagined and real) refers to beliefs about the anticipated repercussions associated with the 
health threat or illness (e.g., financial hardship). Curability or Controllability refers to the 
perceived belief about the extent to which the health threat or illness can be prevented, 
controlled, prevented from progressing, or cured, by themselves or by others (e.g., 
controllable and curable with medication) (Diefenbach & Leventhal, 1996; Leventhal et al., 
1998).  
Later revisions of the illness representation dimensions proposed that control beliefs 
could be separated into two distinct dimensions: personal control – the amount of control an 
individual perceives that they personally have over the health threat or illness, and treatment 
control - the amount of control an individual perceives their treatment has over the health 
threat or illness. These revisions also included a distinct dimension for cyclical timeline 
perceptions, as well as an illness coherence dimension referring to the extent to which an 
individual demonstrates coherent understanding of the health threat or illness (e.g., confused 
by symptoms), and an emotional representations dimension that refers to an individual’s 
emotional responses to the health threat or illness (e.g., anxious) (Moss-Morris et al., 2002). 
The Illness Perception Questionnaire (IPQ; Weinman, Petrie, Moss-Morris, & Horne, 1996), 
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the Revised Illness Perception Questionnaire (IPQ-R; Moss-Morris et al., 2002), and the 
Brief Illness Perception Questionnaire (B-IPQ; Broadbent, Petrie, Main, & Weinman, 2006), 
are the most widely used instruments to assess these illness representations. The IPQ-R has 
demonstrated acceptable test-retest reliability at three weeks and six months, sound 
discriminant and predictive validity, and good internal reliability, with Cronbach alpha’s 
ranging between .79 and .89 across subscales (Moss-Morris et al., 2002). 
The CSM in Practice 
How individuals’ illness beliefs may influence the way in which they cope with and 
manage a health threat or illness can be explained by the CSM. For example, when 
experiencing a health threat such as a headache, a person will automatically attempt to find 
the location of the pain and try to establish its cause (accessing illness representations), 
considering factors like the sharpness of the pain, dehydration, or whether a similar pain has 
been experienced previously. How this person will then cope with and treat the headache 
depends on the answers to these questions. Potential outcomes include visiting a doctor or 
health professional (for example, if they interpret the pain to be a symptom of an underlying 
illness), taking pain relieving medication (for example, if they know they are prone to a 
headache when they have slept badly), asking for advice from a friend or family member (for 
example, if they have a friend who has medical training), increasing hydration (for example, 
if they have read that dehydration can lead to headaches), or waiting to see whether the pain 
subsides on its own (for example, if this strategy was effective previously). This evaluation 
and decision-making process is influenced by three key sources of information, bodily 
experiences (e.g., the location of the headache), information based on previous experiences 
with illness (e.g., a previous diagnosis of cancer), and information gathered from the external 
social environment (e.g., from family and friends, health professionals, and the media) 
(Leventhal et al., 1980). Cultural and social factors (e.g., “My family told me to stop getting 
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upset over nothing”), as well as emotional responses to the health threat (headache; e.g., “I’m 
afraid my cancer may have returned”), also play a key role in this process (Diefenbach & 
Leventhal, 1996).  
Once a coping response has been chosen and enacted, the person will evaluate or 
appraise the effectiveness of that response. For example, if the person had attempted to 
alleviate their headache by increasing hydration levels, they might ask themselves whether 
this was successful and whether they feel any better. If the headache is not relieved with 
additional hydration, the individual will then revise their illness representations and initial 
self-diagnosis, as well as seek an alternative explanation for the headache (for example, by 
visiting a health professional). Emotional responses are also generated in parallel with this 
cognitive process, for example, for a person with a previous cancer diagnosis, a headache 
might provoke extreme anxiety, and could lead the person to engage in behaviours that may 
reduce this fear. The CSM thus suggests that coping responses (and later appraisal) are 
performed with respect to the emotional responses elicited by a health threat, as well as by 
the cognitive activity that generates the representations of the health threat (Diefenbach & 
Leventhal, 1996). It is thought that this process may be more complex for people who 
experience multiple health threats or illnesses, where multimorbid representations may 
impact coping behaviours and health outcomes. For example, co-morbid anxiety/depression 
are often experienced with chronic illnesses and may result in maladaptive cognitions (e.g., 
catastrophising or hopelessness), which in turn may negatively influence coping attempts and 
illness self-management. 
The CSM and Chronic Illness 
The CSM and the illness representation dimensions have been instrumental in helping 
to understand how people respond to and experience chronic illness. A seminal systematic 
review by Hagger and Orbell (2003) summarised how the illness representation dimensions 
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measured by the IPQ are related to coping behaviours and illness outcomes. In particular, 
they found that greater perceived controllability over an illness was associated with more 
adaptive coping strategies (e.g., cognitive reappraisal, problem-focused coping), while 
perceiving an illness as highly symptomatic with a chronic timeline and serious consequences 
was associated with more maladaptive coping strategies (e.g., avoidance/denial, expressing 
emotion). With regard to illness outcomes, perceptions of the illness as curable and 
controllable were associated with more positive illness outcomes (e.g., psychological well-
being, vitality), while perceptions of increased symptomology (higher identity), a chronic 
timeline, and more severe consequences were associated with negative illness outcomes (e.g., 
psychological distress). A more recent meta-analytic review by Dempster, McCorry, and 
Howell (2015) found further support for the relationship between illness representations and 
psychological distress over a range of physical health conditions, with higher identity (more 
perceived symptoms), more serious consequences, a more cyclical timeline, higher emotional 
representations (a stronger emotional response), less controllability, and less illness 
coherence, associated with higher levels of depression and anxiety. The associations 
identified across both of these reviews provide strong support for the CSMs illness 
representation dimensions, and highlight the importance of understanding individuals’ 
subjective illness representations. 
The CSM and Cancer 
Despite the important insights provided by Hagger and Orbell (2003) and Dempster et 
al. (2015), neither review explicitly examined the relationships between illness 
representations, coping, and outcomes, in people with cancer or in people with 
anxiety/depression (or allowed for separate results by illnesses). Therefore, in order to 
appropriately examine and understand how illness representations relate to coping behaviours 
and illness outcomes in people with these illnesses, this thesis provides the first systematic 
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reviews with meta-analyses of these relationships (Study 1 and Study 2).  
Interest in the relationships between illness representations and coping behaviours and 
illness representations and illness outcomes in people with cancer specifically has increased 
over time, with the number of publications examining the CSM in the cancer domain steadily 
increasing (particularly since the creation of the IPQ; Weinman et al., 1996). The illness 
representations held by people with cancer may be particularly relevant to understanding how 
people with cancer cope and function, as research has shown that cancer patients have strong 
and easily accessible representations based on illness experience that differ from the 
representations of people without a cancer diagnosis (Anagnostopoulos & Spanea, 2005; 
Buick & Petrie, 2002). Due to the differing nature of these representations, explorations of 
the relationships between representations, coping, and outcomes in people with cancer 
specifically were required. 
Illness representations appear to be particularly relevant for coping behaviours and 
illness outcomes in people with cancer. For example, Gould, Brown, and Bramwell (2010) 
found higher perceived personal control to be associated with more adaptive coping strategies 
(e.g., problem-focused coping and acceptance/growth), while perceptions of a more cyclical 
timeline and less illness coherence were associated with maladaptive coping strategies (e.g., 
denial/disengagement), in people with gynaecological cancer. With respect to illness 
outcomes, Dempster et al. (2012) found perceptions of a more chronic or cyclic timeline, 
more severe consequences, less personal and treatment control, and less illness coherence, to 
be associated with higher levels of depression and anxiety in people with oesophageal cancer.  
At times the size and direction of the associations between illness representations, 
coping, and outcomes, in people with cancer have been found to vary across studies. For 
example, Keeling, Bambrough, and Simpson (2013) found a moderate negative relationship 
between illness coherence and anxiety in people with low-grade brain tumours, suggesting 
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that less understanding of their cancer was associated with higher levels of anxiety. In 
contrast, Freeman-Gibb (2012) found a negligible positive relationship between illness 
coherence and anxiety in people with breast cancer, suggesting that a better understanding of 
their cancer was associated with more anxiety, though the negligible size of the effect 
suggests that this association is weak and may not be particularly meaningful. Both the large 
number of studies examining illness perceptions in people with cancer, as well as the 
inconsistencies in findings across some studies, warranted the completion of a systematic 
review and meta-analysis to determine whether illness representations are related to coping 
behaviours and illness outcomes across studies of people with cancer, as well as to clarify the 
strength and direction of these relationships (Study 1). 
The CSM and Mental Illness 
No study has quantitatively synthesised the literature examining the relationships 
between illness representations, coping behaviours, and illness outcomes, in people with 
anxiety/depression. Therefore, in order to address this gap in the literature, as well as to find 
out whether it would be appropriate to use the CSM as a basis for examining the 
representations of people with co-morbid cancer and anxiety/depression (Study 3), this thesis 
included a systematic review and meta-analysis to specifically examine the relationships 
between illness representations, coping, and outcomes in people with anxiety and/or 
depression (Study 2).  
The CSM was originally designed to explain how cognitive structures and 
representations can explain coping responses in people with physical illnesses. However, the 
model has also been found to be useful for examining and understanding how people’s 
representations can influence coping behaviours and illness outcomes in mental illnesses. For 
example, Elwy, Yeh, Worcester, and Eisen (2011) found those who sought treatment for 
depression had perceptions of a better understanding of depression (higher illness coherence) 
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and perceived treatment would control their depression (higher treatment control), while 
those who did not seek treatment for depression perceived that treatment would not control 
their depression (lower treatment control) and that the depression would be short-term (acute 
timeline). With regard to illness outcomes, Lu et al. (2014) found that perceived chronic 
timeline, more severe consequences, stronger emotional representations, and less perceived 
personal control were associated with depression severity, anxiety, stress, and psychological 
distress, in people with depression. Further, two recent reviews have offered support for the 
illness representation dimensions of the CSM in people with mental illness and depression 
respectively (Alderson, Foy, Glidewell, McLintock, & House, 2012; Baines & Wittkowski, 
2013).  
Alderson et al. (2012) used a narrative synthesis to examine beliefs about depression 
in people with current depressive symptoms. Beliefs were coded into the main categories of 
illness representations, though five additional thematic categories were found for beliefs that 
did not clearly fit within the CSM framework (understandability, the depression cycle, 
existential and self, suicidal thinking, and stigma, blame, and responsibility). They noted that 
illness representations in depression may be more complex than those in physical illnesses, 
highlighting the marked variations between participants across depression identity and 
timeline beliefs, with many different labels used to describe depression, and acute, chronic, 
and cyclic timelines all mentioned. Further, most study participants perceived complex multi-
factor causes for their depression, held strong beliefs about treatment control, and felt that 
depression had mostly negative consequences that affected all current and future aspects of 
life (e.g., physical health, social and home life), with some participants experiencing a lack of 
any control over depression. Finally, there was difficulty in distinguishing between an 
emotional representation for depression and the emotional symptoms of depression, though 
depression was found to be associated with fear, anxiety, sadness, despair, and guilt. When 
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examining these findings, a consideration of the three key elements of Beck’s cognitive triad 
(A. T. Beck, 1967), negative views about the self, world, and future, may help to explain how 
depression influences subjective representations through negative automatic thoughts (A. T. 
Beck, Rush, Shaw, & Emery, 1979). For example, a negative view of the future may lead to 
perceptions of a more chronic timeline of depression, while negative self and world views 
may lead to perceptions of less control over depression. Although this study provided insight 
into how the experience of depressive symptoms may be related to the illness representation 
dimensions, no formal review of how representations could impact coping and outcomes was 
included.  
More recently, a systematic review examining the relationships between illness 
representations and coping behaviours and illness representations and illness outcomes in 
people with mental illness was conducted by Baines and Wittkowski (2013) across 13 
studies. This review included a qualitative synthesis and summary of four studies that 
specifically examined the representations of people with depression, though no such 
summary was included for studies of people with anxiety. This summary revealed that 
perceptions of more negative consequences and a higher identity were associated with the use 
of maladaptive coping strategies (e.g., self-blame); perceptions of a more chronic timeline 
was associated with increased medication adherence and treatment seeking; and perceptions 
of a higher identity, more chronic timeline, more severe consequences, and less personal 
control were associated with increased depression severity. 
The CSM has increased understanding of how people self-regulate, manage, and cope 
with physical illnesses (Dempster et al., 2015; Hagger & Orbell, 2003). Further, research 
examining illness representations in people with mental illness has demonstrated the CSMs 
applicability for also understanding how people self-regulate mental illnesses (Alderson et 
al., 2012; Baines & Wittkowski, 2013). However, in order to further understand how the 
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CSM can inform coping and outcomes in people with anxiety/depression specifically, a 
systematic review and meta-analysis of the relationships between illness representations and 
coping behaviours, as well as illness representations and illness outcomes, in this population 
was required (Study 2), something not yet examined in previous review studies.  
Co-morbid Illness Representations 
As previously highlighted, many quantitative and qualitative studies across multiple 
single chronic illnesses (e.g., diabetes, cancer, asthma, depression) have used the CSM as a 
basis for improving our understanding of illness behaviour. In particular, this research 
highlights the relationships between the CSMs illness representation dimensions and coping 
behaviours as well as illness outcomes. However, given the high prevalence of co-existing 
multiple illnesses (multimorbidity, co-morbidity), examining illness representations in single 
illnesses alone may miss important information about the impact of multimorbidity on 
representations of each individual condition, as well as missing information about the 
representations of multimorbidity itself (e.g., representations of the relationships between 
multiple illnesses). Importantly, research has recently begun to investigate illness 
representations in people with multiple illnesses. A qualitative study by Bower et al. (2012) 
explored multimorbid illness representations in people with at least two of five conditions: 
type 2 diabetes, chronic arthritis, chronic obstructive pulmonary disease, coronary heart 
disease, and depression. This study was one of the first to investigate what the content of 
illness representations might look like for people with multimorbidity. For individual 
conditions, several illness representation dimensions including identity, cause, consequences, 
and illness coherence, were found to be impacted by multimorbidity. For example, 
multimorbidity compounded the consequences experienced by participants, with difficulty in 
linking individual symptoms with a particular illness reducing coherence and impacting 
perceptions of identity and cause. Several dimensions relating to representations of 
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multimorbidity were also identified, including medication burden (the perceived burden of 
taking medications for multiple conditions), condition priority (the relative importance 
assigned to each condition), and management synergies and antagonisms (the perception that 
managing one condition may benefit or aggravate another condition). These three 
dimensions’ impact how people self-manage their illnesses, and may be appropriate targets 
for intervention.  
A qualitative study with participants who had co-morbid diabetes and depression by 
Mc Sharry, Bishop, Moss-Morris, and Kendrick (2013) emphasised the importance of 
understanding how people perceive the relationships between their illnesses, and provided 
further evidence for the existence of multimorbid illness representations that influence how 
illnesses are self-managed. Illnesses were either described as unrelated with separate 
management strategies used for each, or as related with interactions between each illness. For 
those who saw interactions between diabetes and depression, causal relationships were often 
perceived (e.g., diabetes as causing depression or depression as causing diabetes), with the 
nature of these relationships impacting the management of both illnesses. Further, either 
integrated or conflicting self-management strategies were described by people who perceived 
diabetes and depression as related. For example, symptoms of depression such as fatigue and 
apathy interfered with diabetes self-management strategies such as exercise. Similar to Bower 
et al. (2012) medication burden was highlighted as a concern for people with multimorbid 
conditions, with difficulties in self-management perhaps related to a failure in self-regulation 
caused by the high self-regulatory demands associated with multimorbidity (Detweiler-
Bedell, Friedman, Leventhal, Miller, & Leventhal, 2008).  
A systematic review by Alderson et al. (2012) aimed to examine people’s beliefs 
about depression in the presence of a chronic physical illness. However, a systematic 
literature search only located two qualitative studies that examined beliefs about depression 
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associated with a chronic physical illness. Due to the paucity of research in this area, 
Alderson, Foy, Glidewell, and House (2014) later conducted a qualitative study of beliefs 
about depression in people with coronary heart disease and/or diabetes. They found that 
general beliefs about depression were unable to be separated from beliefs about depression 
related to diabetes or coronary heart disease, again highlighting the importance of 
multimorbid representations for understanding illness beliefs and designing interventions. 
These qualitative studies (Alderson et al., 2014; Bower et al., 2012; Mc Sharry et al., 
2013) support the existence of the CSMs illness representation dimensions (e.g., cause, 
consequences, coherence), with these studies also highlighting the existence of additional 
illness representations that are specific to multimorbidity. Such multimorbid representations 
are likely to vary for different combinations of illnesses (e.g., diabetes and depression versus 
cancer and depression), with this partially demonstrated by the findings of the studies 
described. Therefore, using the CSM (as the best existing framework) may help to gain a 
deeper understanding of, as well as provide additional insights into, the illness representations 
of people with cancer and anxiety/depression specifically. Representations may differ for 
people with this specific combination of illnesses for several reasons. For example, people 
with cancer experience varying cancer types, stages of disease progression, and treatment 
types, and these factors are very likely to influence representations of co-morbid 
anxiety/depression. Further, pharmacological treatments such as chemotherapy are associated 
with multiple side effects, while cancer-related surgery can affect issues such as body image. 
People with cancer also often experience fear of cancer recurrence (FCR), a unique form of 
anxiety experienced by cancer patients/survivors that comprises fears or worries about a 
return or progression of a previous or new cancer (Lee-Jones, Humphris, Dixon, & Hatcher, 
1997; Simard, Savard, & Ivers, 2010). How FCR interacts with multimorbid representations, 
coping behaviours, and self-management strategies, may also provide important insights for 
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this population. Due to the unique issues associated with experiencing co-morbid cancer and 
anxiety/depression, as well as the lack of research into the experience of co-morbid cancer 
and anxiety/depression specifically, there is a need for more exploratory research to 
understand how people with this common combination of physical and mental illness make 
sense of their illnesses and associated difficulties (Study 3).  
Comparing Support Needs across People with Cancer and Anxiety/Depression 
How a person experiences cancer and anxiety/depression can be markedly different 
based on their varying histories of each illness, with these varying aetiologies shown to cause 
significant differences in health outcomes (Angst, Gamma, Rössler, Ajdacic, & Klein, 2009). 
It follows that these variances are therefore highly likely to also cause differences in support 
needs for people with cancer and anxiety/depression. In order to facilitate a better 
understanding of how support needs might differ between people with cancer and 
anxiety/depression, a comparison of the support needs of people with cancer and different 
histories of anxiety/depression was required (Study 4). 
In the field of psycho-oncology there is a common (mis)conception that 
anxiety/depression are a normal part of the cancer experience (Pasquini & Biondi, 2007). 
Unfortunately, this misconception has precluded appropriate treatment for anxiety/depression 
in people with cancer, with many cancer patients requiring yet not receiving adequate 
treatment (Nakash et al., 2014; Pasquini & Biondi, 2007; Sanjida et al., 2016). Despite this 
misconception, research has shown that people with cancer do not always develop 
anxiety/depression, with varying levels of distress experienced across cancer patients 
(Helgeson, Snyder, & Seltman, 2004; Henselmans, Helgeson, et al., 2010). Further, a person 
who is diagnosed with cancer may have a long-term pre-existing diagnosis of 
anxiety/depression or experience episodic anxiety/depression in response to significant life 
events. How such varying histories of anxiety/depression may influence the support needs of 
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people with cancer and anxiety/depression has rarely been considered across research in 
psycho-oncology. 
Although the support needs of people with cancer have been extensively researched 
(Harrison, Young, Price, Butow, & Solomon, 2009), a recent review found that interventions 
aimed at reducing unmet supportive care needs in cancer patients have limited effectiveness 
(Carey et al., 2012). Further, interventions for cancer patients with distress rarely consider 
how a prior history of anxiety/depression may influence intervention effectiveness, and often 
provide mixed results and conflicting conclusions (Galway et al., 2012; Jacobsen & Jim, 
2008; Lepore & Coyne, 2006). Examining and comparing the support needs of people with 
varying histories of cancer and anxiety/depression may therefore inform the creation of more 
appropriately focused and targeted interventions. Why support needs may differ between 
people with cancer and varying histories of anxiety/depression relates to the significant 
differences in health outcomes between people with long-term anxiety/depression and people 
with episodic anxiety/depression. For example, long-term depression has been found to 
require more treatment, be more clinically serious, be more often co-morbid with anxiety, and 
lead to reduced well-being and poorer social and psychological outcomes than episodic 
depression (Angst et al., 2009). In order to create more appropriate interventions and better 
support people with cancer and anxiety/depression, research should examine and compare the 
support needs of people who have cancer and long-term anxiety/depression and people who 
have cancer and episodic anxiety/depression (Study 4).  
The Present Thesis 
The present thesis investigates the role of the Common Sense Model of Self-
Regulation of Health and Illness (Leventhal et al., 1980) in understanding how people’s 
representations of cancer and anxiety/depression influence their coping behaviours, self-
management strategies, and illness outcomes, and what particular support needs people with 
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cancer and anxiety/depression express based on their understanding of their illnesses.  
As highlighted above, cancer and anxiety/depression commonly occur as co-morbid 
conditions, leading to poor health and illness outcomes. However, too little is currently 
known about the psychological processes underlying this combination of illnesses. Chapter 2 
presents a systematic review of the relationships between illness representations and coping 
behaviours and illness representations and illness outcomes in people with cancer. Chapter 3 
presents a second systematic review of the relationships between illness representations and 
coping behaviours and illness representations and illness outcomes, but this time in people 
with depression. Chapter 4 examines the content of multimorbid illness representations and 
the relationship between these multimorbid representations and self-management strategies in 
people with cancer and anxiety/depression. Chapter 5 explores how support needs differ 
between people with long-term anxiety/depression and episodic anxiety/depression, as well 
as between people with anxiety/depression associated with cancer and anxiety/depression not 
associated with cancer. Chapter 6 concludes this thesis with an integrative discussion of the 
study findings, overall limitations, both theoretical and practical implications, and 
suggestions for future research. 
 
Study 1 (Chapter 2): Illness representations, coping, and illness outcomes in people with 
cancer: A systematic review and meta-analysis 
 
Aim: To provide a systematic overview of the relationships between the Common Sense 
Model’s illness representations and health and coping outcomes in people with cancer. 
 
Due to the large pool of existing literature examining the relationship between illness 
representations, coping behaviours, and illness outcomes in people with cancer, as well as the 
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inconsistency across some of these study findings, Study 1 involved the completion of a 
systematic review and meta-analysis to synthesise the existing literature and reach a 
consensus on the strength and direction of these relationships. A systematic literature search 
identified 54 studies meeting inclusion criteria, with 38 studies providing sufficient data to be 
included in the meta-analysis and the remaining 16 studies included in a narrative review. 
 
Study 2 (Chapter 3): Illness representations, coping, and illness outcomes in depression: A 
systematic review and meta-analysis 
 
Aim: To provide a systematic overview of the relationships between the Common Sense 
Model’s illness representations and health and coping outcomes in people with depression. 
 
Although clear relationships have been found between the CSMs illness 
representation dimensions and coping and outcomes in people with chronic physical illnesses, 
the ability of this model to explain relationships between illness beliefs and behaviour in 
people with mental illnesses is less well established, with no quantitative synthesis examining 
this relationship in people with depression specifically. Study 2 therefore involved the 
completion of a systematic review and meta-analysis to examine the relationships between 
illness representations, coping, and outcomes in people with depression. Nineteen studies 
were located following a systematic literature search, with 10 providing sufficient data for 
meta-analysis, and nine included in a narrative review. 
 
Study 3 (Chapter 4): ‘It was all intertwined’: Illness representations and self-management in 
people with cancer and anxiety/depression 
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Aim: To explore the content of individual’s multimorbid representations of cancer and 
anxiety/depression, as well as how these relate to their coping behaviours and self-
management strategies. 
 
Though well established in single chronic illnesses, research has only recently begun 
to investigate the content and role of illness representations in people with multiple illnesses, 
with research yet to examine the illness representations of people with co-morbid cancer and 
anxiety/depression. Study 3 aimed to address this gap in existing literature by qualitatively 
examining the nature of illness representations for both cancer and anxiety/depression, 
whether all individuals think about the relationships between cancer and anxiety/depression 
in similar ways, and how particular illness representations might facilitate different coping 
behaviours or self-management strategies for cancer and anxiety/depression. To examine 
these aims, 21 semi-structured face-to-face interviews were conducted, and a theoretical 
thematic analysis provides a detailed analysis of differences in representations between those 
who identified links between cancer and anxiety/depression and those that did not.  
 
Study 4 (Chapter 5): A qualitative comparison of the support needs of people with cancer 
based on their history of anxiety/depression 
 
Aim: To examine and compare the support needs of people with cancer and varying histories 
of anxiety/depression in order to provide suggestions for improvements in support and 
service provision.  
 
The field of psycho-oncology (both in research and in practice) rarely takes into 
account the origin and history of anxiety/depression in a person with cancer, instead 
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assuming it to be related to the cancer diagnosis. In order to determine whether and how this 
history may influence the support needs of people with cancer and anxiety/depression, 
interview transcripts from 21 people (same participant pool as Study 3) were analysed (Study 
4). Study 4 categorised participants into four groups based on their history of 
anxiety/depression, specifically considering whether they had experienced long-term 
anxiety/depression or episodic anxiety/depression, as well as whether they had experienced 
anxiety/depression that was associated with their cancer diagnosis or anxiety/depression that 
was not associated with their cancer diagnosis. Following categorisation, an inductive 
thematic analysis was used to collate codes into relevant themes and highlight important 
differences between groups. 
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Chapter 2 
Study 1 
Illness representations, coping, and illness outcomes in people with cancer: A systematic 
review and meta-analysis* 
 
 
 
 
 
 
 
 
 
                                                          
*Richardson, E. M., Schüz, N., Sanderson, K., Scott, J. L., Schüz. B. (2016). Illness 
representations, coping, and illness outcomes in people with cancer: A systematic review and 
meta-analysis. Psycho-Oncology. Advance online publication. doi: 10.1002/pon.4213 (see 
Appendix 2.1) 
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Abstract 
Objective: Cancer is associated with negative health and emotional outcomes in those 
affected by it, suggesting the need to better understand the psychosocial determinants of 
illness outcomes and coping. The Common Sense Model (CSM) is the leading psychological 
model of self-regulation in the face of illness, and assumes that subjective illness 
representations explain how people attempt to cope with illness. This systematic review and 
meta-analysis examines the associations of the CSM’s illness representation dimensions with 
health and coping outcomes in people with cancer. 
Methods: A systematic literature search located 54 studies fulfilling the inclusion criteria, 
with 38 providing sufficient data for meta-analysis. A narrative review of remaining studies 
was also conducted. 
Results: Random-effects models revealed small to moderate effect sizes (Fischer’s Z) for the 
relations between illness representations and coping behaviours (in particular between control 
perceptions, problem-focused coping, and cognitive reappraisal), and moderate to large effect 
sizes between illness representations and illness outcomes (in particular between identity, 
consequences, emotional representations, and psychological distress). The narrative review of 
studies with insufficient data provided similar results.  
Conclusions: The results indicate how illness representations relate to illness outcomes in 
people with cancer. However, more high quality studies are needed to examine causal effects 
of illness representations on coping and outcomes. High heterogeneity indicates potential 
moderators of the relationships between illness representations and health and coping 
outcomes, including diagnostic, prognostic, and treatment related variables. This review can 
inform the design of interventions to improve coping strategies and mental health outcomes 
in people with cancer. 
Keywords: cancer; oncology; illness perceptions; common sense model of illness 
representations; systematic review and meta-analysis 
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Background 
Cancer is one of the most prevalent diseases worldwide, with more than 14 million 
new cancer cases diagnosed annually (International Agency for Research on Cancer & World 
Health Organisation, 2014). Often, people with cancer experience negative health outcomes 
(e.g., anxiety, depression, psychological distress, poor role/physical functioning, and reduced 
quality of life) and face extraordinary coping challenges (Croom, Hamann, & Kehoe, 2013; 
Deimling et al., 2006; Edwards & Clarke, 2004; Harrington et al., 2010; O'Brien & Moorey, 
2010; Singer et al., 2010). These outcomes and coping behaviours depend on individual 
representations of illness (Diefenbach & Leventhal, 1996), but to date, no systematic review 
and meta-analysis has provided an overview of the complex relationships between illness 
representations, coping and illness outcomes in cancer to inform the content of psychological 
interventions based on subjective illness representations. 
Illness Representations and the Common Sense Model 
The Common Sense Model of Self-Regulation of Health and Illness (CSM; Leventhal 
et al., 1980) is a widely accepted psychological model of the processes underlying health and 
coping in people with chronic illness. According to the CSM, individual representations of 
health threats (i.e., people’s common-sense understanding of their illness; Leventhal et al., 
1998; Leventhal et al., 1980) and the according emotional response guide peoples’ coping 
responses in parallel processes, which are later appraised in terms of their success or failure 
(Diefenbach & Leventhal, 1996) (Figure 2.1). 
The CSM orders illness representations into distinct dimensions. Identity refers to the 
label of the health threat (e.g. cancer) and its symptoms (e.g. fatigue). Cause refers to the 
individual’s beliefs about the cause of the health threat (e.g. genetic weakness). Timeline 
refers to the perceived time-frame of disease development, duration, and recovery (e.g. acute, 
chronic, or cyclical). Consequences (both imagined and real) are beliefs about what effect the 
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health threat may have on an individual’s life (e.g. absence from work). Curability or 
controllability refers to the degree to which someone believes that the health threat can be 
controlled or cured by themselves or others (e.g. incurable but controllable with medication) 
(Leventhal et al., 1998). This dimension has later been revised to represent two distinct 
dimensions - personal control - the amount of control an individual perceives to have over 
the course of their illness, and treatment control - the amount of control the individual 
believes their treatment has over the illness. Illness coherence refers to the extent to which a 
patient’s illness representations provide coherent understanding of the illness, and emotional 
representations describe an individual’s emotional responses to the illness (Moss-Morris et 
al., 2002). The most widely used instruments to assess illness representations are the Illness 
Perception Questionnaire (IPQ; Weinman et al., 1996), the Revised Illness Perception 
Questionnaire (IPQ-R; Moss-Morris et al., 2002), and the Brief Illness Perception 
Questionnaire (B-IPQ; Broadbent et al., 2006). The IPQ-R has acceptable test-retest 
reliability, sound discriminant and predictive validity, and good internal reliability (Moss-
Morris et al., 2002). 
Figure 2.1. The common sense model of self-regulation of health and illness (Leventhal et 
al., 1980), adapted from Diefenbach and Leventhal (1996). 
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In a seminal systematic review of the CSM, Hagger and Orbell (2003) have shown 
that the IPQ dimensions are related to both coping behaviours (such as avoidance/denial and 
medication adherence) and illness outcomes (e.g., depression and physical functioning) 
across a range of chronic and acute illnesses. In particular, greater perceived controllability 
was associated with more adaptive coping strategies, while perceiving an illness as highly 
symptomatic with a chronic timeline and serious consequences was associated with more 
maladaptive coping strategies. Perceptions of the illness as curable and controllable were 
associated with positive illness outcomes, while perceived negative consequences, chronic 
timeline, and higher identity (more perceived symptoms) were associated with negative 
illness outcomes. These relations highlight the importance of subjective representations for 
understanding how people cope with illness and their illness outcomes. However, the review 
by Hagger and Orbell (2003) included only one study of cancer patients. Further, in the 13 
years since this original review, the number of publications examining illness representations 
in cancer have greatly increased. 
Illness Representations in Cancer: The Present Review 
Illness representations might be particularly relevant to understanding coping and 
illness outcomes in the area of cancer, as people hold strong and readily accessible 
representations of cancer based on common-sense knowledge (Anagnostopoulos & Spanea, 
2005; Buick & Petrie, 2002). These representations determine coping and illness outcomes, 
for example higher levels of control and better understanding have been associated with 
lower rates of anxiety and depression (Dempster et al., 2012).  
However, the size (and occasionally direction) of these associations varies across 
studies, with one study finding a moderate negative relationship between illness coherence 
and anxiety (Keeling et al., 2013), whereas another study found a negligible positive 
relationship between illness coherence and anxiety (Freeman-Gibb, 2012). Such inconsistent 
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findings warrant a systematic review to determine a consensus on the strength and direction 
of the relationships between illness representations and health and coping outcomes. 
The findings of this review have the potential to inform clinical interventions based 
on illness representations. Some previous intervention studies in other chronic illness patients 
(e.g., Siemonsma et al., 2013) support the malleability of coping behaviours and illness 
outcomes via modifying illness representations, although to date, none have been conducted 
with cancer patients.  
Aims and Hypotheses 
The present review aims to provide the first systematic overview of the relationships 
between illness representations and health and coping outcomes in people with cancer. 
Consistent with the findings from Hagger and Orbell (2003) involving diverse chronic 
illnesses, we hypothesised that higher identity, acute/chronic timeline, cyclical timeline, 
consequences, and emotional representations, as well as lower personal control, treatment 
control, and illness coherence, would be associated with more maladaptive coping behaviours 
(e.g., higher levels of avoidance/denial) and more negative illness outcomes (e.g., higher 
levels of anxiety). In contrast, lower identity, acute/chronic timeline, cyclical timeline, 
consequences, and emotional representations, as well as higher personal control, treatment 
control, and illness coherence, were predicted to be associated with more adaptive coping 
behaviours (e.g., higher levels of cognitive reappraisal) and more positive illness outcomes 
(e.g., higher quality of life). 
Methods 
Literature Search, Inclusion Criteria, and Study Selection 
This study followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) Statement (Moher, Liberati, Tetzlaff, Altman, & The PRISMA Group, 
2009; Appendix 2.2), with no ethical approval required. A systematic literature search was 
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conducted using Scopus, Web of Science, PubMed, PsycINFO, and CINAHL. In an attempt to 
locate ‘grey literature’ additional searches were conducted through Google Scholar. For the 
full search strategy for each database refer to Appendix 2.3. A manual search of the reference 
lists of included articles was also completed to identify additional studies. Attempts were 
made to locate missing data sets by contacting relevant authors.  
Studies were eligible for inclusion if they met the following criteria: quantitative 
design, including any subscale from the IPQ (Weinman et al., 1996), the IPQ-R (Moss-
Morris et al., 2002), or the B-IPQ (Broadbent et al., 2006), measuring coping behaviours or 
illness outcomes, adult participants (over 18 years) with a cancer diagnosis, written in 
English or German, and conducted after 1995 (post IPQ development).  
Following three consecutive literature searches and full-text coding by the first author 
(using a coding manual and coding sheet: see Appendix 2.4 and Appendix 2.5), the final 
number of studies for the systematic review was 54, with 38 included in the meta-analysis 
(based on relevant data) (Beatty & Scott, 2013; Cameron et al., 2005; Chen, 2012; Cook et 
al., 2015a; Corter, Findlay, Broom, Porter, & Petrie, 2013; Costanzo, Lutgendorf, & Roeder, 
2011; Croom, 2012; Croom et al., 2013; Dempster et al., 2012; Donovan, 2003; Duric et al., 
2007; S. Y. Fan, Eiser, Ho, & Lin, 2013; Fischer et al., 2013; Förster & Taubert, 2006; Foster 
et al., 2015; Freeman-Gibb, 2012; A. Gibbons, 2013; Gould et al., 2010; Green, Steinnagel, 
Morris, & Laakso, 2014; Henselmans, Sanderman, et al., 2010; Hopman & Rijken, 2014; 
Karademas & Giannousi, 2013; Keeling et al., 2013; Llewellyn, McGurk, & Weinman, 2006, 
2007b; Llewellyn, Weinman, McGurk, & Humphris, 2008; McCorry et al., 2013; Mols, 
Lemmens, Bosscha, van den Broek, & Thong, 2014; Paschali, Hadjulis, Papadimitriou, & 
Karademas, 2015; Rozema, Völlink, & Lechner, 2009; Scharloo et al., 2010; Silva, Moreira, 
& Canavarro, 2012; Thuné-Boyle, Myers, & Newman, 2006; Traeger, 2009; Traeger et al., 
2009; van der Kloot et al., 2014; Wu, Mohamed, Winkel, & Diefenbach, 2013; Zivkovic, 
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Buljan, Blajic, & Situm, 2008). A flow-chart of the study selection process can be found in 
Figure 2.2, with a detailed description of the search process in Appendix 2.6. 
 
Figure 2.2. Flow-chart of the study selection process.  
 
Classification of Coping Behaviours and Illness Outcomes 
Categories of coping behaviours were adapted from Hagger and Orbell (2003) to 
include the behaviours most frequently mentioned in the cancer literature. Eleven categories 
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were identified: expressing emotion, cognitive reappraisal, avoidance/denial, problem-
focused coping (generic and specific behaviours separately), treatment decision making, 
medication adherence, adherence to treatment visits, doctor visits, seeking social support, and 
other (specified) coping behaviour. Only three of these categories (cognitive reappraisal, 
avoidance/denial, and problem-focused coping [generic]) could be used in the meta-analysis 
due to a lack of studies measuring or reporting the other categories. 
Illness outcomes were also classified using the categories in Hagger and Orbell (2003) 
and extended if necessary. Thirteen categories were identified: affect (negative/positive), 
anxiety, depression, psychological distress, treatment related distress, decisional 
uncertainty/regret, psychological well-being, vitality, role functioning, physical functioning, 
disease state, quality of life, and other (specified) illness outcome. Only seven of these 
categories (anxiety, depression, psychological distress, psychological well-being, role 
functioning, physical functioning, and quality of life) were used in the meta-analysis due to a 
lack of studies measuring or reporting the other categories.  
Data Extraction and Meta-Analytic Strategy 
We extracted publication date, cancer type, sample characteristics (age and sex), study 
design, IPQ version, coping behaviours, illness outcomes, and a summary of the relevant 
results from all identified articles (Appendix 2.7 shows a summary of studies included in the 
meta-analysis; Appendix 2.8 shows a summary of studies included in the narrative review).  
To assist in evaluating validity of results, risk of bias was assessed using four criteria 
relevant to the research aims: (i) whether each version of the IPQ had been administered as 
recommended; (ii) which IPQ dimensions were reported; (iii) whether equivalent 
correlational analyses were conducted across studies; (iv) whether adjustments were made for 
confounding variables. 
Zero-order correlations were the most frequently reported effect size, and therefore 
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the average correlation coefficient weighted by sample size and calculated using Fischer’s Z 
transformations (rz) was used as the measure of effect in the meta-analysis. We interpreted 
.10 as a small effect, .30 as a moderate effect, and .50 as a large effect (Cohen, 1992). The 
meta-analyses were conducted in R (R Core Team, 2014) using the ‘metafor’ package 
(Viechtbauer, 2010). A random-effects meta-analysis was performed, which accommodates 
the assumption that the true effect size (the effect size in the underlying population of studies) 
may vary from study to study due to heterogeneity (Borenstein, Hedges, Higgins, & 
Rothstein, 2010). In the present meta-analysis, the studies were likely to be heterogeneous 
due to differing study designs, cancer types, treatment types, and other sampling 
characteristics.  
To examine heterogeneity between studies, Q and I2 statistics were calculated. To 
assess publication bias (‘file drawer problem’), funnel plots and the ‘fail-safe N’ (Nfs) were 
examined, and moderator analyses (random-effects meta-regression) were conducted as 
appropriate. In these analyses, cross-sectional (0) and longitudinal (1) design were entered as 
predictors of the effect sizes between studies, and B’s can be interpreted as differences in the 
pooled effect sizes between cross-sectional and longitudinal studies. For additional 
information regarding the meta-analytic strategy used in our review, please refer to Appendix 
2.9. 
Results 
Study Characteristics 
Thirty-six (66.67%) of the studies had a cross-sectional design, two (3.70%) were 
experimental with only baseline correlations extracted, and 16 (29.63%) were longitudinal 
with intervals ranging from one week to twelve months. Sample sizes ranged between 43 and 
1019, with a mean sample size of 182. Eleven different types of cancer were reported, with 
the most common breast cancer (15 studies, 27.78%), followed by head and neck cancer 
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(seven studies, 12.96%), and prostate cancer (six studies, 11.11%). Sixteen studies (29.63%) 
reported heterogeneous cancer populations (multiple cancer types) and were classified as ‘not 
specified’. Other cancer types included colorectal, oesophageal, gynaecological, oral, 
ovarian, liver, brain, and skin. Cancer stage was coded, but only 19 of 38 studies (50%) in the 
meta-analysis provided data on participants’ cancer stage, which additionally was often based 
on different staging systems (e.g., TNM, idiosyncratic systems) with no separate results 
provided for differing cancer stages. In 27 studies (50% of all articles reviewed), the IPQ was 
adapted to be ‘cancer specific’, rather than using the generic version. This involved minor 
changes in wording and the inclusion of cancer specific symptoms and causes. For more key 
study characteristics refer to Appendix 2.7 and Appendix 2.8. 
Risk of Bias Assessment 
 Risk of bias assessment was based on the fidelity of measurement of illness 
representations and outcomes as well as study design. The majority of studies (42 out of 54) 
administered the IPQ, IPQ-R, or B-IPQ as recommended, with some studies (12 out of 54) 
only partially adhering to guidelines by developers. Those studies either used shortened 
versions of subscales, added items to subscales, or adapted items to suit the sample or cancer 
patients specifically. Most studies reported the correlations of the illness representation 
dimensions they had assessed, with those that did not contacted for missing data. However, 
data was unable to be obtained for three studies omitting cause and three that failed to report 
non-significant results. In 30 out of 38 studies Pearson’s correlation coefficients were 
reported, with Spearman’s correlation coefficients used in two, lagged, point-biserial, and 
bivariate used in one each, and three studies not specifying a correlation type. Four studies 
adjusted for either demographic or cancer-specific confounding variables (Croom, 2012; 
Gould et al., 2010; van der Kloot et al., 2014; Wu et al., 2013), see Appendix 2.10.  
Relationship of Illness Representations to Coping Behaviours: Quantitative Analysis 
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Table 2.1 shows that the relations between coherence, cyclical timeline, 
consequences, emotional representations and avoidance/denial, and the relations between 
identity, acute/chronic timeline and generic problem-focused coping, were subject to high 
heterogeneity, with the remaining I2 values indicating moderate-low heterogeneity between 
studies.  
The majority of results from the meta-analyses between coping behaviours and illness 
representations indicate small to moderate effects (Table 2.1, Forest plots in Appendix 2.11).  
Cognitive reappraisal. The strongest correlate of cognitive reappraisal was personal 
control, with higher levels of control associated with higher levels of cognitive reappraisal. 
Other correlates included acute/chronic timeline, emotional representations, and treatment 
control.  
Avoidance/denial. The strongest correlate of avoidance/denial was emotional 
representations, with higher levels of emotional representations associated with higher levels 
of avoidance. The other key correlate of avoidance/denial was cyclical timeline.  
Problem focused coping (generic). The strongest correlate of problem-focused 
coping (generic) was personal control, with higher levels of control associated with higher 
levels of problem-focused coping. The other key correlate of problem-focused coping 
(generic) was consequences. 
Publication bias: Funnel plots and fail-safe N. 
Across all relationships between illness representations and coping behaviours, funnel 
plots (Appendix 2.12) were generally symmetrical. Although some funnel plots were skewed, 
it has been recommended that these plots be interpreted with caution, as any skew in the 
funnel may be explained by considerable heterogeneity amongst studies, indicating that 
publication bias is unlikely (Lau, Ioannidis, Terrin, Schmid, & Olkin, 2006). Fail-safe N was 
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Table 2.1  
Meta-Analyses of the Relationships between Illness Representations and Coping Behaviours 
 Cognitive-Reappraisal  Avoidance/Denial  Problem-Focused-Coping-(Generic) 
Illness-
Representation k N rz (95%CI) Nfs Q I
2  k N rz (95%CI) Nfs Q I
2  k N rz (95%CI) Nfs Q I
2 
Identity 4 351 .019 
(-.141, 
.179) 0 6.54 54.38  5 470 .022 
(-.125, 
.169) 0 10.15* 59.96  5 1008 .068 
(-.092, 
.229) 14 25.78*** 76.71 
Cause         6 832 .075* 
(.006, 
.144) 2 4.02 <.01  4 1004 -.031 
(-.093, 
.031) 0 .15 <.01 
Timeline-
(Acute/Chronic) 7 809 -.201** 
(-.341,      
-.062) 66 21.02** 72.67  9 1033 .049 
(-.076, 
.174) 0 28.55*** 73.86  8 1298 .026 
(-.110, 
.162) 0 30.90*** 78.73 
Timeline-
(Cyclical) 6 650 .024 
(-.064, 
.111) 0 5.72 15.90  8 874 .217** 
(.060, 
.373) 94 31.34*** 80.20  7 1141 .054 
(-.053, 
.161) 4 15.25* 57.11 
Consequences 7 732 -.036 
(-.135, 
.064) 0 10.78 40.16  8 879 .130 
(-.010, 
.270) 26 27.45*** 75.46  7 1151 .121* 
(.013, 
.229) 32 13.44* 58.01 
Personal-Control 7 811 .287*** 
(.182, 
.391) 151 12.21 51.35  10 1146 -.005 
(-.082, 
.072) 0 14.68 38.17  7 673 .286*** 
(.178, 
.394) 128 11.62 47.58 
Treatment-
Control 5 572 .183* 
(.014, 
.352) 27 13.46** 72.47  7 797 -.025 
(-.126, 
.075) 0 10.90 46.39  5 435 -.007 
(-.194, 
.179) 0 12.87* 72.70 
Illness-Coherence 6 650 .104** 
(.026, 
.182) 10 5.22 .02  7 755 -.170 
(-.382, 
.042) 39 44.09*** 87.48  6 1029 .082* 
(.002, 
.163) 7 5.90 20.77 
Emotional-
Representations 5 589 
-
.190*** 
(-.272,      
-.108) 34 3.98 .01  8 923 .240** 
(.073, 
.406) 121 41.06*** 83.75  6 1270 -.046 
(-.160, 
.069) 0 13.17* 68.04 
Note. k = number of studies, N = total sample size across included studies, rz = effect size, (95%CI) = 95% confidence intervals around the effect size, Nfs = Rosenthal’s fail-safe N (measure of publication bias),  
Q = measure of heterogeneity (suggests heterogeneity when statistically significant), I2 = measure of heterogeneity (25% = low, 50% = moderate, 75% = high) 
*p < .05, **p < .01, ***p < .001 
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found to range from zero to 151 across the relationships between illness representations and 
coping behaviours (Table 2.1). 
Relationship of Illness Representations to Illness Outcomes: Quantitative Analysis 
High heterogeneity was observed in studies examining psychological distress and 
emotional representations; role functioning and illness coherence; physical functioning and 
identity, consequences, coherence, and emotional representations; and quality of life and 
identity, treatment control, and illness coherence. Overall, there was a wide range of effect 
sizes of the associations between illness outcomes and illness representations, from negligible 
effects to very large effects (Tables 2.2, 2.3, and 2.4). 
Anxiety. The strongest correlate of anxiety was emotional representations, with higher 
emotional representations associated with higher anxiety. Other moderate-strong correlates 
included consequences, identity, cyclical timeline, and acute/chronic timeline.  
Depression. The strongest correlate of depression was emotional representations, with 
higher emotional representations associated with more depression. Other moderate-strong 
correlates included identity, consequences, cyclical timeline, treatment control, and 
acute/chronic timeline. Table 2.2 contains the full set of analyses regarding anxiety and 
depression; forest plots can be found in Appendix 2.11. 
Psychological distress. Emotional representations were the highest correlate of 
psychological distress, with higher emotional representations associated with more distress. 
Other moderate to strong correlates included consequences, identity, cyclical timeline, and 
acute/chronic timeline. 
Psychological well-being. The strongest correlate of psychological well-being was 
consequences, with less consequences associated with more psychological well-being. Table 
2.3 contains all analyses regarding psychological distress and well-being; forest plots are 
shown in Appendix 2.11. 
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Role functioning. The strongest correlate of role functioning was identity, with lower 
identity scores (perceived cancer related symptoms) associated with better role functioning. 
Other correlates included emotional representations, and consequences. 
Physical functioning.  The strongest correlate of physical functioning was identity, 
with lower identity scores associated with better physical functioning. Other correlates 
included consequences, emotional representations, acute/chronic timeline, and treatment 
control.  
Quality of life. The strongest correlate of quality of life was identity, with lower 
identity scores associated with better quality of life. Other moderate to strong correlates 
included consequences, emotional representations, and acute/chronic timeline. Table 2.4 
contains all analyses regarding role functioning, physical functioning, and quality of life; 
forest plots are shown in Appendix 2.11. 
Illness outcomes and publication bias: Funnel plots and fail-safe N. 
Across the relationships, funnel plots (Appendix 2.12) were generally symmetrical, 
although this was difficult to assess in plots with small numbers of studies. The number of 
studies that fell outside the funnel generally varied between none and three, with one plot 
displaying four points outside the funnel (psychological distress and illness coherence). 
Across the relationships between illness representations and illness outcomes the fail-safe N 
ranged from zero to 3975. The two relationships with a fail-safe N of zero (illness coherence 
and physical functioning; illness coherence and quality of life) both also had high 
heterogeneity, suggesting the presence of moderators (Card, 2012). 
Moderator Analyses 
 Study-level moderators. 
We examined whether research design (cross-sectional versus longitudinal) affected 
the effect sizes (correlations between illness representations and coping as well as outcomes) 
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Table 2.2 
Meta-Analyses of the Relationships between Illness Representations and Anxiety, and Illness Representations and Depression  
 Anxiety  Depression 
Illness-Representation k N rz (95%CI) Nfs Q I2  k N rz (95%CI) Nfs Q I2 
Identity 10 1782 .360*** (.295,.426) 702 14.53 39.95  9 1615 .470*** (.392,.549) 977 17.18* 51.73 
Cause 6 1236 .163** (.067,.259) 54 14.14* 59.91  6 1158 .106** (.032,.180) 21 6.52 29.89 
Timeline-(Acute/Chronic) 12 2524 .259*** (.185,.333) 619 32.09*** 67.18  10 2166 .260*** (.179,.341) 433 24.88** 67.56 
Timeline-(Cyclical) 10 1556 .289*** (.208,.371) 406 19.58* 56.28  7 1148 .272*** (.175,.370) 173 12.96* 56.04 
Consequences 15 2777 .443*** (.374,.512) 2548 38.96*** 65.38  13 2388 .416*** (.353,.479) 1643 23.90* 49.66 
Personal-Control 16 2922 -.119*** (-.170,-.068) 192 27.19* 4.73  13 2503 -.195*** (-.234,-.155) 369 9.62 .05 
Treatment-Control 11 2441 -.192*** (-.240,-.144) 308 11.77 24.16  8 1942 -.261*** (-.308,-.215) 350 7.59 4.79 
Illness-Coherence 13 2610 -.205*** (-.285,-.125) 425 39.54*** 73.02  9 2039 -.155*** (-.236,-.074) 128 23.75** 64.87 
Emotional-Representations 11 2083 .738*** (.652,.824) 3975 28.52** 71.05  8 1574 .517*** (.468,.567) 1064 11.04 .01 
Note. k = number of studies, N = total sample size across included studies, rz = effect size, (95%CI) = 95% confidence intervals around the effect size, Nfs = Rosenthal’s fail-
safe N (measure of publication bias), Q = measure of heterogeneity (suggests heterogeneity when statistically significant), I2 = measure of heterogeneity (25% = low, 50% = 
moderate, 75% = high) 
*p < .05, **p < .01, ***p < .001 
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Table 2.3  
Meta-Analyses of the Relationships between Illness Representations and Psychological Distress, and Consequences and Psychological Well-
being 
 Psychological-Distress  Psychological-Well-Being 
Illness-Representation k N rz (95%CI) Nfs Q I2  k N rz (95%CI) Nfs Q I2 
Identity 8 1555 .354*** (.268,.441) 471 15.74* 58.37         
Cause 6 1030 .174*** (.086,.261) 61 9.81 47.92         
Timeline-(Acute/Chronic) 8 1692 .185*** (.137,.233) 140 8.75 .01         
Timeline-(Cyclical) 5 735 .249*** (.103,.395) 69 11.34* 71.40         
Consequences 11 2287 .377*** (.336,.418) 1127 10.84 .01  4 956 -.355*** (-.419,-.291) 135 2.71 .01 
Personal-Control 9 1921 -.091** (-.158,-.023) 35 15.56* 48.02         
Treatment-Control 9 1908 -.130*** (-.205,-.055) 88 18.31* 57.83         
Illness-Coherence 9 1979 -.172*** (-.266,-.078) 146 29.45*** 74.61         
Emotional-Representations 9 2003 .596*** (.496,.696) 2010 34.30** 77.50         
Note. k = number of studies, N = total sample size across included studies, rz = effect size, (95%CI) = 95% confidence intervals around the effect size, Nfs = Rosenthal’s fail-
safe N (measure of publication bias), Q = measure of heterogeneity (suggests heterogeneity when statistically significant), I2 = measure of heterogeneity (25% = low, 50% = 
moderate, 75% = high) 
*p < .05, **p < .01, ***p < .001 
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Table 2.4  
Meta-Analyses of the Relationships between Illness Representations and Role Functioning, Illness Representations and Physical Functioning, and Illness 
Representations and Quality of Life 
 Role-Functioning  Physical-Functioning  Quality-of-Life 
Illness-Representation k N rz (95%CI) Nfs Q I
2  k N rz (95%CI) Nfs Q I
2  k N rz (95%CI) Nfs Q I
2 
Identity 4 1124 -.309*** (-.384,-.235) 136 3.56 28.14  4 1171 -.505*** (-.676,-.335) 350 19.57*** 86.94  6 1289 -.607*** (-.772,-.443) 808 31.04*** 86.22 
Cause                        
Timeline-(Acute/Chronic) 4 1104 -.108*** (-.167,-.049) 11 .60 <.01  6 1323 -.265*** (-.378,-.152) 164 15.01* 72.11  8 1478 -.176*** (-.241,-.112) 97 7.13 24.95 
Timeline-(Cyclical)         4 439 -.347*** (-.442,-.252) 74 1.44 <.01         
Consequences 7 1689 -.184*** (-.272,-.096) 133 18.17** 65.58  8 1693 -.367*** (-.481,-.253) 595 28.10*** 79.30  8 1621 -.445*** (-.530,-.360) 800 16.61* 58.80 
Personal-Control 6 1462 .072** (.021,.124) 5 8.50 .01  6 1334 .118** (.042,.194) 32 8.43 39.89  8 1509 .122** (.042,.203) 50 13.92 50.91 
Treatment-Control 5 1320 .088** (.034,.143) 10 1.91 <.01  5 1244 .178*** (.078,.277) 63 9.59* 62.27  7 1337 .130* (.007,.254) 63 22.64*** 75.83 
Illness-Coherence 5 1346 -.069 (-.269,.132) 10 56.94*** 91.88  5 1232 -.006 (-.179,.167) 0 38.13*** 87.20  6 1296 .043 (-.182,.267) 0 85.81*** 92.84 
Emotional-Representations 4 1132 -.292*** (-.350,-.233) 116 3.51 .09  7 1637 -.205*** (-.312,-.099) 176 19.73** 75.80  7 1539 -.426*** (-.501,-.351) 592 9.89 44.93 
  
Note. k = number of studies, N = total sample size across included studies, rz = effect size, (95%CI) = 95% confidence intervals around the effect size, Nfs = Rosenthal’s fail-safe N (measure of publication 
bias), Q = measure of heterogeneity (suggests heterogeneity when statistically significant), I2 = measure of heterogeneity (25% = low, 50% = moderate, 75% = high) 
*p < .05, **p < .01, ***p < .001 
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in random-effects meta-regressions. Most meta-regressions indicated non-significant and 
negligible moderator effects of study design. However, relationships between depression and 
identity (B = -.15), acute/chronic timeline (B = -.18), and consequences (B = -.15) were 
significantly smaller in longitudinal studies. The same pattern of significantly smaller effect 
sizes in longitudinal studies was also found for the relationships between psychological 
distress and emotional representations (B = -.29) as well as treatment control (B = .16; note 
that the pooled correlation in this case was negative, thus the positive B indicates smaller 
effects), and between anxiety and acute/chronic timeline (B = -.17). Overall, though smaller 
in effect, these findings suggest that relationships between illness representations, illness 
outcomes and coping behaviours were mostly stable overtime. 
Relationship of Illness Representations to Coping Behaviours: Narrative Review  
A narrative review was conducted for the 16 studies where data required for 
quantitative meta-analysis could not be obtained (see Appendix 2.8 for a summary of study 
characteristics). There were five studies (Grande, Arnott, Brundle, & Pilling, 2014; Grande, 
Myers, & Sutton, 2006; Iskandarsyah, Klerk, Suardi, Sadarjoen, & Passchier, 2014; Landers, 
McCarthy, Livingstone, & Savage, 2014; Llewellyn, McGurk, & Weinman, 2007a) that 
examined coping behaviours, four of which (Grande et al., 2014; Grande et al., 2006; 
Iskandarsyah et al., 2014; Landers et al., 2014) focused on problem-focused coping via 
specific behaviours. The results of these studies are in line with the meta-analysis findings, 
with higher personal control associated with positive outcomes from participating in a cancer 
community support group (Grande et al., 2006), particularly in combination with higher 
emotional representations (Grande et al., 2014; Grande et al., 2006). More mixed results 
emerged for illness representations capturing negative consequences of illness; with higher 
identity scores and cyclical timeline related to better medication adherence (Landers et al., 
2014), while women with more negative illness representations (or a more negative view of 
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their breast cancer) were more likely to miss treatment sessions (Iskandarsyah et al., 2014). 
This mixed pattern is perhaps most evident in (Llewellyn et al., 2007a), where several coping 
strategies were associated with each illness representation, for example higher perceived 
consequences of cancer and lower levels of illness coherence (understanding) were associated 
with higher levels of avoidance coping.  
Relationship of Illness Representations to Illness Outcomes: Narrative Review 
 Eleven of the 16 studies not included in the meta-analysis examined illness outcomes 
(Cook et al., 2015b; Cooper, Hankins, Rixon, Eaton, & Grunfeld, 2013; Dempster et al., 
2011; Giannousi, Manaras, Georgoulias, & Samonis, 2010; Gray et al., 2014; Gray et al., 
2011; Jørgensen, Frederiksen, Boesen, Elsass, & Johansen, 2009; Mickevičiene, Vanagas, 
Jievaltas, & Ulys, 2013; Millar, Purushotham, McLatchie, George, & Murray, 2005; Scharloo 
et al., 2005; Traeger et al., 2013), along with one study examining both illness outcomes and 
coping behaviours (Llewellyn et al., 2007a). These findings were also largely in line with the 
results of the quantitative meta-analysis. Poor role functioning was associated with a 
perception of more negative consequences of cancer, less perceived personal control over 
cancer, and more perceived cancer symptoms (Cooper et al., 2013; Scharloo et al., 2005). 
Higher levels of anxiety were associated with less perceived personal and treatment control 
over cancer, a greater emotional impact of cancer (higher emotional representations), and 
more severe consequences of cancer (Cook et al., 2015b; Dempster et al., 2011; Gray et al., 
2014). Similarly, higher levels of depression were associated with less perceived personal and 
treatment control over cancer, a greater emotional impact of cancer, more severe 
consequences of cancer, as well as a more chronic perceived timeline of cancer (Dempster et 
al., 2011; Giannousi et al., 2010; Gray et al., 2014; Llewellyn et al., 2007a). As expected, 
higher levels of psychological distress were also associated with a greater emotional impact 
of cancer, more severe consequences of cancer, a more chronic perceived timeline of cancer, 
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as well as more perceived cancer symptoms (Jørgensen et al., 2009; Mickevičiene et al., 
2013; Millar et al., 2005). Finally, a better quality of life was associated with less perceived 
cancer symptoms, a less cyclical timeline, less severe consequences of cancer, less emotional 
impact of cancer, and greater perceived personal and treatment control over cancer (Gray et 
al., 2011; Jørgensen et al., 2009; Mickevičiene et al., 2013; Scharloo et al., 2005).  
Discussion 
This systematic review and meta-analysis aimed to determine whether and how 
coping behaviours and illness outcomes in cancer are associated with illness representations 
in the Common Sense Model (CSM; Leventhal et al., 1980). The findings were generally 
consistent with our hypotheses and provided support for associations between the illness 
representation dimensions of the CSM, coping behaviours, and illness outcomes in cancer. 
The findings broadly replicated the patterns of associations between illness representations, 
coping, and illness outcomes in chronic illness (Hagger & Orbell, 2003), but add a specific 
cancer perspective, longitudinal data, and a narrative review of relevant studies. These 
findings have particular implications for the content of illness representation based 
interventions (Stanton, Luecken, MacKinnon, & Thompson, 2013). 
Regarding coping behaviours, personal control perceptions appear to be the most 
promising areas to target to improve adaptive coping responses (cognitive reappraisal and 
problem-focused coping). In addition, emotional representations were associated with 
avoidance/denial coping behaviours. These findings are in line with Lazarus’s general coping 
theory (Lazarus, 1993), as perceptions of control have been identified as preconditions for 
effective problem-focused coping, whereas emotional representations might foster emotion-
focused coping responses to the cancer experience; as outlined in the parallel processing 
structure of the CSM. However, it is important to note that normative classifications of 
coping as adaptive or maladaptive are difficult, as factors such as cancer stage, time since 
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diagnosis, and outcome of the coping behaviour, can influence whether a coping strategy 
(such as avoidance/denial) would be considered adaptive or maladaptive (Salander & 
Windahl, 1999). 
Regarding illness outcomes, higher levels of identity (perceived symptoms) and 
consequence perceptions were associated with higher levels of psychological distress, and 
lower levels of functioning and quality of life. Higher levels of control-related illness 
perceptions were associated with lower levels of distress and higher levels of functioning and 
quality of life. The findings for illness coherence had high heterogeneity, suggesting the 
relationships between coherence and illness outcomes may have been influenced by a 
moderator, such as treatment type. For example, an examination of the raw data suggested 
that those without an ostomy who had higher levels of illness coherence experienced better 
quality of life, physical and role functioning (better understanding is associated with better 
illness outcomes for people without an ostomy). In contrast, those with an ostomy and higher 
levels of illness coherence experienced poorer quality of life, physical and role functioning 
(better understanding is associated with worse illness outcomes for people with an ostomy) 
(Mols et al., 2014).  
In general, the relationship between illness representations and coping behaviours 
were not as strong as those between illness representations and illness outcomes. This may be 
due to the fact that there were fewer studies examining coping behaviours than illness 
outcomes, so there was less power to detect effects (Cafri, Kromrey, & Brannick, 2010). 
Another explanation may be a potential overlap between illness representations and illness 
outcomes (e.g., consequences and quality of life or emotional representations and 
psychological distress). Further, as many studies were cross-sectional, emotional 
representations were likely to be highly correlated with measures of psychological distress. 
Finally, the level of specificity of the measures may influence the strength of these 
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relationships, in that illness outcomes (as more general evaluations of health status) may be 
more likely to correlate with illness representations than specific coping behaviours.  
Implications and Future Research Directions 
For many people a cancer diagnosis is associated with acute and/or delayed emotional 
distress, clinical levels of depression and anxiety, poor role and physical functioning, and a 
poor quality of life (e.g., Bultz & Holland, 2006; Carlson et al., 2004; Croom et al., 2013; 
Edwards & Clarke, 2004). Some cancer survivors experience poor mental and physical health 
outcomes for up to ten years post diagnosis (Harrington et al., 2010). Further, coping with 
cancer is extremely complex (Parle, Jones, & Maguire, 1996), with maladaptive coping 
strategies such as avoidance or denial likely to lead to higher levels of worry, anxiety, and 
depression (Deimling et al., 2006). The current systematic review suggests that in order to 
foster coping behaviours and improve mental health outcomes it may be beneficial for 
interventions to target patients’ maladaptive or unrealistic illness representations. It has been 
shown that mapping and challenging maladaptive illness representations, while at the same 
time forming alternative representations, can change both illness representations and role 
functioning, leading to improved psychosocial outcomes (Siemonsma et al., 2013). These 
findings are promising, and illness representations have been suggested as mediators of 
psychosocial intervention effects (Stanton et al., 2013). However, few intervention studies 
exist and none specifically target people with cancer or provide an explicit rationale for 
which illness representations to target. 
The present review provides some suggestions for which illness representations might 
be best to target in interventions, though the cross-sectional nature of the majority of included 
studies precludes judgments regarding causality and suggestions must be considered with 
caution. Interventions that target perceptions of personal control may be useful to increase 
use of adaptive coping strategies such as cognitive reappraisal, and reduce maladaptive 
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coping strategies such as avoidance/denial. Further, interventions that aim to adapt timeline 
perceptions to be less cyclical and chronic, decrease perceptions of the severity of cancer, and 
decrease the perceived emotional impact of cancer, may reduce psychological distress, and 
improve role functioning, physical functioning, and quality of life.  
In interventions targeting illness representations, it is important to acknowledge that 
some perceptions about poor illness outcomes may be realistic; for a person with terminal 
cancer, representations of a chronic timeline, severe consequences, and less personal control 
may be justified. In these cases interventions could better target illness representations such 
as emotional representations and coping. Future research should examine how stage of illness 
influences illness representations, and what type of interventions would be best for cancer 
patients at early versus advanced stages. 
Strengths and Limitations 
Although the CSM has been used extensively to examine health and coping outcomes, 
the present systematic review is the first to assess illness representations with health and 
coping outcomes in people with cancer specifically, with the results helping to guide 
intervention development, particularly by deepening understanding of the nature of cognitive 
responses associated with the cancer experience. A further strength is the inclusion of a 
number of unpublished correlations obtained from authors, creating a comprehensive meta-
analysis. 
The present review has some limitations, including the potential for publication bias, 
missing correlational data, and the examination of cross-sectional and correlational data. To 
control for publication bias a random-effects model was used (Cafri et al., 2010). Although 
the focus on quantitative data may have potentially impacted on the results of the meta-
analysis, the inclusion of the narrative review and synthesis aimed to avoid missing relevant 
or contrasting findings. In addition, an assessment of included studies suggested a low risk of 
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bias at the study level. However, as the majority of studies used cross-sectional study designs 
and correlational analyses, judgements regarding causality or predictive relationships 
between variables are precluded, limiting the conclusions to be drawn from this review. 
Further, zero-order correlations need to be interpreted with caution as it cannot be assumed 
that observed associations will remain stable if other illness representations are accounted for 
in multivariate analyses. 
Another limitation is the potential for overlap between measures (i.e. illness 
representations and illness outcomes). For example, items assessing emotional 
representations and emotional distress may overlap, making these concepts difficult to 
entangle. However, the CSM assumes these to be distinct processes, with Moss-Morris et al. 
(2002) suggesting that emotional representations allow researchers to investigate both coping 
behaviours and illness outcomes. The authors of the IPQ-R claim to have ensured that the 
emotional representations concept was not simply a measure of general mood by ensuring 
discriminant validity with both positive and negative affect (Moss-Morris et al., 2002).  
Consistent with recommendations by Weinman et al. (1996) and Moss-Morris et al. 
(2002) that users adapt the IPQ and IPQ-R to be illness specific, over fifty percent of studies 
included in the systematic review changed these to be ‘cancer specific’. Though each cancer 
specific adaptation could influence the reliability and validity of generic versus specific 
versions of the IPQ, this appears unlikely as the majority of changes involved simply 
replacing wording (e.g., Corter et al., 2013), or adjusting the identity and causes subscales to 
include items specifically related to cancer or a specific cancer type (e.g., Costanzo et al., 
2011; Freeman-Gibb, 2012). 
Several fail-safe Ns of zero were found in analyses with small numbers of studies 
included, suggesting a lack of statistical power (Card, 2012). However, as fail-safe N does 
not take into account heterogeneity, this may be an artefact of the heterogeneous population 
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in the meta-analysis (i.e. differing cancer types, cancer stages, and treatment types) (Card, 
2012). There was high heterogeneity found across several relationships in the meta-anlyses, 
and psychological distress and adaptability to cancer varies greatly with different types of 
cancer (Zabora & MacMurray, 2012) or cancer stages (Strada & Sourkes, 2010). However 
few studies reported this information, precluding moderator analyses on these variables. 
Similarly, treatment type or toxicity might also have impacted associations, with people at a 
higher risk for psychological distress when receiving treatment other than surgery or having 
little role in the treatment decision making process (Admiraal, Reyners, & Hoekstra-Weebers, 
2013; Hack et al., 2010); but again there was insufficient data to allow moderator analyses, as 
underpowered moderator tests may result in failure to detect the true effect of an important 
moderator (Cafri et al., 2010).  
Conclusions 
This systematic review has provided support for the validity of the illness 
representation construct in the CSM, and has summarised the associations between illness 
representations, coping behaviours and illness outcomes in people with cancer. The review 
found small to moderate relationships between illness representations and coping behaviours, 
and moderate to large relationships between illness representations and illness outcomes. 
These findings suggest that cognitive representations are key factors to understanding 
individual responses to cancer.  
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Abstract 
Purpose: The Common Sense Model is the leading psychological model of behavioural self-
regulation in the face of illness, using subjective illness representations to explain how people 
cope with illness. However, this model has rarely been examined in the context of mental 
health. This review summarises associations between illness representations, health and 
coping outcomes in people with depression. 
Methods: A systematic literature search identified 19 out of a potential 1,008 studies, with 10 
providing sufficient data for random-effects meta-analysis, and nine included in a narrative 
review. 
Results: Results found that more severe consequences were associated with more coping 
efforts, while higher identity, consequences, emotional representations, a more chronic 
timeline, and lower control were associated with more severe outcomes. 
Conclusions: The illness representations identified seem to play an important role in 
behavioural self-regulation of depression. This suggests targeting these illness representations 
(in particular, identity, timeline, consequences, control, and emotional representations) in 
psychosocial interventions to improve coping and reduce psychological distress. 
 
Keywords: depression; illness perceptions; common sense model of illness representations; 
systematic review; meta-analysis 
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Depression is a highly prevalent, disabling mental illness that is estimated to affect 
over 350 million people worldwide (Marcus et al., 2012). Depression has been associated 
with greater risk for physical disability (inability to perform activities due to impairment) 
(Brenes et al., 2008; Lenze et al., 2001), poor psychosocial functioning (Wells & Sherbourne, 
1999), and poor quality of life (Brenes, 2007; Wells & Sherbourne, 1999). A key factor in 
both the etiology and treatment of depression are negative beliefs or schemas that lead to 
negative thoughts that occur when faced with adverse life events, leading to negative or 
depressed mood (A. T. Beck et al., 1979). These negative beliefs also influence how people 
with depression think about their illness, which in turn influences whether and how people 
cope with and manage depression, make treatment decisions, seek professional help, or 
adhere to anti-depressant medication (Lynch, Kendrick, Moore, Johnston, & Smith, 2006; 
Prins, Verhaak, Bensing, & van der Meer, 2008). These illness-related behaviours are 
perhaps best understood in light of a theory that explicitly addresses how people make 
decisions and cope with illness, which would suggest utilising theories from a Health 
Psychology rather than a Clinical Psychology background.  
In order to understand the idiosyncratic patterns of beliefs that determine how people 
cope with their depression, the Common Sense Model of Self-Regulation of Health and 
Illness (CSM; Leventhal et al., 1980) should be considered. This model has been used widely 
to gain a systematic understanding of how people perceive chronic physical illnesses, and 
how this relates to coping attempts and illness outcomes. In order to establish whether the 
CSM might be a useful framework to inform Cognitive Behavioural Therapy (CBT; A. T. 
Beck et al., 1979), the currently most used and best-evidenced psychotherapeutic intervention 
for depression (Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012), our study aims to provide 
a systematic overview of the associations between the concepts from this theory, coping, and 
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illness outcomes in people with depression1. 
In CBT-based treatments for depression (A. T. Beck et al., 1979; J. S. Beck, 2011), 
those thoughts and beliefs of a client (that are often negative or inaccurate) that contribute to 
the experience of depression are targeted for modification in an attempt to create lasting 
improved emotional and behavioural change. Here, negative automatic thoughts that lead to 
depressive symptoms are challenged through reality-testing and generating alternatives. To 
do this, the person with depression must first become familiar with their own negative 
automatic thoughts and the role they play in influencing their emotions and behaviours. This 
means that in order to treat depression successfully, both client and therapist need to find a 
common ground in defining and understanding depression (e.g., Tryon & Winograd, 2011), 
which underlines the importance of subjective illness concepts. This is where the Common 
Sense Model could make an important contribution. The CSM has been used as a framework 
with which to understand these cognitive processes in people with physical illnesses 
(Leventhal et al., 1980). According to the CSM, individual representations of the illness and 
associated emotional responses work in parallel to guide peoples’ coping responses, which 
are later appraised in terms of their success or failure. Representations, coping, and appraisal 
are part of a multi-directional and self-regulative feedback loop (Diefenbach & Leventhal, 
1996) (Figure 3.1). 
The key factors that explain why and how individuals cope with their illness are 
subjective illness representations (or illness perceptions). These can be defined as 
individuals’ common sense understanding of the illness (Leventhal et al., 1998; Leventhal et 
al., 1980). Identity (“What defines whether I have this illness?”) refers to a person’s 
associations with the label of the illness (e.g. “depression”) and which symptoms someone 
                                                          
1 Anxiety was also included in the systematic search process; however only one study including anxiety was 
located and therefore it could not be examined in this review. 
55 
associated with this illness (e.g. fatigue). Cause refers to a person’s beliefs about the causes 
of the illness (e.g. stress). Timeline refers to the perceived duration of the illness (e.g. acute or 
chronic). Consequences (both imagined and real) refer to perceived beliefs about the effect of 
the illness on an individual’s life (e.g. loss of social life). Curability or controllability refers 
to people’s perceptions about whether the illness can be controlled or cured by themselves or 
others (e.g. incurable but controllable with treatment) (Leventhal et al., 1998). Later revisions 
of the framework proposed that control beliefs have two distinct dimensions - personal 
control - the amount of control an individual perceives to have over the illness, and treatment 
control - the amount of control the individual perceives their treatment has over the illness. 
These revisions also included a distinct dimension for cyclical timeline perceptions, an illness 
coherence subscale to assess perceptions of an individual’s understanding and comprehension 
of the illness, and a separate emotional representations subscale to assess the individual’s 
emotional response to the illness (Moss-Morris et al., 2002).  
 
Figure 3.1. The common sense model of self-regulation of health and illness (Leventhal et 
al., 1980), adapted from Diefenbach and Leventhal (1996). 
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Illness representations play a key role in how people respond to and experience their 
illness. Systematic reviews on the CSM in physical illness (Hagger & Orbell, 2003) show that 
perceiving an illness as highly symptomatic with a chronic timeline and serious consequences 
is associated with maladaptive coping strategies such as denial, and negative illness outcomes 
such as lower role functioning; while perceptions of the illness as curable and controllable 
were associated with more adaptive coping strategies such as adherence to treatment, and 
positive illness outcomes such as psychological well-being. Focusing on depression and 
anxiety as illness outcomes, a recent review (Dempster et al., 2015) found very similar 
patterns, with perceptions of more serious consequences and greater emotional 
representations most strongly associated with higher levels of depression and anxiety. The 
associations identified in both reviews highlight that it is crucial to gain an understanding of 
individuals’ subjective illness representations. However, neither of these previous systematic 
reviews took into account how these representations may be associated with coping 
behaviours and illness outcomes in people with depression. 
Although the CSM was originally designed in the context of physical illness, it has 
also been successfully applied in mental illness (e.g., Akcakaya, 2012; Glattacker, Heyduck, 
& Meffert, 2013). This is likely due to the fact that mental illnesses such as depression 
require self-management and self-regulation, central components of the CSM. However, 
these relationships may be complicated by potential reciprocity between illness perceptions 
and depression, which may, for example, make it particularly difficult to disentangle 
emotional representations of depression from emotional symptoms of the illness (Alderson et 
al., 2012). Alderson et al. (2012) also note that depression illness perceptions might be more 
complex than those in physical illness, with depression identity and timeline beliefs highly 
idiosyncratic, and most participants perceiving complex multi-factor causes for their 
depression. Further, influenced by depressive schemas, some people with depression might 
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perceive no control over their depression at all.  
A recent review on illness perceptions in mental illness in general by Baines and 
Wittkowski (2013) included a qualitative summary of four studies in people with depression. 
This summary revealed that identity, timeline, personal control, and consequences, were 
associated with depression severity; that identity, consequences, and control beliefs were 
associated with the use of particular coping behaviours; and that control beliefs, timeline, and 
causal beliefs were associated with medication adherence.  
The CSM has led to an improved understanding of how people self-regulate their 
behaviours when faced with physical illness (Dempster et al., 2015; Hagger & Orbell, 2003). 
However, although two systematic reviews on CSM-based illness representations in mental 
illness exist (Alderson et al., 2012; Baines & Wittkowski, 2013), no previous review has 
quantitatively summarised and reviewed the evidence on the relationships between illness 
representations, coping behaviours, and illness outcomes in people with depression 
specifically. This might have particular implications for CBT-based treatments for 
depression: Although CBT has been shown to be effective at changing specific underlying 
beliefs found in depression (Hollon, Stewart, & Strunk, 2005), therapeutic interventions 
could be better targeted to illness-based cognitions. If we are able to identify a common 
pattern of beliefs that lead people with depression to engage in effective and adaptive 
behaviours, then specifically designed targeted CBT programs incorporating appropriate 
aspects of the CSM that aim to improve coping and reduce negative outcomes can be 
designed and implemented. The present review aims to synthesise the research that examines 
how such beliefs are related to coping and illness outcomes in order to provide appropriate 
direction for the creation of such tailored interventions. 
Method 
Literature Search, Inclusion Criteria, and Study Selection 
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This systematic review followed PRISMA guidelines (Moher et al., 2009, Appendix 
3.1). The following databases were searched: Scopus, Web of Science, PubMed, PsycINFO, 
and Google Scholar. The keywords were: (anxiety OR "anxiety disorder*" OR depress* OR 
"depress* disorder*") AND ("illness perception*" OR "illness representation*" OR "common 
sense" OR Leventhal* OR IPQ*). See Appendix 3.2 for the full search strategy for each 
database. Manual searches of reference lists of included articles were conducted to identify 
additional studies for review, with attempts to locate missing data sets undertaken by 
contacting relevant authors. 
Inclusion criteria for studies in this review were: (a) used the Illness Perception 
Questionnaire (IPQ; Weinman et al., 1996), the Revised IPQ (IPQ-R; Moss-Morris et al., 
2002), or the Brief IPQ (B-IPQBroadbent et al., 2006), (b) measured coping behaviours or 
illness outcomes, (c) adult participants (over 18 years) with a diagnosis of depression or 
anxiety, (d) was written in English or German. 
Following database screening, 2098 articles were identified, with 1008 articles 
remaining following duplicate removal. Of these, 965 studies were removed for not meeting 
inclusion criteria. Inter-rater agreement between two authors during abstract screening was 
68.63% (Cohen’s Kappa = .69). Full texts were retrieved of the remaining 43 articles, with a 
further 26 excluded. Two additional studies were found and included following a manual 
search of the reference lists, which left 19 studies for coding (manual and coding sheet in 
Appendix 3.3 and 3.4). Ten studies provided appropriate and relevant statistical data and 
could be included in the meta-analysis (Akcakaya, 2012; Baines, Wittkowski, & Wieck, 
2013; C. Brown et al., 2001; Cabassa, Lagomasino, Dwight-Johnson, Hansen, & Xie, 2008; 
Fortune, Barrowclough, & Lobban, 2004; Glattacker et al., 2013; Horn, Kneisler, Schuster, & 
Traue, 2010; Houle et al., 2013; Lu et al., 2014; Vollmann et al., 2010), with the remaining 
nine studies subject to a narrative review (C. Brown et al., 2007; Elwy et al., 2016; Elwy et 
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al., 2011; Hunot, Horne, Leese, & Churchill, 2007; Kelly, Sereika, Battista, & Brown, 2007; 
Mc Sharry et al., 2013; O'Mahen, Flynn, Chermack, & Marcus, 2009; Patel, Wittkowski, 
Fox, & Wieck, 2013; E. C. Ward, Mengesha, & Issa, 2014). A flow chart of the study 
selection process is displayed in Figure 3.2. See Table 3.1 for a summary of key 
characteristics of the studies.  
Coding of Coping Behaviours and Illness Outcomes 
The coping behaviours included in the articles reviewed were categorised into logical 
subsets using categories adapted from Hagger and Orbell (2003), with seven categories 
identified: expressing emotion, avoidance/denial, problem-focused coping (generic), 
treatment decision making, medication adherence, seeking social support, and other 
(specified) coping behaviour. Due to small cell sizes (most of these coping categories were 
only populated by one study), these categories were collapsed into one ‘coping’ scale which 
measured the extent to which participants used or did not use the above specified coping 
behaviours. 
Illness outcomes were also classified using adapted and extended categories identified 
by Hagger and Orbell (2003), resulting in nine categories: affect (positive), anxiety, 
depression (severity), psychological distress, psychological well-being, vitality, role 
functioning, physical functioning, other illness outcome (general health). Similar to the 
classification of coping behaviours, small cell sizes prevented an analysis of distinct 
categories, and analogous to Hagger and Orbell (2003), affect, anxiety, depression, 
psychological distress, and psychological well-being were collapsed into one ‘psychological 
distress’ dimension. Although it may seem circular to examine psychological distress when 
our population of interest is people with depression, some illness representations are 
associated with less psychological distress (e.g., control perceptions), suggesting that this 
relationship is of practical importance. 
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Figure 3.2. Flow chart of the study selection process. 
Records identified through 
database searching 
(n = 2098) 
Records after duplicates removed 
(n = 1008) 
Titles screened 
(n = 1008) 
Titles excluded 
(n = 852) 
Abstract screened 
(n = 156) 
Abstracts excluded 
(n = 113) 
Full-text articles 
assessed for eligibility 
(n = 43) 
Full text-articles 
excluded, with reasons 
(n = 26) 
Studies included in 
qualitative synthesis 
(n = 19) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 10) 
Additional records identified 
through other sources 
(n = 2) 
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Table 3.1 
Data Extraction and Study Characteristics 
Authors (Date) 
Depression 
or Anxiety 
Sample Size 
(Completed all 
Time Points) 
Sex (T1) Age (T1) Study Design IPQ Type Coping Behaviour Illness Outcome Relevant Results 
Akcakaya (2012) Depression 112 60% Male 
M = 59, SD = 
10.3, Range = 
30 - 81 
Longitudinal 
IPQ-R: Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Depression 
(Severity), Anxiety 
Consequences, timeline (acute/chronic), 
and emotional representations were 
significantly related to depression 
severity, while only emotional 
representations were significantly 
related to anxiety. 
Baines, Wittkowski, & 
Wieck (2013) 
Depression 
(Postpartum) 
43 100% Female 
M = 29.36, 
SD = 5.79, 
Range = 18 - 
40 
Longitudinal 
IPQ-R: Identity, Cause, Timeline 
- Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Depression 
(Symptom Severity) 
More perceived symptoms (higher 
identity scores), a more chronic 
timeline, less perceived personal 
control, and higher rates of emotional 
distress, were significantly related to 
depression symptom severity. 
Brown, Battista, Sereika, 
Bruehlman, Dunbar-
Jacob, & Thase (2007) 
Depression 191 70.68% Male 
M = 45.1, SD 
= 15.9 
Cross-sectional IPQ 
Multiple - e.g., 
Expressing Emotion, 
Cognitive Reappraisal, 
Avoidance/Denial, 
Other 
Multiple - e.g., 
Depression, 
Physical 
Functioning 
Illness representations associated with 
psychosocial functioning included 
perceived control, perceived duration, 
and perceived cause of depressive 
symptoms. Several coping behaviours 
(e.g., expressing emotion, cognitive 
reappraisal, avoidance/denial) mediated 
or moderated the relationship between 
illness representations and psychosocial 
functioning. 
 
Brown, Dunbar-Jacob, 
Palenchar, Kelleher, 
Bruehlman, Sereika, & 
Thase (2001) 
Depression 41 66% Female 
M = 43, SD = 
15.7 
Cross-sectional 
IPQ: Identity, Cause, Timeline, 
Consequences, Controllability, 
Expressing Emotion, 
Avoidance/Denial, 
Problem-Focused 
Coping Generic (x2), 
Other Coping 
Behaviour (x2) (Self-
Blame, Religion), 
Medication Adherence 
 
Perceived negative consequences for 
depression were associated with more 
active coping, religious coping, and 
self-blame, while perception of 
depressive symptoms as more chronic 
was associated with less planning. 
Perception of more depressive 
symptoms (increased identity) was 
associated with more self-blame, 
avoidance, and venting. 
 
Cabassa, Lagomasino, 
Dwight-Johnson, 
Hansen, & Xie (2008) 
Depression 339 
83.78% 
Female 
M = 49.73, 
SD = 12.53 
Cross-sectional 
IPQ-R: Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control 
 Depression 
(Symptom Severity) 
Perceptions of a more chronic timeline 
was significantly related to greater 
depression symptom severity, while 
perceptions of a less cyclical timeline 
were related to greater depression 
symptom severity (though not 
significantly). 
Elwy, Glickman, 
Bokhour, Dell, Mueller, 
Zhao, Osei-Bonsu, 
Rodrigues, Coldwell, 
Ngo, Schlosser, 
Vielhauer, Pirraglia, & 
Eisen (2013) 
Depression 271 93.3% Male 
Range = 20 - 
71+ 
Longitudinal 
IPQ-R: Identity, Cause, Timeline 
- Acute Timeline - Chronic, 
Timeline - Cyclical, 
Consequences, Personal Control, 
Treatment Control, External 
Control Illness Coherence, 
Emotional Representations 
Treatment Decision 
Making 
 
Veterans perceptions of their 
symptoms, cause, timeline (cyclical), 
and personal controllability, predicted 
receiving guideline-concordant 
treatment for depression. 
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Elwy, Yeh, Worcester, 
& Eisen (2011) 
Depression 30 53.33% Male 
M = 44, 
Range = 20 - 
61 
Qualitative IPQ-R 
Treatment Decision 
Making 
 
Those who sought treatment for 
depression had a better understanding 
of depression (illness coherence), 
perceived treatment would control their 
depression, and that there would be 
negative consequences if they did 
nothing. In contrast, those who did not 
seek treatment perceived that treatment 
would not control their depression, that 
the depression would be short-term, and 
that depression did not affect their 
everyday life. 
Fortune, Barrowclough, 
& Lobban (2004) 
Depression 101 100% Female 
M = 33, SD = 
5.5 
Cross-sectional 
IPQ: Identity, Cause, Timeline, 
Consequences, Control/Cure 
 Depression 
(Severity) 
Depression severity was significantly 
related to perception of more symptoms 
(identity), a more chronic timeline, 
more severe consequences, and less 
perceived personal control. 
Glattacker, Heyduck, & 
Meffert (2013) 
Depression 80 74% Female 
M = 48.5, SD 
= 9.5 
Longitudinal 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 
Physical 
Functioning (x2) 
(Pain), Role 
Functioning (x3) 
(Physical, 
Emotional, Social), 
Other Illness 
Outcome (Self-
Rated General 
Health), Vitality, 
Psychological Well-
Being, Depression 
(Symptom Severity) 
Illness perceptions were related to 
functioning. The strongest predictors of 
functioning were generally identity, 
consequences, and timeline 
(acute/chronic). 
Horn, Kneisler, 
Schuster, & Traue 
(2010) 
Depression 59 
69.49% 
Female 
M = 46, SD = 
8.7, Range = 
25 - 62 
Longitudinal 
IPQ-R: Cause, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 
Depression 
(Symptom 
Severity), Affect 
(Positive) 
Perceptions of a more cyclical timeline, 
more severe consequences, and stronger 
emotional representations were 
associated with increased depression 
symptom severity, while perceptions of 
a more chronic timeline, more severe 
consequences, stronger emotional 
representations, less personal control, 
and less illness coherence were 
associated with decreased positive 
affect. 
Houle, Villaggi, 
Beaulieu, Lespérance, 
Rondeau, & Lambert 
(2013) 
Depression 88 53.4% Male 
M = 42, SD = 
12.2 
Cross-sectional 
IPQ-R: Cause, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Treatment Decision 
Making (x3) 
(Antidepressant 
Acceptability, 
Psychotherapy 
Acceptability, 
Psychotherapy 
Preference) 
 
A perceived chronic timeline of 
depression was associated with 
preference for psychotherapy treatment, 
higher levels of treatment control was 
associated with higher levels of 
antidepressant acceptability, and a 
perception of more severe 
consequences of depression was 
associated with higher levels of 
psychotherapy acceptability. 
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Hunot, Horne, Leese, & 
Churchill (2007) 
Depression 
and Anxiety 
147 75% Female 
M = 40.1, SD 
= 12.6 
Longitudinal IPQ-R Medication Adherence  
Illness perceptions were not associated 
with antidepressant adherence. 
Kelly, Sereika, Battista, 
& Brown (2007) 
Depression 189 
70.4% 
Female 
M = 45.19, 
SD = 15.91, 
Range = 18 - 
87 
Cross-sectional 
IPQ: Identity, Cause, Timeline, 
Consequences, Control/Cure, 
Emotional Reactions 
Multiple - e.g., 
Expressing Emotion, 
Cognitive Reappraisal, 
Avoidance/Denial, 
Treatment Decision 
Making, Other 
 
Greater emotional reactions to 
depression were associated with 
maladaptive coping for both men and 
women, while greater perceived control 
over depression was associated with 
more adaptive coping strategies for 
women. 
Lu, Tang, Shan Liow, 
Wei Ni Ng, Su Hui Ho, 
& Chun Mun Ho (2014) 
Depression 110 54% Female 
M = 41.7, SD 
= 12.3, Range 
= 19 - 67 
Cross-sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Cognitive Reappraisal 
(Adaptive 
Rumination), Other 
Coping Behaviour 
(Maladaptive 
Rumination) 
Depression, 
Anxiety, 
Psychological 
Distress (x2) 
(Stress, Negative 
Emotions) 
Perceived chronic timeline, more severe 
consequences, less perceived personal 
control, and stronger emotional 
representations were associated with 
severity of depression, anxiety, stress, 
and negative emotions (psychological 
distress). Adaptive rumination was 
most strongly related to perceptions of 
a less chronic timeline, while 
maladaptive rumination was most 
strongly related to a perception of more 
severe consequences. 
Mc Sharry, Bishop, 
Moss-Morris, & 
Kendrick (2013) 
Depression 17 
52.9% 
Female 
Range = 31 - 
78 
Qualitative CSM Generally No specific DV No specific DV 
Diabetes and depression representations 
varied for those who saw interactions 
between conditions (e.g. in terms of 
causation), and those who saw their 
conditions as unrelated. Problems with 
medication adherence were frequently 
described, often with respect to the 
difficulty of living with multimorbid 
conditions. 
O'Mahen, Flynn, 
Chermack, & Marcus 
(2009) 
Depression 
(Perinatal) 
82 100% Female 
M = 30.02, 
SD = 4.9, 
Range = 19 - 
39 
Longitudinal 
IPQ: Cause, Timeline, 
Consequences, Control/Cure 
Other Coping 
Behaviour (Treatment 
Use) 
 
Beliefs in a more chronic timeline for 
depression symptoms significantly 
predicted treatment use. 
Patel, Wittkowski, Fox, 
& Wieck (2013) 
Depression 
(Postnatal) 
11 100% Female 
M = 29.4, 
Range = 22 - 
35 
Qualitative CSM Generally No specific DV No specific DV 
Although participants identified with 
PND, the CSM dimensions did not map 
onto the key themes identified - which 
were more related to self-worth. 
Vollmann, Scharloo, 
Salewski, Dienst, 
Schonauer, & Renner 
(2010) 
Depression 41 
56.10% 
Female 
M = 49.56, 
SD = 10.40, 
Range = 17 - 
67 
Cross-sectional 
IPQ-R: Identity, Cause, Timeline 
- Acute/Chronic, Timeline - 
Cyclical, Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Social Support (x5)  
Activation-oriented support was 
regarded as more helpful when people 
perceived depression as less chronic, as 
more controllable by treatment, and as 
caused by immunity malfunction. 
Ward, Mengesha, & Issa 
(2014) 
Depression 13 100% Female 
M = 71, 
Range = 60 - 
78 
Qualitative CSM Generally No specific DV No specific DV 
Women generally believed that 
depression was a normal reaction to life 
circumstances and that culturally 
sanctioned coping behaviours (e.g. 
religion and resilience) were 
appropriate. These factors may provide 
a barrier for seeking professional 
mental health care. 
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Data Extraction and Meta-Analytic Strategy 
From all articles included in the systematic review, authors and date of publication, 
depression type, sample characteristics (sex and age), study design, IPQ version and 
subscales, coping behaviours, illness outcomes, and a summary of relevant results were 
extracted (Table 3.1). 
 Zero-order correlations were the most frequently reported effect size in the included 
studies. Thus the average correlation coefficient weighted by sample size and calculated 
using Fischer’s Z transformations (rz). Where necessary, correlations were reversed to 
maintain consistency across studies (i.e., correlations with psychological well-being were 
reversed). If more than one measure was used by a single study to assess an outcome within 
the same category (e.g., emotional social support and informational social support), the 
average weighted correlation coefficient was calculated and used in order to avoid bias. 
Further, to minimise heterogeneity due to design, only the baseline (Time 1) result was used 
for longitudinal studies that measured an outcome at more than one time point. Eight authors 
were contacted to provide correlations not reported in the articles, with responses from four 
authors received, and three authors able to provide the relevant data required for meta-
analysis. The remaining articles were included in a narrative review. 
The meta-analyses were conducted in R (R Core Team, 2014) using the ‘metafor’ 
package (Viechtbauer, 2010). A random-effects meta-analysis was conducted, which allows 
for the assumption that the true effect size (the effect size in the underlying population of 
studies) may vary from study to study as a result of heterogeneity (Borenstein et al., 2010). 
The studies were likely to be heterogeneous in the present meta-analysis because of differing 
design, depression types, treatment types, and other sampling characteristics. 
To assess heterogeneity between studies, Q and I2 statistics were calculated. The Q 
statistic assesses the ratio of the variation in the observed effects to the within-study error, 
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suggesting heterogeneity when statistically significant (Huedo-Medina, Sanchez-Meca, 
Marin-Martinez, & Botella, 2006). The I2 statistic indicates the percentage of variance across 
studies that can be attributed to heterogeneity rather than chance, with increasing values 
representing increasing heterogeneity. While the I2 statistic gives an indication of the extent 
of true heterogeneity, the Q statistic provides only an indication of statistical significance. An 
I2 value of 25% is considered low, 50% considered moderate, and 75% considered high 
(Higgins, Thompson, Deeks, & Altman, 2003). 
Results 
Study Characteristics 
Sample sizes ranged between 11 and 339 (M  = 103). One study included participants 
with both anxiety and depression (Hunot et al., 2007), and three studies examined 
perinatal/postnatal/postpartum depression specifically (Baines et al., 2013; O'Mahen et al., 
2009; Patel et al., 2013). All studies except one (90%) adapted the IPQ to be ‘depression 
specific’, rather than using a generic measure of illness representations. This involved minor 
changes in wording and the inclusion of depression specific symptoms and causes, and 
accordingly resulted in some heterogeneity with regards to the assessment of depression. See 
Table 3.1 for more key study characteristics. 
Risk of Bias Assessment 
          Risk of bias was evaluated using four criteria relevant to the research aims assessed: (i) 
whether each version of the IPQ was administered as recommended; (ii) which IPQ 
dimensions were reported and assessed; (iii) study design; (iv) whether confounding variables 
were adjusted for. With respect to administration of the IPQ, IPQ-R, or B-IPQ, 36.64% of 
studies adhered to guidelines by developers (lower risk of bias), 31.58% partially adhered to 
guidelines by developers (medium risk of bias), and 31.58% used the CSM as a theoretical 
basis for qualitative interviews or did not adhere to developers’ guidelines (higher risk of 
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bias). The majority of studies (68.42%) assessed and reported all measured illness 
representation dimensions (lower risk of bias), with 5.26% assessing but not reporting all 
measured illness representations dimensions (medium risk of bias), and 26.32% not assessing 
nor reporting all measured illness representation dimensions (higher risk of bias). With regard 
to study design, 36.84% of studies were longitudinal (lower risk of bias), 42.11% of studies 
were cross-sectional (medium risk of bias), and 21.05% of studies were qualitative (high risk 
of bias). Only one study (C. Brown et al., 2001) adjusted for potential confounds (low risk of 
bias). See Appendices 3.5 and 3.6 for summary tables and a graph on risk of bias. 
Relationship of Illness Representations to Coping and Psychological Distress: 
Quantitative Analysis 
Table 3.2 shows that only the relationships between acute/chronic timeline and coping 
and acute/chronic timeline and psychological distress were subject to high heterogeneity (I2 = 
73.02 and I2 = 71.02 respectively). The remaining I2 values indicate moderate to low 
heterogeneity.  
The results from the meta-analyses between coping and illness representations 
represented small to moderate effects (following Cohen, 1992), while the results between 
psychological distress and illness representations represented small to large effects (Table 
3.2, Forest plots in Appendix 3.7). The strongest correlate of coping was consequences, with 
more depression-related consequences indicating more use of coping behaviours (both 
adaptive and maladaptive), rz = .205, 95% CI [.051, .360]. The next strongest correlates 
included cause (rz = .194, 95% CI [-.245, .632]) and treatment control (rz = .162, 95% CI [-
.014, .339]). 
Overall, there were stronger and more significant relationships between illness 
representations and psychological distress than between illness representations and coping. 
The strongest correlate of psychological distress was emotional representations, with higher 
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levels of emotional representations (stronger emotional responses to depression) indicating 
more psychological distress, rz = .481, 95% CI [.378, .583]. Other correlates included identity 
rz = .442, 95% CI [.289, .595], consequences rz = .435, 95% CI [.296, .573], acute/chronic 
timeline rz = .330, 95% CI [.193, .466], and personal control rz = -.253, 95% CI [-.384, -
.122]. Treatment control rz = -.151, 95% CI [-.301, -.002] and illness coherence rz = -.105, 
95% CI [-.202, -.007] were also statistically significantly related to psychological distress, but 
had smaller effect sizes. It is worth noting here that similar results and effect sizes were found 
for both cross-sectional and longitudinal data when analysed separately. 
Across all relationships funnel plots (Appendix 3.8) were generally symmetrical, 
suggesting that publication bias was unlikely (Light & Pillemer, 1984). The number of 
studies that fell outside the funnel varied between none and two, with those points falling 
outside the plot likely to represent heterogeneity in the data. Fail-safe N ranged from zero to 
198 across the relationships between illness representations and coping and illness 
representations and psychological distress (see Table 3.2). This suggests that we can only be 
confident that some of the relationships identified would not be altered by finding a large 
number of missing or unpublished contradictory data (Rosenthal, 1979).    
Relationship of Illness Representations to Coping and Psychological Distress: Narrative 
Review 
Nine of the 19 studies did not report relevant data, or data could not be obtained from 
authors on request. Using thematic analysis, we conducted a narrative review of these studies 
and identified four common themes. These themes broadly replicate the findings of the meta-
analysis. 
One theme related to perceptions of specific causes of depression that influenced both 
coping behaviours and illness outcomes. Elwy et al. (2016) found that veterans who 
perceived the cause of their symptoms to be family problems were less likely to receive 
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Table 3.2 
Meta-Analyses of the Relationships between Illness Representations and Coping, and Illness Representations and Psychological Distress 
 Coping  Psychological Distress 
 k N rz (95% CI) Nfs Q I2  k N rz (95% CI) Nfs Q I2 
Identity         4 342 .442*** (.289, .595) 89 5.68 48.16 
Cause 2 48 .194 (-.245, .632) 0 1.25 19.92         
Timeline (Acute/Chronic) 3 169 -.084 (-.397, .228) 0 6.88* 73.02  7 858 .330*** (.193, .466) 183 23.88*** 71.02 
Timeline (Cyclical)         6 759 .069 (-.003, .141) 5 3.14 <.01 
Consequences 3 170 .205** (.051, .360) 5 2.33 <.01  6 520 .435*** (.296, .573) 198 12.09* 58.37 
Personal Control 2 129 .048 (-.129, .225) 0 <.01 <.01  5 419 -.253*** (-.384, -.122) 42 6.69 41.82 
Treatment Control 2 129 .162 (-.014, .339) 1 .39 <.01  5 418 -.151* (-.301, -.002) 12 9.11 55.12 
Illness Coherence 2 129 .089 (-.087, .266) 0 .03 <.01  5 419 -.105* (-.202, -.007) 4 1.58 <.01 
Emotional Representations 2 129 .067 (-.109, .244) 0 .97 <.01  5 420 .481*** (.378, .583) 163 3.61 8.23 
Note. k = number of studies, N = total sample size across included studies, rz = effect size, (95%CI) = 95% confidence intervals around the effect size, Nfs = Rosenthal’s fail-
safe N (measure of publication bias), Q = measure of heterogeneity (suggests heterogeneity when statistically significant), I2 = measure of heterogeneity (25% = low, 50% = 
moderate, 75% = high), *p < .05, **p < .01, ***p < .001
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guideline-concordant treatment following a positive screen for depression. E. C. Ward et al. 
(2014) found that older African American women generally perceived that their depression 
was a normal reaction to life circumstances and that culturally accepted behaviours such as 
religion and resilience were appropriate strategies for coping with such depression. These 
studies suggest that perceiving external and stable causes for depression is associated with 
less help-seeking. C. Brown et al. (2007) suggests mechanisms for the cause-coping 
relationship by showing that the coping behaviours venting and self-blame mediated the 
relationship between the perceived cause stress and interpersonal problems (outcome). 
A second theme revolved around the effects of timeline perceptions and treatment 
seeking, but with more heterogeneous results. A more chronic timeline predicted treatment 
use (antidepressant or psychotherapy/counselling) (O'Mahen et al., 2009), while those who 
did not seek treatment for depression perceived a more acute or cyclical timeline (Elwy et al., 
2016; Elwy et al., 2011). In contrast, E. C. Ward et al. (2014) highlight that a perceived 
chronic timeline of depression may be a barrier to seeking appropriate professional mental 
health care. Further, C. Brown et al. (2007) found that two coping behaviours (behavioural 
disengagement and self-blame) partially mediated the relationship between perceived 
timeline of depression and psychosocial functioning. 
The third theme was related to the role of consequences for coping, which also 
revealed some diverse patterns and relationships. The perception of less severe consequences 
of depression in one’s day-to-day life was associated with reduced treatment seeking (Elwy et 
al., 2011), but at the same time, perceiving more severe consequences of depression was 
associated with less problem-solving oriented coping strategies and more maladaptive coping 
strategies such as behavioural disengagement or rumination (Kelly et al., 2007). 
A fourth theme emerged around the relationship of control perceptions and coping 
behaviours. Higher levels of control perceptions were associated with less likelihood of 
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receiving guideline concordant treatment for Veterans (Elwy et al., 2016). However, contrary 
to this, higher treatment control perceptions were associated with more treatment seeking 
(Elwy et al., 2011). In addition, higher treatment and personal control perceptions were 
associated with the use of more adaptive coping strategies, such as problem solving, positive 
reframing, and active coping, for women (Kelly et al., 2007). While on the other hand, low 
control perceptions predicted behavioural disengagement which in turn predicted lower 
psychosocial functioning (C. Brown et al., 2007).  
A further three studies could not be easily or clearly synthesised using thematic 
analysis. Hunot et al. (2007) found no significant relationship between continued 
antidepressant use and illness representations, and non-continued antidepressant use and 
illness representations. Mc Sharry et al. (2013) examined multimorbid illness representations 
and self-management in people with depression and diabetes. They found that diabetes and 
depression representations varied for those who perceived interactions between each 
condition (e.g., in terms of causation), and those who saw their illnesses as unrelated. These 
multimorbid representations were described as impacting on participants’ self-management. 
For example, due to the difficulty of living with multimorbid conditions, problems with 
medication adherence were commonly described. Finally, Patel et al. (2013) examined illness 
representations in mothers with postnatal depression using semi-structured interviews and 
concluded that the themes identified from these interviews did not clearly map onto the key 
illness representation dimensions of the CSM. Instead, this study revealed more complex 
conceptualisations of postnatal depression that seemed to be attached to mothers’ sense of 
self and self-worth.  
In summary, this narrative review broadly replicates the findings from the meta-
analyses, with the majority of studies finding and reporting some association between illness 
representations and coping behaviours or illness representations and illness outcomes. 
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Discussion 
The aim of this systematic review and meta-analysis was to determine whether and 
how illness representations are associated with coping behaviours and illness outcomes for 
people with depression. The CSM has been used extensively to examine health and coping 
outcomes in physical illness, however the present systematic review and meta-analysis was 
the first to assess the associations of illness representations specifically with health and 
coping outcomes in people with depression. This review provides new insights into the utility 
of the CSM for mental health, and can be used as the basis for interventions aimed at 
improving the health and coping outcomes of those with depression.  
Illness Representations and Coping Behaviours 
The strongest relationship with regard to coping identified in the meta-analysis was 
between consequences and the use of coping behaviours, with perceptions of more severe 
consequences associated with the use of more coping behaviours. The narrative review also 
found more severe consequences to be associated with the use of more coping strategies 
(including behavioural disengagement and rumination), though more severe consequences 
were also found to be associated with less treatment seeking. When combined, this suggests 
that the more severe people perceive the consequences of depression to be, the more likely 
they are to use various strategies to cope with it, but at the same time seem less likely to seek 
treatment. To understand this seemingly paradoxical relationship with both more maladaptive 
and less adaptive coping strategies, control beliefs might be of importance. More personal 
and treatment related control were associated with the use of not only more coping strategies, 
but specifically with the use of more adaptive coping strategies (including positive reframing, 
problem solving, active coping, and treatment seeking). This means that the more control a 
person feels over their depression, and the more control a person feels that their treatment has 
over their depression, the more likely that person is to use an adaptive coping strategy. This 
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finding is in line with research examining physical health conditions and recommendations 
for best practice in CBT. Finally, the narrative review also found that a more chronic timeline 
was associated with less treatment seeking. Taken together, these findings suggest that in 
order to increase the use of coping strategies it may be beneficial to target beliefs around 
consequences, both personal and treatment control, and chronicity of timeline. For example, 
personal control beliefs can be targeted in traditional CBT interventions that encourage 
patients to take more control over depressive thoughts, symptoms, and feelings (J. S. Beck, 
2011), but at the same time exploring causal and timeline beliefs might enrich CBT practice 
and provide target points for cognitive restructuring. In addition, interventions that explicitly 
target beliefs about depression and its treatment could remove barriers to treatment adherence 
(Elwy et al., 2011). 
Illness Representations and Illness Outcomes 
Findings from our meta-analysis matched previous reviews (Baines & Wittkowski, 
2013; Dempster et al., 2015; Hagger & Orbell, 2003), with higher identity (perceived 
symptoms), perceptions of a more chronic timeline, perceptions of more severe 
consequences, and stronger emotional representations, associated with more psychological 
distress. In contrast, higher perceived personal and treatment control, as well as stronger 
illness coherence, were found to be associated with lower levels of psychological distress. 
The narrative review generally revealed similar patterns of relationships between illness 
representations and illness outcomes. These findings suggest that identity, timeline, and 
control perceptions are the key illness representations to target in therapeutic interventions. 
For example, psychoeducational strategies could focus on increasing understanding and 
perceived control over depression, correcting beliefs regarding treatment control and the 
expected timeline of depressive episodes, reducing consequences and perceptions of severe 
consequences of depression, and improving emotional responses to depression.  
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Implications 
The current systematic review suggests that in order to both improve and increase the 
use of coping strategies, and improve mental illness outcomes such as psychological distress, 
it would be beneficial to target unrealistic or maladaptive illness representations in evidence-
based psychosocial interventions. For people with some chronic physical illnesses it has been 
shown that challenging maladaptive illness representations and forming alternate 
representations can both change illness representations and lead to improved psychosocial 
outcomes (Siemonsma et al., 2013). However, although such findings are promising, only 
few intervention studies exist (with none specifically targeting depression). Further, very few 
of these intervention based studies provide an explicit rationale for which illness 
representations are best to target. The present review provides some suggestions for which 
illness representations would be best to target in intervention trials – in particular perceived 
control. Further, interventions aimed at adapting timeline perceptions to be less chronic, 
decreasing perceptions of severe consequences of depression, and reducing the perceived 
emotional impacts of depression, may lead to less psychological distress. 
Limitations 
This review is limited by a lack of quantitative research examining the relationship 
between illness representations and specific coping behaviours, meaning that instead of 
assessing which representations were associated with the use of adaptive versus maladaptive 
coping strategies, we were only able to examine which illness representations were associated 
with the use of coping strategies in general. This lack of data also led results to suggest that 
the relationships between illness representations and coping behaviours were not as strong as 
those between illness representations and illness outcomes. However, the limited quantitative 
results, combined with the findings from the qualitative review, do provide some interesting 
insights into the relationships between illness representations and coping behaviours in 
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people with depression.  
It can be argued that a substantial overlap between depression, the illness outcomes 
measured (psychological distress), and illness representations (particularly emotional 
representations) precludes interpreting relationships between these factors. It seems obvious 
that if a person is depressed, this will influence their illness perceptions and the extent to 
which they experience psychological distress. However, according to Cognitive Theory 
(Clark & Watson, 1991), people have relatively stable core beliefs that can influence how 
people interpret and respond to specific information, and these core beliefs also impact 
individuals’ interpretation of illness. Therefore, specific illness representations may not only 
be influenced by how an individual perceives the illness, but also by their more generalised 
core beliefs.  
There is also the potential for overlapping items assessing depression, illness 
outcomes (psychological distress), and illness representations. For example, at times items 
assessing emotional representations and items assessing psychological distress may overlap, 
making these concepts difficult to entangle. However, the development process of the IPQ-R 
suggests discriminant validity between the emotional representations construct and positive 
and negative affect (Moss-Morris et al., 2002). In future, studies should take care to use items 
and measures that assess each individual construct as uniquely as possible to ensure 
appropriate discriminant validity is achieved. 
An assessment of included studies suggests some risk of bias at the study level, 
particularly when examining administration and modification of the IPQ, IPQ-R, and B-IPQ. 
These adaptations have the potential to differ substantially from the original questionnaires, 
meaning that the reliability and validity of the IPQ/IPQ-R may be affected. However, as the 
majority of studies included in the present review have adjusted the IPQ or IPQ-R by 
replacing generic wording to be more specific (e.g., illness for depression), or by adjusting 
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the identity and causes subscales to assess symptoms and causes that relate specifically to 
depression, this appears unlikely.  
Conclusion 
This systematic review provides support for the validity of the CSM’s illness 
representation dimensions for predicting illness outcomes (specifically psychological 
distress) in people with depression. Our findings suggest that such representations including 
perceived control, timeline, consequences, identity, and emotional representations are key to 
understanding how people respond to depression. These relationships can inform CBT-based 
interventions that target inaccurate or maladaptive illness representations. However, the low 
number and varying quality of the studies reviewed suggests that more high-quality research 
is needed before we can confirm which dimensions underlie the subjective illness 
understandings of people with depression. 
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Chapter 4 
Study 3 
‘It was all intertwined’: Illness representations and self-management in people with 
cancer and anxiety/depression* 
 
 
 
 
 
 
 
 
 
 
                                                          
*Richardson, E. M., Scott, J. L., Schüz, N. Sanderson, K., & Schüz, B. (2016). ‘It was all 
intertwined’: Illness representations and self-management in people with cancer and 
anxiety/depression. Manuscript under review. 
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Abstract 
Objective: Cancer and anxiety/depression frequently co-occur, leading to poorer outcomes 
for these illnesses. However, the majority of existing research investigates how participants 
view single illnesses alone. This study aimed to explore the content of individuals’ 
multimorbid representations and how these relate to their coping behaviours and self-
management strategies for cancer and anxiety/depression. 
Design: A semi-structured qualitative research design with theoretical thematic analysis.  
Main Outcome Measures: Multimorbid illness representations, coping behaviours, and self-
management strategies. 
Results: In interviews with 21 participants multimorbid representations varied, with three 
participants viewing cancer and anxiety/depression as unrelated, five participants uncertain 
about the relationship between cancer and anxiety/depression, and the majority of participants 
(13) perceiving cancer and anxiety/depression as related. This third group of participants 
often described relationships as causal, with representations having both positive and 
negative influences on coping behaviours and self-management strategies. Representations 
were shown to change over the course of the cancer experience, with fear of cancer 
recurrence and the influence of participants’ most challenging illness also discussed. 
Conclusions: People hold multimorbid illness representations that can influence self-
management. An awareness of these representations by researchers, health professionals, and 
patients is important for the creation of future interventions that aim to improve and maintain 
patient well-being.  
 
Keywords: cancer; anxiety; depression; multimorbidity; illness representations 
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Anxiety and depression commonly occur as co-morbid illnesses in cancer patients. A 
meta-analysis of 60 studies (Massie et al., 2011) investigated the prevalence of co-occurring 
cancer and depression, estimating this co-occurrence at between 1.5 and 52%. Massie et al. 
(2011) suggested that this high variability in prevalence may be due to differences in the 
measurement of depression, different criteria used to define depression, and varying 
conceptualisations of depression (e.g., depression severity, depressed mood, minor 
depression, major depression, depressive disorder, adjustment disorder with depressed mood, 
and dysthymia), across the studies included in their meta-analysis. However, despite this 
range in prevalence, Massie et al. (2011) state that it is beyond doubt that cancer is associated 
with high levels of depression. Rates of anxiety amongst cancer patients vary, but some 
research suggests that anxiety accompanies cancer more frequently than depression 
(Mystakidou et al., 2005). For cancer patients, anxiety and depression are associated with 
poorer functioning (social and emotional) and quality of life (Mystakidou et al., 2005), with 
depression (both major depressive disorder and depressive symptoms associated with 
adjustment disorder) even found to predict elevated mortality in those with cancer (Pinquart 
& Duberstein, 2010; Satin et al., 2009). To improve the outcomes of people with co-morbid 
cancer and anxiety/depression, it is important to consider how they experience and think 
about their illnesses, and how these subjective illness representations are associated with 
coping and self-management behaviours.  
One theoretical model that explores how patients’ representations of their illnesses 
relate to coping and self-management is the Common Sense Model of Health and Illness 
(CSM; Leventhal et al., 1980). According to the CSM, when individuals perceive a health 
threat, they access cognitive and emotional representations of that threat based on their 
current experience, information from the external social environment and past illness 
experience, and general knowledge (Leventhal et al., 1980). These representations guide 
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peoples’ coping responses and self-management strategies, and are appraised in terms of their 
success or failure in controlling the health threat and its consequences. Outcome appraisals 
then lead to the refinement of one’s illness representations, as well as the selection of new 
coping/management strategies (Diefenbach & Leventhal, 1996). Being faced with more than 
one health threat or illness makes this process much more complex, with potential 
difficulties, such as misattributions of symptoms or conflicting self-management strategies, 
arising at each stage of the self-regulation process (Schüz, Wolff, Warner, Ziegelmann, & 
Wurm, 2014).  
The key component of the CSM are illness representations; individuals’ common-
sense definitions of health threats (Leventhal et al., 1998; Leventhal et al., 1980), which 
guide individual coping attempts. A range of studies and meta-analyses underline the 
importance of these subjective representations for coping behaviours and illness outcomes in 
people with cancer (Richardson, Schüz, Sanderson, Scott, & Schüz, 2016), depression 
(Alderson et al., 2012), and mental illness (Baines & Wittkowski, 2013). However, only 
recently research has begun to examine illness representations in people with multiple 
illnesses. In a qualitative study on the content of illness representations and reported 
management strategies for people with multimorbidity, Bower et al. (2012) identified specific 
representations about multimorbidity, including medication burden, illness priority, and 
management synergies and antagonisms. In a second qualitative study (Mc Sharry et al., 
2013), participants with co-morbid diabetes and depression either described their illnesses as 
unrelated with separate management strategies for each, or as being related, which in turn 
implied common treatment factors and interactions between the illnesses. Those participants 
who saw interactions between diabetes and depression often perceived one illness as causing 
the other (e.g., diabetes as causing depression), and accordingly described the management of 
both illnesses as either integrated or conflicting, e.g., in perceiving the symptoms of 
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depression to interfere with diabetes self-management. Participants also differed in the 
confidence (strength) with which they described multimorbid illness representations, with 
participants again also highlighting problems associated with medication burden.  
Although these studies supported the CSM’s general framework of illness 
representations guiding coping behaviours and self-management strategies, they also 
identified illness representations that were specific to multimorbidity, highlighting the need 
for more qualitative research in this area. Multimorbid illness representations are likely to 
vary across different illnesses, and examining the specific combination of cancer and 
anxiety/depression may give rise to additional insights into the representations of people with 
multimorbid illnesses. For example, cancer is a complex illness, with varying cancer types, 
stages of disease, and treatment types experienced by patients. Varying cancer types and 
stages mean that the severity of cancer differs widely between patients, with toxic cancer 
treatments such as chemotherapy associated with multiple side effects, and cancer-related 
surgery affecting issues such as body image. These factors are likely to influence 
representations of multimorbid anxiety/depression with cancer, and may provide distinct 
insights into how patients cope with and self-manage these illnesses. Cancer patients also 
commonly experience fear of cancer recurrence (FCR), a form of anxiety uniquely associated 
with fears or worries of a return or progression of a previous or new cancer (Lee-Jones et al., 
1997; Simard et al., 2010). How FCR interacts with multimorbid representations, coping 
behaviours, and self-management strategies, could also provide important insights for this 
population. These unique issues associated with multimorbid cancer and anxiety/depression 
demonstrate the need for exploratory research within this population.  
There is currently little existing research into the experience of multimorbid cancer 
and anxiety/depression, with much of the research instead focusing on: the role of 
anxiety/depression and cancer as separate illnesses for illness management, groups of cancer 
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patients without a formal diagnosis of anxiety/depression, anxiety/depression as assumed 
elements of the sequela associated with adjustment to cancer, or examining predictors of 
anxiety/depression in cancer patients. In addition, the majority of research that has assessed 
experiences of cancer and anxiety/depression has examined the coping behaviours and self-
management strategies of each illness separately, rather than assessing them as integrated 
multimorbid illnesses. This study therefore is a first attempt to explicitly examine the 
experience of co-morbid cancer and anxiety/depression, rather than cancer and 
anxiety/depression separately.  
By using semi-structured interviews, we aimed to address existing gaps in the 
literature by examining the content of illness representations and their associations with 
participants reported coping behaviours and self-management strategies for multimorbid 
cancer and anxiety/depression. Based on previous research by Mc Sharry et al. (2013), three 
key questions were used to guide this study. What kind of illness representations do 
individuals have for both cancer and anxiety/depression? Do all individuals think about the 
relationships between multiple illnesses in similar ways? Do particular illness representations 
facilitate different coping behaviours or self-management strategies? 
Method 
Participants 
Participants were recruited via self-selection sampling through advertisements in local 
hospitals, in face-to-face support groups at Cancer Council Tasmania, and on appropriate 
Facebook pages (cancer support groups). Participants contacted the researcher and 
interviewer via phone or email and were invited to participate in the study if they met the 
following inclusion criteria: over 18 years of age, current or previous diagnosis with any type 
of cancer, current or previous experience with (diagnosed or treated for) anxiety or 
depression or both anxiety and depression.  
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Sample size was based on information power (Malterud, Siersma, & Guassora, 2015), 
a sampling criterion that addresses some of the limitations associated with the use of 
saturation (Glaser & Strauss, 2009; Malterud et al., 2015). Following the application of the 
information power criteria, 21 participants was considered an appropriate sample size, due to: 
the neither especially broad nor narrow study aims, the inclusion of participants specific to 
the research aim (based on meeting inclusion criteria), the study being supported by well-
established theory (the CSM), the strong rapport and interview dialogue between the 
interviewer (ER) and participants (due to a strong knowledge of the theoretical background 
and previous experience working with cancer patients), and the use of cross-case analysis.  
Materials 
Participants were required to complete a consent form, demographics and illness 
characteristics questionnaire, and the shortened version of the Depression Anxiety Stress 
Scale (DASS-21; Lovibond, Lovibond, & Psychology Foundation of Australia, 1995) to 
assess the current severity of the symptoms of each of these three negative emotional states. 
An interviewer guide that contained open-ended questions focusing on participant’s 
experience of cancer, anxiety and/or depression, as well as illness representations (for 
individual illnesses and those relating to multimorbidity), and coping and self-management 
strategies, was used to guide each interview (see Appendix 4.1 for the full interview guide). 
Procedure 
The study protocol was reviewed and approved by [withheld]. Participants were 
informed of the purpose of the study and the researchers’ reasons for conducting it (to 
increase and improve understanding of cancer patients’ thoughts and experiences) during 
contact. Although six participants were known to the interviewer through support work with 
Cancer Council [withheld], relationships were generally not established prior to study 
commencement. Following completion of the consent form, demographics and illness 
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characteristics questionnaire, and DASS-21 (Lovibond et al., 1995), face-to-face one-on-one 
semi-structured interviews were conducted by ER at either Cancer Council [withheld], the 
University [withheld], or in participants own homes. ER was a female PhD candidate in 
psychology with formal training and experience in support work with cancer patients. 
Interviews were audiotaped and lasted between 13 and 82 minutes (M = 50 minutes), ending 
when all key topics had been covered. To maintain rapport and trust between interviewer and 
participant, no field notes were taken during interviews.  
Analysis 
This study followed the Consolidated criteria for Reporting Qualitative research 
(COREQ) Checklist (Tong, Sainsbury, & Craig, 2007) (see Appendix 4.2). Interviews were 
transcribed verbatim and transcripts were imported into NVivo 10 qualitative data analysis 
Software (QSR International Pty Ltd., 2014) for ease of data management and thematic 
analysis. Participants were not given an opportunity to review interview transcripts as all 
information was de-identified to maintain confidentiality and ethical requirements.  
Analyses were conducted from a subtle realist viewpoint, which involves 
acknowledging the subjective perceptions of researchers while attempting to represent the 
underlying existing reality under study (Mays & Pope, 2000). As this study was conducted 
within a CSM framework (with a particular focus on illness representations), our analysis was 
conducted under the a priori assumption that participants have representations about their 
illnesses. Based on recent research examining multimorbid illness representations (Bower et 
al., 2012; Mc Sharry et al., 2013), a theoretical thematic analysis was conducted (Braun & 
Clarke, 2006). This approach is used to provide a more detailed analysis of some particular 
aspect of the data, in this case differences in representations between those who identified 
links between cancer and anxiety/depression and those that did not. However, although a 
theoretical thematic approach was used, themes were not identified in advance but were 
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instead derived from the interview data, allowing for a richer description of that data. 
Data analysis began with data immersion, which involved ER transcribing audiotaped 
interviews verbatim into written form and reading and re-reading completed transcripts to 
familiarise oneself with the data. ER then coded all transcripts into units of meaning using 
NVivo 10. Units of meaning were used rather than line-by-line, sentence, or paragraph blocks 
for coding, as predefined blocks of text may not accurately reflect meanings as intended by 
participants and important contextual information may be missed (Campbell, Quincy, 
Osserman, & Pedersen, 2013). To ensure reliability and to avoid missing important codes a 
second coder (JH) coded 5/21 (23.81%) interviews. Both inter-rater agreement (92.25%) and 
inter-rater reliability were good (Cohen’s Kappa = .664) between ER and JH. Following 
coding, codes were collated into potential themes. Finally, themes were reviewed, cross-
checked for overlap, defined, and named. Participants were not offered a chance to provide 
feedback on these themes, but instead could request to be sent any publications or research 
output arising from the research. 
Results 
Demographics and Illness Characteristics 
Of the 22 participants who were met for interview, 21 were included in the study (3 
males and 18 females), with one participant removed as they did not meet inclusion criteria 
(no diagnosis of or treatment for anxiety and/or depression). Participants were aged between 
23 and 75 years (M = 50 years, SD = 18 years), with four participants experiencing anxiety, 
five participants experiencing depression, and 12 participants experiencing both anxiety and 
depression at some point throughout their lifespan. For more demographics and illness 
characteristics, as well as DASS-21 scores, see Table 4.1 and Appendix 4.3. 
Thematic Analysis 
The main theme in the data was identified as representations of the relationships (or  
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Table 4.1 
Illness Characteristics and DASS-21 Anxiety and Depression Subscale Scores 
Characteristic Characteristic Sub-Categories N (%) 
Primary Cancer Type Breast 9 (42.9%) 
 Bowel 5 (23.8%) 
 Sarcoma 1 (4.8%) 
 Hodgkin’s Lymphoma 1 (4.8%) 
 Non-Hodgkin’s Lymphoma 1 (4.8%) 
 Brain 1 (4.8%) 
 Liver 1 (4.8%) 
 Prostate 1 (4.8%) 
 Unknown Primary 1 (4.8%) 
Diagnosis of Second Primary Cancer Yes 3 (14.3%) 
 No 18 (85.7%) 
Diagnosis of Secondary Cancer  Yes 4 (19.0%) 
 No 17 (81.0%) 
Cancer Treatment Stage Peri-Treatment 5 (23.8%) 
 Post-Treatment 16 (76.2%) 
Cancer Treatment Type Surgery 20 (95.2%) 
 Chemotherapy 16 (76.2%) 
 Radiotherapy 12 (57.1%) 
 Hormone Therapy 6 (28.6%) 
 Tablet Medication 7 (33.3%) 
Order of Illness Diagnosis Cancer pre- Anxiety 2 (12.5%) 
 Anxiety pre- Cancer 11 (68.8%) 
 Anxiety and Cancer Together 3 (18.8%) 
 Cancer pre- Depression 5 (29.4%) 
 Depression pre- Cancer 7 (41.2%) 
 Depression and Cancer Together 5 (29.4%) 
Other Multimorbid Conditions None 9 (42.9%) 
 One 9 (42.9%) 
 Two 3 (14.3%) 
DASS-21 Subscale Subscale Ratings N (%) 
Anxiety Normal 9 (42.9%) 
 Mild 2 (9.5%) 
 Moderate 3 (14.3%) 
 Severe 2 (9.5%) 
 Extremely Severe 5 (23.8%) 
Depression Normal 5 (23.8%) 
 Mild 2 (9.5%) 
 Moderate 2 (9.5%) 
 Severe 2 (9.5%) 
 Extremely Severe 10 (47.6) 
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lack of relationships) between cancer and anxiety/depression, with these relationships guiding 
participants’ coping strategies and illness management. This theme has been broken down for 
discussion into three sub-themes: ‘cancer and anxiety/depression are unrelated’, ‘uncertainty 
about the relationship between cancer and anxiety/depression’, and ‘cancer and 
anxiety/depression are related’. How these representations influence coping and management 
will be discussed separately in each sub-thematic section. Three additional themes, fear of 
cancer recurrence, changing perceptions throughout the cancer experience, and most 
challenging illness, were found across representations of the relationships between cancer and 
anxiety/depression, and will be discussed as separate themes. Figure 4.1 presents a thematic 
map that provides a visual representation of results. To illustrate the main themes and 
highlight important issues, quotations will be presented. Demographic and illness 
characteristics will be provided where relevant, with pseudo-names used to preserve 
anonymity of participants. 
Cancer and anxiety/depression are unrelated. 
Only three participants described cancer and anxiety/depression as unrelated. All 
three participants were female with very similar ages (M = 66 years, range = 65-67 years), 
but had different cancer types (bowel, breast, and non-Hodgkin’s lymphoma). All three 
participants had experienced depression pre-cancer, with two out of three also experiencing 
anxiety pre-cancer. The main reason for seeing no relationship between cancer and 
anxiety/depression was the perception of unrelated causes. 
All three participants described causes for their anxiety/depression unrelated to 
cancer. For example, Ruby described the cause of her anxiety as workload with additional 
links between anxiety, genetics, and low self-esteem. With regard to depression, Ruby 
proposes it ‘is actually triggered by events’ (although not by her cancer diagnosis), while also 
describing links between her anxiety and depression ‘there’s anxiety which is leading to 
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Figure 4.1. Thematic map of representations of cancer and anxiety/depression and their relationships with coping and self-management 
strategies.
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depression’.  
Coping and self-management in participants who perceived no relationship between 
cancer and anxiety/depression varied. For Julia, there was no overlap between the 
management of depression and cancer, with depression only managed through the use of anti-
depressants, while cancer was managed by trying to ‘keep life as normal as possible’ through 
activities such as walking and visiting friends and family. For both Ruby and Bridget, similar 
self-management strategies were used for both cancer and anxiety/depression (e.g., 
distraction through social support, making music, or reading [Bridget]), though no explicit 
links were made about managing these illnesses in tandem. Ruby, however did identify some 
links between mental and physical health, in that when feeling anxious or concerned, things 
like posture and diet deteriorate, leading to poorer health. According to Ruby ‘if you can 
catch that and you just get it right, then you physically feel better.’.  
Uncertainty about the relationship between cancer and anxiety/depression. 
Five participants did not describe clear relationships between cancer and 
anxiety/depression. Participants in this group varied in age, gender, and cancer type, though 
four out of five participants experienced their depression and/or anxiety pre-cancer. Two 
participants, Bonnie and Janet, considered cancer as a potential cause for their depression, 
while another two participants, Adam and Mary, considered anxiety/depression as a potential 
cause for their cancer. However, all four of these participants mentioned alternate causes they 
had also considered. For example, Bonnie did not mention cancer as a cause for her 
depression originally, when questioned specifically she suggested the physical consequences 
of the cancer and its treatment may play a part in causing her depression, ‘this can come over 
me, um, if it’s been particularly difficult, if I feel like, that um, it’s restricted my life too 
much.’.  
 One participant, Matthew, did not perceive any causal links between depression and 
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cancer and was not depressed at the time of his cancer, but did highlight how having cancer 
made it more difficult to cope with underlying depression.  
I wasn’t depressed at the time I had cancer. (ER: Mmhm). Um, I was in a really good space. Um, but it 
definitely sort of having something like that happen makes everything a lot harder … Like it didn’t 
make me depressed but I, it was definitely a lot more of a struggle because it happened. (Matthew) 
Matthew also identified how having a predisposition to depression made it more difficult to 
cope with cancer. 
It definitely made it harder, because you know, you struggle to cope with things, and you know like I 
said those coping mechanisms that you have, if you can’t do those, like you, they’re in place for a 
reason and you do them for a reason. (ER: Mm.). Um, especially when you’re, you’re sick and stuff 
and you can’t do those. It, it did, you know, have an impact. (Matthew) 
The other four participants had fairly distinct coping and self-management strategies 
for cancer and anxiety/depression, with this mostly due to the timeline of development for 
each illness (fairly distant) and the different causal factors for each illness. 
 Cancer and anxiety/depression are related. 
The remaining 13 participants described relationships between cancer and 
anxiety/depression, with these relationships often considered causal.  
Anxiety/depression causes cancer. 
Four participants described anxiety/depression as a cause for their cancer, with, for 
example, Samuel suggesting depression was the cause of his cancer, ‘I believe, honestly that I 
got it through depression and stress.’ Sophie, who developed depression following the 
passing of her mother, believed that depression may have helped her cancer to grow. 
The depression would have helped the cancer, well it would have helped the cancer grow, um I would 
think. Um, because it has to be expressed somehow. I think when you internalise stuff, uh, in that way, 
um. Because we’re very good at talking about things that make us happy and our joys, but not the 
other, we keep it in, it must, and it has to come out some way surely. (Sophie) 
 Cancer causes anxiety/depression. 
The remaining nine participants described the opposite relationship, with cancer 
believed to be a direct cause for their anxiety/depression: ‘I’m anxious because I have cancer, 
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yes’ (Anna), or ‘I think the cancer caused the depression, yes.’ (Georgia).  
Another common point of discussion across participants was that the consequences of 
cancer (symptoms, treatment side-effects, etc.) were linked with causing or influencing 
anxiety/depression. Participants suffered from a wide range of cancer-related consequences 
that were perceived as causing anxiety/depression, including visible scars from treatment, 
physical disabilities, hair loss, inability to work, fertility difficulties, and loss of 
independence. For example, Sarah, who had a brain tumour (Medullablastoma) and needed 
extensive treatment including surgery, chemotherapy, and radiotherapy, described several 
permanent physiological consequences from her cancer and its treatment. She described these 
consequences and the resultant loss of control as the main reason for her anxiety and 
depression.  
When I started feeling depressed, um, was, I guess when I lost my hair … when I realised how much of 
my life I’d, that I’ve lost control of. Because when I was, um, younger, like when I, like I couldn’t, I 
could always have an escape. (ER: Mm.). Like, you know, even through work, or you know, working 
really hard, thinking to myself, “well I’m going to be able to make myself better, or I’m going to be 
able to get over, get above this” ... because I had control. … and then going from that type of person to 
losing my hearing, losing my hair, confidence, the ability to be independent, and not working… (Sarah) 
Cancer, anxiety, and depression are intertwined. 
Several participants suffered from cancer and both depression and anxiety, with some 
of these participants suggesting that all three illnesses were intertwined. For example, Sarah 
suggested that for her ‘Anxiety brings on depression, and cancer brings on anxiety. It is really 
just a ball …  It’s just a rolling ball.’. When relationships were perceived between cancer and 
anxiety/depression, attempting to cope with and manage them was described as being more 
difficult than dealing with one illness alone, with several participants, including Lisa, 
describing this challenge. 
ER: So having all three of those, how much harder did that make things? Lisa: Oh it was excruciating. 
Just even the needles for my chemo, my anxiety… I used to have a double dose on my anxiety pills 
before they tried to put a needle in. (ER: Mm.). Um, and being a needle-phobe doesn’t help, but the 
anxiety was always sky high when I walked into the hospital. So I would pop a pill in the car on the 
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way in, then in the waiting room I’d pop another one, so that’s double dosing. (ER: Mm.). Um, and 
even then it was a struggle for them to get a line in. So, it was… I, it just made everything that much 
harder. … Even just going to an appointment with the oncologist and she’d talk about what she’d 
found. What the diagnosis was. What, you know, what the cancer … That was really hard. (ER: Mm.). 
Um, and then I’d leave there and, and I’d sink into the biggest, um, a funk, you know. (Lisa) 
 Coping and self-management strategies. 
Although cancer and anxiety/depression were seen as related by the majority of 
participants, this did not necessarily mean that these participants used strategies to help cope 
with and manage their illnesses together. Quite often, separate self-management strategies 
were utilised for each illness. However, some participants highlighted that managing one 
aspect of an illness may be of benefit to their other illness. For example, Cheryl, who had 
metastatic breast cancer, explained how meditation and relaxation was not only beneficial for 
reducing her anxiety, but also for helping to heal her body.  
However, several participants also described how interactions between cancer and 
anxiety/depression can negatively impact coping and self-management. For example, at times 
it can be difficult to determine the best way to manage a particular symptom, particularly 
when it is unclear whether it is a symptom of the cancer, a treatment side-effect, or a 
symptom of anxiety/depression.  
Um, depression yeah. When you’ve got that foggy state in your mind and you’re fatigued and your 
treatment, it, it can be really really hard to motivate yourself. But it’s more a, I’m not sure how much 
it’s treatment related or (ER: Mm.) what it, it’s just really hard to, sort of, um. I sort of feel when I’m 
being down and crap and stuff like that I just thinking, “ok I probably am depressed” but I just think 
“ok these are going to be the side effects of the treatment that I’ll need to work through”, and yep. 
(Cheryl)  
Further for some participants with anxiety/depression, the symptoms of cancer or the 
side-effects from cancer treatment prevented them from being able to participate in their 
normal anxiety/depression coping strategies. For example, Matthew described the importance 
of exercise, specifically running, as a coping strategy for depression (or to keep depression 
dormant), ‘So exercise is normally a massive one for me … If I don’t, you know, I just go 
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downhill really quickly’. However, after his diagnosis of liver cancer, surgery and 
chemotherapy were required, limiting his ability to exercise, and requiring him to find other 
coping strategies. 
 Similarly, some participants suggested that the symptoms of anxiety/depression 
prevented them from undertaking either their usual cancer prevention strategies, or general 
lifestyle and health factors that are known to help prevent cancer. For example, Mary stated 
that in the past her depression had prevented her from ‘yoga and gym and horse riding and 
rowing and going out of walks’, while Lisa explains how the consequences of her depression 
prevent her from doing the healthy living practices that she knows will help to prevent future 
cancer.  
Not eating the healthy foods that I know are going to protect me from future cancer. (ER: Yes.). But 
eating the comfort foods that are undermining my whole health plan. Um, also the inability to go out 
and do exercise. (ER: Mm.). Um, because gentle walking is my chosen form of activity. … But when 
I’m feeling depressed do you think I can walk out that door? (ER: Mm.). Nup. … We came to the 
country for lifestyle… (ER: Yes.) for fresh air, to grown our own fruit and veg, to have healthier food, 
all that sort of stuff. (ER: Yes.). And when I give in to the depression, it undermines everything. (ER: 
Mm, mm.). I don’t’ look after my family properly. I don’t look after myself properly. (Lisa) 
 That constant looking over your shoulder - Fear of cancer recurrence.  
 One particularly important issue that is fairly unique to the cancer space and arose 
commonly when discussing the relationship between cancer and anxiety, was fear of cancer 
recurrence for those post cancer treatment (FCR; Lee-Jones et al., 1997; Simard et al., 2010). 
FCR is common but can become problematic when it influences behaviour. Most participants 
mentioned some experience of FCR, particularly around check-ups, tests, or scans. 
‘You worry at times. (ER: Yes.). When, when you come up to the six monthly pathology I still. “ah 
here we go again”, you know (ER: Mm.) sort of thing … And it’s a bit of anxiety there, but nothing 
that you don’t cope with and handle.’. (Adam) 
However, several participants described experiences of FCR at a more debilitating level. For 
example, Rebecca described the constant focus on any abnormality or discomfort she noticed 
within her body post cancer. 
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An ache or pain is never just an ache or pain to me, it’s always like, could it be more. (ER: Mm.). … 
Whereas most people get an ache or pain they wouldn’t even think of cancer… (ER: Yes.) would be 
the furthest thing from their mind. But for me, every ache or pain could be that. (Rebecca) 
For participants like Danielle, this constant FCR led them to experience depression. 
I lived on this level of anxiety for quite a while, quite a high level, without realising that’s what it was. 
(ER: Mm.). And it just tires you out. And then you get depressed, because you, yeah, you’re tired and 
you lock yourself in the house, and you don’t get out of bed because you’re scared you’re gonna hurt 
yourself. (Danielle) 
Several participants also described how this constant FCR also drove particular coping 
behaviours and self-management strategies, not all of which were adaptive. Examples of 
these behaviours included adjusting eating behaviours and food choices, taking multiple 
dietary supplements, constantly searching the internet ‘engrossed in Dr Google’, and making 
constant calls or visits to previous or current treating health professionals.  
Um, basically cause after the treatment was finished I was like always at the Doctors. Like I’d always 
be going back to the GP. I would go, “I’ve got a pain in my elbow”… (ER: Yeah.). and I would, you 
know that was like a classic example, “I have a pain in my elbow, like I must have cancer in my 
elbow”. (ER: Mm.). And he’s going “no”, you know, check me elbow out, “it’s fine”. By the time I’d 
walk back to the car, this pain I’d had for a couple of weeks had gone. (Rebecca) 
 
I could be perfectly fine in the morning, and I’d bump my knee, and by lunch time I would have cancer 
in my knee and in my bones, and I’d be ringing the oncologist and saying I need a bone scan. And you 
know, and I just bumped my knee! But that’s where it took me. … And they’re still there. That’s my 
first thought. It’s still there. (ER: Mm.). Every time something hurts. I was driving home from Burnie 
yester, last night. And the front of my shoe was hurting, and I had to keep rubbing it. It was quite sore. 
(ER: Mm.). And I was thinking, “Oh God, I’ve got cancer in my bones now. Oh Danielle don’t be an 
idiot. It’s just a strain from the accelerator for the last four and a half hours.” Like, you know, it’s gone 
today. *Laughs*. (Danielle) 
Who am I now? - Changing perceptions throughout the cancer experience. 
An additional theme arising related to changing self-perceptions throughout the 
cancer experience and how these interact with experiences of anxiety/depression, as well as 
coping and self-management. In having such a large impact on one’s life, it is unsurprising 
that many participants described cancer as leading to changes in perceptions, self-image, 
attitudes, and opinions. For several participants these changes were positive, with Melanie 
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describing improvements in her attitude towards work and Bridget describing changes to how 
her and her partner live their lives, ‘we don’t hold off … either in terms of doing this or 
enjoying things, or even saving money … you know, now is when we need to do it’. 
However, at times these changes presented challenges for participants, particularly when 
related to changes in self-image.  
And looking in the mirror at myself and saying, “That’s not you… You didn’t…” I looked like you 
before, more or less. A lot older obviously, but long blonde hair. (ER: Yeah.). Had all my life been 
someone with long blonde hair. And then suddenly I’m not that person anymore. (ER: Mm.). And 
probably will never be the person that I was before. (ER: Mm.). So it’s kind of dealing with that too. 
Who am I now? (Kathryn) 
Changes in self-perception were often associated with experiences of loss and grief. 
For example, Georgia described how cancer led to a ‘loss of sense of identity because it’s 
changed who I am as a person. It’s changed the way I view myself, and my self-image … and 
the way I view the world.’. This loss was particularly evident amongst participants with 
metastatic cancer, who had been required to face their mortality at a deeper level.  
I was doing really well. … We’d had Amelia, I’d returned from maternity leave, I was getting back on 
track with work, we were considering having another child, I’d gone off the pill, you know, we were at 
that sort of stage of our lives, and… that’s all sort of gone. … I feel like things have been taken away 
from me. And, to start off with a lot of it was grieving the life that we were going to have. Because I 
had to stop thinking, planning. … I wasn’t able to plan at all. … I didn’t feel like I wanted to plan six 
months ahead. … My husband wanted to go sort of do like a bucket list thing, and let’s tick everything 
off, let’s do all the things that we would have done in, in the future, but I couldn’t even do that cause I 
didn’t want it to be like the last hoorah, “ok we’re going to travel and then I can die after that”. (Anna) 
Associated with these perceptions of loss and grief, were representations around 
normality. Several participants, including Julia, mentioned trying to ‘keep life as normal as 
possible” as one way of coping with their cancer. While other participants, like Mary, 
realised that life ‘might not ever be the same again’. Lori described not remembering ‘what 
it’s like to have a normal life’, while Lisa explained ‘There is no life as normal.’. Some 
participants also described having to learn to accept their ‘new normal’, while others 
struggled with family or friends who believed that they should be ‘back to normal’ post-
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treatment. 
And he thinks that now that I don’t have to see the doctors for twelve months that things are back to 
normal. But I’m thinking “well, normal for me is different.”. (Melanie) 
I don’t know if I’m going to get over this - Most challenging illness. 
Some participants suggested that anxiety/depression were more challenging than 
cancer. This was particularly true amongst participants who had recurring or chronic 
anxiety/depression and/or who had completed treatment for, or were in remission from, their 
cancer. Participants described several reasons for these beliefs, including a more chronic or 
cyclical timeline for anxiety/depression, less control over anxiety/depression, and less 
understanding of anxiety/depression. Julia highlighted how the more chronic nature of 
depression makes it more challenging to cope with, ‘the cancer diagnosis, treatment, bla, bla, 
bla, that’s all over now. (ER: Yes.). Whereas the depression will go on forever’. When 
describing why depression was more challenging for her, Sophie highlighted her lack of 
understanding of depression, as well as the absence of the depression label. 
I think on reflection the depression is harder. … Because it wasn’t named. I was just living in a 
particular way. (ER: Mm.). Ah, whereas the cancer it’s named. It’s like, you can do something with 
that if you so choose. (ER: Mm.). And because medicine is such, then there are things that can happen 
to help that. Um, and I’ve always, I always think that the knowing, knowing something is better than 
not knowing. (Sophie) 
Several participants, including Danielle, described struggling with anxiety/depression 
because of a lack of control over their illness, ‘The anxiety is probably the hardest to deal 
with, to be honest. … When it’s not under control, it just has such a debilitating effect.’ 
Adam described a similar lack of control, ‘Anxiety’s something in there that, almost out of 
your control. (ER: Mm.). You’ve got to really, really work harder, to control it, than what you 
do to cope with the facts of having cancer.’ Although Lisa described both cancer and 
depression as extremely challenging, she explained that depression, at its worst, was more 
difficult than cancer, as it led to her losing the will to live.  
Well… cancer was really, really, really hard. Um, because it, it’s physical inside you. (ER: Yes.). … 
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See with cancer, I wanted to live and that’s why I let them poison me… (ER: Mm.) that’s why I let 
them stick needles into me, and that’s why I went through all of those things is because I wanted to 
live. But when I was at my worst with depression I wanted to die. … So perhaps depression was… at 
its worst… was harder than cancer. … I think the thing with cancer is you can see the light at the end of 
the tunnel. ‘Cause you know these are the steps you’ve got to go through before they tell you that your 
treatment’s finished. (ER: Yes.). You, you know what’s coming. But with depression you don’t. ... It’s 
almost like, you know, even when you’re feeling good you know that somewhere it’s just lurking. 
(Lisa) 
In contrast, several participants, including all four participants with metastatic cancer, 
described cancer as more challenging than anxiety/depression. The life-threatening nature of 
cancer, particularly metastatic cancer, as well as a lack of control over cancer, were described 
as the main reasons for perceiving cancer as participants most challenging illness. Mary, who 
was recently diagnosed with Stage IV bowel cancer, provided a clear insight into how cancer 
stage and the life-threatening nature of metastatic cancer can influence perceptions of cancer. 
I have stage four cancer… (ER: Mm.). I’d rather be depressed again and not have cancer. I can get over 
the depression… (ER: Mm.) and then be… live ‘til 80, please. Um, but if I had stage one cancer, 
maybe I’d answer differently. (ER: Mm.). Cause as I said, especially early on in my diagnosis I kept 
thinking “this is going to be quick fix and over and move on with life.” (ER: Yes.). So if I felt, if I still 
felt like that, then maybe I’d answer differently. But as a stage four cancer person absolutely 100% I 
would rather be depressed than have cancer, because I can, I know I can get over depression … but I 
don’t know if I’m gonna get over this. 
Discussion 
This qualitative study aimed to examine multimorbid illness representations and their 
associations with coping behaviours and self-management strategies in people with cancer 
and anxiety/depression. Our findings suggest that patients think about the relationships 
between multiple illnesses in different ways, with some viewing cancer and 
anxiety/depression as unrelated, some unsure about the relationship between cancer and 
anxiety/depression (think that there could possibly be a connection between them), and some 
viewing cancer and anxiety/depression as related. We also found that participants’ 
representations had clear links with coping and self-management behaviours.  
Three participants perceived cancer and anxiety/depression as unrelated, with all three 
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participants experiencing anxiety/depression pre-cancer. These participants did not discuss 
links between cancer and anxiety/depression, instead discussing alternative causes for their 
mental illness/es. Further, two participants described a lack of understanding of their 
illnesses, particularly demonstrating confusion regarding the difference between anxiety and 
depression. Finally, although two participants mentioned using the same coping behaviours 
and self-management strategies for both cancer and anxiety/depression, no explicit links were 
made between these strategies.  
Five participants were uncertain about the relationship between cancer and 
anxiety/depression, with four participants describing multiple potential causes for either 
cancer or anxiety/depression (including cancer or anxiety/depression itself). This indicates a 
lack of understanding about the causes of cancer and anxiety/depression. For these 
participants, coping and self-management behaviours were different for each illness, and this 
appeared to be mainly due to the distant timeline between diagnoses. Although one 
participant suggested no causal relationship between his cancer and depression, he did 
describe how cancer had made it more difficult to cope with underlying depression, and how 
underlying depression had made it more difficult to cope with cancer. 
Similarly to a previous study of diabetes and depression (Mc Sharry et al., 2013), the 
majority of participants (13) described relationships between their illnesses. In general, these 
participants described either causal links between cancer and anxiety/depression, how 
consequences of cancer and its treatment caused anxiety/depression, or how cancer caused 
fear of cancer recurrence (FCR) related anxiety, which at times then led to depression. For 
these participants, the type of links described influenced the coping behaviours and self-
management strategies undertaken. For example, for those whose cancer had led to FCR, 
coping and self-management strategies that ease this fear were frequently described, 
including adjusting eating behaviours, taking dietary supplements, using the internet to search 
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for health information, or making constant calls or visits to treating Doctors. In our 
interviews, the strategies described were often maladaptive, suggesting the need for 
appropriate intervention. Similarly to previous research (Bower et al., 2012; Mc Sharry et al., 
2013), both separate and combination coping and self-management behaviours were 
described, with behaviours beneficial to both illnesses employed at times, while symptoms or 
side-effects of one illness were sometimes suggested to prevent normal coping and self-
management strategies for the other illness. Interestingly, in contrast to previous research 
(Bower et al., 2012; Mc Sharry et al., 2013), issues in managing multiple medications were 
rarely described.  
Both within and between participants, changing perceptions and needs throughout the 
cancer experience were described, suggesting that different representations may be present at 
different stages of illness timeline, and that these representations may need to be re-assessed 
and modified depending on content and adaptability. This was also true with respect to 
coping behaviours and self-management strategies, which varied across different timelines 
and stages of illness. These findings provide support for the CSM’s feedback loop, which 
suggests that individuals act as problem solvers who constantly appraise their coping/self-
management behaviours and change illness representations accordingly, leading to the 
adoption of new management strategies (Leventhal et al., 1998; Leventhal et al., 1980). 
However, longitudinal studies are required to gain a more systematic understanding of 
specific changes in multimorbid illness representations and their associations with coping 
behaviours and self-management strategies. 
Several participants described anxiety/depression as more challenging than cancer. 
These participants were often sufferers of recurring or chronic anxiety/depression and/or in 
remission from their cancer. Reasons for the more challenging nature of anxiety/depression 
was related to representations of a more chronic or cyclic timeline for anxiety/depression, less 
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control over anxiety/depression, and less understanding of anxiety/depression. In contrast, 
several participants described cancer as more challenging than anxiety/depression. 
Importantly, all four participants with metastatic cancer were included in this group. Reasons 
for the more challenging nature of cancer included perceiving less control over cancer, and 
beliefs about the life-threatening nature of cancer. A lack of control was identified as an 
important factor for participants no matter which illness they described as most challenging, 
with less perceived control associated with a range of coping behaviours and illness outcomes 
(Richardson et al., 2016). Perceived control is also associated with the use of varying self-
management strategies, such as decision making and priority setting (Bratzke et al., 2015). 
Although not always inaccurate (particularly for those with metastatic cancer), control beliefs 
may be important to target in interventions, as they continually appear as important predictors 
of coping, self-management, and mental health.  
Research suggests that patients will prioritise a dominant chronic illness (Bratzke et 
al., 2015), and therefore it may be beneficial to add additional items that assess participants 
most challenging or dominant illness to questionnaires such as the Illness Perception 
Questionnaire (Moss-Morris et al., 2002; Weinman et al., 1996). If patients state one illness 
as more challenging than another, it may be possible to determine which individual illness 
representations are more likely to be determinants of behaviour. However, due to the 
changing nature and re-prioritisation of representations over time (Bratzke et al., 2015), the 
potential for these beliefs to be unstable must be considered before attempting to rely on their 
content in an intervention. 
Limitations 
Due to the lack of existing research examining illness representations in people with 
cancer and anxiety/depression, qualitative methods were using to explore such 
representations. A limitation associated with the use of qualitative methods is the potential for 
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the subjective perceptions of researchers to unknowingly influence the analysis. However, in 
conducting this study from a subtle realist viewpoint, our subjective perceptions were 
constantly acknowledged while we attempted to represent the existing reality under study 
(Mays & Pope, 2000). The possibility of recall bias by participants must also be considered 
as a potential limitation in qualitative research. 
The study lacked measurement of crude diagnostic indicators, such as whether 
participants had ever been hospitalised or had outpatient contact for clinical depression or 
anxiety. Further, although we recruited participants who had received either a formal 
diagnosis or previous treatment for anxiety/depression, there was no clear differentiation 
between those with major depression and those with ‘normal’ psychological distress 
associated with the cancer experience.  
Our participant sample varied widely in terms of cancer type, cancer stage, and 
treatment type, with this heterogeneity likely responsible for variations across some results. 
For example, the results of the DASS-21 found that although our sample had an almost even 
number of participants who had experienced depression/anxiety (four with anxiety only, five 
with depression only, and 12 with both anxiety and depression), there were large differences 
across anxiety and depression scores, with 42.9% of participants experiencing normal anxiety 
in comparison to 23.8% experiencing normal depression, and 23.8% of participants 
experiencing extremely severe anxiety in comparison to 47.6% experiencing extremely 
severe depression. It is possible that more consensus might have been found by using a more 
focused sample, for example by only interviewing participants with breast cancer, or by only 
interviewing participants with Stage I (early-stage) disease. In contrast, additional insights 
might have been uncovered with the inclusion of a more diverse sample. For example, our 
sample only included three males, making meaningful gender differences difficult to 
examine. Despite these potential limitations, our sample was able to provide both overlapping 
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and unique representations, suggesting a good mix between specificity and diversity.  
Implications 
This study identified a number of multimorbid illness representations, including 
differing representations of relationships between cancer and anxiety/depression, fears of 
cancer recurrence, participants’ identification of their most challenging illness, and changing 
beliefs across the illness experience. This suggests that standardised assessments of illness 
representations such as the illness perception questionnaire (Moss-Morris et al., 2002; 
Weinman et al., 1996) might not be applicable for multiple illnesses, but would need 
adaptation (e.g., C. J. Gibbons et al., 2013; Mc Sharry, Bishop, Moss-Morris, Holt, & 
Kendrick, 2015). Such adaptations may lead to an increased understanding of determinants of 
current behaviours, as well as the implementation of more appropriate treatment approaches 
by health professionals. 
The CSMs illness representation dimensions have been used increasingly in 
interventions for single illnesses. These intervention trials have shown positive results, with 
more accurate illness representations, increases in illness coherence and perceived control, 
improved mental health, and participation in more positive self-management strategies 
adopted (Broadbent, Ellis, Thomas, Gamble, & Petrie, 2009; Petrie, Perry, Broadbent, & 
Weinman, 2012; Siemonsma et al., 2013). Interventions for patients with multimorbidity 
could potentially use a similar approach to the interventions that have been trialled for single 
illnesses, though modifications to take into account the more complex nature of multimorbid 
representations would be required. For example, combined or competing representations, 
prioritisation of a more challenging illness, and changing representations over time, would 
need to be considered before a comprehensive intervention program could be implemented. 
People with multimorbid cancer and anxiety/depression require more support, with 
research demonstrating that oncologists are often poor at recognising distress and the need for 
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further counselling in their patients (Söllner et al., 2001). However, in recognising such 
needs, health professionals should not always assume that anxiety/depression is specifically 
related to the cancer experience or adjustment process. Education for health professionals 
regarding the content of patients multimorbid illness representations, as well as the 
importance and impact of multimorbidity, particularly with respect to cancer and 
anxiety/depression, is important for improving patient outcomes. Health professionals should 
also be educated about the benefits of combination management strategies, where health 
behaviours such as exercise or mindfulness can lead to improved patient outcomes across 
multimorbid illnesses (Ledesma & Kumano, 2009; Mishra, Scherer, Geigle, et al., 2012; 
Mishra, Scherer, Snyder, et al., 2012). However, for these strategies to be successful, care 
must be taken to ensure that participants multimorbid illness representations are congruent 
with their implementation. Finally, health professionals must be made aware of the ongoing 
challenges that cancer survivors and metastatic cancer patients face, with patients often 
requiring assistance to accept their ‘new normal’. 
Conclusion 
This study provides support for the CSM as an effective basis for exploring patients 
multimorbid representations, with differing illness representations of, and management 
strategies for, cancer and anxiety/depression identified across participants. However, 
although specific illness representation dimensions from the CSM have been used in 
interventions for single illnesses, the experience of multimorbid illnesses cannot currently be 
fully addressed by the CSM, with a need to consider additional and more complex 
representations. Future research should attempt to confirm whether representations identified 
in this study can help to inform intervention design for cancer and anxiety/depression. If a 
clear understanding of patients’ multimorbid representations can be gained, it may help to 
improve health care interactions, as well as the coping behaviours and self-management 
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strategies, of those with cancer and anxiety/depression. 
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Chapter 5 
Study 4 
A qualitative comparison of the support needs of people with cancer based on their 
history of anxiety/depression* 
 
 
 
 
 
 
 
 
 
 
                                                          
*Richardson, E. M., Scott, J. L., Schüz, N., Sanderson, K., & Schüz, B. (2016). A qualitative 
comparison of the support needs of people with cancer based on their history of 
anxiety/depression. Manuscript submitted for publication. 
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Abstract 
Purpose: Research rarely considers the origin or history of a cancer patient’s anxiety and/or 
depression, instead assuming that these illnesses are related to the cancer experience. The aim 
of this study was to compare differences in the support needs of people who have 
experienced anxiety/depression as part of the cancer experience and people who have not, as 
well as between people who have experienced episodic anxiety/depression and people who 
have experienced long-term anxiety/depression. 
Methods: Twenty-one semi-structured interviews were conducted with people with a current 
or previous diagnosis of cancer, and a current or previous experience with anxiety and/or 
depression. Participants were split into four groups based on their history with cancer and 
anxiety/depression, and an inductive thematic analysis was conducted to identify themes 
across groups. 
Results: Two superordinate themes (with three and two subordinate themes respectively) 
were found: ‘coping with cancer’ and ‘health care system support provision’. Important 
differences were found across groups, with participants in Group 4 (who had long-term 
anxiety/depression and whose anxiety/depression was not associated with the cancer 
diagnosis) coping best with cancer, experiencing less fear of cancer recurrence, and 
highlighting more positive experiences with hospital and support services.  
Conclusions: The origin and history of a person’s anxiety/depression is important to consider 
when determining how they might cope with cancer, what their support needs are, and how 
much support they may require during the diagnosis, treatment, and survivorship phases of 
cancer.    
 
Keywords: cancer; anxiety; depression; co-morbidity; support; needs 
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Traditionally, psycho-oncology has examined anxiety and/or depression as conditions 
resulting from the cancer experience (Pasquini & Biondi, 2007). However, not all people with 
cancer develop anxiety/depression, and their levels of distress vary (Helgeson et al., 2004; 
Henselmans, Helgeson, et al., 2010). Further, some people have pre-existing 
anxiety/depression which then becomes co-morbid with cancer, while others experience 
episodes of anxiety/depression that occur in response to significant life events (including the 
cancer diagnosis). These examples highlight that anxiety/depression experienced by someone 
with cancer can have differential aetiology. However, the role of these origins and how they 
influence the cancer experience and the support needs of people with cancer and 
anxiety/depression is rarely considered in psycho-oncology research (Jacobsen & Jim, 2008; 
Pasquini & Biondi, 2007).  
The most important areas in need of support for people with cancer include physical 
health and daily living, psychological health, health system and information, and social 
support (Harrison et al., 2009). Although there are several interventions aimed at addressing 
these needs, a recent review has found that such interventions generally have limited 
effectiveness (Carey et al., 2012). Further, though much of the research and interventions for 
people with cancer aim at improving distress, and one study has specifically examined how 
screening for distress might uncover unmet needs in people with cancer (van Scheppingen et 
al., 2011), research so far has not taken into account whether needs differ according to which 
illness (cancer or anxiety/depression) came first, or the causes of anxiety/depression. It is 
therefore unclear whether and how the needs of people with cancer are influenced by their 
history with anxiety/depression.  
Comparing the support needs of people with varying histories of cancer and 
anxiety/depression will allow us to identify and discuss how the potentially differing needs of 
people according to their cancer and anxiety/depression history can best be addressed. For 
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example, those who have experienced anxiety/depression as part of the cancer experience 
might differ from those who have not, and those who have experienced episodes of 
anxiety/depression in relation to significant life events might differ from those who have 
experienced long-term anxiety/depression. Support needs may differ between these groups, as 
long-term depression tends to be clinically more serious, is more often co-morbid with 
anxiety, requires more treatment, and leads to poorer social and psychological outcomes and 
reduced well-being, than episodic depression (Angst et al., 2009). Examining differences 
between these groups is important because although intervention studies often take into 
account psychological distress at baseline (Schneider et al., 2010), they rarely consider how a 
prior history of anxiety/depression may influence intervention effectiveness. Further, the 
outcomes of interventions for cancer patients with distress are often mixed, and previous 
systematic and meta-analytic reviews yielded disparate conclusions that are often difficult to 
interpret (Galway et al., 2012; Jacobsen & Jim, 2008; Lepore & Coyne, 2006). This 
highlights the need for more research on how the aetiology and sequence of cancer and 
mental illness may determine the support needs of people with cancer and anxiety/depression. 
This knowledge can form the basis for better targeted and more effective interventions, as 
well as improved access to appropriate support services, for people with cancer and 
anxiety/depression. 
This study therefore aims to explicitly examine and compare the existing supports and 
needs of people with cancer and different histories of anxiety/depression (e.g., episodic 
versus long-term) through semi-structured interviews, allowing for insights to be gained 
through thematic analysis without researcher preconceptions. Two key questions were used to 
guide this study: 
1. How do different histories of anxiety/depression influence the support needs of people 
with cancer?  
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2. How can support providers and health professionals better assist people with cancer 
and anxiety/depression based on their history with each illness? 
Method 
Participants 
Twenty-one participants was considered an appropriate sample size for this study 
based on information power (Malterud et al., 2015). Information power provides clear criteria 
for ascertaining appropriate sample sizes in qualitative research while addressing some of the 
limitations associated with the use of saturation (Glaser & Strauss, 2009; Malterud et al., 
2015) (see Appendix 5.1). Participants were recruited via self-selection sampling through 
advertisements in Cancer Council Tasmania face-to-face support groups, local hospitals, and 
appropriate Facebook pages (cancer support groups). Persons interested in participating 
contacted the researcher via phone or email and were then invited to participate in the study 
upon meeting the following inclusion criteria: over 18 years of age, current or previous 
diagnosis with any type of cancer, current or previous experience with (diagnosed or treated 
for) anxiety or depression or both anxiety and depression. Ethics approval was obtained from 
the Tasmanian Human Research Ethics Committee (H0014664). 
Materials 
 Participants completed a consent form, demographics and illness characteristics 
questionnaire, and the shortened version of the Depression Anxiety Stress Scale (DASS-21; 
Lovibond et al., 1995) to assess the symptom severity of each negative emotional state. An 
interviewer guide with open-ended questions was used to direct each interview (see Appendix 
4.1). 
Procedure 
Face-to-face one-on-one semi-structured interviews were conducted following 
completion of the consent form, demographics and illness characteristics questionnaire, and 
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DASS-21 (Lovibond et al., 1995). The first author conducted each interview (ER; female 
PhD student with formal training and experience in support work with cancer patients) at a 
place convenient to participants (university, Cancer Council, or participants’ homes). 
Audiotaped interviews lasted between 13 and 82 minutes (M = 50 minutes), ending after all 
key topics were covered. For additional methodological information see Appendix 5.1. 
Analysis 
 This study followed the Consolidated criteria for Reporting Qualitative research 
(COREQ) Checklist (Tong et al., 2007; see Appendix 5.2). Following verbatim transcription, 
transcripts were de-identified and imported into NVivo 10 (QSR International Pty Ltd., 2014) 
for data management and thematic analysis. 
 A subtle realist viewpoint guided analyses, where the researchers’ subjective 
perceptions were acknowledged while attempting to represent the underlying existing reality 
under study (Mays & Pope, 2000). An inductive thematic analysis was conducted (Braun & 
Clarke, 2006). This approach involves a data-driven way of identifying themes, where data is 
coded without any pre-existing coding frames or researcher preconceptions. Thematic 
analysis was guided by Braun and Clarke (2006), who provide clear steps for conducting 
such an analysis. 
Data analysis began with data immersion (ER transcribing interviews and reading 
completed transcripts several times to familiarise with the data). All transcripts were then 
coded into units of meaning by ER using NVivo 10. Units of meaning were used for coding, 
as predefined blocks of text (lines or sentences) may inaccurately reflect intended meanings 
of participants and important contextual information may be missed (Campbell et al., 2013). 
A second coder (JH) coded 5/21 (23.8%) interviews to ensure reliability. Between ER and JH 
inter-rater agreement was high (92.25%) and inter-rater reliability was good (Cohen’s Kappa 
= .664).  
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Based on their history with cancer and anxiety/depression, participants were 
categorised by two authors (ER and JS) into four groups: cancer associated with 
anxiety/depression AND a history of episodic anxiety/depression or anxiety/depression 
caused by cancer alone (Group 1; ten participants); cancer associated with anxiety/depression 
AND long-term anxiety/depression (Group 2; six participants); cancer that was not associated 
with anxiety/depression AND a history of episodic anxiety/depression (Group 3; one 
participant); cancer that was not associated with anxiety/depression AND long-term 
anxiety/depression (Group 4; four participants; see Table 5.1). Following the creation of these 
groups, codes were collated into potential themes, with themes then reviewed, cross-checked 
for overlap, defined, and named.  
 
Table 5.1 
Participant Groupings Based on History of Cancer and Anxiety/Depression 
 Episodic anxiety/depression  
(or caused by cancer alone) 
Long-term anxiety/depression 
Cancer associated 
anxiety/depression 
Group 1 Group 2 
No cancer associated 
anxiety/depression 
Group 3 Group 4 
 
 
Results 
Demographics and Illness Characteristics 
Twenty-two participants were seen, with 21 (3 males, 18 females) meeting inclusion 
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criteria for participation (one participant had no formal diagnosis of or treatment for 
anxiety/depression). Participants were aged between 23 and 75 years (M = 50 years, SD = 18 
years) and had a current or previous cancer diagnosis, with four participants experiencing 
anxiety, five experiencing depression, and 12 participants experiencing both anxiety and 
depression at some point throughout their lifespan. Table 5.2 contains additional 
demographics and illness characteristics. 
 
Table 5.2 
Demographics and Illness Characteristics 
Characteristic Characteristic Sub-Categories N (%) 
Country of Birth  Australia 16 (76.2%) 
 New Zealand 1 (4.8%) 
 England 3 (14.3%) 
 Scotland 1 (4.8%) 
Education (highest level obtained) Year 9 or Below 1 (4.8%) 
 Year 10 2 (9.5%) 
 Year 12 2 (9.5%) 
 Certificate 5 (23.8%) 
 Diploma 3 (14.3%) 
 Undergraduate Degree 5 (23.8%) 
 Post-Graduate Degree 3 (14.3%) 
Employment Status Paid Full-Time Work 2 (9.5%) 
 Paid Part-Time Work 2 (9.5%) 
 Paid Casual Work 2 (9.5%) 
 Retired 6 (28.6%) 
 Not Working Due to Health 6 (28.6%) 
 Job Seeker 1 (4.8%) 
 Other 2 (9.5%) 
Relationship Status Married 10 (47.6%) 
 Divorced 1 (4.8%) 
 Separated 1 (4.8%) 
 De-facto Relationship 4 (19.0%) 
 Single 5 (23.8%) 
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Primary Cancer Type Breast 9 (42.9%) 
 Bowel 5 (23.8%) 
 Sarcoma 1 (4.8%) 
 Hodgkin’s Lymphoma 1 (4.8%) 
 Non-Hodgkin’s Lymphoma 1 (4.8%) 
 Brain 1 (4.8%) 
 Liver 1 (4.8%) 
 Prostate 1 (4.8%) 
 Unknown Primary 1 (4.8%) 
Diagnosis of Second Primary Cancer Yes 3 (14.3%) 
 No 18 (85.7%) 
Diagnosis of Secondary Cancer  Yes 4 (19.0%) 
 No 17 (81.0%) 
Cancer Treatment Stage Peri-Treatment 5 (23.8%) 
 Post-Treatment 16 (76.2%) 
Cancer Treatment Type Surgery 20 (95.2%) 
 Chemotherapy 16 (76.2%) 
 Radiotherapy 12 (57.1%) 
 Hormone Therapy 6 (28.6%) 
 Tablet Medication 7 (33.3%) 
Order of Illness Diagnosis Cancer pre- Anxiety 2 (12.5%) 
 Anxiety pre- Cancer 11 (68.8%) 
 Anxiety and Cancer Together 3 (18.8%) 
 Cancer pre- Depression 5 (29.4%) 
 Depression pre- Cancer 7 (41.2%) 
 Depression and Cancer Together 5 (29.4%) 
Other Multimorbid Conditions None 9 (42.9%) 
 One 9 (42.9%) 
 Two 3 (14.3%) 
 
 
DASS-21 
On average, anxiety scores were in the moderate range (M = 7.43, SD = 8.80), stress 
scores were in the severe range (M = 15.52, SD = 8.02), and depression scores were in the 
extremely severe range (M = 14.00, SD = 11.33), though scores on each subscale ranged from 
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normal to extremely severe.  
Thematic Analysis 
Differences between the four participant groups (see Table 5.1) were identified across 
two superordinate themes, with each superordinate theme broken into several additional 
subordinate themes (see Figure 5.1). The first superordinate theme, ‘Coping with Cancer’, 
describes and compares coping strategies, personal relationships, and fear of cancer 
recurrence (FCR) across participant groups. The second superordinate theme, ‘Health Care 
System Support Provision’, describes and compares hospital care and support services across 
participant groups.  
Coping with Cancer 
In general, participants in Groups 1 and 2 did not cope as well with their cancer as 
participants in Groups 3 and 4. More specifically, participants in Groups 1 and 2 required 
more coping strategies and resources to cope with their cancer, while also perceiving and 
describing less social support and a higher FCR, than participants in Groups 3 and 4. 
Coping strategies. 
Most participants in Groups 1 and 2 received formal psychological treatment for 
cancer-related anxiety/depression, though participants in Group 2 generally described this 
treatment in much less detail and/or were less likely to include this as a coping strategy for 
cancer. Participants in Groups 3 and 4 reported the use of less formal coping and self-
management strategies, such as being positive, taking control where possible, keeping busy, 
and keeping life as normal as possible, with no treatment for cancer-related anxiety and 
depression described by these participants.  
With regard to support groups specifically, eight of ten people in Group 1, and four 
out of five people in Group 2, attended a support group for cancer-related support. The 
participants in Groups 3 and 4 did not attend a cancer-related support group. The majority of 
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Figure 5.1. Thematic map comparing support needs of people with cancer and anxiety/depression. 
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participants attending support groups found them highly beneficial. 
Personal relationships. 
For participants in Group 1, strong social support was important, with participants 
describing how their cancer diagnosis strengthened some relationships but led to the loss of 
others (most often friendships). Cancer was sometimes described as changing the individual, 
and therefore changing their relationships. Although some participants in Group 2 described 
strengthened relationships with their partner or spouse, the majority of these participants 
described losing friendships and feeling isolated, with less positive social support mentioned 
overall.  
I had a … friend the other day, a month or two ago I sent her a message and she asked me how I was 
and I just text her back saying I felt like crap and I was angry and everything, and you know you don’t 
hear from them for a month. So you’ve got to be careful about what you say otherwise… (ER: Mm.) 
people just walk away or they just stay away for a, you know, yeah. (Rosalina, Group 2) 
In contrast, participants in Groups 3 and 4 described strong social support and personal 
relationships, with no loss of relationships or support from loved ones described.  
Fear of cancer recurrence (FCR). 
FCR was experienced by participants in Groups 1 and 2, particularly when waiting for 
test results and when experiencing physiological symptoms that could be a sign of recurrence. 
However, only participants in Group 1 experienced highly maladaptive FCR post cancer 
treatment, which was described as occurring once they had time to process what had 
happened to them.  
It wasn't until after, well after 12 months that I really … started to feel the effects of anxiety and stuff. 
(ER: Mm.). When the oncologist visits dropped off, when you didn't need to see a surgeon again. … 
When chemo finished … So that's when it started to mess with me. (Freya, Group 1) 
If I started to feel an ache or pain somewhere … I would get that focused on it I’d physically make, 
make myself … sick, and I’d, you know, I’d feel worse than I was, you know, I’d have tingly feelings 
and all sorts of weird feelings that I thought “well I’m going to die” or something… (Eve, Group 1). 
Participants in Groups 3 and 4 were much less concerned about FCR, with minor 
worry occurring when awaiting test results and when thinking about the possibility that they 
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may miss symptoms of a recurrence.  
Health Care System Support Provision 
In general, participants in Groups 2 and 4 described experiencing good support from 
the hospital and appropriate integration with support services, while participants in Group 1 
described a lack of support and information from the hospital and a lack of integration with 
appropriate support services. The participant in Group 3 made no specific comments 
regarding the hospital system or use of support services.  
Hospital care. 
Participants in Group 1 generally described a lack of support and information from 
the hospital with regard to mental health and support services (though some participants felt 
adequately supported). This was particularly highlighted by participants at the post-treatment 
stage. 
It’s a business … getting the cancer sorted out, and getting the cancer over with, as far as the hospital 
and all that is concerned. (ER: Mm.). So, and it was like, once it stopped it was like “ah, what now?” 
… I said to my psychologist today, “It was like… the treatment should only be starting now...” (Sienna, 
Group 1) 
In contrast, participants in Groups 2 and 4 felt that the hospital system was mostly 
good, with less needs described.  
I went Private, and they were brilliant. … They’d give you this and they’d give you that, and I didn’t 
take any of it, because well why, there was people going to be worse off than me. (Quinn, Group 4) 
In general, interviews suggested that those with no prior support or treatment in place 
for anxiety/depression required more support from the hospital than those with long-term 
and/or previous mental illness experiences.  
Support services. 
A lack of integration with appropriate support services for people with cancer, a lack 
of information, and few links with counselling or psychological support services, were 
described by multiple participants in Group 1. In particular, Doctors (and the hospital system) 
were often described as failing to link their patients with appropriate support services. 
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I don’t know what it would be like for anybody who, um, doesn’t have support. … cause the Doctor 
didn’t, nobody sort of said “do you want counselling?”. … there was no offer of counselling. … Even 
nobody mentioned the Support Group. (Bella, Group 1) 
Doctors need to be more responsible, more proactive ... and stop being this sausage factory of putting 
people through as quickly as you possible. … And I think a lot of people probably find it more difficult 
after treatment has finished, because there's nothing. … And … the lack of links with people that are 
integrative medicine specialists, like um homoeopathic, ah naturopaths, physio … psychologists. 
There's just no central link to the whole thing. (Bianca, Group 1) 
In contrast, participants in Group 2 (bar one) and Group 4 perceived solid links with 
support services, though some of these participants had links with mental health services 
already in place prior to their cancer diagnosis.  
Discussion 
This qualitative study aimed to compare and examine the existing supports and needs 
of people with cancer and different histories of depression/anxiety. Our findings suggest that 
a person’s support needs may differ based on their history of coping with anxiety/depression 
premorbid to their cancer diagnosis. More specifically, we found that participants with 
anxiety/depression associated with cancer (no matter the origin or history of their 
anxiety/depression) were much more likely to access formal coping strategies such as 
psychological treatment for cancer-related anxiety/depression, attend cancer support groups, 
lose personal relationships because of their cancer, and experience severe maladaptive FCR, 
than participants with anxiety/depression not associated with cancer (no matter the origin or 
history of their anxiety/depression). Our results also found that participants with episodic or 
cancer-related anxiety/depression felt less well supported by the hospital system and 
experienced less links with support services than participants with long-term 
anxiety/depression.  
Many of the participants in this study had a vulnerability for experiencing 
anxiety/depression associated with their cancer due to their history of long-term 
anxiety/depression (Mehta & Roth, 2015). Interestingly, however, only some of these 
participants experienced cancer related anxiety/depression (Group 2), with these same 
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participants demonstrating poorer coping, needing more anxiety/depression treatment, and 
experiencing worse FCR. To better understand why this might have occurred, it is important 
to consider how and why those with a premorbid history of long-term anxiety/depression and 
anxiety/depression in response to their cancer (Group 2) might differ from those with a 
similar history who did not experience any cancer-related anxiety/depression (Group 4). 
Participants in Group 2 were generally younger than those in Group 4, had an average of one 
additional chronic illness per person (whereas only one participant in Group 4 had an 
additional chronic illness), reported they received more misinformation and misdiagnoses 
from health professionals, described less positive social support interactions, and perceived 
more, and more severe, cancer related psychosocial consequences. This is in line with 
previous research that suggests that cancer patients who are younger (Dunn et al., 2013; 
Hulbert-Williams, Neal, Morrison, Hood, & Wilkinson, 2012; Linden, Vodermaier, 
Mackenzie, & Greig, 2012), have additional chronic illnesses (J. M. Gunn et al., 2010; 
Ritchie, Kvale, & Fisch, 2011), less social support (Pinar, Okdem, Buyukgonenc, & Ayhan, 
2012; Singer et al., 2012), and more negative illness representations (Richardson et al., 2016), 
are more likely to experience higher levels of distress. This suggests that together with these 
potential risk factors, people who also have a history of long-term anxiety/depression and 
who have not developed coping strategies to manage these issues might be at risk to develop 
cancer-related anxiety/depression, and therefore may be more at need for support to prevent 
or decrease such anxiety/depression. 
Participants with episodic or cancer-related anxiety/depression (Group 1) often felt 
less supported by the hospital system and experienced less access to appropriate support and 
mental health services than participants with long-term anxiety/depression (Groups 2 and 4). 
Our findings suggest that this was likely due to a lack of prior exposure to mental health and 
support services, as participants with previous or existing links with such services required 
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less hospital support and service access. One other potential explanation for this pattern of 
results lies with the setting for our study, a regional area of Australia (Australian Bureau of 
Statistics, 2011) with no cancer-specific hospitals, cancer centres, and a lack of individualised 
services and tailored support (particularly psychological services). Research suggests that 
people in rural/regional settings often experience worse outcomes, limited access to tailored 
cancer-specific hospital care, a lack of psychological support, and few links and referrals to 
other key support services (Butow et al., 2012; K. Gunn, Turnbull, McWha, Davies, & Olver, 
2013). 
Implications 
 Our study suggests that a person’s history of anxiety/depression may influence how 
they cope with their cancer experience. In terms of distress trajectories in cancer patients 
(Dunn et al., 2013; Helgeson et al., 2004; Henselmans, Helgeson, et al., 2010; Lam, Shing, 
Bonanno, Mancini, & Fielding, 2012), our findings suggest that those who have a history of 
anxiety/depression that is unrelated to cancer might be better able to cope with the combined 
burden resulting from both the mental and physical illness than those whose 
anxiety/depression is cancer related. The knowledge that inexperience in coping with 
anxiety/depression might place a person at risk of a trajectory of chronic distress post cancer 
could inform targeted implementation of appropriate resources and services for people at risk. 
However, more research is needed to determine which facets of a person’s anxiety/depression 
history might be most important in predicting such trajectories. Coping repertoire and skills 
to manage psychological distress would be particularly worthy of exploration. 
In terms of service provision, our study is in line with previous research (K. Gunn et 
al., 2013; Rainbird, Perkins, Sanson-Fisher, Rolfe, & Anseline, 2009) and suggests a need for 
patients to receive additional support and information from hospitals, as well as referrals to 
external mental health and support services where required. However, hospitals often lack the 
120 
resources to implement such changes, particularly in rural/regional areas. This study suggests 
that these limited resources are best directed towards increasing information and links with 
support services for people with cancer related anxiety/depression, rather than for those who 
report coping well with a history of long-term anxiety/depression. This is because the latter 
group often already have existing support systems in place, while people with cancer related 
anxiety/depression are distressed, have less social support, and experience more severe FCR. 
For the same reasons it is also suggested that health professionals recommend the use of 
appropriate support services (including support groups) to people with cancer related 
anxiety/depression. Our findings highlight the importance of investigating a cancer patient’s 
history of anxiety/depression to determine how much support they may (or may not) require.  
Limitations 
 Although we attempted to differentiate between people with episodic 
anxiety/depression and people with long-term anxiety/depression, no clinical diagnostic 
measures or criteria were used to assess this during the interview process. Instead, two 
researchers (ER and JS – a clinical psychologist) placed participants into groups based on 
participant data (demographic and interview). Participants were assigned to groups based 
upon consideration of their reported family history of psychological disorders, psychological 
responses to past significant life events and premorbid experience of anxiety/depression 
generally, as well as their reports of their response to their cancer experience. 
Due to the widely varied cancer types, cancer stages, and treatment types, experienced 
by our sample, more consensus could potentially have been found with the use of a more 
focused sample, such as the inclusion of participants who only have bowel cancer or early-
stage disease (Stage 1). Conversely, our more diverse sample may have led to additional 
insights. As our sample provided both overlapping and unique representations across groups, 
a good balance between specificity and diversity appears to have been achieved. However, as 
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only one participant had episodic anxiety/depression that was not related to cancer (Group 3), 
results from this specific participant category should not be generalised to others in similar 
situations. 
Conclusions 
In conclusion, our study has highlighted the need for both researchers and health 
professionals to give more consideration to the origin and history of a person’s 
anxiety/depression in order to determine how they might cope with cancer, their support 
needs, and the amount of support required during the diagnosis, treatment, and survivorship 
phases of cancer. 
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The aim of the present thesis was to understand how people cognitively represent 
cancer and anxiety/depression and to examine how these illness representations might 
influence coping behaviours, self-management strategies, illness outcomes, and support needs 
using the Common Sense Model of Self-Regulation of Health and Illness (CSM; Leventhal et 
al., 1980). Four complementary studies were conducted to build an evidence base to meet this 
aim. Study 1 involved the completion of a systematic review and meta-analysis to synthesise 
existing literature on the relationships between illness representations, coping behaviours, and 
illness outcomes in people with cancer. Study 2 consisted of a systematic review and meta-
analysis synthesising the findings of the relationships between illness representations, coping 
behaviours, and illness outcomes in people with depression (a lack of published studies 
precluded a systematic review on studies in people with anxiety). As a first foray into 
exploring co-morbid illness representations in people with cancer and anxiety/depression, 
Study 3 involved the completion of qualitative interviews with people who had this 
combination of illnesses. These interviews were aimed at examining the content of 
multimorbid illness representations, as well as analysing how these representations would 
impact the use and effectiveness of self-management strategies. Finally, Study 4 examined 
how the subjective support needs of cancer patients/survivors differed between people with 
varying histories of anxiety/depression (e.g., episodic versus long-term) and how these needs 
might fit with a person’s co-morbid illness representations in order to provide suggestions for 
how support provision could be improved for this population. The key aims, findings, and 
conclusions from each of these studies are summarised in Table 6.1. This discussion chapter 
will integrate the main findings from each of these four studies, highlight both the theoretical 
and practical implications uncovered by this research, identify areas and considerations for 
future research, discuss potential limitations, and draw overall conclusions.  
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Table 6.1  
Summary of the Findings in the Present Thesis 
 Aims Findings Conclusions 
Study 1 
Chapter 2 
To provide a systematic 
overview of the 
relationships between the 
Common Sense Model’s 
(CSM) illness 
representations and health 
and coping outcomes in 
people with cancer. 
Greater identity, consequences, and emotional 
representations, a more chronic timeline, as well as 
less illness coherence, personal and treatment 
control, was associated with more adaptive coping 
behaviours (e.g., cognitive reappraisal) and illness 
outcomes (e.g., psychological distress).   
Illness representations are key factors to understanding 
how individuals respond to cancer, with interventions 
aimed at changing or reframing maladaptive 
representations required to improve the coping 
strategies and illness outcomes of people with cancer. 
Study 2 
Chapter 3 
To provide a systematic 
overview of the 
relationships between the 
CSMs illness 
representations and health 
and coping outcomes in 
people with depression. 
More severe consequences were found to be 
associated with more coping efforts, while greater 
identity, consequences, and emotional 
representations, a more chronic timeline, and lower 
control were associated with increased psychological 
distress.  
This review suggests that illness representations are 
important for understanding how people respond to 
depression, with research examining the effectiveness 
of adjusting key representations in CBT-based 
interventions required.  
Study 3 
Chapter 4 
To explore the content of 
individual’s multimorbid 
representations of cancer 
and anxiety/depression, as 
well as how these relate to 
their coping behaviours and 
self-management strategies. 
The majority of participants perceived cancer and 
anxiety/depression as related, though some perceived 
them as unrelated or were unsure about their 
relationship. When described as related, participants 
using adaptive combination self-management 
strategies (e.g., meditation) coped better than those 
who tried to ease cancer related anxiety/depression 
with strategies that could be considered maladaptive 
(e.g., internet research). 
In order to improve health care interactions and 
increase the use of adaptive self-management 
strategies, health professionals need to develop a 
deeper understanding of patients’ multimorbid 
representations of cancer and anxiety/depression, the 
effectiveness of combination management for 
multimorbid illnesses, and the ongoing challenges 
faced by cancer patients and survivors. 
Study 4 
Chapter 5 
To examine and compare 
the support needs of people 
with cancer and varying 
histories of 
anxiety/depression in order 
to provide suggestions for 
improvements in support 
and service provision. 
Cancer patients with long-term anxiety/depression 
that was not associated with their cancer diagnosis 
coped best with cancer and experienced less fear of 
cancer recurrence. These participants also highlighted 
more positive experiences with, and required less 
support from, hospitals and support services.  
Both researchers and health professionals should 
examine a cancer patient’s origin and history of 
anxiety/depression in order to facilitate improvements 
in coping with cancer, reduce fear of cancer 
recurrence, and determine the type and amount of 
support needed by a person living with or post a cancer 
diagnosis.  
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Summary of the Main Findings 
Illness Representations, Coping Behaviours, and Illness Outcomes in People with Cancer, 
Anxiety, and/or Depression 
In Study 1, Study 2, and Study 3, the illness representation dimensions were related 
both to specific coping behaviours and illness outcomes in people with cancer, depression, 
and cancer and anxiety/depression. Study 1 found that less perceived personal control over 
cancer, less perceived treatment control over cancer, perceptions of a more chronic or 
cyclical timeline for cancer, perceptions of more serious consequences of cancer, and a 
stronger emotional impact of cancer (higher emotional representations), were associated with 
the use of maladaptive coping strategies such as avoidance/denial. In contrast, perceptions of 
more personal and treatment control, acute timeline perceptions, less perceived 
consequences, and less emotional impact of cancer, were associated with the use of more 
adaptive coping strategies such as cognitive reappraisal and problem focused coping. Study 2 
included a limited number of studies investigating the relationships between illness 
representations and coping behaviours in people with depression. This meant that for the 
meta-analysis in Study 2, specific coping behaviours were collapsed into one coping scale 
that measured the extent to which participants used or did not use a coping behaviour, making 
comparisons with Study 1 difficult. The meta-analysis in Study 2 found that perceptions of 
more severe depression related consequences and more perceived treatment control were 
related to the use of more coping strategies (both adaptive and maladaptive). However, 
similarly to the findings of Study 1, the summary of the studies included in the narrative 
review suggests that more perceived personal and treatment control were associated with the 
use of more adaptive coping strategies (e.g., treatment seeking, problem solving, active 
coping, positive reframing). 
With regard to illness outcomes, Study 1 found that more perceived symptoms of 
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cancer (higher identity), perceptions of a more chronic or cyclical timeline for cancer, 
perceptions of more severe consequences of cancer, less perceived personal control over 
cancer, less perceived treatment control over cancer, and more emotional impacts of cancer 
(higher emotional representations), were associated with worse illness outcomes, including 
higher anxiety, depression, and psychological distress, as well as poorer psychological well-
being, role functioning, physical functioning, and quality of life. The opposite profile of 
perceptions (lower identity, timeline, consequences, emotional representations, and higher 
personal and treatment control) was associated with better illness outcomes (less anxiety, 
depression, and psychological distress, and better role and physical functioning, and quality 
of life). Study 2 found similar associations to those identified in Study 1, with a stronger 
emotional impact of depression (higher emotional representations), perceptions of more 
depression related symptoms (higher identity), perceptions of more severe depression related 
consequences, perceptions of a more chronic timeline for depression, less perceived personal 
and treatment control over depression, and less perceived understanding of depression (illness 
coherence), associated with higher levels of psychological distress. Overall these findings 
were consistent with the existing literature, in which similar associations between illness 
representations, coping behaviours, and illness outcomes in people with a variety of chronic 
physical and mental illnesses were found (Baines & Wittkowski, 2013; Dempster et al., 2015; 
Hagger & Orbell, 2003) 
A final important finding from Study 1 pertains to the high rates of heterogeneity that 
was identified across several meta-analytic analyses. For example, illness coherence had 
particularly high heterogeneity, meaning that associations between coherence and outcomes 
were unable to be identified, most likely due to the presence of a moderator. Several other 
relationships between illness representations and illness outcomes were found to have high 
heterogeneity, and although several potential moderators were identified (e.g., cancer type, 
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cancer stage, treatment type, or treatment toxicity) these were unable to be examined due to 
missing and unreported information. The systematic review by Hagger and Orbell (2003) also 
found considerable heterogeneity amongst relationships between illness representations, 
coping behaviours, and illness outcomes in people with different chronic illnesses. However, 
similarly to the findings of Study 1, moderator analyses were unable to be examined due to 
the low number of studies in their sample. 
Using the CSM as a framework to explore the illness representations of people with 
co-morbid cancer and anxiety/depression, Study 3 found both support for the existing illness 
representation dimensions as applied to single illnesses, as well as for new multimorbid 
representations of illness. Specifically, more symptoms of cancer (higher identity), more 
severe consequences of cancer, and less perceived control caused by the cancer, prevented 
the use of adaptive coping strategies and were associated with more severe 
anxiety/depression. These findings matched those of Study 1 and Study 2, in which identity, 
consequences, and control were found to have similar associations with anxiety, depression, 
psychological distress, and coping strategies (e.g., lower cognitive-reappraisal and problem-
focused coping) in people with cancer and in people with depression. However, in Study 3 
these findings were extended by the existence of subjective representations about 
multimorbidity. Study 3 participants were found to think about the relationships between 
cancer and anxiety/depression in different ways. While some perceived them as unrelated or 
were unsure about their relationship, the majority of participants perceived their cancer and 
anxiety/depression as related. These results matched those from a previous study by Mc 
Sharry et al. (2013) in people with diabetes and depression. In Study 3, when participants 
described cancer and anxiety/depression as unrelated or were unsure about their relationship, 
a distant timeline between illness diagnoses, less understanding of anxiety/depression, and 
the use of separate coping and self-management strategies for each illness were most often 
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described. Separate self-management strategies for illnesses perceived as unrelated were also 
generally described by participants in the study by Mc Sharry et al. (2013). When illnesses 
were considered related these links were often described as being causal (Mc Sharry et al., 
2013). For example, some participants believed their cancer caused their anxiety/depression, 
while others believed their anxiety/depression caused their cancer. It is important to note that 
generally the consequences of cancer and its treatment were described as causing 
anxiety/depression, rather than the cancer itself. Both separate and combination coping and 
self-management strategies were described by people who perceived their cancer and 
anxiety/depression as related, with participants who used adaptive combination strategies 
(e.g., meditation) coping better with cancer related anxiety/depression than those who used 
maladaptive strategies (e.g., unguided internet research).  
Study 3 also identified representations on prioritising illnesses, and participants 
identified the illness they found most challenging (cancer or anxiety/depression), with a more 
chronic or cyclical timeline, less perceived control, and less understanding (illness 
coherence), associated with perceptions of a more challenging illness. These findings were 
supported by Bower et al. (2012), who highlighted the importance of perceived control for 
illness prioritisation. Which illness a person finds most challenging appears likely to 
influence which illness they will prioritise in terms of self-management and treatment (Mc 
Sharry et al., 2013; Schüz et al., 2014). Changing perceptions and needs were also identified 
across the cancer experience, with different illness representations likely to be present at 
different stages of the illness timeline. These changing representations were associated with 
changes in coping and self-management strategies. Study 3 also highlighted how 
representations related to fear of cancer recurrence (FCR) often lead to the use of maladaptive 
coping and self-management strategies. For example, those who perceived a cyclical timeline 
for cancer, more severe consequences of cancer, less perceived control over cancer, and less 
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understanding (illness coherence) of cancer, were more likely to have high FCR, and to use 
coping and self-management aimed at reducing this FCR. However, these strategies were 
often maladaptive (e.g., constantly calling or visiting the doctor), suggesting the need for 
appropriate intervention in this population. These findings from Study 3 are also related to 
the findings of Study 1, with a more cyclical timeline, more severe consequences, less 
perceived control, and less illness coherence, associated with higher levels of anxiety in 
cancer patients (anxiety is a crucial aspect of FCR; Lee-Jones et al., 1997; Simard et al., 
2010), as well as the use of less adaptive coping strategies (e.g., a more cyclical timeline is 
related to increased avoidance/denial).  
Study 4 extended this perspective by examining which illness representations 
influenced the support needs of people with cancer and varying histories of 
anxiety/depression. In order to examine these differences, participants were placed into four 
groups. These groups were created based on whether participants had episodic 
anxiety/depression or long-term anxiety/depression, and whether or not participants perceived 
their anxiety/depression to be associated with their cancer. Perceptions of more, and more 
severe, psychosocial consequences of cancer in people with long-term anxiety/depression, 
were associated with poorer coping, a need for more anxiety/depression treatment, and worse 
FCR. Further, participants with episodic or long-term anxiety/depression that did not 
experience any cancer related anxiety/depression perceived greater control over their 
illnesses, leading to better coping and outcomes. Finally, participants with long-term 
anxiety/depression generally perceived more control over their illnesses and had a better 
perceived understanding of their illnesses (more illness coherence), with these participants 
requiring less support from the hospital system and support services. In contrast, those 
participants with episodic or cancer related anxiety/depression often perceived less control 
over and understanding of their illnesses, with less hospital support, access to external 
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support services, and access to mental health services described.  
In summary, all four studies provide strong evidence for the applicability of the CSM 
to people with cancer and anxiety/depression, with the CSMs illness representation 
dimensions found to be particularly important for predicting the health and coping outcomes 
of the people in this population. The most important predictors of coping behaviours, illness 
outcomes, and support needs, included timeline, consequences, control, and illness 
coherence, with support found for each of these dimensions across all four studies. Other 
illness representation dimensions were found to be important across specific studies only 
(identity, Studies 1, 2, and 3; cause, Study 3). Finally, while emotional responses (emotional 
representations) to illnesses (e.g., fear) were found to influence coping and self-management 
strategies throughout this thesis, associations between emotional representations and illness 
outcomes were difficult to disentangle in studies that examined anxiety/depression as an 
illness (rather than an outcome).  
Support Needs for People with Cancer and Anxiety/Depression  
Study 3 and Study 4 demonstrate the need for people with cancer and 
anxiety/depression to receive better support, with these studies able to provide insights into 
the specific support needs of people with these illnesses. Similarly to previous research, 
Study 3 found that illness representations and associated support needs change throughout the 
cancer experience, with different needs identified at different stages of illness timeline (e.g., 
at diagnosis versus during treatment versus post treatment) (Fischer et al., 2013; McDowell, 
Occhipinti, Ferguson, Dunn, & Chambers, 2010). Because of this, continued support for 
cancer patients and survivors with anxiety/depression is paramount, with more consideration 
of these needs at key stages of the cancer experience required by health professionals. 
Support needs were also found to differ based on which illness participants found more 
challenging (anxiety/depression or cancer), with more needs associated with the illness they 
131 
found more challenging. Further, Study 3, Study 4, and previous research have found that 
higher levels of FCR have been associated with more support needs from the hospital, 
external support services, and health professionals (Simard et al., 2013). Both Studies 3 and 4 
also found that people with extremely severe cases of FCR often constantly contact health 
professionals for advice, and can even require hospitalisation. In order to address the needs of 
people with cancer and anxiety/depression, Study 3 suggested that health professionals 
should increase their understanding of the illness representations held by people with these 
illnesses. 
Study 4 found differences between the support needs of people with cancer and 
episodic anxiety/depression and people with cancer and long-term anxiety/depression, as well 
as between people with anxiety/depression related to (or caused by) their cancer and people 
with anxiety/depression that was not related to their cancer. More specifically, participants 
with both episodic and long-term anxiety/depression that was perceived as associated with 
their cancer coped less well with their cancer, required more psychological treatment for their 
anxiety/depression, attended more cancer support groups, lost more personal relationships 
because of their cancer, and experienced worse FCR, than participants with 
anxiety/depression that was not associated with their cancer. Further, people with episodic 
cancer related anxiety/depression generally felt less supported by the hospital system and 
experienced fewer links with appropriate support services than people with long-term 
anxiety/depression. This suggests that people with episodic cancer related anxiety/depression 
have a need for increased access to relevant support services. Overall, despite a large body of 
literature aimed at reducing support needs and improving illness outcomes in people with 
cancer, it appears that there is still room for improvement in this area (Carey et al., 2012; 
Galway et al., 2012). More knowledge about the content of illness representations appears 
likely to deepen our understanding of the needs of people with cancer and anxiety/depression, 
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as well as to provide insights into how to address such needs.  
Theoretical Implications and Future Research Directions 
Role of the CSM in Cancer and Anxiety/Depression 
The Common Sense Model of Self-Regulation of Health and Illness (CSM; Leventhal 
et al., 1980) is the most widely used model to examine the cognitive processes underlying 
coping behaviours, self-management strategies, and illness outcomes in people with chronic 
illness. All four of the studies in this thesis found relationships between the CSMs illness 
representation dimensions, coping, and outcomes, and provided support for the CSM as an 
appropriate framework for examining the content of illness representations. Additionally, 
these studies support the CSM as a basis for examining how such illness representations 
relate to coping and outcomes in people with cancer and anxiety/depression. Each of the 
distinct illness representation dimensions identified by the model and its associated 
questionnaires (Leventhal et al., 1980; Moss-Morris et al., 2002; Weinman et al., 1996) were 
supported by the present thesis, though the extent to which each representation was supported 
varied across and between studies. These representations were also found to be associated 
with coping behaviours and illness outcomes in people with cancer, people with depression, 
and people with co-morbid cancer and anxiety/depression. In general, the results of this 
thesis, as well as the results of previous review studies (e.g., Baines & Wittkowski, 2013; 
Dempster et al., 2015; Hagger & Orbell, 2003), have found that a more positive profile of 
representations is associated with the use of more adaptive coping behaviours and better 
illness outcomes, while a more negative profile of representations is associated with the use 
of more maladaptive coping behaviours and worse illness outcomes. Although the findings 
for these relationships were well supported across people with cancer (Study 1) and 
depression (Study 2) there was a lack of existing research examining these relationships in 
people with anxiety, with only one study including participants with anxiety located across 
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the systematic search process included as a part of Study 2 (Hunot et al., 2007). Why this 
may be the case is not evident, and future research is therefore needed to investigate the 
relationships between the illness representation dimensions of the CSM, coping behaviours, 
and illness outcomes in people with anxiety specifically. 
The CSMs multi-directional and self-regulative feedback loop suggests that cognitive 
and emotional responses to an illness guide coping and self-management strategies in 
parallel, with these strategies later appraised in terms of their success or failure for 
controlling the illness and its consequences. This appraisal process then leads to the 
refinement of illness representations, coping behaviours, and self-management strategies, 
where the feedback loop can start again (Diefenbach & Leventhal, 1996; Hale et al., 2007; 
Leventhal et al., 1998). Study 3 provided support for this feedback loop, where evidence for 
changing illness representations, support needs, coping behaviours, and self-management 
strategies throughout the cancer experience were highlighted. This is in line with research by 
Mc Sharry et al. (2013), who found that the self-management behaviours associated with 
illness representations underwent constant appraisal. When coping behaviours were appraised 
as successful, this positive appraisal was found to reinforce patients’ confidence in their 
multimorbid representations (e.g., that their anxiety/depression was caused by the 
consequences of their cancer). Further, patients with less clear representations expressed 
unclear goals for self-management strategies, which in turn resulted in evaluating these 
strategies as less successful (Mc Sharry et al., 2013). Overall, these findings provide support 
for the CSMs feedback loop in suggesting that individuals act as problem solvers who 
constantly appraise and alter their representations and coping behaviours. However, in order 
to gain a more systematic understanding of specific changes in illness representations and 
associated coping behaviours over time, as well as how this feedback loop might work for 
people with multiple illnesses (e.g., co-morbid cancer and anxiety/depression), longitudinal 
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studies are required (Mc Sharry et al., 2013). These studies should also focus on how the 
existence of complex multimorbid illness representations and the use of 
synergistic/antagonistic self-management strategies might influence the functioning of the 
CSMs feedback loop. 
Expanding the CSM 
A number of multimorbid illness representations were identified in Study 3, including 
varied representations of the relationships between (or causes of) cancer and 
anxiety/depression, beliefs about FCR, perceptions of participants most challenging illness, 
and changing beliefs across the illness experience. In addition, both Study 3 and Study 4 
highlighted the importance of examining a person’s history with their illnesses (e.g., which 
illness came first). The majority of these multimorbid representations were supported by 
previous qualitative research (Bower et al., 2012; Mc Sharry et al., 2013). Importantly, each 
of these multimorbid factors and/or representations were shown to influence coping and self-
management strategies, with Schüz et al. (2014) suggesting that the way in which people 
operationalise their illnesses (e.g., combined multimorbid representations versus illness-
specific representations) might be dependent on the specific illness outcome under 
examination (e.g., medication adherence versus physical functioning), though more research 
is needed to examine such relationships. Although the CSM takes into account some 
multimorbid factors (e.g., prior illness experience), these findings suggest that the CSM may 
need to be adjusted or expanded to be more applicable to people with multiple illnesses. In 
particular, the inclusion of specific multimorbid illness representations including perceptions 
of the connections, relationships, and causes between illnesses, priorities amongst illnesses, 
and synergies and antagonisms in the management of illnesses, is recommended, as these 
were the most commonly identified multimorbid representations across studies (Bower et al., 
2012; Mc Sharry et al., 2013).  
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The development of standardised measures would allow for easier examination and 
assessment of multimorbid illness representations. Currently, the most widely used measures 
of illness representations are the illness perception questionnaires (Broadbent et al., 2006; 
Moss-Morris et al., 2002; Weinman et al., 1996); however these questionnaires need 
adaptation to be applicable for multiple illnesses. C. J. Gibbons et al. (2013) proposed a new 
measure of illness perceptions for people with multiple illnesses based on these existing 
questionnaires and previous qualitative research. Their Multimorbidity Illness Perceptions 
Scale (MULTIPLeS) consists of five individual subscales including emotional 
representations, treatment burden, prioritising conditions, causal links, and activity 
limitations, as well as a summary scale comprising all items from each subscale that 
measures the overall perceived impact of multimorbidity. Four subscales (emotional 
representations, prioritising conditions, causal links, and activity limitations) were supported 
by the results of Study 3, while the prioritisation and causal links scales were also partially 
supported by the results of Study 4. Neither Study 3 nor Study 4 provided support for the 
treatment burden scale, with multimorbid medication burden not arising as an important 
concern in studies of people with cancer and anxiety/depression (Studies 3 and 4). As FCR is 
a cancer specific consequence, it was not considered for inclusion in the MULTIPLeS. If a 
specific measure for people with cancer and anxiety/depression was to be created, the 
inclusion of a subscale that specifically measures FCR, or items measuring FCR as part of an 
emotional representations subscale, should be considered. Overall, findings suggest that the 
MULTIPLeS may be appropriate to examine the types of research questions addressed in 
Study 3, Study 4, and previous research (Bower et al., 2012; Mc Sharry et al., 2013). 
However, as the MULTIPLeS has not yet been validated for people with co-morbid cancer 
and anxiety/depression, future research is needed to assess its relevance for answering such 
questions in this particular population.  
136 
Other specific measures of multimorbid illness representations are also beginning to 
be developed, with Mc Sharry et al. (2015) creating the Diabetes and Depression 
Representation and Management Questionnaire (DDRMQ). This questionnaire consists of ten 
subscales including separate representations, negative linked representations, incoherent 
representations, separate management, linked management integration, linked management 
struggle, general medication negative effects, general medication burden, diabetes medication 
worry, and depression medication worry. The majority of these subscales (separate 
representations, negative linked representations, incoherent representations, separate 
management, linked management integration, linked management struggle) appear 
transferrable to people with cancer and anxiety/depression, as they are supported by the 
findings of Study 3 and Study 4. Study 3 also partially supported each of the medication 
related subscales (general medication negative effects, general medication burden, and 
medication worry). However, as this questionnaire was developed specifically for diabetes 
and depression, cancer specific representations (e.g., FCR representations) were not included. 
Similarly to the MULTIPLeS, the DDRMQ, if adapted for cancer and anxiety/depression, 
may be useful for examining the content of illness representations and their relationships with 
self-management strategies. Nevertheless, the applicability of both the MULTIPLeS and the 
DDRMQ (altered for people with cancer and anxiety/depression) would need to be 
investigated in people with cancer and anxiety/depression before either could be used as an 
appropriate measure of multimorbid illness representations in this population. If neither prove 
to be appropriate, then a similar more specific questionnaire could be created for people with 
cancer and anxiety/depression (as has been done with the DDRMQ).  
Practical Implications and Future Research Directions 
Future CSM Interventions 
There is an increasing interest in designing interventions based on the CSM to 
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improve coping strategies and illness outcomes in people with chronic illnesses. A recent 
systematic review by Jones, Smith, and Llewellyn (2015) highlights that interventions 
informed by the CSM have the potential to improve adherence behaviours in people with 
various chronic illnesses (however, no studies of people with cancer, anxiety, or depression 
were included). In this review, interventions that had the largest effect on behaviour were 
those that were delivered by psychologists, involved multiple sessions, included information 
about antecedents, reattribution, and action planning, and targeted control beliefs (matching 
the findings from the studies in the present thesis). Illness representation based interventions 
have also been successful in changing outcomes other than adherence. For example, Keogh et 
al. (2011) conducted a family-based intervention aimed at changing negative/inaccurate 
illness representations. They found this intervention improved illness self-management, 
psychological well-being, diet, exercise, and family support in people with poorly controlled 
type 2 diabetes. Further, Broadbent et al. (2009) found that if illness representations of people 
with myocardial infarctions were successfully changed, people gained a better understanding 
of illness information, had higher intentions to attend rehabilitation classes, less anxiety about 
returning to work, exercised more, and called their GP less. Based on these findings and on 
the findings of the current thesis, it is suggested that interventions informed by the CSM have 
the potential to improve coping and outcomes for people with chronic illnesses. However, 
such interventions for people with cancer should consider several cancer specific factors that 
may influence the illness representations in this population. For example, representations that 
would generally lead to more negative illness outcomes for a person with a chronic illness 
(e.g., representations of a more chronic timeline and severe consequences) may be realistic 
for a person with cancer, particularly when at an advanced or metastatic stage. In these cases, 
it may be better to target emotional responses to cancer (emotional representations) and focus 
on facilitating the use of more adaptive coping behaviours. Targeting emotional 
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representations might be particularly important for people with cancer and 
anxiety/depression, as relieving anxiety/depression might improve a person’s ability to cope 
with cancer. In some cases, it may also be beneficial to target different aspects of certain 
illness representations. For example, although increasing perceived levels of personal or 
treatment control over the cancer may not be possible, increasing control over other key 
factors (e.g., everyday events such as pain management) has been found to improve both 
physical and psychological outcomes (Sand, Olsson, & Strang, 2009; Thompson, Sobolew-
Shubin, Galbraith, Schwankovsky, & Cruzen, 1993).  
Support for the use of the CSM as a basis for interventions in cancer patients was 
provided by Stanton et al. (2013), who synthesised information from 16 randomised 
psychosocial intervention trials in adults diagnosed with cancer. Their review concluded that 
altering cancer related illness representations in psychosocial interventions has benefits for 
cancer patients. Two interventions included in this study specifically attempted to use the 
CSMs illness representation dimensions to improve illness outcomes (Traeger et al., 2013; S. 
Ward et al., 2008). A representational intervention to decrease cancer pain (RIDcancerPain) 
was created and conducted by S. Ward et al. (2008). This study used an approach to patient 
education that involved assessing a patient’s illness representations (based on the CSMs 
representation dimensions) and providing educational information to reduce any 
misconceptions described by patients (Arida, Sherwood, Flannery, & Donovan, 2016; 
Donovan & Ward, 2001; Donovan et al., 2007). The RIDcancerPain was delivered in one 
face-to-face psychoeducational session lasting between 20 and 60 minutes. Five steps were 
completed beginning with a representational assessment of current beliefs about cancer pain 
with respect to identity, cause, timeline, consequences, and cure/control. An exploration of 
any misconceptions and a discussion of any problems arising from holding these 
misconceptions was then conducted. Following this, replacement information was provided, 
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and finally patients were given an opportunity for clarification, and a summary of the session. 
This intervention program was found to reduce existing barriers (misconceptions associated 
with specific illness representations) and pain severity in people with metastatic cancer, 
though several illness outcomes remained unimproved by the intervention (e.g., overall well-
being). These findings by S. Ward et al. (2008), along with the findings of the present thesis, 
suggest that interventions aimed at adjusting inaccurate or maladaptive illness representations 
are likely to be beneficial for improving outcomes in people with cancer. However, 
interventions examining which illness representations are most amenable to change, as well 
as which outcomes might be most improved, are required. 
A more recent intervention study in men with prostate cancer by Traeger et al. (2013) 
examined whether changes in illness representations would mediate intervention-based 
improvements in emotional well-being. Their cognitive-behavioural stress management 
(CBSM) intervention involved ten weekly two hour sessions focusing on stress management 
and health maintenance through training in relaxation, cognitive restructuring, problem-
solving, coping skills, interpersonal skills, and enhancing support networks. Illness 
perceptions were specifically targeted through psychoeducation about prostate cancer, 
cognitive restructuring of cancer related illness representations, and discussion of cancer 
related experiences, and were designed to normalise experiences and address self-perceptions 
in the cancer context. The CBSM intervention was found to change key illness perceptions 
(perceived treatment efficacy or treatment control and understanding of the cancer experience 
or illness coherence), which in turn led to improvements in emotional well-being. Traeger et 
al. (2013) suggested that interventions might be further improved by including more explicit 
strategies for modifying illness representations, as well as by exploring how such 
interventions can influence representations that change over time. Study 3 supported these 
suggestions, further highlighting how representations and needs change across the cancer 
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experience, with changes in illness representations also associated with changes in coping 
and self-management strategies. Specific research into how future interventions might be able 
to address such changes over time is required in order to maximise their effectiveness for 
improving coping and outcomes.  
Research using CSM based interventions has led to some promising improvements in 
illness outcomes in people with chronic illnesses including cancer. However, interventions 
that specifically aim to challenge and modify maladaptive or unrealistic illness 
representations in people with cancer and anxiety/depression have yet to be created and 
trialled, and therefore the creation and assessment of such interventions is an important area 
for future research. The studies in this thesis, as well as the findings from research previously 
highlighted, provide some suggestions for which illness representations would be best to 
target in future interventions for people with cancer, anxiety, depression, and co-morbid 
cancer and anxiety/depression. For example, interventions that aim to adapt causal 
perceptions to be more accurate, timeline perceptions to be less cyclical and chronic, decrease 
perceptions of the amount and severity of the consequences associated with cancer, increase 
perceived personal and treatment control over cancer, and decrease the perceived emotional 
impacts of cancer, may increase the use of adaptive coping strategies, reduce poor illness 
outcomes such as psychological distress, and improve quality of life. Future interventions 
based on the CSM for people with cancer and anxiety/depression should also take into 
account the existence of multimorbid representations, including causal representations (e.g., 
did one illness cause the other illness), which illness a person prioritises or finds most 
challenging, beliefs about FCR, and the synergisms/antagonisms associated with self-
managing multiple illnesses.  
With regard to how such interventions might best target these representations, it is 
suggested that a combination of psychoeducation from cognitive-behavioural therapy (CBT; 
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A. T. Beck et al., 1979) and the education based Representational Approach (RA; Donovan & 
Ward, 2001), might be effective for improving coping and outcomes in people with cancer 
and anxiety/depression. In CBT-based treatments (A. T. Beck et al., 1979; J. S. Beck, 2011) a 
client’s negative and/or inaccurate thoughts and beliefs are modified in order to change and 
improve emotional responses and behaviours. Before modifications can be made, the patient 
must become familiar with such thoughts and how they impact emotions and behaviours, 
with the CSM providing an evidence based starting point for examining the content of such 
thoughts. These negative automatic thoughts can then be challenged through 
psychoeducation, reality-testing, and generating alternatives. For example, consider a person 
who holds a strong belief that their cancer will return (high FCR), who perceives a low 
amount of control over their cancer, and who self-diagnoses any minor ache or pain as a sign 
of a cancer recurrence. For this person, reality-testing these beliefs (e.g., how likely is it that a 
headache is a sign of your cancer returning), and then providing psychoeducation (e.g., 
providing information about how rare a recurrence of that type of cancer would be), could 
change these representations to be more accurate and adaptive. However, although CBT has 
been found to be effective for changing specific underlying beliefs in anxiety and depression 
(Hollon et al., 2005), therapeutic interventions have yet to use CBT for targeting illness-based 
cognitions.   
The CSM was used to guide the development of the Representation Approach (RA) to 
patient education (Arida et al., 2016; Donovan & Ward, 2001; Donovan et al., 2007). This 
approach involves investigating the patients existing illness beliefs using key dimensions 
from the CSM: identity, cause, timeline, consequences, and control/cure, and explores any 
misconceptions, gaps, or confusions described. After discussing the consequences of these 
representations for behaviours, information that fills gaps in knowledge, clarifies confusions, 
and replaces misconceptions, is provided. The RA has shown potential for changing illness 
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representations and improving illness outcomes by challenging and altering maladaptive 
cognitions in people with cancer, with early interventions using the RA showing promise 
(e.g., S. Ward et al., 2008).  
A combination of CBT and the RA may prove effective for improving coping and 
outcomes in people with cancer and anxiety/depression, as previous research has 
demonstrated that relatively brief psychoeducational interventions based on the CSM are 
useful for identifying and modifying illness representations, and in turn improving coping 
and outcomes (Petrie & Weinman, 2012). However, any intervention aimed at improving the 
health and coping outcomes of people with cancer and anxiety/depression must also consider 
how illness representations change over time, as well as how a person’s illness history can 
influence coping and support needs (highlighted by Studies 3 and 4). For example, people 
with cancer and long-term anxiety/depression may be less likely to require assistance from 
the hospital system and other external support services than people with cancer and episodic 
anxiety/depression. In summary, although psychosocial interventions aimed at changing 
patients’ illness representations have shown promise, more research investigating the types 
and timing of such interventions, as well as the effectiveness of such interventions in people 
with cancer and anxiety/depression, are required.  
Health Professionals’ Understanding of Illness Representations 
It is important that health care providers have a good understanding of a patient’s 
illness and a patient’s illness beliefs (Street, Makoul, Arora, & Epstein, 2009). However, the 
results of Study 3 and Study 4 suggest that patients do not believe this is the case. Therefore, 
in order to better support people with cancer and anxiety/depression, health professionals 
need to gain a better understanding of the illness representations experienced by people with 
these illnesses, and how these representations might be associated with the use of particular 
coping strategies and with specific illness outcomes. Education for health professionals 
143 
regarding the content of such representations (individual and multimorbid), as well as the 
importance and impact of multimorbidity itself, would be important to improve patient 
coping and outcomes. For example, Study 3 and Study 4, as well as previous research by 
Bower et al. (2012) and Mc Sharry et al. (2013), suggest that if health professionals were 
aware of which illness their patients perceived as most challenging and which illness they 
would prioritise, they would have a clearer picture of where support is most needed for each 
patient. Previous research has also highlighted the importance of a shared understanding 
between health professionals and patients for improving patient outcomes (Street et al., 
2009). Further, health professionals should be aware that these illness representations will 
change over time, and therefore continued assessment would be required. Studies 3 and 4, as 
well as research by McDowell et al. (2010), suggest that these assessments might be 
particularly important at key stages of an illness experience, for example when a person with 
cancer moves from the treatment phase to the survivorship phase. As well as providing a 
solid footing for interventions with patients, the Representational Approach (Donovan & 
Ward, 2001) may provide a good basis for improving a health professionals understanding of 
illness representations. This approach to patient education offers a theoretically based model 
that can help support health professionals to develop a shared understanding of a person’s 
illness representations with the aim of collaboratively developing personalised plans for self-
management behaviours (Arida et al., 2016). 
Challenge of Co-Morbid Cancer and Anxiety/Depression for Support Provision 
Because cancer and anxiety/depression often co-occur (Massie et al., 2011; 
Mystakidou et al., 2005; Roy-Byrne et al., 2008), and because these co-morbid conditions are 
often associated with worse outcomes for patients (L. F. Brown et al., 2010; Mystakidou et 
al., 2005; Pasquini & Biondi, 2007), it is important that health professionals ask about a 
person’s past and present mental health when they have been diagnosed with cancer. Study 4 
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showed that examining a person’s history with anxiety/depression may lead to important 
insights into how they might cope with their cancer diagnosis, and the amount and type of 
support required. However, research has shown that oncologists in particular often require 
further training to better recognise patient distress and patients’ need for further counselling 
(Gouveia et al., 2015; Söllner et al., 2001). To improve a health professional’s ability to 
identify patient distress, as well as to improve their knowledge of when a patient needs to be 
referred to additional support services or counselling, validated screening tools such as the 
revised Beck Depression Inventory (BDI-II; A. T. Beck, Steer, & Brown, 1996) or the 
Depression Anxiety Stress Scale (DASS; Lovibond et al., 1995) should be utilised. Further, 
specific training programs for health professionals that focus on providing appropriate 
relational and psychological evaluation skills, including taking a detailed history of illnesses 
as suggested by the findings of Study 4, could be implemented to improve accurate detection 
of distress. Future research should evaluate the effectiveness of these different procedures in 
health professionals who care for people with cancer and anxiety/depression.  
A further challenge for people with co-morbid cancer and anxiety/depression is self-
management, as the symptoms of one condition (or the side-effects of the treatment of one 
condition) might interfere with the coping or self-management strategies for the other 
condition. For example, Study 3 found that for a person who uses exercise to help cope with 
their depression, a cancer diagnosis might limit their ability to exercise and therefore 
exacerbate their depression. These interactions have also been highlighted by previous 
research in people with co-morbid diabetes and depression: Mc Sharry et al. (2013) found 
that although exercising lowered the sugar level of a person with diabetes, their depression 
made it difficult for them to find the energy for exercise. Health professionals should be 
mindful of the management difficulties or antagonisms that occur in patients with multiple 
illnesses so that alternative management strategies can be implemented. As well as being 
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made aware of the potentially negative impacts of multimorbidity on coping and self-
management strategies, health professionals should also be aware of the potential benefits of 
synergistic combination management strategies, as these are likely to improve patient 
outcomes across multimorbid illnesses. For example, Study 3 highlighted how one participant 
found meditation beneficial for reducing her anxiety and improving cancer related 
consequences, while Bower et al. (2012) described how one participant felt that exercise 
improved both her mood (depression) and arthritis. However, more formal studies of these 
synergistic effects are required before specific recommendations can be made.  
The survivorship phase (Aziz, 2007) is another important part of the cancer 
experience, with a need for more support at this time highlighted by the findings of Study 3. 
This post treatment or remission stage of the cancer experience is often described as being 
even more difficult than peri treatment, with FCR, anxiety, and depression often worsening at 
this stage (Baker, Denniston, Smith, & West, 2005; Harrington et al., 2010). The participants 
in Studies 3 and 4 described a lack of support at this post treatment stage, demonstrating the 
need for many cancer survivors to find both their own coping strategies, as well as access to 
appropriate support services and allied health professionals. These findings are in line with 
previous research, as FCR and uncertainty about the future are often highlighted as unmet 
needs for cancer patients and survivors (Harrison et al., 2009; McDowell et al., 2010). 
Although not experiencing FCR, patients with metastatic cancer often describe constant 
concerns about the progression of their cancer, as well as difficulties with self-management 
of symptoms, treatment side effects, mental health, and coping with the prospect of death (G. 
Fan, 2007; Irving & Lloyd-Williams, 2010; Rainbird et al., 2009; Schofield, Carey, & 
Aranda, 2006). Overall, these findings suggest that the mental health and support needs of 
cancer patients and survivors need to be better monitored across the entire cancer experience 
rather than purely at the diagnosis or treatment stage, with more support particularly required 
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for people with cancer and anxiety/depression post treatment. 
Provision of Appropriate Support and Information 
Connecting cancer patients and survivors with appropriate support services and allied 
health professionals is extremely important for the promotion of positive outcomes (K. Gunn 
et al., 2013; Pascoe, Edelman, & Kidman, 2000). However, the studies in this thesis found a 
lack of integration between people with cancer and anxiety/depression and appropriate 
support services and information provision. Specifically, health professionals and hospitals 
often failed to connect people with cancer and anxiety/depression to appropriate support 
services at key stages of the cancer experience. This lack of support and information was 
particularly evident immediately post treatment, when the majority of contact with hospitals 
and health professionals had ended. Inadequate access to appropriate support services has 
been found to impair patient outcomes, increase distress, and increase FCR (Pascoe et al., 
2000; Wang et al., 2016). Therefore, to improve information provision and support for people 
at this time in particular, the distribution of a tool-kit or information pack might be beneficial 
(Jefford & Tattersall, 2002). This pack could include information on common thoughts and 
emotions post treatment (cognitive and emotional representations guided by the findings of 
Study 3), what to do when experiencing such thoughts and emotions, and information on 
where and how to access appropriate support services when required. The findings of Studies 
3 and 4 suggest that this type of information pack may be particularly relevant for those 
people in regional/rural settings where tailored access to psycho-oncological support is 
limited (Butow et al., 2012; K. Gunn et al., 2013; Underhill et al., 2009).  
Limitations 
 In addition to the limitations that have been discussed in previous chapters, several 
more general limitations and methodological issues must be considered. These limitations are 
discussed below. 
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Sample 
Due to the reasonably small number of studies located in Study 1, and the limited 
participant pool for Studies 3 and 4, each of these studies included participants with varying 
cancer types (e.g., breast or bowel), stages (e.g., early-stage or metastatic), treatments (e.g., 
chemotherapy or surgery), treatment severity/toxicity (e.g., targeted cancer therapy or 
traditional chemotherapy), and treatment stages (e.g., peri-treatment or post-treatment). It is 
highly likely that each of these factors would impact the illness representations of people with 
cancer or with cancer and anxiety/depression, as psychological distress (including anxiety 
and depression) and adaptability to cancer have been shown to vary between cancer types and 
cancer stages (Admiraal et al., 2013; Linden et al., 2012; Strada & Sourkes, 2010; Zabora, 
Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001), as well as between treatment types 
and toxicity of treatment (Admiraal et al., 2013; Hack et al., 2010). For example, Linden et 
al. (2012) found that people with lung, gynaecological, or haematological cancer reported the 
highest amount of distress at diagnosis, while cancer patients who received treatment other 
than surgery (e.g., chemotherapy or radiotherapy) were found by Admiraal et al. (2013) to be 
at a higher risk for experiencing psychological distress. However, these factors were unable 
to be examined in Study 1 through the use of moderator analyses due to the provision of 
insufficient data by studies included in the meta-analyses. These factors were also unable to 
be examined in Studies 2 and 3 due to the limited participant pool, though the overlapping 
representations and support needs identified suggests these representations and needs may 
often be similar across varying cancer types, stages, and treatments. To find out how these 
factors might influence illness representations, self-management strategies, and support 
needs, future research should consider comparing people with varying cancer types, stages, or 
treatments. 
A further limitation lies in the setting and location of Study 3 and Study 4. The 
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majority of Tasmania is considered a regional area (Australian Bureau of Statistics, 2011) and 
has no cancer-specific hospitals or cancer centres, as well as a lack of individualised support 
and limited access to psychological services. As people living in such regional and remote 
areas often have different outcomes, needs, and access to services than those living in major 
urban or metropolitan areas (Butow et al., 2012; Underhill et al., 2009), it is likely that the 
results of the present thesis (particularly Studies 3 and 4) will have limited applicability for 
people living outside of regional areas. Therefore, the results of Study 3 and Study 4 should 
not be generalised to such populations. 
The systematic literature search conducted in Study 2 only found one study that 
examined the relationships between illness representations, coping behaviours, and illness 
outcomes in participants with anxiety, demonstrating a dearth of research in this area. 
However, depression and anxiety often occur concurrently, with substantial overlap between 
these illnesses identified (T. A. Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Clark 
& Watson, 1991; Pomerantz & Rose, 2014; Zbozinek et al., 2012). This suggests that similar 
relationships may exist between illness representations and anxiety as between illness 
representations and depression. Nonetheless, more studies are needed to confirm whether this 
is true, and until then caution should be taken when making inferences regarding the 
relationships between illness representations, coping behaviours, and illness outcomes in 
people with anxiety. 
Studies 3 and 4 focused on people with depression and/or anxiety and an analysis of 
differences between people who had only anxiety, only depression, or both anxiety and 
depression was not conducted. This means that important differences may have been missed 
between such groups. However, as previously identified, anxiety/depression have been shown 
to have substantial overlap, meaning that the differences between these illnesses may be 
minimal, though future research would be needed to establish whether this is true. Further, 
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Study 3 did not make clear differentiations between those with diagnosable depression or 
anxiety and those with ‘normal’ psychological distress associated with the cancer experience, 
and while Study 4 did attempt to differentiate between people with episodic 
anxiety/depression and people with long-term anxiety/depression, no clinical diagnostic 
criteria or measures were used to assess these factors during the interview process. Instead, 
people were eligible to participate if they reported a previous diagnosis of, or previous 
treatment for, anxiety/depression via self-report. Although comparative studies have found 
self-reports to be relatively consistent with objective illness data (Chaudhry, Jin, & Meltzer, 
2005), future research should confirm the presence of multimorbidity using objective 
measures such as medical records or diagnoses from general practitioners (Fortin et al., 
2004).  
Research Design 
Studies 3 and 4, as well as the majority of studies included in Study 1 and Study 2, 
were cross-sectional in nature, meaning that judgements regarding causality, predictive 
relationships between variables, and changes over time were precluded. However, Study 1 
did use a moderator analysis to compare whether research design (cross-sectional versus 
longitudinal) influenced the effect sizes of the relationships between illness representations 
and coping behaviours and illness representations and illness outcomes. Overall these 
analyses suggested that relationships between illness representations, coping behaviours, and 
illness outcomes in people with cancer were mostly stable over time, though slightly smaller 
in effect. Further, Studies 3 and 4 found that illness representations and self-management 
strategies were likely to change over time, though this information was provided by self-
report and therefore caution should be taken if generalising such results. Future studies 
should employ longitudinal research designs to determine how illness representations, coping 
behaviours, and illness outcomes might change over time in people with cancer and 
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anxiety/depression. 
There is currently no known existing research examining the content of specific 
illness representations or the relationship of these illness representations to coping and self-
management strategies in people with co-morbid cancer and anxiety/depression. Furthermore, 
there is a lack of research examining how the support needs of people with cancer vary based 
on their history with anxiety/depression. Therefore, qualitative research methods were 
employed to explore such representations, strategies, and needs. Although the use of 
qualitative methods have been increasingly accepted for exploratory research (Michell, 
2004), at times the use of such methods can be seen as a limitation, particularly when poorly 
constructed and lacking theoretical and analytical detail (Collingridge & Gantt, 2008). In the 
present thesis, qualitative methods were deemed appropriate for use in Studies 3 and 4, as 
exploration of a relatively new area of research was required. Further, the Consolidated 
Criteria for Reporting Qualitative Research (COREQ; Tong et al., 2007) was used in these 
studies to ensure the appropriate standards for qualitative research were met. A further 
limitation of qualitative research is the potential for subjective researcher perceptions to 
unknowingly influence thematic analysis, though as Studies 3 and 4 were conducted from a 
subtle realist viewpoint, subjective researcher perceptions were constantly acknowledged 
throughout the analysis process (Mays & Pope, 2000). Finally, the possibility of self-report or 
recall bias by the participants in Studies 3 and 4 must also be considered as a potential 
limitation of those studies. Overall, despite the possible limitations associated with the use of 
qualitative research, important implications were able to be drawn from these studies, though 
caution must be taken when generalising such results. Future research should address these 
limitations by using experimental or questionnaire-based research to confirm the findings 
from Studies 3 and 4. 
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Conclusions 
This thesis has demonstrated the importance of understanding subjective illness 
representations for facilitating better coping behaviours, self-management strategies, illness 
outcomes, and access to support services in people with cancer and anxiety/depression. 
Further, the CSM was shown to provide a strong theoretical basis from which to explore such 
representations. Illness representations including timeline, consequences, personal control, 
and illness coherence, were found to have important associations with coping behaviours and 
illness outcomes in people with cancer, anxiety, and depression. Further, multimorbid 
representations including combined or competing causal representations, beliefs regarding the 
prioritisation of the illness perceived as most challenging, beliefs about FCR, and perceived 
synergies and antagonisms in the management of illnesses, were identified as having 
important associations with self-management strategies and illness outcomes in people with 
co-morbid cancer and anxiety/depression. These findings highlighted the need for the 
development of future interventions that aim to adjust incorrect or maladaptive 
representations in people with cancer and anxiety/depression. Further, the discovery of 
multimorbid representations suggests the CSM may need to be adjusted or expanded to be 
more applicable for people with multiple illnesses. Finally, this thesis also highlighted the 
importance of increasing health professionals’ understanding of illness representations and 
illness history. This will both foster the promotion of suitable self-management strategies and 
increase referrals to appropriate psycho-oncological support services, helping to improve the 
health outcomes of people with cancer and anxiety/depression. 
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Scopus Syntax  
Advanced Search 
 
PUBYEAR > 1995 AND TITLE-ABS-KEY(tumour* OR cancer* OR oncolog* OR 
carcinoma* OR maligna* OR neoplasm* OR metasta* OR *sarcoma* OR “gestational 
trophoblastic” OR leukaemia OR lymphoma OR mesothelioma OR myeloma OR 
myelodysplastic OR *blastoma OR melanoma OR waldenstrom) AND TITLE-ABS-
KEY("illness perception*" OR "illness representation*" OR “common sense” OR Leventhal* 
OR “self-regulation” OR IPQ*) 
  
 
Web of Science Syntax 
Basic Search  
 
((tumour* OR cancer* OR oncolog* OR carcinoma* OR maligna* OR neoplasm* OR 
metasta* OR *sarcoma* OR “gestational trophoblastic” OR leukaemia OR lymphoma OR 
mesothelioma OR myeloma OR myelodysplastic OR *blastoma OR melanoma OR 
waldenstrom) AND ("illness perception*" OR "illness representation*" OR “common sense” 
OR Leventhal* OR “self-regulation” OR IPQ*)) 
 
Timespan 1995 - 2014 
 
 
PubMed Syntax  
Advanced Search 
 
(tumour*[TIAB] OR cancer*[TIAB] OR oncolog*[TIAB] OR carcinoma*[TIAB] OR 
maligna*[TIAB] OR neoplasm*[TIAB] OR metasta*[TIAB] OR *sarcoma*[TIAB] OR 
“gestational trophoblastic”[TIAB] OR leukaemia[TIAB] OR lymphoma[TIAB] OR 
mesothelioma[TIAB] OR myeloma[TIAB] OR myelodysplastic[TIAB] OR *blastoma[TIAB] 
OR melanoma[TIAB] OR waldenstrom [TIAB]) AND ("illness perception*"[TIAB] OR 
"illness representation*"[TIAB] OR “common sense”[TIAB] OR Leventhal*[TIAB] OR 
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Custom Date Range 1995 - 2014 
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Command Line 
 
AB,TI(tumour* OR cancer* OR oncolog* OR carcinoma* OR maligna* OR neoplasm* OR 
metasta* OR *sarcoma* OR “gestational trophoblastic” OR leukaemia OR lymphoma OR 
mesothelioma OR myeloma OR myelodysplastic OR *blastoma OR melanoma OR 
waldenstrom) AND AB,TI("illness perception*" OR "illness representation*" OR “common 
sense” OR Leventhal* OR “self-regulation” OR IPQ*) 
 
Enter a specific date range starting 1995 ending 2014 
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Google Scholar Syntax 
 
With the exact phrase: 
Illness Representation     Illness Representations  
Illness Perception      Illness Perceptions  
Self-Regulation     Common Sense  
IPQ       
 
With at least one of the words: cancer tumour oncology carcinoma malignant malignancy 
neoplasm metastatic metastasis sarcoma leukaemia lymphoma 
 
In the title of the article 
 
Return articles dated between 1995 – 2014 
 
 
CINAHL (follow-up search) Syntax  
 
((tumour* OR cancer* OR oncolog* OR carcinoma* OR maligna* OR neoplasm* OR 
metasta* OR *sarcoma* OR “gestational trophoblastic” OR leukaemia OR lymphoma OR 
mesothelioma OR myeloma OR myelodysplastic OR *blastoma OR melanoma OR 
waldenstrom) AND ("illness perception*" OR "illness representation*" OR “common sense” 
OR Leventhal* OR “self-regulation” OR IPQ*)) 
 
Published date: 1995 - 2015 
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Coding Manual 
1 General Information 
ID No. _______________                                                     Cancer Type ______ DV _______  
 
An article identification number should be included at the top left of each page under ID No., and again in the 
General Publication Information section of the coding sheet. The 7-digit ID is specified in BLOCK CAPITALS. 
It is composed of: 
• the first three letters of the surname of the first author 
• the last two digits of the publication year 
• the first two letters of the surname of the second author (if no secondary author: xx) 
 
If several cancer types are examined in a publication, a private coding sheet is filled out for each type of cancer. 
The cancer types in an article are numbered. This number is entered in the upper right corner of each page under 
Cancer Type, and again in the Cancer and Sample Information section of the coding sheet. If the publication 
examines only one cancer type, the number of the cancer type followed by the word “only” is entered here. Cancer 
Type has been adopted from the American Cancer Society and should be coded as per the categories below: 
1 = Adrenal  
2 = Anal 
3 = Bile Duct 
4 = Bladder 
5 = Bone 
6 = Brain / Spinal Cord (Central Nervous System) Tumour 
7 = Breast  
8 = Breast in Men 
9 = Cancer of Unknown Primary Source  
10 = Cervical 
11 = Colon / Rectum (Colorectal or Bowel) 
12 = Endometrial 
13 = Esophagus/ Esophageal 
14 = Ewing Family of Tumours 
15 = Eye 
16 = Head and Neck 
17 = Gallbladder 
18 = Gastric 
19 = Gastrointestinal Carcinoid Tumours 
20 = Gastrointestinal Stromal Tumour (GIST) 
21 = Gestational Trophoblastic Disease 
22 = Kaposi Sarcoma 
23 = Kidney Cancer  
24 = Laryngeal and Hyphopharyngeal  
25 = Leukemia 
26 = Acute Lymphocytic Leukemia (ALL)  
27 = Acute Myeloid Leukemia (AML) 
37 = Hodgkin Lymphoma (Hodgkin Disease) 
38 = Non-Hodgkin Lymphoma 
39 = Lymphoma of the Skin 
40 = Malignant Mesothelioma 
41 = Multiple Myeloma 
42 = Myelodysplastic Syndrome (MDS) 
43 = Nasal Cavity and Paranasal Sinus 
44 = Neuroblastoma 
45 = Oral Cavity and Oropharyngeal 
46 = Osteosarcoma 
47 = Ovarian 
48 = Pancreatic  
49 = Penile  
50 = Pituitary Carcinomas or Tumours  
51 = Prostate 
52 = Renal Cell Carcinoma 
53 = Retinoblastoma  
54 = Rhabdomyosarcoma (RMS) 
55 = Salivary Gland 
56 = Sarcoma (Soft Tissue Sarcoma) 
57 = Skin Cancer 
58 = Basal and Squamous Cell Skin Cancers 
59 = Melanoma Skin Cancer 
60 = Small Intestine 
61 = Stomach 
62 = Testicular 
63 = Thymus 
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28 = Chronic Lymphocytic Leukemia (CLL) 
29 = Chronic Myeloid Leukemia (CML) 
30 = Chronic Myelomonocytic Leukemia (CMML) 
31 = Liver 
32 = Lung  
33 = Non-Small Cell Lung Cancer (NSCLC) 
34 = Small Cell Lung Cancer (SCLC) 
35 = Lung Carcinoid Tumour 
36 = Lymphoma 
64 = Thyroid 
65 = Urethral 
66 = Uterine Sarcoma 
67 = Vaginal 
68 = Vulvar 
69 = Waldenstrom Macroglubulinemia (WM) 
70 = Wilms Tumour 
71 = Cancer Type Not Specified 
99 = Other Cancer Type (Specify) 
 
Note: Please code cancer type with the most specific cancer type code possible. 
If in the publication several dependent variables (including separate subscales) are analysed (e.g. psychological 
distress, and avoidance/denial), each dependent variable is given a number in terms of its DV (Subscale) Type. 
This number is entered in the upper right corner of each page under DV, and again in the dependent variable 
section of the coding sheet. These numbers are the same for all cancer types. DV (Subscale) Type has been adopted 
from Hagger and Orbell (2003) and should be coded as per the categories below: 
Coping Behaviours 
1. Expressing Emotion  
2. Cognitive Reappraisal 
3. Avoidance/Denial 
4. Problem-Focused Coping (Generic) 
5. Problem-Focused Coping (Specific - Other) 
6. Treatment Decision Making 
7. Medication Adherence  
8. Adherence to Treatment Visits 
9. Doctors Visits 
10. Seeking Social Support 
98.  Other Coping Behaviour (Specify) 
Illness Outcomes 
11. Affect (Negative/Positive) 
12. Anxiety 
13. Depression 
14. Psychological Distress 
15. Treatment Related Distress 
16. Decisional Uncertainty / Regret 
17. Psychological Well-Being 
18. Vitality 
19. Role Functioning  
20. Physical Functioning 
21. Disease State 
22. Quality of Life 
99. Other Illness Outcome (Specify) 
Redundant Information 
If multiple coding sheets are filled in for one article, the details that apply to the entire article should be recorded 
in only one coding sheet, and the corresponding check box (to the right of the questions) should be ticked in other 
relevant coding sheets.  
Therefore a ticked box means that the missing information may be taken from another coding sheet.  
Missing Information 
There are two types of missing information: 
• Not Applicable: is crossed out in coding sheet and later encoded in data entry with 777.  
• Missing: is left open (and possibly supplemented, if one has written to the author). 
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Decimal Places 
All sample values should be a maximum of two decimal places (rounded).  
All statistical values should be a maximum of three decimal places.  
 
Exclusion Criteria 
If one of the following criteria apply, the study must be excluded:  
• Study did not use a Quantitative Design: The study used one or more invalidated or unstandardised key measure of interest. 
• Study did not use the IPQ or IPQ-R: The study did not measure Illness Representations from the CSM using the Illness Perception 
Questionnaire or the Revised Illness Perception Questionnaire. 
• Study did not measure Coping Behaviours or Illness Outcomes 
• Study contained Participants without a Cancer Diagnosis 
• Study used (only) Children or Adolescents: Participants must not be under the age of eighteen. 
• Study in a language other than English or German: Note: We will consider studies in other languages if they include clear results. 
• Study was conducted prior to 1995: The study was conducted prior to the creation of the IPQ. 
A coding sheet must be created for any excluded study. However, it is sufficient to only fill in the general 
information for publication section. In addition, the “Study will be Excluded” box should be ticked and reasons 
should be provided in the comments box on the last page.  
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2 Comments on the Study 
 Study will be Excluded  Write to Authors  Important Comments 
 
If problems occurred during encoding, the relevant box should be ticked (with details to be included in the Final 
Details box on the last page of the coding sheet).  
• Study will be Excluded: Reason for exclusion in the final data set. 
• Write to Authors: If the publication is lacking important statistical information (e.g. information about the sample size or standard 
deviations), the coder will try to check this information with the authors. The missing details are mentioned in the Final Details 
box.  
• Important Comments: If any problems/comments are entered in the Final Details box, this field should be ticked – unless these are 
reasons for exclusion or information about a lack of statistical information. 
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3 General Publication Information 
Article Identification Number (ID-No.): __ __ __ __ __ __ __   Study in Article: _________ 
The Article Identification Number should be the same 7-digit ID (specified in BLOCK CAPITALS) as appears at 
the top left hand corner of each page. It is composed of  
• the first three letters of the surname of the first author 
• the last two digits of the publication year 
• the first two letters of the surname of the second author (if no secondary author: xx) 
 
If the publication contains several studies that refer to different samples, these studies are numbered. For each 
study, a separate coding sheet should be created. The respective number of the study is then given here.  
Coder: ___________  Coding Date____ / ___ / _______  Time of Day: ___________  
Coder: Enter initials of Coder 
Coding Date: Day / Month / Year 
Time of Day: Specify at the start of encoding in order to determine the total duration of coding 
 
Authors: ________________________________________________  Publication Year: _________ 
Specify the last name of the first three authors. If more than three authors are mentioned, all the other authors are 
abbreviated with et al. The publication year is four digits.  
 
Title (first six words): ______________________________________________________________ 
Note the first six words from the title of the publication.  
 
Country of Origin - Author: _________ Other Origin: ______________________ 
The Country of Origin of the first author is usually noted on the publication. If not, it should be googled and 
entered using the codes below. If the author has more than one Country of Origin, enter this under Other Origin. 
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Coding of Country of Origin 
1 = USA 
2 = Canada 
3 = Germany 
4 = Great Britain 
5 = Netherlands 
6 = Scandinavia 
7 = Australia 
8 = Western Europe (excluding G, GB, N, Scandinavia) 
9 = Eastern Europe (including Russia) 
99 = Other (Specify) 
 
 
Discipline of the First Author: _________ Other Discipline: ____________________ 
The discipline of the first author is usually noted on the publication. If not, it should be googled and entered using 
the codes below. If the author has more than one discipline listed, enter this under Other Discipline. 
Coding of Discipline 
1 = Psychology 
2 = Psychiatry 
3 = Medicine  
4 = Sociology 
5 = Economy 
6 = Education 
99 = Other 
 
Publication Found In: _________   Other Place Publication Found: _____________   
Coding where the Publication was Found 
1 = Scopus 
2 = Web of Science 
3 = PubMed 
4 = PsycINFO  
5 = Google Scholar 
6 = Manual Search in Journals 
7 = Hand-Searched Reference Lists 
8 = Contact with Researchers 
99 = Other Source 
 
Note: Some publications may be found (or exist) in more than one location or database. The code given will reflect 
the first place the coders have found the publication. 
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Type of Publication: _____  Other Publication: ______ Citations: _______ Impact: _________   
Coding the Type of Publication 
1 = Journal with Peer Review 
2 = Journal without Peer Review 
3 = Book / Book Chapters 
4 = Dissertation (PhD) 
5 = Honours Thesis or Master’s Thesis (or German Diploma) 
6 = Conference Presentation / Poster (Abstract or Full Paper) 
7 = Unpublished Manuscript 
8 = Internet Document 
99 = Other 
 
Citations 
How many citations does the study have (in Scopus)? 
 
Impact 
What is the Impact Factor of the Journal (in Journal Citation Reports)? 
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4 Description of the Study 
Study Type: _____________  IPQ or IPQ-R Dimension: ___________________________________ 
Reliability Source: ________ Coefficients Type: ________ Number of Items: ___________ 
Study: _______________________________________________________________________________ 
Coding of Study Type         Coding of IPQ or IPQ-R Dimension  
1 = Cross-Sectional 
2 = Longitudinal 
3 = Experimental 
4 = Pseudo-Experimental 
99 = Other Study Type 
1 = Identity 
2 = Cause (Generic) 
3 = Timeline (Acute/Chronic) 
4 = Consequences 
5 = Personal Control 
6 = Treatment Control Items 
7 = Illness Coherence Items 
8 = Timeline Cyclical 
9 = Emotional Representations 
10 = IPQ Only – Cure-Control 
11 = All Dimensions of IPQ 
12 = All Dimensions of IPQ-R 
Coding of Reliability Source 
0 = No Information 
1 = No Information, but reference to another publication (specify study) 
2 =Yes, calculated using the sample from this publication (specify values) 
3 = Yes, calculated using a different sample (values and specify study) 
If reliability coefficients are given for individual subscales, these should be included later in the coding sheet (in 
the Statistical Analyses and Effect Sizes section). 
If coefficients are drawn from both this sample (coding 2) and from other studies (coding 3) in the publication, 
only the coefficients of the concrete sample are to be coded.  
If there is no information about reliability, but there is a reference in the description of the instrument, this 
corresponds to Coding 1.  
Coding of Coefficient Type 
1 = Internal Consistency, E.g. Cronbach’s  
2 = Split- Halves Reliability 
3 = Test-Retest Reliability 
4 = Parallel Test Reliability 
5 = Mean Value of Several Coefficients 
6 = No Precise Indication 
99 = Other Coefficient 
Study 
If a reliability coefficient is (or is not) stated, and reference is made to another study, the first three authors and 
the year of publication of the study are stated under “Study”.  
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Number of Items 
If all dimensions of the IPQ or IPQ-R were measured, provide the number of items for the entire measure here. 
The number of items for each individual subscale should be included later in the coding sheet (in the Statistical 
Analyses and Effect Sizes section).  
If Experimental: 
Number of Groups: _______ 
Assignment: _______ 
Group a: _______________ 
Group b: _______________ 
Group c: _______________ 
Group d: _______________ 
The values of various groups are often reported, e.g. for women and for men. In this case, the statistics for each 
group are reported on a single coding sheet.  
Note: Only fill out this section of the coding sheet if the study is experimental. 
Number of Groups 
Specify the number of groups for which statistics are available. If only one group is available, use a 1. Further, all 
other fields must not be filled in, but instead crossed out and encoded with 777 (not applicable).  
Assignment 
Group allocation:   
1 = Randomisation: The subjects were randomly assigned to the groups. 
2 = Matched Groups: Each person of one group matches a person of the other group. Each pair has similar properties (e.g. the same age or the 
same sex). 
3 = Natural Groups, parallelised: E.g., women’s and men’s groups are natural groups. These two groups can also be parallelised for other 
characteristics (e.g. by having the same mean age). 
4 = Natural Groups without further assignment: E.g., comparison of women and men, without other sampling features. 
Group a, Group b, etc.  
Each group is assigned a continuous index a, b, c, etc. Note which identify groups, e.g. group a = men, group b = 
women, or group a = pre-treatment, group b = peri-treatment, group c = post-treatment.  
If more than four groups were analysed, the other group affiliations are simply noted on the margin or on a separate 
piece of paper. 
Number of Measurement Points: _______ Year of the First Data Collection:   __________ 
Number of Measurement Points: Enter a number or 99, when the number of measurement times varied within the 
sample. These are only included when statistical information is available for the measurement point. 
Year of the First Data Collection: Enter the four-digit year number. If given several years for the first MP, the 
earliest year is coded.  
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Lag Between Assessments ________:   
MP 2   __________________________________  
MP 3   __________________________________ 
MP 4   __________________________________ 
MP 5   __________________________________ 
MP 6   __________________________________ 
MP 7   __________________________________ 
MP 8   __________________________________  
This box can only be filled in if the distance between the MPs is the same for all individuals, and if statistics are 
available. The time interval is specified in months (rounded if necessary).  
Use this scale for the conversion of years, weeks and days into months: 
1 Day = 0.03 Months 
1 Week = 0.25 Months 
1 Year = 12 Months 
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5 Cancer and Sample Information 
The information on the sample should refer to the smallest unit of analysis (e.g., males and females separately). 
If there are several groups, information on the sample for each group should be recorded separately. If this is not 
possible and only information on the total sample can be accessed, it is sufficient to fill in the Cancer and Sample 
Information box on a single coding sheet and to tick the box on the right – meaning that this data is applicable 
across all groups.  
Sometimes statistics are only available at the group level, and other times only for the entire sample. In this case, 
you can mark information as generally applicable by placing a tick in the smaller box to the right of each row. A 
ticked box means that this information refers to the whole sample. If this box is not ticked, it means that this 
information refers to the specific group.  
 
Type of Sample: _______________________   
The nature of the sample may change during a longitudinal study. For example, students might participate, and 
after a passage of time, leave the university. It is therefore crucial for to identify what the type of sample was at 
the first MP.  
Coding the Type of Sample 
1 = Representative Sample  
2 = Non-representative Sample of the general population (specify if the study has a name) 
3 = Students 
4 = Clinical Sample (E.g. those assessed in a hospital) 
5 = Cancer Groups, Societies, and Communities (E.g. self-help groups, internet communities) 
99 = Other type of Sample (specify) 
 
Cancer Type: ______  Cancer Stage: _________________________________________     
Coding of Cancer Type 
Cancer Type has been adopted from the American Cancer Society and should be coded as per the categories 
below: 
1 = Adrenal  
2 = Anal 
3 = Bile Duct 
4 = Bladder 
5 = Bone 
6 = Brain / Spinal Cord (Central Nervous System) Tumour 
7 = Breast  
8 = Breast in Men 
9 = Cancer of Unknown Primary Source  
10 = Cervical 
11 = Colon / Rectum (Colorectal or Bowel) 
12 = Endometrial 
37 = Hodgkin Lymphoma (Hodgkin Disease) 
38 = Non-Hodgkin Lymphoma 
39 = Lymphoma of the Skin 
40 = Malignant Mesothelioma 
41 = Multiple Myeloma 
42 = Myelodysplastic Syndrome (MDS) 
43 = Nasal Cavity and Paranasal Sinus 
44 = Neuroblastoma 
45 = Oral Cavity and Oropharyngeal 
46 = Osteosarcoma 
47 = Ovarian 
48 = Pancreatic  
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13 = Esophagus/ Esophageal 
14 = Ewing Family of Tumours 
15 = Eye 
16 = Head and Neck 
17 = Gallbladder 
18 = Gastric 
19 = Gastrointestinal Carcinoid Tumours 
20 = Gastrointestinal Stromal Tumour (GIST) 
21 = Gestational Trophoblastic Disease 
22 = Kaposi Sarcoma 
23 = Kidney Cancer  
24 = Laryngeal and Hyphopharyngeal  
25 = Leukemia 
26 = Acute Lymphocytic Leukemia (ALL)  
27 = Acute Myeloid Leukemia (AML) 
28 = Chronic Lymphocytic Leukemia (CLL) 
29 = Chronic Myeloid Leukemia (CML) 
30 = Chronic Myelomonocytic Leukemia (CMML) 
31 = Liver 
32 = Lung  
33 = Non-Small Cell Lung Cancer (NSCLC) 
34 = Small Cell Lung Cancer (SCLC) 
35 = Lung Carcinoid Tumour 
36 = Lymphoma 
49 = Penile  
50 = Pituitary Carcinomas or Tumours  
51 = Prostate 
52 = Renal Cell Carcinoma 
53 = Retinoblastoma  
54 = Rhabdomyosarcoma (RMS) 
55 = Salivary Gland 
56 = Sarcoma (Soft Tissue Sarcoma) 
57 = Skin Cancer 
58 = Basal and Squamous Cell Skin Cancers 
59 = Melanoma Skin Cancer 
60 = Small Intestine 
61 = Stomach 
62 = Testicular 
63 = Thymus 
64 = Thyroid 
65 = Urethral 
66 = Uterine Sarcoma 
67 = Vaginal 
68 = Vulvar 
69 = Waldenstrom Macroglubulinemia (WM) 
70 = Wilms Tumour 
71 = Cancer Type Not Specified 
99 = Other Cancer Type (Specify) 
Note: Please code cancer type with the most specific cancer type code possible. 
Coding of Cancer Stage 
The Tumour-Node-Metastasis (TNM) Classification of Malignant Tumours will be used to code cancer stage.  
In the TNM system, T refers to the size or direct extent of the primary tumour. Higher numbers indicate 
increased size, extent, or degree of penetration. Each Cancer Type has specific indicators for classification of a 
number. N describes whether or not the cancer has spread into nearby Lymph Nodes. Higher numbers indicate 
greater Lymph Node involvement. M informs whether or not distant metastases have been identified (spread of 
cancer to other parts of the body). 
1 = TX – Primary Tumour cannot be evaluated 
2 = T0 – No evidence of Primary Tumour (it cannot be found) 
3 = Tis – Carcinoma in situ (early cancer with no invasion of Tumour cells into surrounding tissue) 
4 = T1 – Presence of Tumours 
5 = T2 - Presence of Tumours 
6 = T3 - Presence of Tumours 
7 = T4 - Presence of Tumours 
8 = NX – Lymph Nodes cannot be evaluated 
9 = N0 – No regional Lymph Node Metastasis (Tumour cells are absent) 
10 = N1 – Regional Lymph Node Metastasis present 
11 = N2 - Regional Lymph Node Metastasis present 
12 = N3 – Regional Lymph Node Metastasis 
13 = MX – Distant Metastasis cannot be evaluated 
14 = M0 – No distant Metastasis (no distant Cancer spread) 
15 = M1 – Distant Metastasis (Cancer has spread to distant organs or tissues) 
99 = Other Cancer Stage (some cancers are not classified using TNM, e.g. early grade brain tumours – specify the correct stage and include relevant details) 
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Cancer Duration: M = ____________  SD = __________    Range from _______ to _________     
Cancer Duration: Record information here regarding the length of time participants have suffered from (been 
diagnosed with) cancer (in months).  
Use this scale for the conversion of years, weeks and days into months: 
1 Day = 0.03 Months 
1 Week = 0.25 Months 
1 Year = 12 Months 
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum Cancer Duration. 
 
Age at Onset: M = ____________  SD = _________     Range from _______ to _________    
Age at Onset: Record information here regarding which age participants were diagnosed with cancer (in months).  
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum Age at Onset. 
 
Treatment Type: ______  Treatment Stage: __________________________________           
Coding of Treatment Type               Coding of Treatment Stage 
1 = Surgery   
2 = Radiotherapy 
3 = Chemotherapy  
4 = Hormone Therapy 
99 = Other Treatment (Specify) 
1 = Pre-Treatment 
2 = Peri-Treatment (Currently Undergoing Treatment) 
3 = Post-Treatment 
 
 
Size of the Sample at each Measurement Point:   
MP 1   __________  
MP 2   __________  
MP 3   __________  
MP 4   __________  
 
MP 5   __________  
MP 6   __________  
MP 7   __________  
MP 8   __________  
    
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Here the sample size at each measurement time point is indicated. Sample size includes all participants, regardless 
of whether or not they were later excluded from the analysis. The point is to show how the sample has changed 
over time (i.e. mostly reduced).  
If multiple groups are examined separately, only the respective group size is specified. 
 
Total N: ______________ Retention Rate: _________ %  
Total N: The number of individuals that participated at all time points.  
Retention Rate: How high is the percentage of those who have participated in all MPs (total N),  compared to the 
sample for the first MP (can be calculated from the ratio of MP 1 and total N).  
 
Proportion of Men at MP 1:  _______ %  
Proportion of Men: Always indicate the MP for which the proportion of men refers.  
 
Age at MP 1 _____:  M = __________ SD = __________ Range from __________ to _________  
Age at MP 1: Specify to whom the information relates. If data is available for several MPs, the information for 
MP 1 is reported.  
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum age. 
 
Ethnicity: ____ Other Ethnicity: ____  Country of Origin: ____  Other Country of Origin: ____  
Coding of Ethnicity 
Ethnicity is specified only if the proportion of this ethnic group makes up a minimum of 50% of the sample.  
1 = White (Caucasian, Anglo-American, European) 
2 = Black 
3 = Hispanic 
4 = Indigenous People 
5 = Asian 
6 = Mixed (when two ethnic groups are represented with 50% each) 
99 = Other (specify) 
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Coding of Country of Origin 
Specify in which Country the study was conducted. 
1 = USA 
2 = Canada 
3 = Germany 
4 = Great Britain 
5 = Netherlands 
6 = Scandinavia 
7 = Australia 
8 = Western Europe (excluding G, GB, N, Scandinavia) 
9 = Eastern Europe (including Russia) 
99 = Other (Specify) 
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6 Dependent Variable 
No. ______ Did the Study aim to change the Dependent Variable? ________ 
Number of Dependent Variables 
If there are several DVs (including separate subscales), the DVs are numbered in terms of their DV (Subscale) 
Type and a separate coding sheet for each DV is created. This number should also be entered in the top right hand 
corner of every page. Note. As each subscale can be a DV of its own, the number of DVs should include subscales 
(if their details are to be recorded separately throughout the coding sheet). At “No.” the number of DVs is given. 
If only one DV is encoded, this field is crossed out and later coded with 777 (not applicable).  
Did the Study aim to change the Dependent Variable/s? 
Did the study aim to change the DV: 
0 = No 
1 = Yes 
 
DV Global: _________ DV Name: ___________________________________________________ 
There are three aspects of the DV that need to be coded. In DV Global, the global category is entered. These are 
distinguished as:  
1 = Coping Behaviour 
2 = Illness Outcome 
99 = Other (Please Specify) 
DV Name indicates the name of the DV which is used in the publication.  
 
Subscale: __________________________ DV (Subscale) Type: _______________ 
Subscale 
If only one subscale of an instrument is used, or if data is provided separately for several subscales, this is noted 
here (by recording the name of the subscale). All other information (e.g., reliability and number of items) will 
always refer to this subscale, and not the entire instrument.  
DV (Subscale) Type has been adopted from Hagger and Orbell (2003) and should be coded as per the categories 
below: 
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Coping Behaviours 
1. Expressing Emotion  
2. Cognitive Reappraisal 
3. Avoidance/Denial 
4. Problem-Focused Coping (Generic) 
5. Problem-Focused Coping (Specific - Other) 
6. Treatment Decision Making 
7. Medication Adherence  
8. Adherence to Treatment Visits 
9. Doctors Visits 
10. Seeking Social Support 
98.  Other Coping Behaviour (Specify) 
Illness Outcomes 
11. Affect (Negative/Positive) 
12. Anxiety 
13. Depression 
14. Psychological Distress 
15. Treatment Related Distress 
16. Decisional Uncertainty / Regret 
17. Psychological Well-Being 
18. Vitality 
19. Role Functioning 
20. Physical Functioning 
21. Disease State 
22. Quality of Life 
99. Other Illness Outcome (Specify) 
 
Data Source: _______  Additional Information: _________________________________________ 
Coding of the Data Source 
1 = Self-report Questionnaire 
2 = Self-report Interview 
3 = Self-report on Ambulatory Assessment 
5 = Observation 
6 = Ratings by Others (include who provided the ratings) 
7 = Analysis of Written Reports (e.g., diaries or autobiographies) 
8 = Physiological Measures 
9 = Objective Measures (e.g., pill bottle count) 
99 = Other Data Source  
Caution: The use of a scale does not always mean that the data source is a self-report questionnaire. Often the 
scales are presented in an interview, making it a self-report interview.  
 
Instrument:     Code: ____________ Number of Items: _______________    
Reliability: Coefficients:  MP ___ MP ___ MP ___ MP ___ MP ___ MP ___ 
Source: _________ Type: ________ _______ _______ _______ _______ _______ _______ 
Study: _______________________________________________________________________________ 
Coding of the Instrument 
Measures of Coping Behaviours 
1 = COPE (Carver, Scheier, & Weintraub, 1989) 
2 = Utrechtse Coping Questionnaire (UCL; Schreurs, & Willige, 1988) 
3 = Impact of Event Scale - Revised (IES-R; Weiss & Marmar, 1997) 
4 = Ways of Coping Checklist - Revised (WCCL-R; Vitaliano, Russo, Carr, 
Maiuro, & Becker) 
5 = Ways of Coping Questionnaire (WCQ; Folkman & Lazarus, 1988) 
Measures of Illness Outcomes 
12 = Medical Outcomes Study 36/20/12 Item Short Form (MOS SF-36/20/12; 
Stewart, Hays, & Ware, 1988) 
13 = General Health Questionnaire 60/30/28/12 Item (GHQ-60/30/28/12; 
Goldberg, 1978) 
14 = Positive and Negative Affect Schedule (PANAS; Watson, Clark, & 
Tellegen, 1988) 
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6 = Medication Adherence Reporting Scale - 5 (MARS-5; Horne, 2001) 
7 = The Morisky Medication Adherence Scale – 8 (MMAS-8; Morisky, 
Green, & Levine, 1986) 
8 = Ways of Coping – Cancer Version (WOC-CA; Dunkel-Schetter, 
Feinstein, Taylor, & Falke, 1992) 
9 = Cancer Coping Questionnaire (CCQ; Moorey, Frampton, & Greer, 2003) 
10 = Mental Adjustment to Cancer Scale (or Mini-Mac 1994) (MAC; Watson, 
Greer, Young, Inayat, Burgess, & Robertson, 1988) 
11 = Other Measure of Coping Behaviour (Specify) 
15 = Generalised Anxiety Disorder 7-Item Scale (GAD-7; Spitzer, Kroenke, 
Williams, & Lowe, 2006) 
16 = State-Trait Anxiety Inventory (STAI; Speilberger, Gorsuch, Lushene, 
Vagg, & Jacobs, 1983) 
17 = Centre for Epidemiological Studies Depression Scale Revised (CESD-
R; Eaton, Muntaner, Smith, Tien, & Ybarra, 2004) 
18 = Patient Health Questionnaire – 2/9 Item (PHQ-9/2; Kroenke, & Spitzer, 
2002; Kroenke, Spitzer, & Williams, 2003) 
19 = Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983) 
20 = Impact of Event Scale – Revised (IES-R; Weiss & Marmar 1996) 
21 = Psychological Adjustment to Illness Scale – Self Report (PAIS-SR; 
Derogatis, 1986) 
22 = Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzeger, & 
Borkovec, 1990) 
23 = Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) 
24 = Well-being Questionnaire (WB-Q12 or WB-Q22; Bradley, 1994) 
25 = World Health Organisation Quality of Life (or BREF) (WHOQOL; 
WHO, 1998)  
26 = European Organisation for Research and Treatment of Cancer Quality 
of Life Questionnaire (EORTC QLQ-C30; EORTC 1993) 
27 = Mental Adjustment to Cancer Scale (or Mini-Mac 1994) (MAC; Watson, 
Greer, Young, Inayat, Burgess, & Robertson, 1988) 
28 = Other Measure of Illness Outcome (Specify) 
Number of Items 
Number of items specifies the number of items the construct was measured with. If only one subscale is used, 
only list the number of items for this subscale.  
Source of Reliability Information 
0 = No Information 
1 = No Information, but reference to another publication (specify study) 
2 =Yes, calculated using the sample from this publication (specify values) 
3 = Yes, calculated using a different sample (values and specify study) 
If there is no information about reliability, but there is a reference in the description of the instrument, this 
corresponds to Coding 1.  
If coefficients are drawn from both this sample (coding 2) and from other studies (coding 3) in the publication, 
only the coefficients of the concrete sample are to be coded.  
Type of Reliability Coefficient 
1 = Internal Consistency, E.g. Cronbach’s  
2 = Split- Halves Reliability 
3 = Test-Retest Reliability 
4 = Parallel Test Reliability 
5 = Mean Value of Several Coefficients 
6 = No Precise Indication 
99 = Other Coefficient 
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MPs for Reliability Coefficients 
If a reliability coefficient is given, it is placed in the small table. These should be noted at each MP, for as far as 
possible. If several reliability coefficients exist for a MP (eg, Cronbach's alpha and split-half coefficient), only 
report Cronbach’s alpha.  
If only one reliability coefficient is given for the study, cross out other MP boxes.  
If a reliability coefficient is not given, but reference is made to another study, the coefficient from that study 
should be provided in (beneath) the first MP box, with no number given to the MP itself. 
 
Study 
If a reliability coefficient is (or is not) stated, and reference is made to another study, the first three authors and 
the year of publication of the study are stated under “Study”.  
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7 Statistical Analyses and Effect Sizes 
Type of Statistics Provided: _____________________ 
Means, Standard Deviations, and Standard Errors 
T1  N = ______ T2  N = ______ T3  N = ______ T4  N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
T5  N = ______ T6  N = ______ T7  N = ______ T8 N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
Coding of the Type of Statistics Provided 
1 = Mean Values, Standard Deviations, Standard Errors 
2 = Correlations 
3 = Regression 
4 = Multilevel Models 
5 = Method with Latent Variables (E.g. Structural Equation Models, Latent Class Models) 
6 = More Data (E.g. Averages and Correlations) 
99 = Other (specify) 
In this table, all the means (M), standard deviations (SD), and standard errors (SE) are given for the dependent 
variable, separately for all measurement times. In addition, the sample size (for which the data refer to) is specified 
for each measurement time (N = _________).  
Correlations and Reliabilities 
Type: 
r1     N = _____ r2    N = _____ 
IPQ Reliability MP 
_____ 
IPQ Reliability MP 
_____ 
t1 t2 r p t1 t2 r p Coeff. Items Coeff. Items 
Identity             
Cause (generic)             
Timeline (acute/chronic)             
Timeline Cyclical             
Consequence             
Personal Control             
Treatment Control             
Illness Coherence             
Emotional Representations             
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If correlation coefficients are provided, please include the type of correlation in the top left hand corner of the 
correlation and reliabilities table. 
If cause is included in the data set, provide relevant details in the Final Details box. 
If bivariate correlations between different time points are reported, these can be specified here. N is the size of the 
sample. At t1 and t2 place the relevant MP details. The correlation is given at r. The p-value is given at p.  
If correlation coefficients are provided, regression weights do not need to be recorded. 
If no correlation data is provided, this should be noted in the Final Details box and the Write to Authors box on 
the front page of the coding sheet should be ticked. 
IPQ reliability coefficients for one or two MPs can be entered in this table. If there is only one MP, cross out the 
other MP box.  
For each subscale reported, provide the relevant coefficient at Coeff., and the number of items included in that 
subscale at Items. 
Regressions 
 Time 1 Time 2 
 Standardised 
Regression 
Coefficients 
Unstandardised 
Regression Coefficients 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression Coefficients 
  SE df p B SE df p  SE df p B SE df p 
Identity 
 
                
Cause 
(generic) 
                
Timeline 
(acute/chronic) 
                
Timeline Cyclical 
 
                
Consequence 
 
                
Personal Control 
 
                
Treatment Control                 
Illness Coherence 
 
                
Emotional 
Representations 
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The standardised () and unstandardised (B) regression coefficients should be reported here. In addition, the 
standard error (SE), the degrees of freedom (df) and p-value (p) of the coefficient should be coded.  
 
Source of Statistical Information 
 
Page:  __________   Table/Graph: __________________________ 
 
In order to find the statistical information quickly, record the page number, and if applicable, the number of the 
table or graph from which the information was collected. If the statistical information was taken from the text, 
enter “text” here. 
 
Moderator Variables: _______   _______   _______   _______   _______   _______   _______ 
 
 
Other Moderator Variables (Authors’ Term): _____________________________________________ 
If Moderator Variables of the relationship between Illness Perceptions and Outcomes have been examined, 
provide information here.  
Coding of Moderator Variables 
1 = Social Support 
3 = Extraversion 
4 = Neuroticism 
5 = Other Personality Characteristics (E.g. Optimism, Self-Esteem, etc.) 
6 = Previous Experience with Cancer 
7 = Socio-Economic Status 
8 = Age 
9 = Number of Other Illnesses 
10 = Coping Strategies 
99 = Other (Specify) 
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8 Concluding Information 
Time for Coding: _________ minutes  
Problems/Comments:  
 
 
 
Study Interpretation: 
 
 
 
 
At the end of coding an article, the time needed for encoding should be noted.  
In addition, there is space for problems and comments. If information is missing, the missing information should 
be listed here. 
Finally, include a brief interpretation of the study in this box. This can be transcribed or taken directly from the 
publication abstract. 
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Appendix 2.5 Coding sheet (Study 1) 
 
ID No. _______________ Cancer Type ______     DV _______ 
 
Comments on the study 
 Study will be Excluded  Write to Authors   Important Comments 
 
General Publication Information 
Article Identification Number (ID-No.): __ __ __ __ __ __ __  Study in Article: _________ 
Coder: ___________  Coding Date ___ / ___ / _______  Time of Day: ___________  
Authors: ________________________________________________  Publication Year: _________ 
Title (first six words): ______________________________________________________________ 
Country of Origin - Author: _________ Other Origin: _______________________________ 
Discipline of the First Author: _________ Other Discipline: _____________________________ 
Publication Found In: ________ Other Place Publication Found: ________________ 
Type of Publication: _____ Other Publication: _______    Citations: ______ Impact: ________   
 
Description of the Study 
Study Type: _________________ IPQ or IPQ-R Dimension: _____________________________ 
Reliability Source: ________ Coefficient Type: ________ Number of Items: ___________ 
Study: _______________________________________________________________________________ 
If Experimental: 
Number of Groups: ______ 
Assignment: _______ 
 
Group a: ______________ 
Group b: ______________ 
 
Group c: ______________ 
Group d: ______________ 
Number of Measurement Points: _________ Year of the First Data Collection:   __________ 
Lag Between Assessments ________:   
MP 2   __________________________________  
MP 3   __________________________________ 
MP 4   __________________________________ 
MP 6   __________________________________ 
MP 7   __________________________________ 
MP 8   __________________________________ 
MP 9   __________________________________  
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Cancer and Sample Information 
 
Type of Sample: __________________  
Cancer Type: ___________________ 
Cancer Stage: _____________________________             
Cancer Duration: M = ____________  SD = ________    Range from _______ to _________         
Age at Onset: M = ____________  SD = ________    Range from _______ to _________         
Treatment Type: ________________ Treatment Stage: __________________________             
 
Sample Size at each Measurement Point: 
MP 1   __________  
MP 2   __________  
MP 3   __________  
MP 4   __________  
 
MP 5   __________  
MP 6   __________  
MP 7   __________  
MP 9   __________  
   
 
 
 
 
 
Total-N: ______________ Retention Rate: _________ %  
Proportion of Men at MP 1:  _______ %  
Age at MP 1:  M = __________ SD = __________ Range from __________ to _________  
Ethnicity: ____  Other Ethnicity: ____  Country of Origin: ____  Other Country of Origin: ____  
 
 
Dependent Variables 
 
No. ______ Did the Study aim to change the Dependent Variable/s?  ________ 
DV Global: _______  DV Name: __________________________________________________ 
Subscale: __________________________ DV (Subscale) Type:___________________ 
Data Source: __________ Additional Info: ______________________________________ 
Instrument: Code: ____________ Number of Items: _____________  
Reliability: Coefficients:  MP ___ MP ___ MP ___ MP ___ MP ___ MP ___ 
Source: _________ Type: ________ _______ _______ _______ _______ _______ _______ 
Study: _______________________________________________________________________________ 
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Statistical Analyses and Effect Sizes 
 
Type of Statistics Provided: ______________________ 
Means, Standard Deviations, and Standard Errors 
T1  N = ______ T2  N = ______ T3  N = ______ T4  N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
T5  N = ______ T6  N = ______ T7  N = ______ T8 N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
 
Correlations and Reliabilities 
 
Type: 
r1     N = _____ r2    N = _____ 
IPQ Reliability 
MP _____ 
IPQ Reliability 
MP _____ 
t1 t2 r p t1 t2 r p 
Coeff. Items Coeff. 
Item
s 
Identity             
Cause (generic)             
Timeline (acute/chronic)             
Timeline Cyclical             
Consequence             
Personal Control             
Treatment Control             
Illness Coherence             
Emotional Representations             
 
Regression Coefficients 
 
 Time 1 Time 2 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression 
Coefficients 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression 
Coefficients 
 SE df p B SE df p  SE df p B SE df p 
Identity 
 
                
Cause 
(generic) 
                
Timeline 
(acute/chronic) 
                
Timeline Cyclical 
 
                
Consequence 
 
                
Personal Control 
 
                
Treatment 
Control 
                
Illness 
Coherence 
                
Emotional 
Representations 
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Source of Statistical Information 
 
Page:  __________   Table/Graph: __________________________ 
 
 
 
Moderator Variables 
 
 
Moderator Variables: _______   _______   _______   _______   _______   _______   _______ 
 
 
Other Moderator Variables (Authors’ Term): _____________________________________________ 
 
 
Final Details 
 
Time for Coding: _________ Minutes  
Problems/Comments:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Interpretation: 
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Appendix 2.6 Study selection process (Study 1) 
 
Following database screening, 1846 articles were identified, with 983 articles 
remaining after the removal of duplicates. A title search eliminated 443 studies not meeting 
the inclusion criteria. The remaining 540 abstracts were screened, and a further 494 of these 
were excluded for not meeting inclusion criteria. There was a high level of agreement in the 
abstract screening process between the first and last author, with an inter-rater agreement of 
97.59% (Cohen’s Kappa = .86). A further four studies were added following a manual search 
of the reference lists of the 46 studies already identified for inclusion. These 50 studies were 
coded by the first author using a coding manual and coding sheet (see Appendix 4 and 
Appendix 5), with a random subsample of studies (20%, k = 10) double-coded by the last 
author. Following coding, five studies that had duplicative data or did not meet the inclusion 
criteria were excluded.  
A second search for relevant literature was conducted in August 2014 using the same 
process. One hundred and twenty four additional studies were identified, with 49 studies 
remaining following the removal of duplicates. Of these, 43 did not meet inclusion criteria, 
based on a high level of agreement between the first and last author, with an inter-rater 
agreement of 96.49% (Cohen’s Kappa = .81). The remaining six studies were again coded by 
the first author, with a subsample (33.33%, k = 2) coded by the last author. Correlations were 
extracted from a subsample of all studies by the first and last author separately (19.61%, k = 
5). Out of 101 correlations, 100 were correctly recorded by both researchers (99.01%); the 
remaining correlation was resolved through discussion and an examination of raw data.  
A final search for relevant literature was conducted in March 2015 using the same 
search strategy. Two hundred and thirty one studies were identified, with 63 studies 
remaining following the removal of duplicates. Of these, 60 studies did not meet inclusion 
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criteria, based on high level of agreement between the first and last author (95.24%, Cohen’s 
Kappa = .70). Following coding, the remaining three studies were coded by the first author. 
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Appendix 2.7 Quantitative data extraction and study characteristics table (Study 1) 
 
Authors (Date) Cancer Type 
Sample Size 
(Completed all 
Time Points) 
Sex (T1) Age (T1) Study Design IPQ Type Coping Behaviour Illness Outcome Relevant Results 
Beatty and Scott 
(2013) 
Not Specified 88 31% Male 
M = 56.81, 
SD = 10.67 
Cross-
sectional 
IPQ-R: Identity, Cause, 
Consequences 
Seeking Social 
Support, Problem-
Focused Coping 
(Specific-Other) 
(eHealth Info), Other 
(eHealth Support)  
Psychological Distress 
Identity, psychological cause, and 
consequences were predictive of 
searching for health-related information 
online and psychological distress. Cause 
was also predictive of social support. 
Cameron, Booth, 
Schlatter, 
Ziginskas, 
Harman, & 
Benson (2005) 
Breast 110 100% Female 
M = 51.48, 
SD = 9.26 
Cross-
sectional 
IPQ-R: Cause, Personal 
Control, Emotional 
Representations 
Seeking Social 
Support (x2), 
Avoidance/Denial 
Anxiety, Depression 
Emotional representations predicted 
depression, anxiety, and avoidance. 
Higher personal control was associated 
with lower depression. Cause (stress) 
was associated with anxiety. 
Chen (2013) 
Oral Cavity and 
Oropharyngeal 
103 100% Male M = 42.5 
Cross-
sectional 
IPQ-R: Timeline - 
Acute/Chronic and Cyclical, 
Personal and Treatment 
Control, Consequences 
Other (Self-
Transcendence) 
Depression 
Timeline, Consequences, and Control 
were significant predictors of self-
transcendence and depression. 
Cook, Salman, 
Dunn, Holcombe, 
Cornford, & 
Fisher (2015) 
Not Specified 
(Breast & 
Prostate) 
229 34% Male 
M = 61.3, SD 
= 8.9, Range 
= 38 - 85 
Cross-
sectional 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence 
 
Anxiety, Depression, 
Psychological Distress 
(Trauma) 
Higher identity, timeline 
(acute/chronic), consequences, and 
treatment control (PD only), explained 
an additional 20%, 18%, and 22% of the 
variance in anxiety, depression, and 
psychological distress respectively 
(controlling for age/gender). 
Corter, Findlay, 
Broom, Porter, & 
Petrie (2013) 
Breast 153 100% Female 
Age range: 45 
- 61+ 
Cross-
sectional 
B-IPQ  
Anxiety (Fear of 
Recurrence) 
All illness perceptions (apart from 
control) were associated with fear of 
recurrence. 
Costanzo, 
Lutgendorf, & 
Roeder (2011) 
Breast 71 100% Female 
M = 55, SD = 
10.8, Age 
range: 32 - 89  
Longitudinal 
IPQ-R: Cause, Timeline - 
Acute/Chronic, 
Consequences, Personal 
Control 
Problem-Focused 
Coping (Specific-
Other) (Decreased Fat 
Intake, Increased 
Fruit/Vegetable Intake, 
Increased Physical 
Activity, Decreased 
Alcohol Intake, 
Increased Stress 
Reduction) 
 
Women who believed their cancer had 
more severe consequences and those 
that attributed the development of 
cancer to health behaviours or stress, 
were most likely to report improvements 
in health behaviours. 
Croom (2012) Not Specified 88 100% Female 
M = 58.2, SD 
= 11.3 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence 
 Anxiety, Depression 
Illness perceptions predicted anxiety and 
depression. Identity was the strongest 
predictor of depression and cyclical 
timeline the strongest predictor of 
anxiety. 
Croom, Hamann, 
Kehoe, Paulk, & 
Wiebe (2013) 
Not Specified 105 100% Female 
M = 58.29, 
SD = 11.05, 
Age range: 
24-83 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence 
Problem-Focused 
Coping (Generic) 
(Advanced-Illness 
Behaviours) 
Quality of Life 
Illness perception variables accounted 
for a large proportion of the variance for 
QOL and advanced-illness behaviours, 
with identity the strongest predictor of 
QOL and chronic timeline the strongest 
predictor of advanced-illness 
behaviours. 
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Dempster, 
McCorry, 
Brennan, 
Donnelly, Murray, 
& Johnston (2012) 
Oesophageal 484 66% Male 
M = 65, SD = 
9.94 
Cross-
sectional 
IPQ-R: Cause, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence 
 Anxiety, Depression 
Several illness perceptions predicted 
anxiety and depression. Consequences 
was the strongest predictor, with more 
severe consequences associated with 
higher levels of anxiety and depression. 
Donovan (2003) Ovarian 713 100% Female 
Total: M = 
53.42, SD = 
48.94, Range 
= 22-91 
Cross-
sectional 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Problem-Focused 
Coping (Generic) 
(Coping) 
Treatment Related 
Distress, Psychological 
Well-Being (Life 
Satisfaction) 
Illness perceptions predicted problem-
focused coping, treatment related 
distress, and psychological well-being. 
Identity was the strongest predictor of 
all three outcomes. 
Duric, Butow, 
Sharpe, Boyle, 
Beith, Wilcken, 
Heritier, Coates, 
Simes, & Stockler 
(2007) 
Breast 83 100% Female 
M = 55, 
Range = 25-
73 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Treatment Decision 
Making (Preferences - 
small benefits of 
adjuvant 
chemotherapy), 
Treatment Decision 
Making (Preferences - 
negligible benefits of 
adjuvant 
chemotherapy) 
Depression, Treatment 
Related Distress 
Identity and consequences were 
associated with treatment decision 
making, treatment related distress, and 
depression. 
Fan, Eiser, Ho, & 
Lin (2013) 
Liver 
(Heptocellular 
Carcinoma) 
286 76.22% Male 
M = 59.85, 
SD = 12.16, 
Range = 
25.46 - 84.81 
Cross-
sectional 
B-IPQ 
Problem-Focused 
Coping (Generic), 
Other (Emotion-
Focused Coping) 
Psychological Distress 
(Emotional Functioning), 
Physical Functioning, 
Quality of Life (Health-
Related) 
Cognitive representations (combined) 
and emotional representations predicted 
global HRQOL, physical functioning, 
and emotional functioning.  
Fischer, 
Wiesenhaan, 
Heijer, Kleijn, 
Nortier, & 
Kaptein (2013) 
Breast 57 100% Female 
M = 50.7, SD 
= 6.9, Range 
= 37 - 72 
Longitudinal 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Problem-Focused 
Coping (Generic), 
Other (Emotional 
Support), 
Avoidance/Denial, 
Cognitive Reappraisal 
Psychological Distress 
Several illness perception dimensions 
predicted each coping outcome. All 
illness perceptions other than control 
(personal and treatment) predicted 
psychological distress.  
Förster & Taubert 
(2006) 
Not Specified 156 58.3% Male 
M = 63, SD = 
10.5, Range = 
34 - 86 
Longitudinal 
IPQ-R: Cause, Timeline - 
Acute/Chronic, Personal 
Control 
Problem-Focused 
Coping (Generic), 
Cognitive Reappraisal 
(x2), Other (Self-
Blame)  
Depression, Quality of 
Life, Disease State 
Control beliefs were predictive of 
adaptive coping behaviours (problem-
solving, reappraisal). Shorter timeline 
predicted higher levels of quality of life. 
Foster, Breckons, 
Cotterell, 
Barbosa, Calman, 
Corner, Fenlon, 
Foster, Grimmett, 
Richardson, & 
Smith (2015) 
Not Specified 182 
80.8% 
Female 
M = 50, SD = 
9.51, Range = 
23 - 79 
Cross-
sectional 
B-IPQ: Identity, Timeline - 
Acute/Chronic, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Other (Self-Efficacy) 
Individuals most likely to report low 
self-efficacy included those with an 
overall more negative perception of 
cancer. 
Freeman-Gibb 
(2012) 
Breast 107 100% Female 
Range = 26 - 
75 
Cross-
sectional 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Other (Cognitive 
Coping Strategies), 
Other (Self-Blame), 
Avoidance/Denial, 
Cognitive Reappraisal 
Anxiety (x2) (Fear of 
Recurrence) 
Several illness perception dimensions 
predicted trait anxiety and each coping 
outcome. Fear of cancer recurrence was 
related to emotional representations, 
timeline (acute/chronic), perceived 
consequences/severity, and symptom 
attribution (identity).  
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Gibbons (2013) Breast 57 100% Female 
M = 56.35, 
SD = 5.20, 
Range = 40 - 
77 
Longitudinal 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
Cognitive Reappraisal, 
Other (Fatalism), 
Avoidance/Denial 
Psychological Distress 
(Perceived Stress), Anxiety 
(x3) (State), Depression, 
Psychological Distress (x2) 
(Cancer-related), 
Psychological Distress 
(Helplessness - 
Hopelessness) 
Illness perceptions are important 
predictors of distress and coping 
outcomes over the first 12 months after 
a diagnosis of breast cancer. 
Gould, Brown, & 
Bramwell (2010) 
Other 
Gynaecological 
61 100% Female 
M = 56.34, 
SD = 18.41 
Cross-
sectional 
IPQ-R: Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence 
Problem-Focused 
Coping (Generic), 
Other (Emotion/social 
support), 
Avoidance/Denial, 
Cognitive Reappraisal, 
Other (Religion) 
Affect 
Several illness perceptions were 
associated with each coping outcome. 
Illness coherence and consequences 
were the strongest predictors of affect. 
Green, Steinnagel, 
Morris, & Laakso 
(2014) 
Not Specified 
(Breast and 
Prostate) 
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61.2% 
Female 
M = 60.60, 
SD = 9.55, 
Range = 32 - 
84 
Cross-
sectional 
IPQ-R:  Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Problem-Focused 
Coping (Specific-
Other) (Nutrition, 
Physical Activity) 
 
Illness perception dimensions did not 
seem to predict nutrition in this sample. 
However, identity, personal control, and 
illness coherence predicted nutrition. 
Henselmans, 
Sanderman, 
Helgeson, de 
Vries, Smink, & 
Ranchor (2010) 
Breast 133 100% Female 
M = 57, SD = 
9 
Longitudinal IPQ-R: Personal Control  
Depression, Anxiety 
(State), Role Functioning 
(Threat Appraisal), 
Anxiety (Worry) 
A strong sense of control over the cure 
of breast cancer predicted lower 
depression, state anxiety, threat 
appraisal, and worry.  
Hopman & Rijken 
(2014) 
Not Specified 267 
50.46% 
Female 
M = 64.31, 
SD = 12.21, 
Range = 21 - 
89 
Cross-
sectional 
IPQ-R: Cause, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Cognitive Reappraisal, 
Other (Fatalism), 
Avoidance/Denial 
Anxiety, Psychological 
Distress (Helplessness - 
Hopelessness) 
More passive ways of coping were more 
often found in patients who perceived 
their illness as long lasting, more 
emotionally burdening, and having more 
negative consequences. 
Karademas & 
Giannousi (2013) 
Not Specified 72 55.56% Male 
M = 55.01, 
SD = 13.29, 
Range = 31 - 
74 
Cross-
sectional 
IPQ-R: Personal Control, 
Treatment Control 
 Anxiety, Depression, 
Quality of Life 
Findings suggest that both 
representations of control (personal and 
treatment) are important for adaptation 
to illness. With higher levels of personal 
and treatment control associated with 
lower levels of anxiety and depression. 
Keeling, 
Bambrough, & 
Simpson (2013) 
Brain 74 
52.70% 
Female 
M = 38.30, 
SD = 10.67 
Cross-
sectional 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Anxiety, Depression, 
Affect (Positive) 
Illness perceptions play a significant 
role in emotional distress experienced 
by people with low-grade brain tumours 
but did not play such a role in positive 
affect. 
Llewellyn, 
McGurk, & 
Weinman (2006) 
Head and Neck 55 65% Male 
M = 59, SD = 
13.4, Range = 
23 - 89 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Illness 
Coherence, Emotional 
Representations 
 
Quality of Life 
(Individualised), Physical 
Functioning (x2), 
Psychological Distress 
(Emotional Functioning), 
Role Functioning (x2) 
(Social Functioning) 
(Cognitive Functioning), 
Other (General Health), 
Vitality, Psychological 
Several illness perception dimensions 
predicted several health outcomes. 
Higher emotional representations 
predicted poorer QOL, and higher levels 
of anxiety and depression. 
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Well-being, Anxiety, 
Depression 
Llewellyn, 
McGurk, & 
Weinman (2007) 
Head and Neck 82 66% Male 
M = 59.9, SD 
= 12.5, Range 
= 23 - 89 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Illness 
Coherence, Emotional 
Representations 
Cognitive Reappraisal 
(x3), Problem-Focused 
Coping (Generic) (x2), 
Avoidance/Denial 
(x2), Other (Substance 
Use), Seeking Social 
Support (x2), 
Expressing Emotion, 
Other (Humour), 
Other (Religion), 
Other (Self-Blame)  
Physical Functioning, 
Psychological Well-being 
(Mental Component 
Summary), Quality of Life 
Illness perceptions predicted several 
health and coping outcomes. Emotional 
representations was often the highest or 
one of the highest predictors of the 
various outcomes.  
Llewellyn, 
Weinman, 
McGurk, & 
Humphris (2008) 
Head and Neck 50 66% Male 
M = 59.9, SD 
= 12.5, Range 
= 23 - 89 
Longitudinal 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Illness 
Coherence, Emotional 
Representations 
 Anxiety (Fear of 
Recurrence) 
Emotional representations and 
consequences were the highest 
predictors of fear of recurrence, with 
higher levels leading to more fear. 
McCorry, 
Dempster, Quinn, 
Hogg, Newell, 
Moore, Kelly, & 
Kirk (2013) 
Breast 75 100% Female 
M = 57.2, SD 
= 10.4 
Longitudinal 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Anxiety, Depression 
Emotional representations and 
consequences were the highest 
predictors of both anxiety and 
depression, with higher levels of each 
leading to more anxiety and depression. 
Mols, Lemmens, 
Bosscha, van den 
Broek, & Thong 
(2014) 
Rectal 
1019 (538 no 
ostomy, 408 
ostomy) 
58.77% Male 
[56.1% Male 
(no ostomy), 
62.3% Male 
(ostomy)] 
Median = 
68.72 
[Median = 
67.0 (no 
ostomy), 
Median = 
69.8 
(ostomy)] 
Cross-
sectional 
B-IPQ: Identity, Timeline - 
Acute/Chronic, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 
Anxiety, Depression, 
Quality of Life, Physical 
Functioning, Role 
Functioning (x3) 
(Cognitive Functioning) 
(Social Functioning), 
Psychological Distress 
(Emotional Functioning) 
Those survivors with or without an 
ostomy had several illness perceptions 
related to functioning. However, 
survivors with an ostomy believed that 
their illness has significantly more 
serious consequences, will last longer, 
and were more concerned about their 
illness. 
Paschali, Hadjulis, 
Papadimitriou, & 
Karademas (2015) 
Not Specified 93 43.01% Male 
M = 58.34, 
SD = 11.18 
Cross-
sectional 
IPQ-R:  Cause, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Problem-Focused 
Coping (Generic) 
(Positive Adjustment 
to Cancer), 
Avoidance/Denial 
(Negative Adjustment 
to Cancer) 
Physical Functioning 
Several illness perceptions were related 
to physical functioning, positive 
adjustment to cancer, and negative 
adjustment to cancer. 
Rozema, Völlink, 
& Lechner (2009) 
Breast 119 100% Female 
M = 46.8, SD 
= 8.21, Range 
= 22 - 64 
Cross-
sectional 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Emotional Representations 
Problem-Focused 
Coping (Generic), 
Avoidance/Denial 
(x2), Seeking Social 
Support, Expressing 
Emotion 
Physical Functioning 
(Physical Health), 
Psychological Well-being 
(Mental Health) 
Patients who view their illness as a 
condition with serious symptoms 
(identity) and consequences, a chronic 
timeline, and who view their illness as 
uncontrollable were found to report 
worse physical and mental health. 
Scharloo, 
Baatenburg de 
Jong, Langeveld, 
van Velzen-
Verkaik, Doorn-
Head and Neck 95 64.89% Male 
M = 59.5, SD 
= 11.3, Range 
= 28 - 84 
Longitudinal 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
 
Quality of Life, Physical 
Functioning, Role 
Functioning (x3) 
(Cognitive Functioning) 
(Social Functioning), 
Illness perceptions were related to 
functioning. The strongest predictor of 
functioning was generally identity, with 
higher levels associated with poorer 
functioning. 
234 
op den Akker, & 
Kaptein (2010) 
Illness Coherence, Emotional 
Representations 
Psychological Distress 
(Emotional Functioning) 
Silva, Moreira, & 
Canavarro (2012) 
Breast 78 100% Female 
M = 52.08, 
SD = 8.86, 
Range = 30 - 
68 
Cross-
sectional 
B-IPQ: Consequences 
Cognitive Reappraisal 
(Posttraumatic 
Growth) 
Anxiety, Depression, 
Physical Functioning 
(Physical QOL), 
Psychological Well-being 
(Psychological QOL), Role 
Functioning (Social QOL) 
A more negative perception of the 
impact of breast cancer was significantly 
associated with higher emotional 
distress and impaired physical and 
psychological QOL, but was unrelated 
to posttraumatic growth. 
Thune-Boyle, 
Myers, & 
Newman (2006) 
Not Specified 72 54% Female 
M = 56, 
Range = 22 - 
83 
Cross-
sectional 
IPQ: Consequences, 
Cure/Control 
 Anxiety, Depression 
More severe consequences predictor 
higher levels of both anxiety and 
depression. 
Traeger (2009) Prostate 261 100% Male 
M = 65.4, SD 
= 7.6 
Cross-
sectional 
IPQ-R: Consequences  
Role Functioning (x3) 
(Sexual Bother) (Sexual 
Function) (Social WB), 
Quality of Life (Health-
Related), Other (General 
Health), Physical 
Functioning (x2) 
(Functional WB), 
Psychological Distress 
(Emotional WB) 
More severe consequences predicted 
worse functioning and a poorer QOL. 
Traeger, Penedo, 
Gonzalez, Dahn, 
Lechner, 
Schneiderman, & 
Antoni (2009) 
Prostate 214 100% Male 
M = 64.9, SD 
= 7.4 
Cross-
sectional 
IPQ-R: Cause, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence 
 
Psychological Distress (x2) 
(Life Stress) (Emotional 
WB), Role Functioning 
(Sexual Function) 
More severe perceived consequences of 
prostate cancer were associated with 
poorer emotional well-being, 
particularly among men experiencing 
greater life stress. 
Van Der Kloot, 
Kobayashi, 
Yamaoka, Inoue, 
Nortier, & 
Kaptein (2014) 
Not Specified 
(Breast & Lung) 
80 
62.92% 
Female 
M = 55.99, 
SD = 8.53 
Longitudinal 
B-IPQ: Identity, Timeline - 
Acute/Chronic, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 
Quality of Life, Role 
Functioning (x2) (Social 
Functioning) (Physical and 
Role Functioning), 
Psychological Distress 
(Psychological 
Functioning) 
Illness perceptions were related to 
functioning. The strongest predictors of 
functioning were generally identity, 
consequences, and emotional 
representations.  
Wu, Mohamed, 
Winkel, & 
Diefenbach 
(2013) 
Prostate 53 100% Male 
M = 64.52, 
SD = 9.02, 
Range = 43 - 
84 (For the 
TOTAL 
sample - 53 - 
NOT at T1) 
Longitudinal 
IPQ-R: Timeline - 
Acute/Chronic, Treatment 
Control 
 Quality of Life 
A more chronic timeline and higher 
levels of treatment control were 
associated with better QOL, but not 
significantly. 
Živkovic, Buljan, 
Blajic, & Situm 
(2008) 
Melanoma Skin 
Cancer 
60 
56.67% 
Female 
M = 52, 
Range = 29 - 
74 
Cross-
sectional 
B-IPQ  
Quality of Life (x2) 
(Subjective QOL) (The 
Impact of Illness on QOL), 
Depression 
Several illness perception dimensions 
are correlated with patients' QOL, the 
influence illness has on QOL, and 
depression. 
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Appendix 2.8 Qualitative data extraction and study characteristics table (Study 1) 
Authors (Date) Cancer Type 
Sample Size All 
Time Points 
Sex (T1) Age (T1) Study Design IPQ Type 
Coping 
Behaviour 
Illness Outcome Relevant Results 
Cook, Salman, 
Dunn, Holcombe, 
Cornford, & 
Fisher (2015) 
Not Specified 
(Breast & 
Prostate) 
206 
35.44% Male 
(final sample - 
T2) 
M = 61.50, SD = 
9.00, Range = 39 - 
85 (final sample - 
T2) 
Longitudinal 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence 
 
Anxiety, Depression, 
Psychological Distress 
(Trauma) 
Illness perceptions at T1 predicted 
between 10% for trauma and 12% for 
anxiety of the variance in T2 outcomes 
(controlling for age/gender). Perceived 
lack of personal control and a 
perception of more serious 
consequences predicted T2 anxiety, 
while less illness coherence predicted 
T2 depression and trauma.  
Cooper, Hankins, 
Rixon, Eaton, & 
Grunfeld (2013) 
Breast, 
Gynaecologic
al, Prostate, 
Head and 
Neck 
Breast (89), 
Gynaecological 
(56), Prostate 
(88), Head and 
Neck (47) 
Breast (100% 
Female), 
Gynaecological 
(100% Female), 
Prostate (100% 
Male), Head 
and Neck 
(74.5% Male) 
Breast (M = 49, 
SD = 7), 
Gynaecological 
(M = 48, SD = 
10), Prostate (M = 
54, SD = 11), 
Head and Neck 
(M = 52, SD = 9) 
Longitudinal 
IPQ-R: Timeline - 
Acute/Chronic, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
 Role Functioning (Return 
to Work) 
Consequences were associated with 
return to work in those with breast 
cancer and head and neck cancer. 
Personal control was associated with 
return to work in those with 
gynaecological cancer. 
Dempster, 
McCorry, 
Brennan, 
Donnelly, Murray, 
& Johnston (2011) 
Oesophageal 189 74.07% Male 
M = 64.8, SD = 
8.83 
Longitudinal 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Anxiety, Depression 
Several illness perception dimensions 
predicted anxiety and depression over 
a 12 month period. 
Giannousi, 
Manaras, 
Georgoulias, & 
Samonis (2010) 
Not Specified 206 66% Female 
M = 55, SD = 
12.53 
Cross-
sectional 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 Depression 
Multiple regression analysis showed 
that consequences, emotional 
representations, illness identity, and 
psychological attributions were the 
best predictors for depression. 
Grande, Arnott, 
Brundle, & Pilling 
(2014) 
Not Specified 43 61.3% Male 
M = 66.48, SD = 
8.95 
Longitudinal 
IPQ-R: Personal Control, 
Emotional Representations 
Seeking Social 
Support (x2)  
 Emotional representations significantly 
predicted support group participation. 
Grande, Myers, & 
Sutton (2006) 
Not Specified 
SG-Y = 63, SG-N 
= 44 
SG-Y = 16.1%, 
SG-N = 38.6% 
SG-Y Median = 
61 (IQR = 15.3), 
SG-N Median = 
64.5 (IQR = 18.8) 
Cross-
sectional 
IPQ-R: Personal Control, 
Emotional Representations 
Seeking Social 
Support 
 
Support group participants felt more 
control over their cancer, but were 
more distressed and anxious (higher 
emotional representations). 
Gray, Hall, 
Browne, Johnston, 
Lee, Macleod, 
Mitchell, Samuel, 
& Campbell 
(2014) 
Colorectal 496 55% Male 
M = 66, SD = 
11.11 
Cross-
sectional 
IPQ-R: Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
 Anxiety, Depression 
Reporting a high negative life and 
emotional impact (emotional 
representations) predicted anxiety 
caseness and increased the odds of 
depression caseness. 
Gray, Hall, 
Browne, Macleod, 
Lee, Johnston, 
Wyke, Samuel, 
Weller, & 
Campbell (2011) 
Colorectal 496 55% Male 
M = 66, SD = 
11.11 
Cross-
sectional 
IPQ-R:  Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
 Quality of Life 
Higher identity, cyclical timeline, and 
consequences were predictive of lower 
QOL, while higher personal and 
treatment control was associated with 
higher QOL. 
236 
Iskandarsyah, de 
Klerk, Suardi, 
Sadarjoen, & 
Passchier (2014) 
Breast 70 100% Female 
M = 45.6, SD = 
7.88, Range = 28 - 
66 
Cross-
sectional 
B-IPQ: Identity, Timeline - 
Acute/Chronic, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
Adherence to 
Treatment 
Visits (x2) 
 
More negative illness perceptions and 
whether a traditional healer had been 
consulted after diagnosis were 
associated with missing treatment 
sessions. Treatment related distress 
was most closely associated with 
missing treatment sessions. 
JØrgensen, 
Frederiksen, 
Boesen, Elsass, & 
Johansen (2009) 
Breast 177 100% Female 
M = 53.27, Range 
= 25 - 74 
Experimental 
IPQ-R: Identity, Cause, 
Timeline - Acute/Chronic, 
Consequences, Personal 
Control, Treatment Control, 
Emotional Representations 
 
Quality of Life, 
Psychological Distress 
(Emotional Distress) 
Baseline analysis showed that illness 
perceptions were associated with 
distress and QOL. Consequences and 
treatment control were associated with 
QOL, while cause (stress or worry) and 
emotional representations were 
associated with distress. 
Landers, 
McCarthy, 
Livingstone, & 
Savage (2014 
Rectal 143 61.5% Male Range = 35 - 80 
Cross-
sectional 
IPQ: Identity, Cause, IPQ-R: 
Timeline - Acute/Chronic, 
Timeline - Cyclic, 
Consequences, Personal 
Control, Treatment Control, 
Emotional Representations 
Problem-
Focused 
Coping 
(Specific) (x3), 
Medication 
Adherence 
 
Respondents reporting more bowel 
symptoms (identity) and high timeline 
cyclical scores were more likely to use 
certain self-care strategies. 
Llewellyn, 
McGurk, & 
Weinman (2007) 
Head and 
Neck 
50 66% Male 
M = 59.9, SD = 
12.5, Range = 23 - 
89 
Longitudinal 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline - 
Cyclical, Consequences, 
Personal Control, Illness 
Coherence, Emotional 
Representations 
Multiple Multiple - e.g. Depression 
Beliefs about the chronicity of the 
disease (timeline beliefs) were 
predictors of depression after 
treatment. 
Miĉkevicienė, 
Vanagas, Jievalta, 
& Ulys, (2013) 
Prostate 501 100% Male 
M = 69.3, SD = 
8.8 
Cross-
sectional 
IPQ-R: Identity, Timeline - 
Acute/Chronic, Timeline -
Cyclical, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence, 
Emotional Representations 
 
Quality of Life, Physical 
Functioning, Role 
Functioning (x3) 
(Cognitive Functioning) 
(Social Functioning), 
Psychological Distress 
(Emotional Functioning) 
Several illness perception dimensions 
were associated with functioning. 
Consequences were often the strongest 
predictor of functioning. 
Millar, 
Purushotham, 
McLatchie, 
George, & Murray 
(2005) 
Breast 213 100% Female 
M = 59.4, SD = 
10.9, Range = 29 - 
98 
Longitudinal 
IPQ: Identity, Timeline, 
Consequences, Cure/Control 
 Psychological Distress 
Psychological morbidity (distress) in 
the year following breast cancer 
surgery is reliably predicted by the 
patient's perception of the impact of 
the symptoms (identity) and the 
timeline of the disease. 
Scharloo, 
Baatenburg de 
Jong, Langeveld, 
van Velzen-
Verkaik, Doorn-
op den Akker, & 
Kaptein (2005) 
Head and 
Neck 
68 58.33% Male 
M = 60, Range = 
41 - 84 
Cross-
sectional 
IPQ-R:  Identity, Cause, 
Timeline - Acute/Chronic, 
Timeline - Cyclical, 
Consequences, Personal 
Control, Treatment Control, 
Illness Coherence, Emotional 
Representations 
 
Quality of Life, Physical 
Functioning, Role 
Functioning (x3) 
(Cognitive Functioning) 
(Social Functioning), 
Psychological Distress 
(Emotional Functioning) 
Illness perceptions were significantly 
related to the QLQ-C30 physical, role, 
emotional, cognitive, social 
functioning, and global health scales. 
Traeger, Penedo, 
Benedict, Dahn, 
Lechner, 
Schneiderman, & 
Antoni (2013) 
Prostate 257 100% Male 
M = 65.3, SD = 
7.7 
Experimental 
IPQ-R: Cause, Consequences, 
Personal Control, Treatment 
Control, Illness Coherence 
 
Psychological Distress (x2) 
(Emotional WB) (Life 
Stress), Role Functioning 
(x2) (Sexual Function) 
(Urinary Function) 
For men reporting higher stress upon 
study entry, Cognitive-Behavioural 
Stress Management (intervention) 
related improvements were partially 
explained by changes in some illness 
perceptions. 
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Appendix 2.9 Meta-analytic strategy – additional information (Study 1) 
 
Zero-order correlations were the most frequently reported effect size, and therefore 
the average correlation coefficient weighted by sample size and calculated using Fischer’s Z 
transformations (rz) was used as the measure of effect in the meta-analysis. Correlations were 
reversed where necessary to maintain consistency across studies (e.g., when measuring 
emotional functioning rather than psychological distress). If a study used more than one 
measure to assess an outcome within the same category (e.g., generalised anxiety and trait 
anxiety), the smallest correlation coefficient was used in order to obtain a more conservative 
estimate of the correlation and to avoid bias. Further, if a study measured an outcome at more 
than one time point, only the Time 1 (baseline) result was used to minimise heterogeneity due 
to design. Authors of papers that did not report correlations were contacted. A qualitative 
narrative review was conducted for studies that did not include sufficient data and where data 
could not be obtained.  
To examine heterogeneity between studies, Q and I2 statistics were calculated. The Q 
statistic assesses the ratio of the variation in the observed effects to the within-study error, 
and suggests heterogeneity when statistically significant (Huedo-Medina, Sanchez-Meca, 
Marin-Martinez, & Botella, 2006). The I2 statistic indicates the percentage of variance across 
studies that is due to heterogeneity rather than chance, with increasing values meaning 
increasing heterogeneity. This, the I2 statistic gives an indication of the extent of true 
heterogeneity, whereas the Q statistic only provides an indication of statistical significance. It 
has been suggested that an I2 value of 25% is low, 50% is moderate, and 75% is high 
(Higgins, Thompson, Deeks, & Altman, 2003).  
In a meta-analysis, no matter how systematic the search process, there is always the 
chance that the results will be biased due to unpublished, missing, or otherwise unidentified 
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studies that potentially report non-significant or even contrary findings. This phenomenon 
was described by Rosenthal (1979) as the ‘file drawer problem’, and suggests that there may 
be a range of unpublished studies living in the file drawers of researchers. One of the 
implications of this problem is that there is a publication bias towards results that are 
statistically significant or that have larger effect sizes. Funnel plots and the ‘fail-safe N’ (Nfs) 
were used to assess this risk of bias. Funnel plots display the relationship between effect size 
and standard error (sample size) (Light & Pillemer, 1984), while the Rosenthal method for 
calculating fail-safe N was applied. This method results in the provision of the number of 
studies with non-significant results that would need to be found to reduce the effect size of 
the present meta-analysis to a negligible level (Rosenthal, 1979). 
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Appendix 2.10 Risk of bias assessment (Study 1) 
Authors (Date) Study Design IPQ, IPQ-R, or B-IPQ: Used 
as recommended 
Dimensions assessed (number of 
items)* 
Correlation 
Analysis 
Adjustment for 
possible confounds 
Meta-Analysis or 
Narrative Review 
Beatty and Scott (2013) Cross-sectional IPQ-R: Yes 
- ‘cancer’ substituted for 
‘illness’ 
 
Identity (14), Cause (6), Consequences 
(6) 
Spearman’s 
Correlation 
None Meta-Analysis 
Cameron, Booth, 
Schlatter, Ziginskas, 
Harman, & Benson 
(2005) 
Cross-sectional IPQ-R: Partially 
- shortened versions of scales 
were used 
- ‘breast cancer’ substituted 
for ‘illness’ 
 
Cause (2), Personal Control (3), 
Emotional Representations (4) 
Pearson’s 
Correlation 
None Meta-Analysis 
Chen (2013) Cross-sectional IPQ-R: Yes Timeline - Acute/Chronic and Cyclical 
(10), Personal and Treatment Control 
(11), Consequences (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Cook, Salman, Dunn, 
Holcombe, Cornford, & 
Fisher (2015) 
Longitudinal IPQ-R: Yes 
- several cause items removed 
Identity (14), Cause (7), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5) 
 
N/A N/A Narrative Review 
Cook, Salman, Dunn, 
Holcombe, Cornford, & 
Fisher (2015) 
Cross-sectional IPQ-R: Yes 
- one identity item added 
- several cause items removed 
Identity (15), Cause (7), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Cooper, Hankins, Rixon, 
Eaton, & Grunfeld 
(2013) 
Longitudinal IPQ-R: Partially 
- adapted for cancer patients 
- additional items added to 
some subscales 
Timeline - Acute/Chronic (5), 
Consequences (6), Personal Control 
(5), Treatment Control (7), Illness 
Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Corter, Findlay, Broom, 
Porter, & Petrie (2013) 
Cross-sectional B-IPQ: Yes 
- ‘breast cancer’ substituted 
for ‘illness’ 
 
Identity (1), Cause (1), Timeline - 
Acute/Chronic (1), Consequences (1), 
Personal Control (1), Treatment 
Control (1), Illness Coherence (1), 
Emotional Representations (2) 
 
Spearman’s 
Correlation 
None Meta-Analysis 
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Costanzo, Lutgendorf, & 
Roeder (2011) 
Longitudinal IPQ-R: Yes 
- cause items were adapted to 
suit breast cancer 
Cause (13), Timeline - Acute/Chronic 
(6), Consequences (6), Personal 
Control (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Croom (2012) Cross-sectional IPQ-R: Partially 
- additional items added to 
some subscales 
- ‘cancer’ substituted for 
‘illness’ 
 
Identity (15), Timeline - Acute/Chronic 
(8), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (6), Illness 
Coherence (5) 
Pearson’s 
Correlation 
- Relationship Length 
- Income 
- The Eastern 
Cooperative Oncology 
Group (ECOG) 
Performance Status 
 
Meta-Analysis 
Croom, Hamann, Kehoe, 
Paulk, & Wiebe (2013) 
Cross-sectional IPQ-R: Yes 
- one identity item added 
Identity (15), Timeline - Acute/Chronic 
(8), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (6), Illness 
Coherence (5) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Dempster, McCorry, 
Brennan, Donnelly, 
Murray, & Johnston 
(2012) 
Cross-sectional IPQ-R: Yes 
- cause items were adapted 
following factor analysis 
Cause (18), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5) 
 
Point-Biserial 
Correlation 
None Meta-Analysis 
Dempster, McCorry, 
Brennan, Donnelly, 
Murray, & Johnston 
(2011) 
Longitudinal IPQ-R: Yes 
- cause items were adapted 
following factor analysis 
Identity, (14), Cause (18), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Donovan (2003) Cross-sectional IPQ-R:  Yes 
- several identity items added 
Identity, (22), Cause (6), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Duric, Butow, Sharpe, 
Boyle, Beith, Wilcken, 
Heritier, Coates, Simes, 
& Stockler (2007) 
Cross-sectional IPQ-R: Yes 
- items were adapted to suit 
breast cancer 
Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
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Fan, Eiser, Ho, & Lin 
(2013) 
Cross-sectional B-IPQ: Yes Identity (1), Cause (1), Timeline - 
Acute/Chronic (1), Consequences (1), 
Personal Control (1), Treatment 
Control (1), Illness Coherence (1), 
Emotional Representations (2) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Fischer, Wiesenhaan, 
Heijer, Kleijn, Nortier, & 
Kaptein (2013) 
Longitudinal IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Förster & Taubert (2006) Longitudinal IPQ-R: Partially 
- shortened versions of scales 
were used 
 
Cause (7), Timeline - Acute/Chronic 
(2), Personal Control (1) 
Lagged 
Correlation 
None Meta-Analysis 
Foster, Breckons, 
Cotterell, Barbosa, 
Calman, Corner, Fenlon, 
Foster, Grimmett, 
Richardson, & Smith 
(2015) 
 
Cross-sectional B-IPQ: Yes Identity (1), Timeline - Acute/Chronic 
(1), Consequences (1), Personal 
Control (1), Treatment Control (1), 
Illness Coherence (1), Emotional 
Representations (2) 
Pearson’s 
Correlation 
None Meta-Analysis 
Freeman-Gibb (2012) Cross-sectional IPQ-R: Yes 
- several identity items added 
- cause items were adapted to 
suit breast cancer 
Identity (20), Cause (18), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Giannousi, Manaras, 
Georgoulias, & Samonis 
(2010) 
Cross-sectional IPQ-R: Partially 
- scales underwent factor 
analysis and were changed 
accordingly 
- several identity items added 
- cause items were adapted 
following factor analysis 
 
Identity (22), Cause (13), Timeline - 
Acute/Chronic (7), Timeline - Cyclical 
(3), Consequences (8), Personal 
Control (6), Treatment Control (4), 
Illness Coherence (4), Emotional 
Representations (8) 
None None Narrative Review 
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Gibbons (2013) Longitudinal IPQ-R: Yes 
- ‘breast cancer’ substituted 
for ‘illness’ 
- several identity items added 
- cause items were adapted to 
suit breast cancer 
Identity (19), Cause (17), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Gould, Brown, & 
Bramwell (2010) 
Cross-sectional IPQ-R: Yes 
- ‘cancer’ substituted for 
‘illness’ 
Timeline - Acute/Chronic (6), Timeline 
- Cyclical (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Illness Coherence (5) 
Pearson’s 
Correlation 
- Age 
- Time Since  
- Diagnosis 
- Cancer Stage 
- Cancer Site 
 
Meta-Analysis 
Grande, Arnott, Brundle, 
& Pilling (2014) 
Longitudinal IPQ-R: Yes Personal Control (6), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Grande, Myers, & Sutton 
(2006) 
Cross-sectional IPQ-R: Yes 
- ‘cancer’ substituted for 
‘illness’ 
 
Personal Control (6), Emotional 
Representations (6) 
N/A N/A Narrative Review 
Gray, Hall, Browne, 
Johnston, Lee, Macleod, 
Mitchell, Samuel, & 
Campbell (2014) 
Cross-sectional IPQ-R: Yes Timeline - Acute/Chronic (6), Timeline 
- Cyclical (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Illness Coherence (5), 
Emotional Representations (6) 
 
N/A N/A Narrative Review 
Gray, Hall, Browne, 
Macleod, Lee, Johnston, 
Wyke, Samuel, Weller, 
& Campbell (2011) 
Cross-sectional IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Green, Steinnagel, 
Morris, & Laakso (2014) 
Cross-sectional IPQ-R:  Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Unspecified 
Correlation 
None Meta-Analysis 
Henselmans, Sanderman, 
Helgeson, de Vries, 
Smink, & Ranchor 
(2010) 
 
Longitudinal IPQ-R: Yes 
- ‘breast cancer’ substituted 
for ‘illness’ 
Personal Control (6) Pearson’s 
Correlation 
None Meta-Analysis 
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Hopman & Rijken 
(2014) 
Cross-sectional IPQ-R: Yes Cause (18), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Iskandarsyah, de Klerk, 
Suardi, Sadarjoen, & 
Passchier (2014) 
Cross-sectional B-IPQ: Yes Identity (1), Timeline - Acute/Chronic 
(1), Consequences (1), Personal 
Control (1), Treatment Control (1), 
Illness Coherence (1), Emotional 
Representations (2) 
 
N/A N/A Narrative Review 
JØrgensen, Frederiksen, 
Boesen, Elsass, & 
Johansen (2009) 
Experimental IPQ-R: Yes 
- several cause items removed 
Identity (14), Cause (3), Timeline - 
Acute/Chronic (6), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Emotional Representations 
(6) 
 
N/A N/A Narrative Review 
Karademas & Giannousi 
(2013) 
Cross-sectional IPQ-R: Yes Personal Control (6), Treatment 
Control (5) 
 
Unspecified 
Correlation 
None Meta-Analysis 
Keeling, Bambrough, & 
Simpson (2013) 
Cross-sectional IPQ-R: Yes 
- several identity items added 
- cause items were adapted 
following factor analysis 
Identity (22), Cause (21), Timeline - 
Acute/Chronic (6), Timeline - 
Cyclical (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Illness Coherence (5), 
Emotional Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Landers, McCarthy, 
Livingstone, & Savage 
(2014) 
Cross-sectional IPQ: Partially 
- scales were adapted for 
cancer patients 
- several cause items removed 
 
Identity (12), Cause (10), IPQ-R: 
Timeline - Acute/Chronic (6), Timeline 
- Cyclic (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Emotional Representations 
(6) 
 
N/A N/A Narrative Review 
Llewellyn, McGurk, & 
Weinman (2006) 
Cross-sectional IPQ-R: Yes Identity (14), Timeline - 
Acute/Chronic (6), Timeline - 
Cyclical (4), Consequences (6), 
Personal Control (6), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
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Llewellyn, McGurk, & 
Weinman (2007) 
Cross-sectional IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Llewellyn, McGurk, & 
Weinman (2007) 
Longitudinal IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Illness Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Llewellyn, Weinman, 
McGurk, & Humphris 
(2008) 
Longitudinal IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
McCorry, Dempster, 
Quinn, Hogg, Newell, 
Moore, Kelly, & Kirk 
(2013) 
Longitudinal IPQ-R: Yes 
- cause items were adapted 
following factor analysis 
Identity (14), Cause (18), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Miĉkevicienė, Vanagas, 
Jievalta, & Ulys, (2013) 
Cross-sectional IPQ-R: Yes Identity (14), Timeline - Acute/Chronic 
(6), Timeline -Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Millar, Purushotham, 
McLatchie, George, & 
Murray (2005) 
 
Longitudinal IPQ: Yes Identity (12), Timeline (3), 
Consequences (7), Cure/Control (6) 
N/A N/A Narrative Review 
Mols, Lemmens, 
Bosscha, van den Broek, 
& Thong (2014) 
Cross-sectional B-IPQ: Yes Identity (1), Timeline - Acute/Chronic 
(1), Consequences (1), Personal 
Control (1), Treatment Control (1), 
Illness Coherence (1), Emotional 
Representations (2) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
245 
Paschali, Hadjulis, 
Papadimitriou, & 
Karademas (2015) 
Cross-sectional IPQ-R: Yes 
- cause items were adapted to 
suit cancer 
Cause (13), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Rozema, Völlink, & 
Lechner (2009) 
Cross-sectional IPQ-R: Partially 
- scales were adapted for 
breast cancer patients 
- several identity items added 
- cause items were adapted 
following factor analysis 
 
Identity (17), Cause (14), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Emotional Representations (6) 
Pearson’s 
Correlation 
None Meta-Analysis 
Scharloo, Baatenburg de 
Jong, Langeveld, van 
Velzen-Verkaik, Doorn-
op den Akker, & Kaptein 
(2010) 
Longitudinal IPQ-R: Partially 
- cause items were adapted to 
suit the sample (though not 
using a formal factor analysis) 
Identity (14), Cause (5), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Scharloo, Baatenburg de 
Jong, Langeveld, van 
Velzen-Verkaik, Doorn-
op den Akker, & Kaptein 
(2005) 
Cross-sectional IPQ-R: Partially 
- cause items were adapted to 
suit the sample (though not 
using a formal factor analysis) 
Identity (14), Cause (5), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
N/A N/A Narrative Review 
Silva, Moreira, & 
Canavarro (2012) 
 
Cross-sectional B-IPQ: Yes Consequences (1) Pearson’s 
Correlation 
None Meta-Analysis 
Thune-Boyle, Myers, & 
Newman (2006) 
Cross-sectional IPQ: Partially 
- scales were adapted for 
breast cancer patients 
 
Consequences (7), Cure/Control (6) Pearson’s 
Correlation 
None Meta-Analysis 
Traeger (2009) Cross-sectional IPQ-R: Yes Consequences (6) Unspecified 
Correlation 
 
None Meta-Analysis 
Traeger, Penedo, 
Benedict, Dahn, Lechner, 
Schneiderman, & Antoni 
(2013) 
Experimental IPQ-R: Partially 
- cause items were adapted 
based on previous research 
(not through a formal factor 
analysis) 
 
Cause (4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5) 
N/A N/A Narrative Review 
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Traeger, Penedo, 
Gonzalez, Dahn, 
Lechner, Schneiderman, 
& Antoni (2009) 
Cross-sectional IPQ-R: Partially 
- cause items were adapted to 
suit the sample (though not 
using a formal factor analysis) 
 
Cause (4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5) 
Pearson’s 
Correlation 
None Meta-Analysis 
Van Der Kloot, 
Kobayashi, Yamaoka, 
Inoue, Nortier, & 
Kaptein (2014) 
Longitudinal B-IPQ: Yes Identity (1), Timeline - Acute/Chronic 
(1), Consequences (1), Personal 
Control (1), Treatment Control (1), 
Illness Coherence (1), Emotional 
Representations (2) 
 
Pearson’s 
Correlation 
- Country 
- Cancer Type 
Meta-Analysis 
Wu, Mohamed, Winkel, 
& Diefenbach (2013) 
Longitudinal IPQ-R: Yes 
- ‘prostate cancer’ substituted 
for ‘illness’ 
 
Timeline - Acute/Chronic (6), 
Treatment Control (5) 
Bivariate 
Correlation 
- Age 
- Sexual Function 
Meta-Analysis 
Živkovic, Buljan, Blajic, 
& Situm (2008) 
Cross-sectional B-IPQ: Yes Identity (1), Cause (1), Timeline - 
Acute/Chronic (1), Consequences (1), 
Personal Control (1), Treatment 
Control (1), Illness Coherence (1), 
Emotional Representations (2) 
Pearson’s 
Correlation 
None Meta-Analysis 
Note: *Dimensions that appear are in bold were assessed by authors but not reported by authors for some outcomes 
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Appendix 2.11 Meta-analysis forest plots between illness representations and coping behaviours and illness representations and illness outcomes 
(Study 1) 
 
Note: See Pages 255-256 for the key to each study code. 
 
 
   
Figure 1. Cognitive Reappraisal and Identity   Figure 2. Cognitive Reappraisal and Acute/Chronic Timeline  Figure 3. Cognitive Reappraisal and Cyclical Timeline 
 
 
 
 
 
Figure 4. Cognitive Reappraisal and Consequences    Figure 5. Cognitive Reappraisal and Personal Control    Figure 6. Cognitive Reappraisal and Treatment Control 
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Figure 7. Cognitive Reappraisal and Illness Coherence    Figure 8. Cognitive Reappraisal and Emotional Representations   Figure 9. Avoidance/Denial and Identity 
 
Figure 10. Avoidance/Denial and Cause     Figure 11. Avoidance/Denial and Acute/Chronic Timeline   Figure 12. Avoidance/Denial and Cyclical Timeline 
 
Figure 13. Avoidance/Denial and Consequences    Figure 14. Avoidance/Denial and Personal Control    Figure 15. Avoidance/Denial and Treatment Control 
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Figure 16. Avoidance/Denial and Illness Coherence    Figure 17. Avoidance/Denial and Emotional Representations   Figure 18. Problem-Focused Coping (Generic) and Identity 
 
Figure 19. Problem-Focused Coping (Generic) and Cause  Figure 20. Problem-Focused Coping (Generic) and Acute/Chronic Timeline     Figure 21. Problem-Focused Coping (Generic) and Cyclical Timeline 
 
Figure 22. Problem-Focused Coping (Generic) and Consequences           Figure 23. Problem-Focused Coping (Generic) and Personal Control   Figure 24. Problem-Focused Coping (Generic) and Treatment Control  
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Figure 25. Problem-Focused Coping (Generic) and Illness Coherence        Figure 26. Problem-Focused Coping (Generic) and Emotional Representations Figure 27. Anxiety and Identity  
 
Figure 28. Anxiety and Cause      Figure 29. Anxiety and Acute/Chronic Timeline   Figure 30. Anxiety and Cyclical Timeline  
 
Figure 31. Anxiety and Consequences    Figure 32. Anxiety and Personal Control    Figure 33. Anxiety and Treatment Control  
251 
 
Figure 34. Anxiety and Illness Coherence Emotional Representations  Figure 35. Anxiety and Emotional Representations   Figure 36. Depression and Identity  
 
Figure 37. Depression and Cause     Figure 38. Depression and Acute/Chronic Timeline   Figure 39. Depression and Cyclical Timeline  
 
Figure 40. Depression and Consequences    Figure 41. Depression and Personal Control    Figure 42. Depression and Treatment Control  
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Figure 43. Depression and Illness Coherence    Figure 44. Depression and Emotional Representations   Figure 45. Psychological Distress and Identity  
 
Figure 46. Psychological Distress and Cause   Figure 47. Psychological Distress and Acute/Chronic Timeline  Figure 48. Psychological Distress and Cyclical Timeline  
 
Figure 49. Psychological Distress and Consequences   Figure 50. Psychological Distress and Personal Control       Figure 51. Psychological Distress and Treatment Control 
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Figure 52. Psychological Distress and Illness Coherence  Figure 53. Psychological Distress and Emotional Representations  Figure 54. Psychological Well-Being and Consequences  
 
Figure 55. Role Functioning and Identity    Figure 56. Role Functioning and Acute/Chronic Timeline  Figure 57. Role Functioning and Consequences  
 
Figure 58. Role Functioning and Personal Control   Figure 59. Role Functioning and Treatment Control   Figure 60. Role Functioning and Illness Coherence  
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Figure 61. Role Functioning and Emotional Representations  Figure 62. Physical Functioning and Identity                    Figure 63. Physical Functioning and Acute/Chronic Timeline 
 
Figure 64. Physical Functioning and Cyclical Timeline    Figure 65. Physical Functioning and Consequences     Figure 66. Physical Functioning and Personal Control  
 
Figure 67. Physical Functioning and Treatment Control     Figure 68. Physical Functioning and Illness Coherence              Figure 69. Physical Functioning and Emotional Representations 
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Figure 70. Quality of Life and Identity      Figure 71. Quality of Life and Acute/Chronic Timeline   Figure 72. Quality of Life and Consequences  
 
 
Figure 73. Quality of Life and Personal Control    Figure 74. Quality of Life and Treatment Control    Figure 75. Quality of Life and Illness Coherence 
 
 
Figure 76. Quality of Life and Emotional Representations 
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Study codes with associated authors and dates 
Study Code Authors (Date) 
BEA13SC Beatty and Scott (2013) 
CAM05BO Cameron, Booth, Schlatter, Ziginskas, Harman, & Benson (2005) 
CHE12XX Chen (2013) 
COO13HA Cooper, Hankins, Rixon, Eaton, & Grunfeld (2013) 
COO15SA Cook, Salman, Dunn, Holcombe, Cornford, & Fisher (2015) 
COO15SA* Cook, Salman, Dunn, Holcombe, Cornford, & Fisher (2015) 
COR13FI Corter, Findlay, Broom, Porter, & Petrie (2013) 
COS11LU Costanzo, Lutgendorf, & Roeder (2011) 
CRO12XX Croom (2012) 
CRO13HA Croom, Hamann, Kehoe, Paulk, & Wiebe (2013) 
DEM12MC Dempster, McCorry, Brennan, Donnelly, Murray, & Johnston (2012) 
DEM11MC Dempster, McCorry, Brennan, Donnelly, Murray, & Johnston (2011) 
DON03XX Donovan (2003) 
DUR07BU Duric, Butow, Sharpe, Boyle, Beith, Wilcken, Heritier, Coates, Simes, & Stockler (2007) 
FAN13EI Fan, Eiser, Ho, & Lin (2013) 
FIS13WI Fischer, Wiesenhaan, Heijer, Kleijn, Nortier, & Kaptein (2013) 
FÖR06TA Förster & Taubert (2006) 
FOS14BR Foster, Breckons, Cotterell, Barbosa, Calman, Corner, Fenlon, Foster, Grimmett, Richardson, & Smith (2015) 
FRE12XX Freeman-Gibb (2012) 
GIA10MA Giannousi, Manaras, Georgoulias, & Samonis (2010) 
GIB13XX Gibbons (2013) 
GOU10BR Gould, Brown, & Bramwell (2010) 
GRA06MY Grande, Myers, & Sutton (2006) 
GRA14AR Grande, Arnott, Brundle, & Pilling (2014) 
GRA14HA Gray, Hall, Browne, Johnston, Lee, Macleod, Mitchell, Samuel, & Campbell (2014) 
GRA11HA Gray, Hall, Browne, Macleod, Lee, Johnston, Wyke, Samuel, Weller, & Campbell (2011) 
GRE14ST Green, Steinnagel, Morris, & Laakso (2014) 
HEN10SA Henselmans, Sanderman, Helgeson, de Vries, Smink, & Ranchor (2010) 
HOP14RI Hopman & Rijken (2014) 
ISK14DE Iskandarsyah, de Klerk, Suardi, Sadarjoen, & Passchier (2014) 
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JØR09FR JØrgensen, Frederiksen, Boesen, Elsass, & Johansen (2009) 
KAR13GI Karademas & Giannousi (2013) 
KEE13BA Keeling, Bambrough, & Simpson (2013) 
LAN14MC Landers, McCarthy, Livingstone, & Savage (2014 
LLE06MC Llewellyn, McGurk, & Weinman (2006) 
LLE07MC Llewellyn, McGurk, & Weinman (2007) 
LLE07MC* Llewellyn, McGurk, & Weinman (2007) 
LLE08WE Llewellyn, Weinman, McGurk, & Humphris (2008) 
MCC13DE McCorry, Dempster, Quinn, Hogg, Newell, Moore, Kelly, & Kirk (2013) 
MIC13VA Miĉkevicienė, Vanagas, Jievalta, & Ulys, (2013) 
MIL05PU Millar, Purushotham, McLatchie, George, & Murray (2005) 
MOL14LE(NO) 
– No Ostomy 
Mols, Lemmens, Bosscha, van den Broek, & Thong (2014)  
MOL14LE(O)  
– Ostomy 
Mols, Lemmens, Bosscha, van den Broek, & Thong (2014)  
PAS15HA Paschali, Hadjulis, Papadimitriou, & Karademas (2015) 
ROZ09VÖ Rozema, Völlink, & Lechner (2009) 
SCH10BA Scharloo, Baatenburg de Jong, Langeveld, van Velzen-Verkaik, Doorn-op den Akker, & Kaptein (2010) 
SCH05BA Scharloo, Baatenburg de Jong, Langeveld, van Velzen-Verkaik, Doorn-op den Akker, & Kaptein (2005) 
SIL12MO Silva, Moreira, & Canavarro (2012) 
THU06MY Thune-Boyle, Myers, & Newman (2006) 
TRA09XX Traeger (2009) 
TRA13PE Traeger, Penedo, Benedict, Dahn, Lechner, Schneiderman, & Antoni (2013) 
TRA09PE Traeger, Penedo, Gonzalez, Dahn, Lechner, Schneiderman, & Antoni (2009) 
VAN14KO Van Der Kloot, Kobayashi, Yamaoka, Inoue, Nortier, & Kaptein (2014) 
WUX13MO Wu, Mohamed, Winkel, & Diefenbach (2013) 
ŽIV08BU Živkovic, Buljan, Blajic, & Situm (2008) 
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Appendix 2.12 Meta-analysis funnel plots between illness representations and coping behaviours and illness representations and illness 
outcomes (Study 1) 
 
 
 
 Figure 1. Cognitive Reappraisal and Identity    Figure 2. Cognitive Reappraisal and Acute/Chronic Timeline   Figure 3. Cognitive Reappraisal and Cyclical Timeline 
 
 
 
 
 
Figure 4. Cognitive Reappraisal and Consequences    Figure 5. Cognitive Reappraisal and Personal Control    Figure 6. Cognitive Reappraisal and Treatment Control 
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Figure 7. Cognitive Reappraisal and Illness Coherence    Figure 8. Cognitive Reappraisal and Emotional Representations        Figure 9. Avoidance/Denial and Identity 
 
Figure 10. Avoidance/Denial and Cause     Figure 11. Avoidance/Denial and Acute/Chronic Timeline           Figure 12. Avoidance/Denial and Cyclical Timeline 
 
Figure 13. Avoidance/Denial and Consequences    Figure 14. Avoidance/Denial and Personal Control           Figure 15. Avoidance/Denial and Treatment Control 
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Figure 16. Avoidance/Denial and Illness Coherence    Figure 17. Avoidance/Denial and Emotional Representations   Figure 18. Problem-Focused Coping (Generic) and Identity 
 
Figure 19. Problem-Focused Coping (Generic) and Cause  Figure 20. Problem-Focused Coping (Generic) and Acute/Chronic Timeline    Figure 21. Problem-Focused Coping (Generic) and Cyclical Timeline 
 
Figure 22. Problem-Focused Coping (Generic) and Consequences         Figure 23. Problem-Focused Coping (Generic) and Personal Control   Figure 24. Problem-Focused Coping (Generic) and Treatment Control   
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Figure 25. Problem-Focused Coping (Generic) and Illness Coherence          Figure 26. Problem-Focused Coping (Generic) and Emotional Representations Figure 27. Anxiety and Identity  
 
Figure 28. Anxiety and Cause              Figure 29. Anxiety and Acute/Chronic Timeline    Figure 30. Anxiety and Cyclical Timeline  
 
 
Figure 31. Anxiety and Consequences             Figure 32. Anxiety and Personal Control    Figure 33. Anxiety and Treatment Control  
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Figure 34. Anxiety and Illness Coherence                Figure 35. Anxiety and Emotional Representations            Figure 36. Depression and Identity 
 
Figure 37. Depression and Cause                         Figure 38. Depression and Acute/Chronic Timeline             Figure 39. Depression and Cyclical Timeline  
 
Figure 40. Depression and Consequences                    Figure 41. Depression and Personal Control             Figure 42. Depression and Treatment Control  
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Figure 43. Depression and Illness Coherence     Figure 44. Depression and Emotional Representations                      Figure 45. Psychological Distress and Identity  
 
Figure 46. Psychological Distress and Cause    Figure 47. Psychological Distress and Acute/Chronic Timeline        Figure 48. Psychological Distress and Cyclical Timeline  
  
Figure 49. Psychological Distress and Consequence     Figure 50. Psychological Distress and Personal Control                     Figure 51. Psychological Distress and Treatment Control 
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Figure 52. Psychological Distress and Illness Coherence  Figure 53. Psychological Distress and Emotional Representations  Figure 54. Psychological Well-Being and Consequences  
 
Figure 55. Role Functioning and Identity    Figure 56. Role Functioning and Acute/Chronic Timeline  Figure 57. Role Functioning and Consequences  
 
Figure 58. Role Functioning and Personal Control   Figure 59. Role Functioning and Treatment Control   Figure 60. Role Functioning and Illness Coherence  
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Figure 61. Role Functioning and Emotional Representations  Figure 62. Physical Functioning and Identity                  Figure 63. Physical Functioning and Acute/Chronic Timeline  
 
Figure 64. Physical Functioning and Cyclical Timeline   Figure 65. Physical Functioning and Consequences   Figure 66. Physical Functioning and Personal Control 
 
Figure 67. Physical Functioning and Treatment Control   Figure 68. Physical Functioning and Illness Coherence  Figure 69.Physical Functioning and Emotional Representations   
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Figure 70. Quality of Life and Identity    Figure 71. Quality of Life and Acute/Chronic Timeline     Figure 72. Quality of Life and Consequences  
 
Figure 73. Quality of Life and Personal Control   Figure 74. Quality of Life and Treatment Control     Figure 75. Quality of Life and Illness Coherence 
 
Figure 76. Quality of Life and Emotional Representations
Appendix 3.1 PRISMA 2009 Statement (Study 2)             267 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  51 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number.  
52 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  53-57 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
57 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
N/A 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
58 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
58 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
App 3.2 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
58-59, Figure 
3.2  
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
64 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
59 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
65 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  64 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
64-65 
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Section/topic  # Checklist item  
Reported on 
page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
67 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
58-59, Figure 
3.2 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
65, Table 3.1 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  65-66; App 3.5-
3.6 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
N/A 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  66-67, Table 
3.2, App 3.7 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  67, App 3.8 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
N/A 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
71-73 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
73-75 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
73, 75 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders 
for the systematic review.  
N/A 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Appendix 3.2 Database search strategies (Study 2) 
 
 
Scopus Syntax  
Advanced Search 
 
PUBYEAR > 1995 AND TITLE-ABS-KEY(anxiety OR "anxiety disorder*" OR depress* OR "depress* 
disorder*") AND TITLE-ABS-KEY("illness perception*" OR "illness representation*" OR "common sense" 
OR Leventhal* OR IPQ*) 
 
 
Web of Science Syntax 
Basic Search  
  
((anxiety OR "anxiety disorder*" OR depress* OR "depress* disorder*") AND ("illness perception*" OR 
"illness representation*" OR “common sense” OR Leventhal* OR IPQ*)) 
 
Timespan 1995 - 2015 
 
 
PubMed Syntax  
Advanced Search 
 
(anxiety[TIAB] OR “anxiety disorder*”[TIAB] OR depress*[TIAB] OR “depress* disorder*”[TIAB]) AND 
("illness perception*"[TIAB] OR "illness representation*"[TIAB] OR “common sense”[TIAB] OR 
Leventhal*[TIAB] OR IPQ*[TIAB]) 
  
Custom Date Range 1995 - 2015 
 
 
PsycINFO Syntax 
Command Line 
 
AB,TI(anxiety OR "anxiety disorder*" OR depress* OR "depress* disorder*") AND AB,TI("illness 
perception*" OR "illness representation*" OR “common sense” OR Leventhal* OR IPQ*) 
 
Enter a specific date range starting 1995 ending 2015 
 
 
Google Scholar Syntax (1995-2015) 
 
With the exact phrase: 
Illness Representation     Illness Representations 
Illness Perception     Illness Perceptions 
Common Sense     IPQ 
 
With at least one of the words: anxiety depression 
 
In the title of the article 
 
Return articles dated between 1995 - 2015 
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Appendix 3.3 Coding manual (Study 2) 
Coding Manual 
1 General Information 
ID No. _______________                                 Depression/Anxiety Type ______ DV _______  
 
An article identification number should be included at the top left of each page under ID No., and again in the 
General Publication Information section of the coding sheet. The 7-digit ID is specified in BLOCK CAPITALS. 
It is composed of: 
• the first three letters of the surname of the first author 
• the last two digits of the publication year 
• the first two letters of the surname of the second author (if no secondary author: xx) 
 
If several depression/anxiety types are examined in a publication, a private coding sheet is filled out for each type 
of depression/anxiety. The depression/anxiety types in an article are numbered. This number is entered in the upper 
right corner of each page under Depression/Anxiety Type, and again in the Depression/Anxiety and Sample 
Information section of the coding sheet. If the publication examines only one depression/anxiety type, the number 
of the depression/anxiety type followed by the word “only” is entered here. Depression/Anxiety Type should be 
coded as per the categories below: 
 
1 = Depression  
2 = Anxiety 
 
 
 
Note: Please include a more specific description of the depression/anxiety type in the Depression/Anxiety and 
Sample Information section of the coding sheet if necessary. 
 
 
 
If in the publication several dependent variables (including separate subscales) are analysed (e.g. psychological 
distress, and avoidance/denial), each dependent variable is given a number in terms of its DV (Subscale) Type. 
This number is entered in the upper right corner of each page under DV, and again in the dependent variable 
section of the coding sheet. These numbers are the same for all depression/anxiety types. DV (Subscale) Type has 
been adopted from Hagger and Orbell (2003) and should be coded as per the categories below: 
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Coping Behaviours 
23. Expressing Emotion  
24. Cognitive Reappraisal 
25. Avoidance/Denial 
26. Problem-Focused Coping (Generic) 
27. Problem-Focused Coping (Specific - Other) 
28. Treatment Decision Making 
29. Medication Adherence  
30. Adherence to Treatment Visits 
31. Doctors Visits 
32. Seeking Social Support 
98.  Other Coping Behaviour (Specify) 
Illness Outcomes 
33. Affect (Negative/Positive) 
34. Anxiety 
35. Depression 
36. Psychological Distress 
37. Treatment Related Distress 
38. Decisional Uncertainty / Regret 
39. Psychological Well-Being 
40. Vitality 
41. Role Functioning  
42. Physical Functioning 
43. Disease State 
44. Quality of Life 
99. Other Illness Outcome (Specify) 
 
Redundant Information 
If multiple coding sheets are filled in for one article, the details that apply to the entire article should be recorded 
in only one coding sheet, and the corresponding check box (to the right of the questions) should be ticked in other 
relevant coding sheets.  
Therefore a ticked box means that the missing information may be taken from another coding sheet.  
 
Missing Information 
There are two types of missing information: 
• Not Applicable: is crossed out in coding sheet and later encoded in data entry with 777.  
• Missing: is left open (and possibly supplemented, if one has written to the author). 
 
Decimal Places 
All sample values should be a maximum of two decimal places (rounded).  
All statistical values should be a maximum of three decimal places.  
Exclusion Criteria 
If one of the following criteria apply, the study must be excluded:  
• Study did not use the IPQ or IPQ-R: The study did not measure Illness Representations from the CSM using the Illness Perception 
Questionnaire or the Revised Illness Perception Questionnaire. 
• Study did not measure Coping Behaviours or Illness Outcomes 
• Study contained Participants without a Diagnosis of Depression or Anxiety 
• Study used (only) Children or Adolescents: Participants must not be under the age of eighteen. 
• Study in a language other than English or German: Note: We will consider studies in other languages if they include clear results. 
• Study was conducted prior to 1995: The study was conducted prior to the creation of the IPQ. 
 
 
A coding sheet must be created for any excluded study. However, it is sufficient to only fill in the general 
information for publication section. In addition, the “Study will be Excluded” box should be ticked and reasons 
should be provided in the comments box on the last page.  
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2 Comments on the Study 
 Study will be Excluded  Write to Authors  Important Comments 
 
If problems occurred during encoding, the relevant box should be ticked (with details to be included in the Final 
Details box on the last page of the coding sheet).  
• Study will be Excluded: Reason for exclusion in the final data set. 
• Write to Authors: If the publication is lacking important statistical information (e.g. information about the sample size or standard 
deviations), the coder will try to check this information with the authors. The missing details are mentioned in the Final Details box.  
• Important Comments: If any problems/comments are entered in the Final Details box, this field should be ticked – unless these are 
reasons for exclusion or information about a lack of statistical information. 
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3 General Publication Information 
Article Identification Number (ID-No.): __ __ __ __ __ __ __   Study in Article: _________ 
 
The Article Identification Number should be the same 7-digit ID (specified in BLOCK CAPITALS) as appears at 
the top left hand corner of each page. It is composed of  
• the first three letters of the surname of the first author 
• the last two digits of the publication year 
• the first two letters of the surname of the second author (if no secondary author: xx) 
 
If the publication contains several studies that refer to different samples, these studies are numbered. For each 
study, a separate coding sheet should be created. The respective number of the study is then given here.  
Coder: ___________  Coding Date____ / ___ / _______  Time of Day: ___________  
 
Coder: Enter initials of Coder 
Coding Date: Day / Month / Year 
Time of Day: Specify at the start of encoding in order to determine the total duration of coding 
 
Authors: ________________________________________________  Publication Year: _________ 
 
Specify the last name of the first three authors. If more than three authors are mentioned, all the other authors are 
abbreviated with et al. The publication year is four digits.  
 
Title (first six words): ______________________________________________________________ 
 
Note the first six words from the title of the publication.  
 
Country of Origin - Author: _________ Other Origin: ______________________ 
 
The Country of Origin of the first author is usually noted on the publication. If not, it should be googled and 
entered using the codes below. If the author has more than one Country of Origin, enter this under Other Origin. 
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Coding of Country of Origin 
1 = USA 
2 = Canada 
3 = Germany 
4 = Great Britain 
5 = Netherlands 
6 = Scandinavia 
7 = Australia 
8 = Western Europe (excluding G, GB, N, Scandinavia) 
9 = Eastern Europe (including Russia) 
99 = Other (Specify) 
 
 
Discipline of the First Author: _________ Other Discipline: ____________________ 
 
The discipline of the first author is usually noted on the publication. If not, it should be googled and entered using 
the codes below. If the author has more than one discipline listed, enter this under Other Discipline. 
Coding of Discipline 
1 = Psychology 
2 = Psychiatry 
3 = Medicine  
4 = Sociology 
5 = Economy 
6 = Education 
99 = Other 
 
Publication Found In: _________   Other Place Publication Found: _____________   
 
Coding where the Publication was Found 
1 = Scopus 
2 = Web of Science 
3 = PubMed 
4 = PsycINFO  
5 = Google Scholar 
6 = Manual Search in Journals 
7 = Hand-Searched Reference Lists 
8 = Contact with Researchers 
99 = Other Source 
 
Note: Some publications may be found (or exist) in more than one location or database. The code given will reflect 
the first place the coders have found the publication. 
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Type of Publication: _____  Other Publication: ______ Citations: _______ Impact: _________   
 
Coding the Type of Publication 
1 = Journal with Peer Review 
2 = Journal without Peer Review 
3 = Book / Book Chapters 
4 = Dissertation (PhD) 
5 = Honours Thesis or Master’s Thesis (or German Diploma) 
6 = Conference Presentation / Poster (Abstract or Full Paper) 
7 = Unpublished Manuscript 
8 = Internet Document 
99 = Other 
 
Citations 
How many citations does the study have (in Scopus)? 
 
Impact 
What is the Impact Factor of the Journal (in Journal Citation Reports)? 
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4 Description of the Study 
Study Type: _____________  IPQ or IPQ-R Dimension: ___________________________________ 
Reliability Source: ________ Coefficients Type: ________ Number of Items: ___________ 
Study: _______________________________________________________________________________ 
Coding of Study Type         Coding of IPQ or IPQ-R Dimension  
1 = Cross-Sectional 
2 = Longitudinal 
3 = Experimental 
4 = Pseudo-Experimental 
5 = Qualitative 
99 = Other Study Type 
1 = Identity 
2 = Cause (Generic) 
3 = Timeline (Acute/Chronic) 
4 = Consequences 
5 = Personal Control 
6 = Treatment Control Items 
7 = Illness Coherence Items 
8 = Timeline Cyclical 
9 = Emotional Representations 
10 = IPQ Only – Cure-Control 
11 = All Dimensions of IPQ 
12 = All Dimensions of IPQ-R 
Coding of Reliability Source 
0 = No Information 
1 = No Information, but reference to another publication (specify study) 
2 =Yes, calculated using the sample from this publication (specify values) 
3 = Yes, calculated using a different sample (values and specify study) 
 
If reliability coefficients are given for individual subscales, these should be included later in the coding sheet (in 
the Statistical Analyses and Effect Sizes section). 
If coefficients are drawn from both this sample (coding 2) and from other studies (coding 3) in the publication, 
only the coefficients of the concrete sample are to be coded.  
If there is no information about reliability, but there is a reference in the description of the instrument, this 
corresponds to Coding 1.  
Coding of Coefficient Type 
1 = Internal Consistency, E.g. Cronbach’s  
2 = Split- Halves Reliability 
3 = Test-Retest Reliability 
4 = Parallel Test Reliability 
5 = Mean Value of Several Coefficients 
6 = No Precise Indication 
99 = Other Coefficient 
 
Study 
If a reliability coefficient is (or is not) stated, and reference is made to another study, the first three authors and the 
year of publication of the study are stated under “Study”.  
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Number of Items 
If all dimensions of the IPQ or IPQ-R were measured, provide the number of items for the entire measure here. 
The number of items for each individual subscale should be included later in the coding sheet (in the Statistical 
Analyses and Effect Sizes section).  
If Experimental: 
Number of Groups: _______ 
Assignment: _______ 
Group a: _______________ 
Group b: _______________ 
Group c: _______________ 
Group d: _______________ 
The values of various groups are often reported, e.g. for women and for men. In this case, the statistics for each 
group are reported on a single coding sheet.  
Note: Only fill out this section of the coding sheet if the study is experimental. 
Number of Groups 
Specify the number of groups for which statistics are available. If only one group is available, use a 1. Further, all 
other fields must not be filled in, but instead crossed out and encoded with 777 (not applicable).  
Assignment 
Group allocation:   
1 = Randomisation: The subjects were randomly assigned to the groups. 
2 = Matched Groups: Each person of one group matches a person of the other group. Each pair has similar properties (e.g. the same age or the 
same sex). 
3 = Natural Groups, parallelised: E.g., women’s and men’s groups are natural groups. These two groups can also be parallelised for other 
characteristics (e.g. by having the same mean age). 
4 = Natural Groups without further assignment: E.g., comparison of women and men, without other sampling features. 
Group a, Group b, etc.  
Each group is assigned a continuous index a, b, c, etc. Note which identify groups, e.g. group a = men, group b = 
women, or group a = pre-treatment, group b = peri-treatment, group c = post-treatment.  
If more than four groups were analysed, the other group affiliations are simply noted on the margin or on a separate 
piece of paper. 
Number of Measurement Points: _______ Year of the First Data Collection:   __________ 
Number of Measurement Points: Enter a number or 99, when the number of measurement times varied within the 
sample. These are only included when statistical information is available for the measurement point. 
Year of the First Data Collection: Enter the four-digit year number. If given several years for the first MP, the 
earliest year is coded.  
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Lag Between Assessments ________:   
MP 2   __________________________________  
MP 3   __________________________________ 
MP 4   __________________________________ 
MP 5   __________________________________ 
MP 6   __________________________________ 
MP 7   __________________________________ 
MP 8   __________________________________  
 
This box can only be filled in if the distance between the MPs is the same for all individuals, and if statistics are 
available. The time interval is specified in months (rounded if necessary).  
Use this scale for the conversion of years, weeks and days into months: 
1 Day = 0.03 Months 
1 Week = 0.25 Months 
1 Year = 12 Months 
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5 Depression/Anxiety and Sample Information 
The information on the sample should refer to the smallest unit of analysis (e.g., males and females separately). If 
there are several groups, information on the sample for each group should be recorded separately. If this is not 
possible and only information on the total sample can be accessed, it is sufficient to fill in the Depression/Anxiety 
and Sample Information box on a single coding sheet and to tick the box on the right – meaning that this data is 
applicable across all groups.  
Sometimes statistics are only available at the group level, and other times only for the entire sample. In this case, 
you can mark information as generally applicable by placing a tick in the smaller box to the right of each row. A 
ticked box means that this information refers to the whole sample. If this box is not ticked, it means that this 
information refers to the specific group.  
 
Type of Sample: _______________________   
 
The nature of the sample may change during a longitudinal study. For example, students might participate, and 
after a passage of time, leave the university. It is therefore crucial for to identify what the type of sample was at 
the first MP.  
 
Coding the Type of Sample 
1 = Representative Sample  
2 = Non-representative Sample of the general population (specify if the study has a name) 
3 = Students 
4 = Clinical Sample (E.g. those assessed in a hospital) 
5 = Depression/Anxiety Groups, Societies, and Communities (E.g. self-help groups, internet communities) 
99 = Other type of Sample (specify) 
 
 
Dep/Anx Type: __________________________________________________________                    
 
 
Coding of Dep/Anx Type 
 
Depression/Anxiety Type should be coded as per the categories below: 
1 = Depression  
2 = Anxiety 
 
Note: Please include a more specific description of the depression/anxiety type in the Depression/Anxiety and 
Sample Information section of the coding sheet if necessary. 
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Dep/Anx Duration: M = ___________  SD = __________    Range from _______ to _________     
 
Dep/Anx Duration: Record information here regarding the length of time participants have suffered from (been 
diagnosed with) depression or anxiety (in months).  
Use this scale for the conversion of years, weeks and days into months: 
1 Day = 0.03 Months 
1 Week = 0.25 Months 
1 Year = 12 Months 
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum Depression/Anxiety Duration. 
 
Age at Onset: M = ____________  SD = _________     Range from _______ to _________    
 
Age at Onset: Record information here regarding which age participants were diagnosed with depression or anxiety 
(in years).  
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum Age at Onset. 
 
Treatment Type: ______  Treatment Stage: __________________________________           
 
Coding of Treatment Type               Coding of Treatment Stage 
1 = Psychological (Specify) 
2 = Antidepressant Medication 
3 = Other Medication (Specify)  
99 = Other Treatment (Specify) 
1 = Pre-Treatment 
2 = Peri-Treatment (Currently Undergoing Treatment) 
3 = Post-Treatment 
 
 
Size of the Sample at each Measurement Point:   
MP 1   __________  
MP 2   __________  
MP 3   __________  
MP 4   __________  
 
MP 5   __________  
MP 6   __________  
MP 7   __________  
MP 8   __________  
    
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Here the sample size at each measurement time point is indicated. Sample size includes all participants, regardless 
of whether or not they were later excluded from the analysis. The point is to show how the sample has changed 
over time (i.e. mostly reduced).  
If multiple groups are examined separately, only the respective group size is specified. 
 
Total N: ______________ Retention Rate: _________ %  
 
Total N: The number of individuals that participated at all time points.  
Retention Rate: How high is the percentage of those who have participated in all MPs (total N),  compared to the 
sample for the first MP (can be calculated from the ratio of MP 1 and total N).  
 
Proportion of Men at MP 1:  _______ %  
 
Proportion of Men: Always indicate the MP for which the proportion of men refers.  
Age at MP 1 _____:  M = __________ SD = __________ Range from __________ to _________  
 
Age at MP 1: Specify to whom the information relates. If data is available for several MPs, the information for 
MP 1 is reported.  
M: Mean value.  
SD: Standard deviation. 
Range: Specify a minimum and maximum age. 
 
Ethnicity: ____ Other Ethnicity: ____  Country of Origin: ____  Other Country of Origin: ____  
 
Coding of Ethnicity 
Ethnicity is specified only if the proportion of this ethnic group makes up a minimum of 50% of the sample.  
1 = White (Caucasian, Anglo-American, European) 
2 = Black 
3 = Hispanic 
4 = Indigenous People 
5 = Asian 
6 = Mixed (when two ethnic groups are represented with 50% each) 
99 = Other (specify) 
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Coding of Country of Origin 
Specify in which Country the study was conducted. 
1 = USA 
2 = Canada 
3 = Germany 
4 = Great Britain 
5 = Netherlands 
6 = Scandinavia 
7 = Australia 
8 = Western Europe (excluding G, GB, N, Scandinavia) 
9 = Eastern Europe (including Russia) 
99 = Other (Specify) 
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6 Dependent Variable 
No. ______ Did the Study aim to change the Dependent Variable? ________ 
 
Number of Dependent Variables 
If there are several DVs (including separate subscales), the DVs are numbered in terms of their DV (Subscale) 
Type and a separate coding sheet for each DV is created. This number should also be entered in the top right hand 
corner of every page. Note. As each subscale can be a DV of its own, the number of DVs should include subscales 
(if their details are to be recorded separately throughout the coding sheet). At “No.” the number of DVs is given. 
If only one DV is encoded, this field is crossed out and later coded with 777 (not applicable).  
Did the Study aim to change the Dependent Variable/s? 
Did the study aim to change the DV: 
0 = No 
1 = Yes 
 
DV Global: _________ DV Name: ___________________________________________________ 
 
There are three aspects of the DV that need to be coded. In DV Global, the global category is entered. These are 
distinguished as:  
 
1 = Coping Behaviour 
2 = Illness Outcome 
99 = Other (Please Specify) 
 
DV Name indicates the name of the DV which is used in the publication.  
 
Subscale: __________________________ DV (Subscale) Type: _______________ 
 
Subscale 
If only one subscale of an instrument is used, or if data is provided separately for several subscales, this is noted 
here (by recording the name of the subscale). All other information (e.g., reliability and number of items) will 
always refer to this subscale, and not the entire instrument.  
 
DV (Subscale) Type has been adopted from Hagger and Orbell (2003) and should be coded as per the categories 
below: 
Coping Behaviours Illness Outcomes 
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23. Expressing Emotion  
24. Cognitive Reappraisal 
25. Avoidance/Denial 
26. Problem-Focused Coping (Generic) 
27. Problem-Focused Coping (Specific - Other) 
28. Treatment Decision Making 
29. Medication Adherence  
30. Adherence to Treatment Visits 
31. Doctors Visits 
32. Seeking Social Support 
98.  Other Coping Behaviour (Specify) 
33. Affect (Negative/Positive) 
34. Anxiety 
35. Depression 
36. Psychological Distress 
37. Treatment Related Distress 
38. Decisional Uncertainty / Regret 
39. Psychological Well-Being 
40. Vitality 
41. Role Functioning 
42. Physical Functioning 
43. Disease State 
44. Quality of Life 
99. Other Illness Outcome (Specify) 
 
 
Data Source: _______  Additional Information: _________________________________________ 
Coding of the Data Source 
1 = Self-report Questionnaire 
2 = Self-report Interview 
3 = Self-report on Ambulatory Assessment 
5 = Observation 
6 = Ratings by Others (include who provided the ratings) 
7 = Analysis of Written Reports (e.g., diaries or autobiographies) 
8 = Physiological Measures 
9 = Objective Measures (e.g., pill bottle count) 
99 = Other Data Source 
  
Caution: The use of a scale does not always mean that the data source is a self-report questionnaire. Often the 
scales are presented in an interview, making it a self-report interview.  
 
Instrument:     Code: ____________ Number of Items: _______________    
Reliability: Coefficients:  MP ___ MP ___ MP ___ MP ___ MP ___ MP ___ 
Source: _________ Type: ________ _______ _______ _______ _______ _______ _______ 
Study: _______________________________________________________________________________ 
 
Coding of the Instrument 
Measures of Coping Behaviours 
1 = COPE (Carver, Scheier, & Weintraub, 1989) 
2 = Utrechtse Coping Questionnaire (UCL; Schreurs, & Willige, 1988) 
3 = Impact of Event Scale - Revised (IES-R; Weiss & Marmar, 1997) 
4 = Ways of Coping Checklist - Revised (WCCL-R; Vitaliano, Russo, Carr, 
Maiuro, & Becker) 
5 = Ways of Coping Questionnaire (WCQ; Folkman & Lazarus, 1988) 
6 = Medication Adherence Reporting Scale - 5 (MARS-5; Horne, 2001) 
7 = The Morisky Medication Adherence Scale – 8 (MMAS-8; Morisky, 
Green, & Levine, 1986) 
8 = Other Measure of Coping Behaviour (Specify) 
Measures of Illness Outcomes 
9 = Medical Outcomes Study 36/20/12 Item Short Form (MOS SF-36/20/12; 
Stewart, Hays, & Ware, 1988) 
10 = General Health Questionnaire 60/30/28/12 Item (GHQ-60/30/28/12; 
Goldberg, 1978) 
11 = Positive and Negative Affect Schedule (PANAS; Watson, Clark, & 
Tellegen, 1988) 
12 = Generalised Anxiety Disorder 7-Item Scale (GAD-7; Spitzer, Kroenke, 
Williams, & Lowe, 2006) 
13 = State-Trait Anxiety Inventory (STAI; Speilberger, Gorsuch, Lushene, 
Vagg, & Jacobs, 1983) 
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14 = Centre for Epidemiological Studies Depression Scale Revised (CESD-
R; Eaton, Muntaner, Smith, Tien, & Ybarra, 2004) 
15 = Patient Health Questionnaire – 2/9 Item (PHQ-9/2; Kroenke, & Spitzer, 
2002; Kroenke, Spitzer, & Williams, 2003) 
16 = Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983) 
17 = Impact of Event Scale – Revised (IES-R; Weiss & Marmar 1996) 
18 = Psychological Adjustment to Illness Scale – Self Report (PAIS-SR; 
Derogatis, 1986) 
19 = Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzeger, & 
Borkovec, 1990) 
20 = Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) 
21 = Well-being Questionnaire (WB-Q12 or WB-Q22; Bradley, 1994) 
22 = World Health Organisation Quality of Life (or BREF) (WHOQOL; 
WHO, 1998)  
23 = Other Measure of Illness Outcome (Specify) 
Number of Items 
Number of items specifies the number of items the construct was measured with. If only one subscale is used, only 
list the number of items for this subscale.  
Source of Reliability Information 
0 = No Information 
1 = No Information, but reference to another publication (specify study) 
2 =Yes, calculated using the sample from this publication (specify values) 
3 = Yes, calculated using a different sample (values and specify study) 
 
If there is no information about reliability, but there is a reference in the description of the instrument, this 
corresponds to Coding 1.  
If coefficients are drawn from both this sample (coding 2) and from other studies (coding 3) in the publication, 
only the coefficients of the concrete sample are to be coded.  
Type of Reliability Coefficient 
1 = Internal Consistency, E.g. Cronbach’s  
2 = Split- Halves Reliability 
3 = Test-Retest Reliability 
4 = Parallel Test Reliability 
5 = Mean Value of Several Coefficients 
6 = No Precise Indication 
99 = Other Coefficient 
 
MPs for Reliability Coefficients 
If a reliability coefficient is given, it is placed in the small table. These should be noted at each MP, for as far as 
possible. If several reliability coefficients exist for a MP (eg, Cronbach's alpha and split-half coefficient), only 
report Cronbach’s alpha.  
If only one reliability coefficient is given for the study, cross out other MP boxes.  
If a reliability coefficient is not given, but reference is made to another study, the coefficient from that study should 
be provided in (beneath) the first MP box, with no number given to the MP itself. 
 
Study 
If a reliability coefficient is (or is not) stated, and reference is made to another study, the first three authors and the 
year of publication of the study are stated under “Study”.  
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7 Statistical Analyses and Effect Sizes 
Type of Statistics Provided: _____________________ 
Means, Standard Deviations, and Standard Errors 
T1  N = ______ T2  N = ______ T3  N = ______ T4  N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
T5  N = ______ T6  N = ______ T7  N = ______ T8 N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
 
Coding of the Type of Statistics Provided 
1 = Mean Values, Standard Deviations, Standard Errors 
2 = Correlations 
3 = Regression 
4 = Multilevel Models 
5 = Method with Latent Variables (E.g. Structural Equation Models, Latent Class Models) 
6 = More Data (E.g. Averages and Correlations) 
99 = Other (specify) 
In this table, all the means (M), standard deviations (SD), and standard errors (SE) are given for the dependent 
variable, separately for all measurement times. In addition, the sample size (for which the data refer to) is specified 
for each measurement time (N = _________).  
 
Correlations and Reliabilities 
Type: 
r1     N = _____ r2    N = _____ 
IPQ Reliability MP 
_____ 
IPQ Reliability MP 
_____ 
t1 t2 r p t1 t2 r p Coeff. Items Coeff. Items 
Identity             
Cause (generic)             
Timeline (acute/chronic)             
Timeline Cyclical             
Consequence             
Personal Control             
Treatment Control             
Illness Coherence             
Emotional Representations             
 
287 
 
If correlation coefficients are provided, please include the type of correlation in the top left hand corner of the 
correlation and reliabilities table. 
If cause is included in the data set, provide relevant details in the Final Details box. 
If bivariate correlations between different time points are reported, these can be specified here. N is the size of the 
sample. At t1 and t2 place the relevant MP details. The correlation is given at r. The p-value is given at p.  
If correlation coefficients are provided, regression weights do not need to be recorded. 
If no correlation data is provided, this should be noted in the Final Details box and the Write to Authors box on 
the front page of the coding sheet should be ticked. 
IPQ reliability coefficients for one or two MPs can be entered in this table. If there is only one MP, cross out the 
other MP box.  
For each subscale reported, provide the relevant coefficient at Coeff., and the number of items included in that 
subscale at Items. 
 
Regressions 
 Time 1 Time 2 
 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression Coefficients 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression Coefficients 
  SE df p B SE df p  SE df p B SE df p 
Identity 
                 
Cause 
(generic)                 
Timeline 
(acute/chronic)                 
Timeline Cyclical 
                 
Consequence 
                 
Personal Control 
                 
Treatment Control                 
Illness Coherence 
                 
Emotional 
Representations                 
 
The standardised () and unstandardised (B) regression coefficients should be reported here. In addition, the 
standard error (SE), the degrees of freedom (df) and p-value (p) of the coefficient should be coded.  
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Source of Statistical Information 
 
Page:  __________   Table/Graph: __________________________ 
 
 
In order to find the statistical information quickly, record the page number, and if applicable, the number of the 
table or graph from which the information was collected. If the statistical information was taken from the text, 
enter “text” here. 
 
Moderator Variables: _______   _______   _______   _______   _______   _______   _______ 
 
 
Other Moderator Variables (Authors’ Term): _____________________________________________ 
 
If Moderator Variables of the relationship between Illness Perceptions and Outcomes have been examined, provide 
information here.  
 
Coding of Moderator Variables 
1 = Social Support 
3 = Extraversion 
4 = Neuroticism 
5 = Other Personality Characteristics (E.g. Optimism, Self-Esteem, etc.) 
6 = Previous Experience with Depression/Anxiety 
7 = Socio-Economic Status 
8 = Age 
9 = Number of Other Illnesses 
10 = Coping Strategies 
99 = Other (Specify) 
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8 Concluding Information 
Time for Coding: _________ minutes  
Problems/Comments:  
 
 
 
Study Interpretation: 
 
 
 
 
At the end of coding an article, the time needed for encoding should be noted.  
In addition, there is space for problems and comments. If information is missing, the missing information should 
be listed here. 
Finally, include a brief interpretation of the study in this box. This can be transcribed or taken directly from the 
publication abstract. 
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Appendix 3.4 Coding sheet (Study 2) 
ID No. _______________ Depression/Anxiety Type ______     DV _______ 
 
Comments on the study 
 Study will be Excluded  Write to Authors   Important Comments 
 
General Publication Information 
Article Identification Number (ID-No.): __ __ __ __ __ __ __  Study in Article: _________ 
Coder: ___________  Coding Date ___ / ___ / _______  Time of Day: ___________  
Authors: ________________________________________________  Publication Year: _________ 
Title (first six words): ______________________________________________________________ 
Country of Origin - Author: _________ Other Origin: _______________________________ 
Discipline of the First Author: _________ Other Discipline: _____________________________ 
Publication Found In: ________ Other Place Publication Found: ________________ 
Type of Publication: _____ Other Publication: _______    Citations: ______ Impact: ________   
 
Description of the Study 
Study Type: _________________ IPQ or IPQ-R Dimension: _____________________________ 
Reliability Source: ________ Coefficient Type: ________ Number of Items: ___________ 
Study: _______________________________________________________________________________ 
If Experimental: 
Number of Groups: ______ 
Assignment: _______ 
 
Group a: ______________ 
Group b: ______________ 
 
Group c: ______________ 
Group d: ______________ 
Number of Measurement Points: _________ Year of the First Data Collection:   __________ 
Lag Between Assessments ________:   
MP 2   __________________________________  
MP 3   __________________________________ 
MP 4   __________________________________ 
MP 6   __________________________________ 
MP 7   __________________________________ 
MP 8   __________________________________ 
MP 9   __________________________________  
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Depression/Anxiety and Sample Information 
 
Type of Sample: __________________  
Dep/Anx Type: ______________________________________________________________              
Dep/Anx Duration: M = ____________  SD = ________    Range from _______ to _________         
Age at Onset: M = ____________  SD = ________    Range from _______ to _________         
Treatment Type: ________________ Treatment Stage: __________________________             
 
Sample Size at each Measurement Point: 
MP 1   __________  
MP 2   __________  
MP 3   __________  
MP 4   __________  
 
MP 5   __________  
MP 6   __________  
MP 7   __________  
MP 9   __________  
   
 
 
 
 
 
Total-N: ______________ Retention Rate: _________ %  
Proportion of Men at MP 1:  _______ %  
Age at MP 1:  M = __________ SD = __________ Range from __________ to _________  
Ethnicity: ____  Other Ethnicity: ____  Country of Origin: ____  Other Country of Origin: ____  
 
 
Dependent Variables 
 
No. ______ Did the Study aim to change the Dependent Variable/s?  ________ 
DV Global: _______  DV Name: __________________________________________________ 
Subscale: __________________________ DV (Subscale) Type:___________________ 
Data Source: __________ Additional Info: ______________________________________ 
Instrument: Code: ____________ Number of Items: _____________  
Reliability: Coefficients:  MP ___ MP ___ MP ___ MP ___ MP ___ MP ___ 
Source: _________ Type: ________ _______ _______ _______ _______ _______ _______ 
Study: _______________________________________________________________________________ 
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Statistical Analyses and Effect Sizes 
 
Type of Statistics Provided: ______________________ 
Means, Standard Deviations, and Standard Errors 
T1  N = ______ T2  N = ______ T3  N = ______ T4  N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
T5  N = ______ T6  N = ______ T7  N = ______ T8 N = ______ 
M SD SE M SD SE M SD SE M SD SE 
            
 
Correlations and Reliabilities 
 
Type: 
r1     N = _____ r2    N = _____ 
IPQ Reliability 
MP _____ 
IPQ Reliability 
MP _____ 
t1 t2 r p t1 t2 r p Coeff. Items Coeff. Items 
Identity             
Cause (generic)             
Timeline (acute/chronic)             
Timeline Cyclical             
Consequence             
Personal Control             
Treatment Control             
Illness Coherence             
Emotional Representations             
 
Regression Coefficients 
 
 Time 1 Time 2 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression 
Coefficients 
Standardised 
Regression 
Coefficients 
Unstandardised 
Regression 
Coefficients 
 SE df p B SE df p  SE df p B SE df p 
Identity 
 
                
Cause 
(generic) 
                
Timeline 
(acute/chronic) 
                
Timeline Cyclical 
 
                
Consequence 
 
                
Personal Control 
 
                
Treatment 
Control 
                
Illness 
Coherence 
                
Emotional 
Representations 
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Source of Statistical Information 
 
Page:  __________   Table/Graph: __________________________ 
 
 
Moderator Variables 
Moderator Variables: _______   _______   _______   _______   _______   _______   _______ 
 
 
Other Moderator Variables (Authors’ Term): _____________________________________________ 
 
Final Details 
Time for Coding: _________ Minutes  
Problems/Comments:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Interpretation: 
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Appendix 3.5 Risk of bias assessment table (Study 2) 
Authors (Date) Study Design IPQ, IPQ-R, or B-IPQ: Used 
as recommended 
Dimensions assessed (number of 
items)* 
Correlation 
Analysis 
Adjustment for 
possible confounds 
Meta-Analysis or 
Narrative Review 
Akcakaya (2012) Longitudinal IPQ-R: Yes 
- ‘depression’ substituted for 
‘illness’ 
Timeline - Acute/Chronic (6), Timeline 
- Cyclical (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Illness Coherence (5), 
Emotional Representations (6) 
Pearson’s 
Correlation 
None Meta-Analysis 
Baines, Wittkowski, & 
Wieck (2013) 
Longitudinal IPQ-R: Partially 
- identity and cause scales 
adapted to suit depression  
- one emotional 
representations item removed 
- two additional answer 
options included 
Identity (14), Cause (21)^, Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4), Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (5) 
Spearman’s 
Correlation 
None Meta-Analysis 
Brown, Battista, Sereika, 
Bruehlman, Dunbar-
Jacob, & Thase (2007) 
Cross-sectional IPQ: Partially 
- modified to suit depression 
- cause items were adapted 
following factor analysis 
 
Identity (23), Cause (5), Timeline (3), 
Consequences (7), Controllability (7)  
N/A N/A Narrative Review 
Brown, Dunbar-Jacob, 
Palenchar, Kelleher, 
Bruehlman, Sereika, & 
Thase (2001) 
 
Cross-sectional IPQ: Partially 
- modified to suit depression 
- additional identity and cause 
items included 
Identity (23), Cause (16), Timeline 
(4), Consequences (7), Controllability 
(7) 
Partial 
Correlation 
Depression Severity Meta-Analysis 
Cabassa, Lagomasino, 
Dwight-Johnson, 
Hansen, & Xie (2008) 
Cross-sectional IPQ-R: Partially 
- modified to suit depression 
- ‘depression’ substituted for 
‘illness’ 
 
Timeline - Acute/Chronic (6), Timeline 
- Cyclical (4), Consequences (6), 
Personal Control (4), Treatment 
Control (4) 
 
Unspecified 
Correlation 
None Meta-Analysis 
Elwy, Glickman, 
Bokhour, Dell, Mueller, 
Zhao, Osei-Bonsu, 
Rodrigues, Coldwell, 
Ngo, Schlosser, 
Vielhauer, Pirraglia, & 
Eisen (2013) 
Longitudinal IPQ-R: No 
- Factor analysis was 
undertaken for all items to 
create new subscales 
Identity (23 - 5 subscales), Cause (26 - 
7 subscales), Timeline - Acute (3) 
Timeline - Chronic (3), Timeline - 
Cyclical (3), Consequences (5), 
Personal Control (7), Treatment 
Control (3), External Control (4) 
Illness Coherence (5), Emotional 
Representations (5) 
N/A N/A Narrative Review 
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Elwy, Yeh, Worcester, & 
Eisen (2011) 
 
Qualitative CSM Generally:  
- Qualitative Interview 
CSM Generally N/A N/A Narrative Review 
Fortune, Barrowclough, 
& Lobban (2004) 
Cross-sectional IPQ: Yes 
- ‘depression’ substituted for 
‘illness’ 
- identity items were adapted 
to suit depression 
 
Identity (14), Cause (11)^, Timeline 
(4), Consequences (7), Control/Cure 
(6) 
Pearson’s 
Correlation 
None Meta-Analysis 
Glattacker, Heyduck, & 
Meffert (2013) 
Longitudinal IPQ-R: Yes 
- ‘depression’ substituted for 
‘illness’ 
- identity items were adapted 
to suit depression 
- German version 
 
Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None 
 
Meta-Analysis 
Horn, Kneisler, Schuster, 
& Traue (2010) 
Longitudinal IPQ-R: Yes 
- German version 
Cause^, Timeline - Acute/Chronic (6), 
Timeline - Cyclical (4), Consequences 
(6), Personal Control (6), Treatment 
Control (5), Illness Coherence (5), 
Emotional Representations (6) 
 
Unspecified 
Correlation 
None Meta-Analysis 
Houle, Villaggi, 
Beaulieu, Lespérance, 
Rondeau, & Lambert 
(2013) 
Cross-sectional IPQ-R: Yes 
- ‘depression’ substituted for 
‘illness’ 
- cause items were adapted 
following factor analysis 
Cause (18)^, Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Hunot, Horne, Leese, & 
Churchill (2007) 
Longitudinal IPQ-R: Yes IPQ-R: Identity (14), Cause (18), 
Timeline - Acute/Chronic (6), Timeline 
- Cyclical (4), Consequences (6), 
Personal Control (6), Treatment 
Control (5), Illness Coherence (5), 
Emotional Representations (6) 
 
N/A N/A Narrative Review 
Kelly, Sereika, Battista, 
& Brown (2007) 
Cross-sectional IPQ: Yes 
- cause items were adapted 
following factor analysis 
Identity (14), Cause (23), Timeline (6), 
Consequences (7), Control/Cure (7), 
Emotional Reactions (9) 
N/A N/A Narrative Review 
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Lu, Tang, Shan Liow, 
Wei Ni Ng, Su Hui Ho, 
& Chun Mun Ho (2014) 
Cross-sectional IPQ-R: Partially 
- modified to suit depression 
Identity (14), Timeline - Acute/Chronic 
(6), Timeline - Cyclical (4), 
Consequences (6), Personal Control 
(6), Treatment Control (5), Illness 
Coherence (5), Emotional 
Representations (6) 
 
Pearson’s 
Correlation 
None Meta-Analysis 
Mc Sharry, Bishop, 
Moss-Morris, & 
Kendrick (2013) 
 
Qualitative CSM Generally:  
- Qualitative Interview 
CSM Generally N/A N/A Narrative Review 
O'Mahen, Flynn, 
Chermack, & Marcus 
(2009) 
Longitudinal IPQ: No 
- Perinatal depression specific 
items were added to several 
subscales 
 
Cause (10), Timeline (3), 
Consequences (8), Control/Cure (8) 
N/A N/A Narrative Review 
Patel, Wittkowski, Fox, 
& Wieck (2013) 
Qualitative CSM Generally:  
- Qualitative Interview 
 
CSM Generally N/A N/A Narrative Review 
Vollmann, Scharloo, 
Salewski, Dienst, 
Schonauer, & Renner 
(2010) 
Cross-sectional IPQ-R: Partially 
- modified to suit depression 
- identity and cause scales 
adapted to suit depression  
Identity (24)^, Cause (19), Timeline - 
Acute/Chronic (6), Timeline - Cyclical 
(4)^, Consequences (6), Personal 
Control (6), Treatment Control (5), 
Illness Coherence (5), Emotional 
Representations (6) 
 
Profile 
Correlation 
None Meta-Analysis 
Ward, Mengesha, & Issa 
(2014) 
Qualitative CSM Generally:  
- Qualitative Interview 
 
CSM Generally N/A N/A Narrative Review 
Note: *Dimensions that appear are in bold were assessed by authors but not reported by authors for some outcomes; ^ = items were measured but not assessed 
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Appendix 3.6 Risk of bias assessment and figure (Study 2)     
Study 
Risk of Bias from 
IPQ Use (Yes vs. 
Partially vs. No) 
Risk of Bias from 
Design (Cross-sectional 
vs. Longitudinal) 
Adjustment for 
Confounds (Yes 
vs. No) 
Assessing and Reporting of IPQ Dimensions 
(Assessed and Reported vs. Assessed and Not 
Reported vs. Measured and Not Assessed) 
- Akcakaya (2012) 1 1 2 1 
- Baines, Wittkowski, & Wieck 
(2013) 
2 1 2 3 
- Brown, Battista, Sereika, 
Bruehlman, Dunbar-Jacob, & 
Thase (2007) 
2 2 2 1 
- Brown, Dunbar-Jacob, 
Palenchar, Kelleher, Bruehlman, 
Sereika, & Thase (2001) 
2 2 1 2 
- Cabassa, Lagomasino, Dwight-
Johnson, Hansen, & Xie (2008) 
2 2 2 1 
- Elwy, Glickman, Bokhour, 
Dell, Mueller, Zhao, Osei-
Bonsu, Rodrigues, Coldwell, 
Ngo, Schlosser, Vielhauer, 
Pirraglia, & Eisen (2013) 
3 1 2 1 
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- Elwy, Yeh, Worcester, & Eisen 
(2011) 
3 3 2 1 
- Fortune, Barrowclough, & 
Lobban (2004) 
1 2 2 3 
- Glattacker, Heyduck, & 
Meffert (2013) 
1 1 2 1 
- Horn, Kneisler, Schuster, & 
Traue (2010) 
1 1 2 3 
- Houle, Villaggi, Beaulieu, 
Lespérance, Rondeau, & 
Lambert (2013) 
1 2 2 3 
- Hunot, Horne, Leese, & 
Churchill (2007) 
1 1 2 1 
- Kelly, Sereika, Battista, & 
Brown (2007) 
1 2 2 1 
- Lu, Tang, Shan Liow, Wei Ni 
Ng, Su Hui Ho, & Chun Mun 
Ho (2014) 
2 2 2 1 
- Mc Sharry, Bishop, Moss-
Morris, & Kendrick (2013) 
3 3 2 1 
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- O'Mahen, Flynn, Chermack, & 
Marcus (2009) 
3 1 2 1 
- Patel, Wittkowski, Fox, & 
Wieck (2013) 
3 3 2 1 
- Vollmann, Scharloo, Salewski, 
Dienst, Schonauer, & Renner 
(2010) 
2 2 2 3 
- Ward, Mengesha, & Issa 
(2014) 
3 3 2 1 
     
Key:     
 
1 = Yes used IPQ 
as recommended 
1 = Longitudinal 1 = Adjusted for 
Confounds 
1 = Assessed and Reported all measured IPQ 
Dimensions 
 
2 = Partially used 
IPQ as 
recommended 
2 = Cross-Sectional 2 = Did not adjust 
for Confounds 
2 = Assessed but did not Report all measured 
IPQ Dimensions 
 
 
 
 
3 = Did not use 
IPQ as 
recommended (or 
qual study) 
3 = Qualitative  3 = Did not Assess nor Report all measured IPQ 
Dimensions 
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Scores:     
 
Risk of Bias from 
IPQ Use 
Risk of Bias from 
Design 
Risk of Bias from 
Confounds 
Risk of Bias from IPQ Assessing and Reporting 
Low 36.84210526 36.84211 5.263158 68.4211 
Medium 31.57894737 42.10526 94.73684 5.26316 
High 31.57894737 21.05263 0 26.3158 
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Appendix 3.7 Meta-analysis forest plots between illness representations and coping and illness representations and psychological distress (Study 
2) 
 
Note: See page 302 for the key to each study code. 
 
 
   
Figure 1. Coping and Cause     Figure 2. Coping and Acute/Chronic Timeline              Figure 3. Coping and Consequences 
 
 
 
 
 
Figure 4. Coping and Personal Control    Figure 5. Coping and Treatment Control                 Figure 6. Coping and Illness Coherence 
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Figure 7. Coping and Emotional Representations   Figure 8. Psychological Distress and Identity                 Figure 9. Psychological Distress and Acute/Chronic Timeline 
 
Figure 10. Psychological Distress and Cyclical Timeline  Figure 11. Psychological Distress and Consequences   Figure 12. Psychological Distress and Personal Control 
 
Figure 13. Psychological Distress and Treatment Control  Figure 14. Psychological Distress and Illness Coherence          Figure 15. Psychological Distress and Emotional Representations 
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Study codes with associated authors and dates 
Study Code Authors (Date) 
ACK12XX Akcakaya (2012) 
BAI13WI Baines, Wittkowski, & Wieck (2013) 
BRO01DU Brown, Dunbar-Jacob, Palenchar, Kelleher, Bruehlman, Sereika, & Thase (2001) 
CAB08LA Cabassa, Lagomasino, Dwight-Johnson, Hansen, & Xie (2008) 
FOR04BA Fortune, Barrowclough, & Lobban (2004) 
GLA13HE Glattacker, Heyduck, & Meffert (2013) 
HOR10KN Horn, Kneisler, Schuster, & Traue (2010) 
HOU13VI Houle, Villaggi, Beaulieu, Lespérance, Rondeau, & Lambert (2013) 
LUX14TA Lu, Tang, Shan Liow, Wei Ni Ng, Su Hui Ho, & Chun Mun Ho (2014) 
VOL10SC Vollmann, Scharloo, Salewski, Dienst, Schonauer, & Renner (2010) 
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Appendix 3.8 Meta-analysis funnel plots between illness representations and coping and illness representations and psychological distress 
(Study 2) 
 
 
   
 Figure 1. Coping and Cause      Figure 2. Coping and Acute/Chronic Timeline    Figure 3. Coping and Consequences 
 
 
 
 
   
Figure 4. Coping and Personal Control    Figure 5. Coping and Treatment Control     Figure 6. Coping and Illness Coherence 
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Figure 7. Coping and Emotional Representations   Figure 8. Psychological Distress and Identity                 Figure 9. Psychological Distress and Acute/Chronic Timeline 
   
Figure 10. Psychological Distress and Cyclical Timeline  Figure 11. Psychological Distress and Consequences   Figure 12. Psychological Distress and Personal Control 
   
Figure 13. Psychological Distress and Treatment Control  Figure 14. Psychological Distress and Illness Coherence          Figure 15. Psychological Distress and Emotional Representations
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Appendix 4.1 Interview guide (Study 3 and Study 4) 
 
Interviewee Number and Codes: 
Interviewer: 
 
Introductory Information: 
Introductions are made… 
Information Sheet 
Consent Forms 
Before we get started I would like to ask you if you have any issues with the recording of 
today’s interview. The recording of the interview is important so that all relevant information 
can be documented. After I have completed interviewing I will be transcribing the audio 
tapes into a written format. Please be advised that following this transcription all audio tapes 
will be destroyed and transcripts will be coded to preserve anonymity.  
 
Interviewee Background and Demographics: 
I would now like you to fill out this short questionnaire which asks you some general 
information about yourself and your illnesses. 
There are some questions about your illness in the questionnaire that we might revisit later in 
the interview. 
 
[NOTE: The indented questions are follow-up questions and don’t need to be asked if 
participants already talked about this content] 
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Questions: 
 
Can you tell me about your health? 
 
Cancer Related Questions: 
Could you please tell me about your cancer? 
 Perhaps you could start by telling me when and how you were diagnosed with cancer? 
 How did you feel when you first found out you had cancer? 
 Did being diagnosed and given the label of cancer help? 
Could you describe/explain your cancer to me? 
 Do you feel you have a good understanding of cancer? 
 Does your illness ‘make sense’ to you? 
Can you tell me about the symptoms of your cancer? 
Do you have any thoughts about what may have caused your cancer? 
 What are these?  
Do you perceive your cancer to be an acute (short-term), chronic (long-term), or cyclic 
(comes and goes) condition? 
 In the past and in the future 
What do you perceive to be the consequences of your cancer? 
 How does cancer impact your life (every-day life)? 
How has cancer changed your life? 
Does it affect your career/relationships? 
What can be done to help your cancer (if anything)?  
 How much control do you feel you have over your cancer? 
 How much control do you feel others have over your cancer? 
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How much worry or stress does your cancer cause you? 
What do you do to treat your cancer? What treatment have you received in the past and what 
treatment are you currently receiving? 
 How much control do you feel your treatment has over your cancer? 
 How much control do you feel you have over your treatment?  
 How easy or difficult do you find it to adhere to your treatment regime and/or 
medication requirements? 
What do you do to cope with your cancer? 
 What coping strategies do you use? (Practical? Social Support?) 
Is there anything else you would like to tell me about your cancer? 
 
Anxiety Related Questions: 
Are you currently or have you ever been diagnosed or treated for anxiety? 
 When and how were you diagnosed with or treated for anxiety? 
How did you feel when you first found out you had anxiety? 
Did being diagnosed and given the label of anxiety help? 
Could you describe/explain your anxiety to me? 
 Do you feel you have a good understanding of anxiety? 
 Does your illness ‘make sense’ to you? 
Can you tell me about the symptoms of your anxiety? 
Do you have any thoughts about what may have caused your anxiety? 
 What are these?  
Do you perceive your anxiety to be an acute (short-term), chronic (long-term), or cyclic 
(comes and goes) condition? 
 In the past and in the future 
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What do you perceive to be the consequences of your anxiety? 
 How does anxiety impact your life (every-day life)? 
How has anxiety changed your life? 
Does it affect your career/relationships? 
What can be done to help your anxiety (if anything)?  
 How much control do you feel you have over your anxiety? 
 How much control do you feel others have over your anxiety? 
How much worry or stress does your anxiety cause you? 
What do you do to treat your anxiety? What treatment have you received in the past and what 
treatment are you currently receiving? 
 How much control do you feel your treatment has over your anxiety? 
 How much control do you feel you have over your treatment? 
 How easy or difficult do you find it to adhere to your treatment regime and/or 
medication requirements? 
What do you do to cope with your anxiety? 
 What coping strategies do you use? (Practical? Social Support?) 
Is there anything else you would like to tell me about your anxiety? 
 
Depression Related Questions: 
Are you currently or have you ever been diagnosed or treated for depression? 
 When and how were you diagnosed with or treated for depression? 
 How did you feel when you first found out you had depression? 
 Did being diagnosed and given the label of depression help? 
Could you describe/explain your depression to me? 
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 Do you feel you have a good understanding of depression? 
 Does your illness ‘make sense’ to you? 
Can you tell me about the symptoms of your depression? 
Do you have any thoughts about what may have caused your depression? 
 What are these?  
Do you perceive your depression to be an acute (short-term), chronic (long-term), or cyclic 
(comes and goes) condition? 
 In the past and in the future 
What do you perceive to be the consequences of your depression? 
 How does depression impact your life (every-day life)? 
How has depression changed your life? 
Does it affect your career/relationships? 
What can be done to help your depression (if anything)?  
 How much control do you feel you have over your depression? 
 How much control do you feel others have over your depression? 
How much worry or stress does your depression cause you? 
What do you do to treat your depression? What treatment have you received in the past and 
what treatment are you currently receiving? 
 How much control do you feel your treatment has over your depression? 
 How much control do you feel you have over your treatment? 
 How easy or difficult do you find it to adhere to your treatment regime and/or 
medication requirements? 
What do you do to cope with your depression? 
 What coping strategies do you use? (Practical? Social Support?) 
Is there anything else you would like to tell me about your depression? 
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Other Chronic Illness Related Questions: 
Please tell me about any other health conditions you have 
When was the condition diagnosed?  
Are you receiving treatment for that condition?  
 What kind of treatment are you receiving? 
What do you do to cope with these other illnesses? 
 What coping strategies do you use? (Practical? Social Support?) 
  
Multimorbidity and Other Questions: 
How have your thoughts about your health changed over time? 
 
What is it like for you to have both cancer and anxiety? 
 Do you think one affects (or even caused) the other? 
 Does having both make things better or worse? 
 How does having both conditions affect your medication or treatment adherence? 
 Is one more challenging than another? 
 Would you prioritise one condition over another? 
 
What is it like for you to have both cancer and depression? 
Do you think one affects (or even caused) the other? 
Does having both make things better or worse? 
Is one more challenging than another? 
 Would you prioritise one condition over another? 
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What is it like for you to have cancer, anxiety and depression? 
 Do you think one affects (or even caused) the other? 
Does having all three make things better or worse? 
Is one more challenging than another? 
 Would you prioritise one condition over another? 
 
What is it like for you to have a number of different health conditions? 
 Do they affect (or even cause) each other? 
 Does having multiple health conditions make things better or worse? 
 Is one more challenging than another? 
 Would you prioritise one condition over another? 
 
Is there anything else you would like to tell me about? 
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COREQ (COnsolidated criteria for REporting Qualitative research) Checklist 
A checklist of items that should be included in reports of qualitative research. You must report the page number in your manuscript 
where you consider each of the items listed in this checklist. If you have not included this information, either revise your manuscript 
accordingly before submitting or note N/A. 
Topic Item No. Guide Questions/Description Reported on 
Page No. 
Domain 1: Research team 
and reﬂexivity 
Personal characteristics 
Interviewer/facilitator 1 Which author/s conducted the interview or focus group? 82-83 
Credentials 2 What were the researcher’s credentials? E.g. PhD, MD 83 
Occupation 3 What was their occupation at the time of the study? 83 
Gender 4 Was the researcher male or female? 83 
Experience and training 5 What experience or training did the researcher have? 83 
Relationship with 
participants 
Relationship established 6 Was a relationship established prior to study commencement? 82 
Participant knowledge of 
the interviewer 
7 What did the participants know about the researcher? e.g. personal 
goals, reasons for doing the research 
82 
Interviewer characteristics 8 What characteristics were reported about the inter viewer/facilitator? 
e.g. Bias, assumptions, reasons and interests in the research topic 
82 
Domain 2: Study design 
Theoretical framework 
Methodological orientation 
and Theory 
9 What methodological orientation was stated to underpin the study? e.g. 
grounded theory, discourse analysis, ethnography, phenomenology, 
content analysis 
83 
Participant selection 
Sampling 10 How were participants selected? e.g. purposive, convenience, 
consecutive, snowball 
81 
Method of approach 11 How were participants approached? e.g. face-to-face, telephone, mail, 
email 
82 
Sample size 12 How many participants were in the study? 84 
Non-participation 13 How many people refused to participate or dropped out? Reasons? 84 
Setting 
Setting of data collection 14 Where was the data collected? e.g. home, clinic, workplace 83 
Presence of non- 
participants 
15 Was anyone else present besides the participants and researchers? 
83 
Description of sample 16 What are the important characteristics of the sample? e.g. demographic 
data, date 
84, Table 4.1, 
App 4.3 
Data collection 
Interview guide 17 Were questions, prompts, guides provided by the authors? Was it pilot 
tested? 
82, App 4.1 
Repeat interviews 18 Were repeat inter views carried out? If yes, how many? N/A 
Audio/visual recording 19 Did the research use audio or visual recording to collect the data? 83 
Field notes 20 Were ﬁeld notes made during and/or after the interview or focus group? 83 
Duration 21 What was the duration of the inter views or focus group? 83 
Data saturation 22 Was data saturation discussed? 82 
Transcripts returned 23 Were transcripts returned to participants for comment and/or 83 
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Topic Item No. Guide Questions/Description Reported on 
Page No. 
  correction?  
Domain 3: analysis and 
ﬁndings 
Data analysis 
Number of data coders 24 How many data coders coded the data? 84 
Description of the coding 
tree 
25 Did authors provide a description of the coding tree? 84, 86,   
Figure 4.1 
Derivation of themes 26 Were themes identiﬁed in advance or derived from the data? 83-84 
Software 27 What software, if applicable, was used to manage the data? 83 
Participant checking 28 Did participants provide feedback on the ﬁndings? 84 
Reporting 
Quotations presented 29 Were participant quotations presented to illustrate the themes/ﬁndings? 
Was each quotation identiﬁed? e.g. participant number 
86, 88-96 
Data and ﬁndings consistent 30 Was there consistency between the data presented and the ﬁndings? 86-103 
Clarity of major themes 31 Were major themes clearly presented in the ﬁndings? 84, 86-96 
Clarity of minor themes 32 Is there a description of diverse cases or discussion of minor themes? 86-96 
 
Developed from: Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item 
checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007. Volume 19, Number 6: pp. 349 
– 357 
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Appendix 4.3 Demographics and DASS-21 Stress subscale scores (Study 3) 
 
Characteristic Characteristic Sub-Categories N (%) 
Country of Birth  Australia 16 (76.2%) 
 New Zealand 1 (4.8%) 
 United Kingdom 4 (19.0%) 
Education (highest level obtained) Year 9 or Below 1 (4.8%) 
 Year 10 2 (9.5%) 
 Year 12 2 (9.5%) 
 Certificate 5 (23.8%) 
 Diploma 3 (14.3%) 
 Undergraduate Degree 5 (23.8%) 
 Post-Graduate Degree 3 (14.3%) 
Employment Status Paid Full-Time Work 2 (9.5%) 
 Paid Part-Time Work 2 (9.5%) 
 Paid Casual Work 2 (9.5%) 
 Retired 6 (28.6%) 
 Not Working Due to Health 6 (28.6%) 
 Job Seeker 1 (4.8%) 
 Other 2 (9.5%) 
Relationship Status Married 10 (47.6%) 
 Divorced 1 (4.8%) 
 Separated 1 (4.8%) 
 De-facto Relationship 4 (19.0%) 
 Single 5 (23.8%) 
DASS-21 Subscale Subscale Ratings N (%) 
Stress Normal 4 (19.0%) 
 Mild 0 (0.0%) 
 Moderate 1 (4.8%) 
 Severe 8 (38.1%) 
 Extremely Severe 8 (38.1%) 
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Appendix 5.1 Additional methodological information (Study 4) 
 
Information power was used to determine the sample size for this study (Malterud, 
Siersma, Guassora, 2015). It provides clear criteria for ascertaining appropriate sample sizes 
in qualitative research while addressing some of the limitations associated with the use of 
saturation (Glaser & Strauss, 2009; Malterud et al., 2015). The sample size for this study was 
ascertained based on its neither especially broad nor narrow aims, the inclusion of 
participants specific to the research aim (based on meeting inclusion criteria), strong rapport 
and interview dialogue between ER and participants (due to a strong knowledge of the 
theoretical background and previous experience working with cancer patients), and the use of 
cross-case analysis.  
Following recruitment and meeting of recruitment criteria, participants were invited to 
participate in the study. Participants were informed of the purpose of the study, as well as the 
researchers’ reasons for completing it (to increase understanding of cancer patients’ thoughts 
and experiences with a view to improving support service provision) at this early stage. 
Relationships were generally not established prior to study commencement, though six 
participants were known to the interviewer through support work with Cancer Council 
Tasmania. Field notes were not taken during interviews to maintain rapport and trust between 
interviewer and participant. Further, although participants were not offered a chance to 
review transcripts or provide feedback on identified themes, they were given an opportunity 
to request to be sent any research output or publications arising from the research.  
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COREQ (COnsolidated criteria for REporting Qualitative research) Checklist 
A checklist of items that should be included in reports of qualitative research. You must report the page number in your manuscript 
where you consider each of the items listed in this checklist. If you have not included this information, either revise your manuscript 
accordingly before submitting or note N/A. 
Topic Item No. Guide Questions/Description Reported on 
Page No. 
Domain 1: Research team 
and reﬂexivity 
Personal characteristics 
Interviewer/facilitator 1 Which author/s conducted the interview or focus group? 109 
Credentials 2 What were the researcher’s credentials? E.g. PhD, MD 109 
Occupation 3 What was their occupation at the time of the study? 109 
Gender 4 Was the researcher male or female? 109 
Experience and training 5 What experience or training did the researcher have? 109 
Relationship with 
participants 
Relationship established 6 Was a relationship established prior to study commencement? App 5.1 
Participant knowledge of 
the interviewer 
7 What did the participants know about the researcher? e.g. personal 
goals, reasons for doing the research 
App 5.1 
Interviewer characteristics 8 What characteristics were reported about the inter viewer/facilitator? 
e.g. Bias, assumptions, reasons and interests in the research topic 
109, App 5.1 
Domain 2: Study design 
Theoretical framework 
Methodological orientation 
and Theory 
9 What methodological orientation was stated to underpin the study? e.g. 
grounded theory, discourse analysis, ethnography, phenomenology, 
content analysis 
109 
Participant selection 
Sampling 10 How were participants selected? e.g. purposive, convenience, 
consecutive, snowball 
108 
Method of approach 11 How were participants approached? e.g. face-to-face, telephone, mail, 
email 
108 
Sample size 12 How many participants were in the study? 110-111 
Non-participation 13 How many people refused to participate or dropped out? Reasons? 110-111 
Setting 
Setting of data collection 14 Where was the data collected? e.g. home, clinic, workplace 109 
Presence of non- 
participants 
15 Was anyone else present besides the participants and researchers? 
109 
Description of sample 16 What are the important characteristics of the sample? e.g. demographic 
data, date 
110-113, 
Table 5.2 
Data collection 
Interview guide 17 Were questions, prompts, guides provided by the authors? Was it pilot 
tested? 
108, App 4.1 
Repeat interviews 18 Were repeat inter views carried out? If yes, how many? N/A 
Audio/visual recording 19 Did the research use audio or visual recording to collect the data? 109 
Field notes 20 Were ﬁeld notes made during and/or after the interview or focus group? App 5.1 
Duration 21 What was the duration of the interviews or focus group? 109 
Data saturation 22 Was data saturation discussed? 108, App 5.1 
Transcripts returned 23 Were transcripts returned to participants for comment and/or App 5.1 
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Topic Item No. Guide Questions/Description Reported on 
Page No. 
  correction?  
Domain 3: analysis and 
ﬁndings 
Data analysis 
Number of data coders 24 How many data coders coded the data? 109-110 
Description of the coding 
tree 
25 Did authors provide a description of the coding tree? 113-114, 
Figure 5.1 
Derivation of themes 26 Were themes identiﬁed in advance or derived from the data? 109 
Software 27 What software, if applicable, was used to manage the data? 109 
Participant checking 28 Did participants provide feedback on the ﬁndings? App 5.1 
Reporting 
Quotations presented 29 Were participant quotations presented to illustrate the themes/ﬁndings? 
Was each quotation identiﬁed? e.g. participant number 
113, 115-117 
Data and ﬁndings consistent 30 Was there consistency between the data presented and the ﬁndings? 113-121 
Clarity of major themes 31 Were major themes clearly presented in the ﬁndings? 113-117 
Clarity of minor themes 32 Is there a description of diverse cases or discussion of minor themes? 113, 115-117 
 
Developed from: Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item 
checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007. Volume 19, Number 6: pp. 349 
– 357 
 
 
 
 
 
